<!DOCTYPE html>
 <!--[if lt IE 7]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9 lt-ie8 lt-ie7"> <![endif]--> <!--[if IE 7]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9 lt-ie8"> <![endif]--> <!--[if IE 8]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9"> <![endif]--> <!--[if gt IE 8]><!--> <html class="aui ltr" dir="ltr" lang="en-US" prefix="og: http://ogp.me/ns#"> <!--<![endif]--> <head> <title>Nutritional supplements for people being treated for active tuberculosis - Grobler, L - 2016 | Cochrane Library</title> <meta content="Nutritional supplements for people being treated for active tuberculosis - Grobler, L - 2016 | Cochrane Library" property="og:title"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD006086.pub4/full" property="og:url"/> <meta content="article" property="og:type"/> <meta content="https://www.cochranelibrary.com/cochrane-theme/images/cochrane_circulargraphic.png" property="og:image"/> <meta content="summary_large_image" name="twitter:card"/> <meta content="Nutritional supplements for people being treated for active tuberculosis - Grobler, L - 2016 | Cochrane Library" name="twitter:title"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD006086.pub4/full" name="twitter:url"/> <meta content="https://www.cochranelibrary.com/cochrane-theme/images/cochrane_circulargraphic.png" name="twitter:image"/> <meta content="initial-scale=1.0, width=device-width" name="viewport"/> <meta content="10.1002/14651858.CD006086.pub4" name="dc.identifier" scheme="DOI"/> <meta content="Nutritional supplements for people being treated for active tuberculosis" name="citation_title"/> <meta content="Liesl Grobler" name="citation_author"/> <meta content="Stellenbosch University" name="citation_author_institution"/> <meta content="Sukrti Nagpal" name="citation_author"/> <meta content="Liverpool School of Tropical Medicine" name="citation_author_institution"/> <meta content="Thambu D Sudarsanam" name="citation_author"/> <meta content="Christian Medical College" name="citation_author_institution"/> <meta content="David Sinclair" name="citation_author"/> <meta content="Liverpool School of Tropical Medicine" name="citation_author_institution"/> <meta content="david.sinclair@lstmed.ac.uk" name="citation_author_email"/> <meta content="Cochrane Database of Systematic Reviews" name="citation_journal_title"/> <meta content="John Wiley &amp; Sons, Ltd" name="citation_publisher"/> <meta content="6" name="citation_issue"/> <meta content="10.1002/14651858.CD006086.pub4" name="citation_doi"/> <meta content="2016" name="citation_date"/> <meta content="2016/06/29" name="citation_online_date"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD006086.pub4/abstract" name="citation_abstract_html_url"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD006086.pub4/full" name="citation_fulltext_html_url"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD006086.pub4/pdf/full" name="citation_pdf_url"/> <meta content="1465-1858" name="citation_issn"/> <meta content="en" name="citation_language"/> <meta content="*Dietary Supplements; Antitubercular Agents [therapeutic use]; Energy Intake; HIV Infections [complications, mortality]; Malnutrition [complications, *diet therapy]; Micronutrients [administration &amp; dosage]; Randomized Controlled Trials as Topic; Tuberculosis [complications, *diet therapy, drug therapy, mortality]" name="citation_keywords"/> <meta content="" name="citation_fulltext_world_readable"/> <link href="https://fonts.googleapis.com/css?family=Source+Sans+Pro:400,700,600,900" rel="stylesheet"/> <script src="https://cmp.osano.com/AzZdRbSORDOOzF9W/d594efc1-9663-477d-9528-6576640e64fd/osano.js"></script> <style> .osano-cm-widget{display: none;} </style> <script src="https://static.addtoany.com/menu/page.js"></script> <script async="" charset="utf-8" src="https://platform.twitter.com/widgets.js"></script> <script async="async" src="//script.crazyegg.com/pages/scripts/0056/6375.js" type="text/javascript"></script> <script type="text/javascript">window.dataLayer={};var xtend=function(){var a={};var b=false;var c=0;var d=arguments.length;if(Object.prototype.toString.call(arguments[0])==="[object Boolean]"){b=arguments[0];c++}var f=function(g){for(var h in g){if(Object.prototype.hasOwnProperty.call(g,h)){if(b&&Object.prototype.toString.call(g[h])==="[object Object]"){a[h]=xtend(true,a[h],g[h])}else{a[h]=g[h]}}}};for(;c<d;c++){var e=arguments[c];f(e)}return a};</script> <!-- Global site tag (gtag.js) - Google Analytics --> <script src="https://www.googletagmanager.com/gtag/js?id=UA-189672-63&amp;l=gDataLayer"></script> <script>window.gDataLayer=window.gDataLayer||[];function gtag(){gDataLayer.push(arguments)}gtag("js",new Date());gtag("config","UA-189672-63");</script> <script type="text/javascript">var o={auth:{customerIds:[],individualId:null,brandedCustomer:null,roles:["Guest"]}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <script type="text/javascript">var o={page:{siteSection:"Content",languageCode:"en",cms:{pageTitle:"Content"}}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <meta content="text/html; charset=utf-8" http-equiv="content-type"/> <link href="https://www.cochranelibrary.com/cochrane-theme/images/favicon.ico" rel="Shortcut Icon"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD006086.pub4&amp;doi=10.1002/14651858.CD006086.pub4&amp;type=cdsr&amp;contentLanguage=" rel="canonical"/> <link href="https://www.cochranelibrary.com/zh/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD006086.pub4&amp;doi=10.1002/14651858.CD006086.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="zh-HANS" rel="alternate"/> <link href="https://www.cochranelibrary.com/zh_HANT/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD006086.pub4&amp;doi=10.1002/14651858.CD006086.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="zh-HANT" rel="alternate"/> <link href="https://www.cochranelibrary.com/hr/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD006086.pub4&amp;doi=10.1002/14651858.CD006086.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="hr-HR" rel="alternate"/> <link href="https://www.cochranelibrary.com/nl/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD006086.pub4&amp;doi=10.1002/14651858.CD006086.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="nl-NL" rel="alternate"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD006086.pub4&amp;doi=10.1002/14651858.CD006086.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="x-default" rel="alternate"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD006086.pub4&amp;doi=10.1002/14651858.CD006086.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="en-US" rel="alternate"/> <link href="https://www.cochranelibrary.com/fr/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD006086.pub4&amp;doi=10.1002/14651858.CD006086.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="fr-FR" rel="alternate"/> <link href="https://www.cochranelibrary.com/de/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD006086.pub4&amp;doi=10.1002/14651858.CD006086.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="de-DE" rel="alternate"/> <link href="https://www.cochranelibrary.com/hi/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD006086.pub4&amp;doi=10.1002/14651858.CD006086.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="hi-HI" rel="alternate"/> <link href="https://www.cochranelibrary.com/hu/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD006086.pub4&amp;doi=10.1002/14651858.CD006086.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="hu-HU" rel="alternate"/> <link href="https://www.cochranelibrary.com/in/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD006086.pub4&amp;doi=10.1002/14651858.CD006086.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="in-ID" rel="alternate"/> <link href="https://www.cochranelibrary.com/ja/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD006086.pub4&amp;doi=10.1002/14651858.CD006086.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="ja-JP" rel="alternate"/> <link href="https://www.cochranelibrary.com/ko/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD006086.pub4&amp;doi=10.1002/14651858.CD006086.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="ko-KR" rel="alternate"/> <link href="https://www.cochranelibrary.com/ms/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD006086.pub4&amp;doi=10.1002/14651858.CD006086.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="ms-MY" rel="alternate"/> <link href="https://www.cochranelibrary.com/fa/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD006086.pub4&amp;doi=10.1002/14651858.CD006086.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="fa-IR" rel="alternate"/> <link href="https://www.cochranelibrary.com/pl/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD006086.pub4&amp;doi=10.1002/14651858.CD006086.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="pl-PL" rel="alternate"/> <link href="https://www.cochranelibrary.com/pt/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD006086.pub4&amp;doi=10.1002/14651858.CD006086.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="pt-PT" rel="alternate"/> <link href="https://www.cochranelibrary.com/ro/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD006086.pub4&amp;doi=10.1002/14651858.CD006086.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="ro-RO" rel="alternate"/> <link href="https://www.cochranelibrary.com/ru/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD006086.pub4&amp;doi=10.1002/14651858.CD006086.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="ru-RU" rel="alternate"/> <link href="https://www.cochranelibrary.com/es/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD006086.pub4&amp;doi=10.1002/14651858.CD006086.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="es-ES" rel="alternate"/> <link href="https://www.cochranelibrary.com/ta/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD006086.pub4&amp;doi=10.1002/14651858.CD006086.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="ta-IN" rel="alternate"/> <link href="https://www.cochranelibrary.com/th/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD006086.pub4&amp;doi=10.1002/14651858.CD006086.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="th-TH" rel="alternate"/> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734739000" rel="stylesheet" type="text/css"/> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/aui.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734739000" rel="stylesheet" type="text/css"/> <link href="/html/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739773519000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/scolaris-content-display/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/notifications-portlet/notifications/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/html/portlet/login/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739773548000" rel="stylesheet" type="text/css"/> <script type="text/javascript">var Liferay={Browser:{acceptsGzip:function(){return false},getMajorVersion:function(){return 80},getRevision:function(){return"537.36"},getVersion:function(){return"80.0"},isAir:function(){return false},isChrome:function(){return true},isFirefox:function(){return false},isGecko:function(){return true},isIe:function(){return false},isIphone:function(){return false},isLinux:function(){return true},isMac:function(){return false},isMobile:function(){return false},isMozilla:function(){return false},isOpera:function(){return false},isRtf:function(){return true},isSafari:function(){return true},isSun:function(){return false},isWap:function(){return false},isWapXhtml:function(){return false},isWebKit:function(){return true},isWindows:function(){return false},isWml:function(){return false}},Data:{NAV_SELECTOR:"#navigation",isCustomizationView:function(){return false},notices:[null]},ThemeDisplay:{getLayoutId:function(){return"7"},getLayoutURL:function(){return"https://www.cochranelibrary.com/en/content"},getParentLayoutId:function(){return"0"},isPrivateLayout:function(){return"false"},isVirtualLayout:function(){return false},getBCP47LanguageId:function(){return"en-US"},getCDNBaseURL:function(){return"https://www.cochranelibrary.com"},getCDNDynamicResourcesHost:function(){return""},getCDNHost:function(){return""},getCompanyId:function(){return"20155"},getCompanyGroupId:function(){return"20195"},getDefaultLanguageId:function(){return"en_US"},getDoAsUserIdEncoded:function(){return""},getLanguageId:function(){return"en_US"},getParentGroupId:function(){return"20182"},getPathContext:function(){return""},getPathImage:function(){return"/image"},getPathJavaScript:function(){return"/html/js"},getPathMain:function(){return"/en/c"},getPathThemeImages:function(){return"https://www.cochranelibrary.com/cochrane-theme/images"},getPathThemeRoot:function(){return"/cochrane-theme"},getPlid:function(){return"20757"},getPortalURL:function(){return"https://www.cochranelibrary.com"},getPortletSetupShowBordersDefault:function(){return true},getScopeGroupId:function(){return"20182"},getScopeGroupIdOrLiveGroupId:function(){return"20182"},getSessionId:function(){return""},getSiteGroupId:function(){return"20182"},getURLControlPanel:function(){return"/group/control_panel?refererPlid=20757"},getURLHome:function(){return"https\x3a\x2f\x2fwww\x2ecochranelibrary\x2ecom\x2fweb\x2fcochrane"},getUserId:function(){return"20159"},getUserName:function(){return""},isAddSessionIdToURL:function(){return false},isFreeformLayout:function(){return false},isImpersonated:function(){return false},isSignedIn:function(){return false},isStateExclusive:function(){return false},isStateMaximized:function(){return false},isStatePopUp:function(){return false}},PropsValues:{NTLM_AUTH_ENABLED:false}};var themeDisplay=Liferay.ThemeDisplay;Liferay.AUI={getAvailableLangPath:function(){return"available_languages.jsp?browserId=other&themeId=cochrane_WAR_cochranetheme&colorSchemeId=01&minifierType=js&languageId=en_US&b=6210&t=1513680837000"},getCombine:function(){return true},getComboPath:function(){return"/combo/?browserId=other&minifierType=&languageId=en_US&b=6210&t=1513680837000&"},getFilter:function(){return"min"},getJavaScriptRootPath:function(){return"/html/js"},getLangPath:function(){return"aui_lang.jsp?browserId=other&themeId=cochrane_WAR_cochranetheme&colorSchemeId=01&minifierType=js&languageId=en_US&b=6210&t=1513680837000"},getStaticResourceURLParams:function(){return"?browserId=other&minifierType=&languageId=en_US&b=6210&t=1513680837000"}};Liferay.authToken="Nio3SV1W";Liferay.currentURL="\x2fweb\x2fcochrane\x2fcontent\x3ftemplateType\x3dfull\x26urlTitle\x3d\x2fcdsr\x2fdoi\x2f10\x2e1002\x2f14651858\x2eCD006086\x2epub4\x26doi\x3d10\x2e1002\x2f14651858\x2eCD006086\x2epub4\x26type\x3dcdsr\x26contentLanguage\x3d";Liferay.currentURLEncoded="\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD006086\x2epub4\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD006086\x2epub4\x2526type\x253Dcdsr\x2526contentLanguage\x253D";</script> <script src="/html/js/barebone.jsp?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;colorSchemeId=01&amp;minifierType=js&amp;minifierBundleId=javascript.barebone.files&amp;languageId=en_US&amp;b=6210&amp;t=1513680837000" type="text/javascript"></script> <script type="text/javascript"></script> <script type="text/javascript">var o={database:"CDSR",page:{pageType:"Article Full Text HTML"},article:{availableLanguage:["en","es","de","pt","ko","ms","ja","hr","fr","pl","ta","fa","zh_HANT"],languageCode:"en",accessStatus:"open-access",doi:"10.1002/14651858.CD006086.pub4",title:"Nutritional supplements for people being treated for active tuberculosis",firstPublishedDate:"Jun 29, 2016 12:00:00 AM",isCurrentVersion:true,editorialGroup:"Cochrane Infectious Diseases Group",availableParts:["PDF Full","PDF Standard","PDF Abstract","HTML","Comments","Information","References","Stats","Related Content"]}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/custom.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734739000" rel="stylesheet" type="text/css"/> <style type="text/css"></style> <script async="" src="https://assets.adobedtm.com/59640f9fa510/7cad07cf7779/launch-a215d9c51521.min.js"></script> <!--[if lt IE 9]> <script src="/cochrane-theme/vendor/respond/dest/respond.min.js?t=1738734739000" type="text/javascript"></script> <![endif]--> </head> <body class="yui3-skin-sam controls-visible guest-site signed-out public-page site"> <div class="site-container"> <a href="#main-content" id="skip-to-content">Skip to Content</a> <div class="cookie-message cookie-message--hidden system-message-container" id="js-cookie-message"> <div class="container"> <a aria-label="Close cookies message" class="fa fa-times js-cookie-close pull-right" href="#"></a> <div class="system-message-wrapper container"> <i aria-hidden="true" class="fa fa-exclamation-triangle"></i> <div class="system-message-title">Cookies</div> <div class="system-message-description"> <p> Our site uses cookies to improve your experience. You can find out more about our use of cookies in About Cookies, including instructions on how to turn off cookies if you wish to do so. By continuing to browse this site you agree to us using cookies as described in <a href="http://olabout.wiley.com/WileyCDA/Section/id-813473.html">About Cookies</a>. </p> <a class="btn secondary js-cookie-close js-cookie-accept" href="#">I accept</a> </div> </div> </div> </div> <script>document.body.className=document.body.className+" js_enabled";</script><header> <div class="container"> <div class="branding"> <h1 class="brand-container"> <a href="https://www.cochranelibrary.com/en/"> <span class="brand-name">The Cochrane Library</span> <img alt="Cochrane Library logo" class="brand-logo" src="https://www.cochranelibrary.com/cochrane-theme/images/en-US_logo.png" title="Cochrane Library"/> </a> </h1> <span class="additional-branding"> <p class="brand-message"> <em>Trusted evidence.</em> <em>Informed decisions.</em> <em>Better health.</em> </p> </span> </div> <div class="desktop-search basic-search-container"> <div class="desktop-search-form"> <div class="portlet-boundary portlet-boundary_scolarissearchportlet_WAR_scolarissearch_ portlet-static portlet-static-end" id="p_p_id_scolarissearchportlet_WAR_scolarissearch_"> <span id="p_scolarissearchportlet_WAR_scolarissearch"></span> <section class="portlet" id="portlet_scolarissearchportlet_WAR_scolarissearch"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Search\x20Portlet')"> <img alt="" id="owel__null__null" src="/scolaris-search/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Search Portlet</span> </span> <span class="portlet-title-text">Scolaris Search Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarissearchportlet_WAR_scolarissearch" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="header-search"> <form action="https://www.cochranelibrary.com/en/content?p_auth=Nio3SV1W&amp;p_p_id=scolarissearchportlet_WAR_scolarissearch&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolarissearchportlet_WAR_scolarissearch_scolarisAction=redirectSearchResult" method="post"> <input name="searchType" type="hidden" value="basic"/> <input name="facetDisplayName" type="hidden" value=""/> <input name="facetQueryTerm" type="hidden" value=""/> <input name="facetQueryField" type="hidden" value=""/> <input name="facetCategory" type="hidden" value=""/> <fieldset class="fieldset"> <legend class="sr-only">Basic Search</legend> <div class="select search-by"> <select aria-label="Search by options" class="custom-select-enabled search-type" name="searchBy" title="Search by options"> <option value="1">Title Abstract Keyword</option> <option value="2">Record Title</option> <option value="3">Abstract</option> <option value="4">Author</option> <option value="5">Keyword</option> <option value="6">All Text</option> <option value="7">Publication Type</option> <option value="8">Source</option> <option value="9">DOI</option> <option value="14">Language</option> <option value="10">Accession Number</option> <option value="11">Trial Registry Number</option> <option value="12">Cochrane Group</option> <option value="13">Cochrane Topic</option> </select> </div> <div class="search-select-crg-container select" style="display: none;"> <select class="search-select-crg-list"></select> </div> <div class="search-select-topic-container select" data-topic-list-url="https://www.cochranelibrary.com/en/content?p_p_id=scolaristopics_WAR_scolaristopics&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=topics-list&amp;p_p_cacheability=cacheLevelPage" style="display: none;"> <select class="search-select-topic-list"></select> </div> <div class="search-select-cl-container select" style="display: none;"> <select class="search-select-cl-list"></select> </div> <div class="search-text-container"> <div class="control-group control-group-inline search-input-wrapper"> <input aria-label="Enter search term" class="field browser-search search-text ui-autocomplete-input" id="searchText" name="searchText" placeholder="Search" size="30" type="text" value=""/>
<div id="autocomplete-results"></div>
</div>
<div class="control-group control-group-inline search-button-wrapper">
<button aria-label="Search" class="searchByBtn" type="submit">
<i aria-hidden="true" class="fa fa-search"></i>
</button>
</div>
</div>
</fieldset>
</form>
</div>
<script>
    window.displayResultURL = 'https://www.cochranelibrary.com/en/content?p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=getSuggestions&p_p_cacheability=cacheLevelPage&_scolarissearchportlet_WAR_scolarissearch_templateType=full&_scolarissearchportlet_WAR_scolarissearch_urlTitle=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD006086.pub4&_scolarissearchportlet_WAR_scolarissearch_contentLanguage=&_scolarissearchportlet_WAR_scolarissearch_type=cdsr&_scolarissearchportlet_WAR_scolarissearch_doi=10.1002%2F14651858.CD006086.pub4';
    window.searchByOption = '';
</script>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
<div class="search-tools-nav">
<a class="btn secondary" href="/en/browse-by-topic">Browse</a>
<a class="btn primary advanced-search-button" href="/en/advanced-search">Advanced search</a>
</div>
</div>
<a class="toggle-menu-switch" href="#"><i aria-hidden="true" class="fa fa-bars"></i> <div class="toggle-menu-text">Open menu</div></a>
</div>
<div class="auxiliary-container">
<div class="container">
<div class="header-auxiliary-menu">
<div class="auxiliary-menu-item language-selector">
<div class="portlet-boundary portlet-boundary_scolarislanguageselector_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header_">
<span id="p_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header"></span>
<section class="portlet" id="portlet_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Language\x20Selector')">
<img alt="" id="bvrs__null__null" src="/scolaris-language-portlet/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Language Selector</span> </span> <span class="portlet-title-text">Scolaris Language Selector</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="language-display" data-content-languages="[de, en, es, fa, fr, hi, hr, id, ja, ko, hu, ms, nl, pl, pt, ru, ro, ta, th, zh_HANT, zh_HANS]"> <a class="open-language-modal" href="#" title="Select your preferred language"> <i class="fa fa-file-text"></i> Review language : English </a> <a class="open-language-modal" href="#" title="Select your preferred language"> <i class="fa fa-globe"></i> Website language : English </a> </div> <div class="language-selector-modal-content" data-modal-title="Language selection" data-size="large" style="display: none;"> <div class="form-content language-selector-modal"> <div class="row-fluid"> <div> <table class="mytable" style="border: 1px solid #f0f0f0" width="90%"> <tbody> <tr class="row-box"> <td><i class="fa fa-file-text icon-size"></i></td> <td><h3>Cochrane review language</h3> <p>Select your preferred language for Cochrane reviews and other content. Sections without translation will be in English.</p> </td> <td> <div> <select id="contentLanguageSelector" onchange="updateLang(this.value)"> <option class="content-language-option" data-languagecode="de" value="de"> Deutsch </option> <option class="content-language-option" data-languagecode="en" selected="" value="en"> English </option> <option class="content-language-option" data-languagecode="es" value="es"> Español </option> <option class="content-language-option" data-languagecode="fa" value="fa"> فارسی </option> <option class="content-language-option" data-languagecode="fr" value="fr"> Français </option> <option class="content-language-option" data-languagecode="hi" value="hi"> हिन्दी </option> <option class="content-language-option" data-languagecode="hr" value="hr"> Hrvatski </option> <option class="content-language-option" data-languagecode="id" value="id"> Bahasa Indonesia </option> <option class="content-language-option" data-languagecode="ja" value="ja"> 日本語 </option> <option class="content-language-option" data-languagecode="ko" value="ko"> 한국어 </option> <option class="content-language-option" data-languagecode="hu" value="hu"> Magyar </option> <option class="content-language-option" data-languagecode="ms" value="ms"> Bahasa Malaysia </option> <option class="content-language-option" data-languagecode="nl" value="nl"> Nederlands </option> <option class="content-language-option" data-languagecode="pl" value="pl"> Polski </option> <option class="content-language-option" data-languagecode="pt" value="pt"> Português </option> <option class="content-language-option" data-languagecode="ru" value="ru"> Русский </option> <option class="content-language-option" data-languagecode="ro" value="ro"> Română </option> <option class="content-language-option" data-languagecode="ta" value="ta"> தமிழ் </option> <option class="content-language-option" data-languagecode="th" value="th"> ภาษาไทย </option> <option class="content-language-option" data-languagecode="zh_HANT" value="zh_HANT"> 繁體中文 </option> <option class="content-language-option" data-languagecode="zh_HANS" value="zh_HANS"> 简体中文 </option> </select> </div> </td> </tr> <tr> <td colspan="1" style="height: 10px"></td> </tr> <tr class="row-box"> <td><i class="fa fa-globe icon-size"></i></td> <td> <div class="language-info"> <h3>Website language</h3> <p>Select your preferred language for the Cochrane Library website.</p> </div> </td> <td> <div class="language-dropdown"> <select id="portalLanguageSelector"> <option class="portal-language-selector" data-portallanguage="en" selected="" value="/en/cdsr/doi/10.1002/14651858.CD006086.pub4/full/en"> English </option> <option class="portal-language-selector" data-portallanguage="es" value="/es/cdsr/doi/10.1002/14651858.CD006086.pub4/full/es"> Español </option> </select> </div> </td> </tr> <tr> <td colspan="1" style="height: 10px"></td> </tr> </tbody> </table> </div> </div> <div style="text-align: right;"> <button class="btn primary btn-cancel" style="margin-left: 10px;" type="button">Cancel</button> <a class="btn secondary ok-btn" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage">Save</a> </div> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
<a class="auxiliary-menu-item signin last" href="https://www.cochranelibrary.com/c/portal/login?p_l_id=20757&amp;redirect=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD006086.pub4%2Ffull" rel="nofollow">
<i class="icon fa fa-user"></i> Sign In
    </a>
<span class="auxiliary-container-extended"></span>
</div>
</div>
</div>
</header>
<div class="main-nav-wrapper">
<span class="main-nav-left-extended"></span>
<nav class="main container">
<ul>
<li class="nav-root-item parent">
<a href="#">Cochrane reviews<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_14" role="presentation">
<a aria-labelledby="layout_14" href="https://www.cochranelibrary.com/en/cdsr/reviews" role="menuitem">
            Search reviews (CDSR)
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_15" role="presentation">
<a aria-labelledby="layout_15" href="https://www.cochranelibrary.com/en/cdsr/reviews/topics" role="menuitem">
            Browse reviews
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_18" role="presentation">
<a aria-labelledby="layout_18" href="https://www.cochranelibrary.com/en/cdsr/table-of-contents" role="menuitem">
            Issues
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_17" role="presentation">
<a aria-labelledby="layout_17" href="https://www.cochranelibrary.com/en/cdsr/editorials" role="menuitem">
            Editorials
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_19" role="presentation">
<a aria-labelledby="layout_19" href="https://www.cochranelibrary.com/en/special-collections" role="menuitem">
            Special Collections
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_20" role="presentation">
<a aria-labelledby="layout_20" href="https://www.cochranelibrary.com/en/cdsr/supplements" role="menuitem">
            Supplements
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_121" role="presentation">
<a aria-labelledby="layout_121" href="https://www.cochranelibrary.com/en/about/about-cochrane-reviews" role="menuitem">
            About Cochrane reviews
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Searching for trials<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_254" role="presentation">
<a aria-labelledby="layout_254" href="https://www.cochranelibrary.com/en/search/releases" role="menuitem">
            What's new (search and CENTRAL)
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_266" role="presentation">
<a aria-labelledby="layout_266" href="https://www.cochranelibrary.com/en/search-help" role="menuitem">
            Search help
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_252" role="presentation">
<a aria-labelledby="layout_252" href="https://www.cochranelibrary.com/en/search-help-quick-guides" role="menuitem">
            Search help quick guides
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_251" role="presentation">
<a aria-labelledby="layout_251" href="https://www.cochranelibrary.com/en/search-faqs" role="menuitem">
            Search FAQs
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_114" role="presentation">
<a aria-labelledby="layout_114" href="https://www.cochranelibrary.com/en/central/about-central" role="menuitem">
            About CENTRAL
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_115" role="presentation">
<a aria-labelledby="layout_115" href="https://www.cochranelibrary.com/en/central/central-creation" role="menuitem">
            How CENTRAL is created
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_241" role="presentation">
<a aria-labelledby="layout_241" href="https://www.cochranelibrary.com/en/retracted-trials" role="menuitem">
            Retracted publications in CENTRAL
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Clinical Answers<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_29" role="presentation">
<a aria-labelledby="layout_29" href="https://www.cochranelibrary.com/en/cca" role="menuitem">
            Browse Clinical Answers
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_91" role="presentation">
<a aria-labelledby="layout_91" href="https://www.cochranelibrary.com/en/cca/about" role="menuitem">
            About Clinical Answers
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">About<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_116" role="presentation">
<a aria-labelledby="layout_116" href="https://www.cochranelibrary.com/en/about/about-cochrane-library" role="menuitem">
            About the Cochrane Library
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_13" role="presentation">
<a aria-labelledby="layout_13" href="https://www.cochranelibrary.com/en/cdsr/about-cdsr" role="menuitem">
            Cochrane Database of Systematic reviews
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_198" role="presentation">
<a aria-labelledby="layout_198" href="https://www.cochranelibrary.com/en/cdsr/editorial-policies" role="menuitem">
            Editorial policies
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_92" role="presentation">
<a aria-labelledby="layout_92" href="https://www.cochranelibrary.com/en/about/author-information" role="menuitem">
            Information for authors
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_212" role="presentation">
<a aria-labelledby="layout_212" href="https://www.cochranelibrary.com/en/about-pico" role="menuitem">
            About PICO
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_207" role="presentation">
<a aria-labelledby="layout_207" href="https://www.cochranelibrary.com/en/about/about-translations" role="menuitem">
            About translations
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_188" role="presentation">
<a aria-labelledby="layout_188" href="https://www.cochranelibrary.com/en/about/releases" role="menuitem">
            What's new
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_216" role="presentation">
<a aria-labelledby="layout_216" href="https://www.cochranelibrary.com/en/data" role="menuitem">
            Data reuse
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_235" role="presentation">
<a aria-labelledby="layout_235" href="https://www.cochranelibrary.com/en/about/about-cochrane-library/editorial-board" role="menuitem">
            Cochrane Library Editorial Board
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Help<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_259" role="presentation">
<a aria-labelledby="layout_259" href="https://m.info.wiley.com/webApp/cochranenewsletter?id=0" role="menuitem">
            Newsletter
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_177" role="presentation">
<a aria-labelledby="layout_177" href="https://www.wiley.com/en-us/customer-success/cochrane-library-training-hub" role="menuitem">
            Cochrane Library Training
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_44" role="presentation">
<a aria-labelledby="layout_44" href="https://www.cochranelibrary.com/en/help/access" role="menuitem">
            Access
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_150" role="presentation">
<a aria-labelledby="layout_150" href="https://www.cochranelibrary.com/en/help/permissions" role="menuitem">
            Permissions and reprints
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_93" role="presentation">
<a aria-labelledby="layout_93" href="https://www.cochranelibrary.com/en/help/media" role="menuitem">
            Media information
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_97" role="presentation">
<a aria-labelledby="layout_97" href="https://www.cochranelibrary.com/en/help/contact-us" role="menuitem">
            Contact us
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_125" role="presentation">
<a aria-labelledby="layout_125" href="https://www.cochranelibrary.com/en/about/terms-and-conditions" role="menuitem">
            Terms and conditions
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_176" role="presentation">
<a aria-labelledby="layout_176" href="https://cochranesupport.wiley.com/s/article/cochrane-library-known-issues" role="menuitem">
            Known issues
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_270" role="presentation">
<a aria-labelledby="layout_270" href="https://www.cochranelibrary.com/search-help" role="menuitem">
            Search help
        </a>
</li>
</ul>
</li>
<li class="about-link"><a href="https://www.cochrane.org/about-us" target="_blank"><span>About Cochrane</span><i class="fa fa-caret-right"></i></a></li>
</ul>
</nav>
</div>
<div class="portlet-boundary portlet-boundary_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_">
<span id="p_scolariscontentlanguagebanner_WAR_scolarislanguageportlet"></span>
<section class="portlet" id="portlet_scolariscontentlanguagebanner_WAR_scolarislanguageportlet">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Language\x20Banner\x20Portlet')">
<img alt="" id="etlj__null__null" src="/scolaris-language-portlet/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Language Banner Portlet</span> </span> <span class="portlet-title-text">Scolaris Content Language Banner Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentlanguagebanner_WAR_scolarislanguageportlet" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<div class="" id="content">
<div class="columns-1" id="main-content" role="main">
<div class="portlet-layout row-fluid">
<div class="portlet-column portlet-column-only span12" id="column-1">
<div class="portlet-dropzone portlet-column-content portlet-column-content-only" id="layout-column_column-1">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="rjus__column1__0" src="/scolaris-content-display/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="publication cdsr container"> <div class="article-navigation-container" id="cdsr-nav"> <nav class="article-navigation"> <ul class="tools-row"> <li> <li class="tools pdf pulldown-menu readcube-menu closed en_US"> <a class="pulldown-menu-trigger" href="#0"> <span class="pdf-icon"> <i class="icon fa fa-file-pdf-o"></i> <span>Download PDF</span> </span> <i aria-hidden="true" class="fa fa-caret-down"></i> </a> <ul class="pulldown-menu-items"> <li class=""> <a class="download media pdf-link-full pdf-link" href="/cdsr/doi/10.1002/14651858.CD006086.pub4/pdf/full/en" title="Article in PDF format"> <span class="readcube-label"> Full </span> <span class="readcube-description"> All content </span> </a> <a class="download media pdf-link-full readcube-epdf-link" href="/cdsr/doi/10.1002/14651858.CD006086.pub4/epdf/full/en" title="Article in PDF format"> <span class="readcube-label"> Full </span> <span class="readcube-description"> All content </span> </a> </li> <li class=""> <a class="download media pdf-link-abstract pdf-link" href="/cdsr/doi/10.1002/14651858.CD006086.pub4/pdf/abstract/en" title="Article in PDF format"> <span class="readcube-label"> Summary </span> <span class="readcube-description"> Abstract and plain language summary only </span> </a> <a class="download media pdf-link-abstract readcube-epdf-link" href="/cdsr/doi/10.1002/14651858.CD006086.pub4/epdf/abstract/en" title="Article in PDF format"> <span class="readcube-label"> Summary </span> <span class="readcube-description"> Abstract and plain language summary only </span> </a> </li> </ul> </li> <li class="tools cite cite-article-link" data-article-id="CD006086.PUB4" data-modal-title="Cite this review"> <span><i aria-hidden="true" class="icon fa fa-share"></i></span> <span>Cite this review</span> </li> </li> </ul> <ul class="tools-row tools-secondary"> <li> <li class="tools print print-cdsr-link" data-content-language="en" data-indicator-tooltip="scolaris.print.modal.language.tooltip.en" data-print-options="[{&quot;param&quot;: &quot;abstract&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Abstract&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Resumen&quot;},{&quot;language&quot;:&quot;fa&quot;,&quot;title&quot;:&quot;چکیده&quot;},{&quot;language&quot;:&quot;fr&quot;,&quot;title&quot;:&quot;Résumé scientifique&quot;},{&quot;language&quot;:&quot;ja&quot;,&quot;title&quot;:&quot;アブストラクト&quot;},{&quot;language&quot;:&quot;ko&quot;,&quot;title&quot;:&quot;초록&quot;},{&quot;language&quot;:&quot;pt&quot;,&quot;title&quot;:&quot;Resumo&quot;}]},{&quot;param&quot;: &quot;pls&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Plain language summary&quot;},{&quot;language&quot;:&quot;de&quot;,&quot;title&quot;:&quot;Laienverständliche Zusammenfassung&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Resumen en términos sencillos&quot;},{&quot;language&quot;:&quot;fa&quot;,&quot;title&quot;:&quot;خلاصه به زبان ساده&quot;},{&quot;language&quot;:&quot;fr&quot;,&quot;title&quot;:&quot;Résumé simplifié&quot;},{&quot;language&quot;:&quot;hr&quot;,&quot;title&quot;:&quot;Laički sažetak&quot;},{&quot;language&quot;:&quot;ja&quot;,&quot;title&quot;:&quot;一般語訳&quot;},{&quot;language&quot;:&quot;ko&quot;,&quot;title&quot;:&quot;쉬운 말 요약&quot;},{&quot;language&quot;:&quot;ms&quot;,&quot;title&quot;:&quot;Ringkasan bahasa mudah&quot;},{&quot;language&quot;:&quot;pl&quot;,&quot;title&quot;:&quot;Streszczenie prostym językiem&quot;},{&quot;language&quot;:&quot;pt&quot;,&quot;title&quot;:&quot;Resumo para leigos&quot;},{&quot;language&quot;:&quot;ta&quot;,&quot;title&quot;:&quot;எளியமொழிச் சுருக்கம்&quot;},{&quot;language&quot;:&quot;zh_HANT&quot;,&quot;title&quot;:&quot;淺顯易懂的口語結論&quot;}]},{&quot;param&quot;: &quot;conclusions&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Authors' conclusions&quot;}]},{&quot;param&quot;: &quot;summaryOfFindings&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Summary of findings&quot;}]},{&quot;param&quot;: &quot;background&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Background&quot;}]},{&quot;param&quot;: &quot;objectives&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Objectives&quot;}]},{&quot;param&quot;: &quot;methods&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Methods&quot;}]},{&quot;param&quot;: &quot;results&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Results&quot;}]},{&quot;param&quot;: &quot;discussion&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Discussion&quot;}]},{&quot;param&quot;: &quot;references&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;References&quot;}]},{&quot;param&quot;: &quot;appendices&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Appendices&quot;},{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Search strategies&quot;}]},{&quot;param&quot;: &quot;characteristics&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Characteristics of studies&quot;}]},{&quot;param&quot;: &quot;data&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Analyses&quot;}]},{&quot;param&quot;: &quot;information&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Information&quot;}]},{&quot;param&quot;: &quot;authors&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Authors&quot;}]},{&quot;param&quot;: &quot;history&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;History&quot;},{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;History&quot;}]}]" data-print-urlbase="/cdsr/doi/10.1002/14651858.CD006086.pub4/print"> <span><i class="icon fa fa-print"></i></span> <span>Print</span> </li> <li class="js-old-version-modal-trigger tools comments comment-on-review" data-article-id="CD006086.PUB4" data-english-only-message="Please note, that commenting is available in English only. Apologies for any inconvenience." data-href="/cdsr/doi/10.1002/14651858.CD006086.pub4/read-comments" data-new-version="" id="comment-on-review"> <span class="comment-icon"><i class="icon fa fa-comment"></i></span> <span class="comments-count">0</span> <span>Comment</span> </li> <li class="tools share-cdsr-link" data-share-url="/cdsr/doi/10.1002/14651858.CD006086.pub4/full"> <span><i class="icon fa fa-share-alt"></i></span> <span>Share</span> </li> <li class="tools follow"> <span class="article-not-followed cochrane-link signin follow-wrapper"> <span> <i class="icon fa fa-plus"></i> </span> <span> Follow </span> </span> </li> </li> </ul> <div class="metrics-wrapper"> <div class="metrics-count"> <span>Full text views: </span> <span>17025 <i class="icon fa fa-info-circle custom-tooltip" style="padding-left: 2px;color: #962d91;" title="Usage represents full text views on Cochrane Library since January 2022 or 2023. For articles published after this date, the usage represents views since the article was first published on Cochrane Library."> </i> </span> </div> </div> <div class="metrics-wrapper nav-link-section"> <div class="altmetric-embed" data-badge-type="1" data-condensed="true" data-doi="10.1002/14651858.CD006086.pub4" data-link-target="_blank"></div> <div class="inline-status-wrapper guidelines-count" data-count-plural="Cited in $1 guidelines" data-count-single="Cited in 1 guideline"> <a href="related-content#guidelines_data" title="Guidelines"></a> </div> </div> <ul class="nav-section-header"> <li> <h3>Contents</h3> </li> </ul> <ul class="nav-long-form nav-link-section"> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD006086.pub4/full"> Abstract </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD006086.pub4/full#pico"> PICOs </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD006086.pub4/full#CD006086-abs-0006"> Plain language summary </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD006086.pub4/full#CD006086-sec-0152"> Authors' conclusions </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD006086.pub4/full#CD006086-sec-0051"> Summary of findings </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD006086.pub4/full#CD006086-sec-0052"> Background </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD006086.pub4/full#CD006086-sec-0059"> Objectives </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD006086.pub4/full#CD006086-sec-0060"> Methods </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD006086.pub4/full#CD006086-sec-0085"> Results </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD006086.pub4/full#CD006086-sec-0143"> Discussion </a> </li> <li class="cdsr-nav-link"> <a class="figures-and-tables-link" href="/cdsr/doi/10.1002/14651858.CD006086.pub4/#"> Figures and tables </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD006086.pub4/references"> References </a> </li> </ul> <div class="nav-section-header"> <h3>Supplementary materials</h3> </div> <ul class="nav-long-form nav-link-section"> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD006086.pub4/appendices#CD006086-sec-0157"> Search strategies </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD006086.pub4/references#characteristicStudies"> Characteristics of studies </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD006086.pub4/references#dataAndAnalyses"> Analyses </a> </li> <li class="cdsr-nav-link download-stats-data-link" data-download-href="/cdsr/doi/10.1002/14651858.CD006086.pub4/media/CDSR/CD006086/table_n/CD006086StatsDataOnly.rm5?content-disposition=attachment&amp;mime-type=application/octet-stream"> <a href="/cdsr/doi/10.1002/14651858.CD006086.pub4/media/CDSR/CD006086/table_n/CD006086StatsDataOnly.rm5?content-disposition=attachment&amp;mime-type=application/octet-stream"> Download data </a> </li> </ul> <ul class="tools-row"> <li> </li> </ul> <ul class="nav-section-header"> <li><h3>Related</h3></li> </ul> <ul class="linked-content linked-content-dropdown" id="linked-content-articles" tabindex="0"> <li class="linked-cca" data-type="cca"> <div class="linked-content-section"> <span class="linked-type">Cochrane Clinical Answers<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-editorials" data-type="editorial"> <div class="linked-content-section"> <span class="linked-type">Editorials<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-podcasts" data-type="podcast"> <div class="linked-content-section"> <span class="linked-type">Podcasts<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-sc" data-type="sc"> <div class="linked-content-section"> <span class="linked-type">Special Collections<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> </ul> <div class="nav-section-header"> <h3>About this review</h3> </div> <ul class="nav-long-form nav-info nav-link-section"> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD006086.pub4/information"> <i> <svg viewbox="0 0 24 24"> <path d="M11,9H13V7H11M12,20C7.59,20 4,16.41 4,12C4,7.59 7.59,4 12,4C16.41,4 20,7.59 20,12C20,16.41 16.41,20 12,20M12,2A10,10 0 0,0 2,12A10,10 0 0,0 12,22A10,10 0 0,0 22,12A10,10 0 0,0 12,2M11,17H13V11H11V17Z"></path> </svg> </i> Information </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD006086.pub4/information#authors"> <i> <svg viewbox="0 0 24 24"> <path d="M12,5.5A3.5,3.5 0 0,1 15.5,9A3.5,3.5 0 0,1 12,12.5A3.5,3.5 0 0,1 8.5,9A3.5,3.5 0 0,1 12,5.5M5,8C5.56,8 6.08,8.15 6.53,8.42C6.38,9.85 6.8,11.27 7.66,12.38C7.16,13.34 6.16,14 5,14A3,3 0 0,1 2,11A3,3 0 0,1 5,8M19,8A3,3 0 0,1 22,11A3,3 0 0,1 19,14C17.84,14 16.84,13.34 16.34,12.38C17.2,11.27 17.62,9.85 17.47,8.42C17.92,8.15 18.44,8 19,8M5.5,18.25C5.5,16.18 8.41,14.5 12,14.5C15.59,14.5 18.5,16.18 18.5,18.25V20H5.5V18.25M0,20V18.5C0,17.11 1.89,15.94 4.45,15.6C3.86,16.28 3.5,17.22 3.5,18.25V20H0M24,20H20.5V18.25C20.5,17.22 20.14,16.28 19.55,15.6C22.11,15.94 24,17.11 24,18.5V20Z"></path> </svg> </i> Authors </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD006086.pub4/information#history"> <i> <svg viewbox="0 0 24 24"> <path d="M13.5,8H12V13L16.28,15.54L17,14.33L13.5,12.25V8M13,3A9,9 0 0,0 4,12H1L4.96,16.03L9,12H6A7,7 0 0,1 13,5A7,7 0 0,1 20,12A7,7 0 0,1 13,19C11.07,19 9.32,18.21 8.06,16.94L6.64,18.36C8.27,20 10.5,21 13,21A9,9 0 0,0 22,12A9,9 0 0,0 13,3"></path> </svg> </i> Version history </a> </li> <li class="cdsr-nav-link"> <a href="/cdsr/doi/10.1002/14651858.CD006086.pub4/information#keywords"> <i> <svg viewbox="0 0 24 24"> <path d="M11 3C10.18 3 9.44 3.5 9.14 4.27L3.64 18.27C3.12 19.58 4.09 21 5.5 21H7.75C8.59 21 9.33 20.5 9.62 19.7L10.26 18H13.74L14.38 19.7C14.67 20.5 15.42 21 16.25 21H18.5C19.91 21 20.88 19.58 20.36 18.27L14.86 4.27C14.56 3.5 13.82 3 13 3M11 5H13L18.5 19H16.25L15.12 16H8.87L7.75 19H5.5M12 7.67L9.62 14H14.37Z"></path> </svg> </i> Keywords (MeSH, PICOs) </a> </li> <li class="cdsr-nav-link"> <a href="/cdsr/doi/10.1002/14651858.CD006086.pub4/related-content"> <i class="icon fa fa-sitemap fa-rotate-270"></i> Related content </a> </li> <li class="cdsr-nav-link translation-notes-link"> <a href="/cdsr/doi/10.1002/14651858.CD006086.pub4/#"> <i> <svg viewbox="0 0 24 24"> <path d="M12.87,15.07L10.33,12.56L10.36,12.53C12.1,10.59 13.34,8.36 14.07,6H17V4H10V2H8V4H1V6H12.17C11.5,7.92 10.44,9.75 9,11.35C8.07,10.32 7.3,9.19 6.69,8H4.69C5.42,9.63 6.42,11.17 7.67,12.56L2.58,17.58L4,19L9,14L12.11,17.11L12.87,15.07M18.5,10H16.5L12,22H14L15.12,19H19.87L21,22H23L18.5,10M15.88,17L17.5,12.67L19.12,17H15.88Z"></path> </svg> </i> Translation notes </a> </li> <li class="cdsr-nav-link"> <a class="request-permissions" data-copyright="Copyright © 2016 The Authors. Cochrane Database of Systematic Reviews published by John Wiley &amp; Sons, Ltd. on behalf of The Cochrane Collaboration." data-creative-commons="true" href="/cdsr/doi/10.1002/14651858.CD006086.pub4/#"> <span class="request-permissions-icon"></span> Request permissions </a> </li> <li class="cdsr-nav-link"> <a href="/data"> <i class="icon fa fa-database"></i> Request data reuse </a> </li> </ul> </nav> </div> <article> <div class="cdsr-header-top"> <div class="cdsr-header-left"> <a class="publish-database" href="/">Cochrane Database of Systematic reviews</a> <span class="publish-type">Review - Intervention</span> </div> <div class="cdsr-header-right"> <div class="inline-status-wrapper"> </div> </div> </div> <header class="publication-header"> <h1 class="publication-title" lang="en">Nutritional supplements for people being treated for active tuberculosis</h1> <div class="publication-metadata-block"> <div class="publication-authors"> <div class="publish-meta-wrapper"> <ul class="authors"> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD006086.pub4/information#CD006086-cr-0002">Liesl Grobler</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD006086.pub4/information#CD006086-cr-0003">Sukrti Nagpal</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD006086.pub4/information#CD006086-cr-0004">Thambu D Sudarsanam</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD006086.pub4/information#CD006086-cr-0005"><i class="icon corresponding-author fa fa-envelope"></i>David Sinclair</a></li> </ul> <span class="author declaration"> <a class="declarationsOfInterestLink" href="/cdsr/doi/10.1002/14651858.CD006086.pub4/information/en#CD006086-sec-0169">Authors' declarations of interest</a> </span> </div> </div> </div> <div class="publication-metadata-block"> <p> <span class="publish-date">Version published: 29 June 2016 </span> <a class="whatsNewLink" href="/cdsr/doi/10.1002/14651858.CD006086.pub4/information/en#versionTable">Version history</a> </p> <div class="doi-header"> <a href="https://doi.org/10.1002/14651858.CD006086.pub4">https://doi.org/10.1002/14651858.CD006086.pub4</a> </div> </div> </header> <div class="publication-control-bar"> <span class="publication-control-button publication-control-collapse"> Collapse all </span> <span class="publication-control-button publication-control-expand"> Expand all </span> </div> <section class="abstract"> <div class="section-header section-collapse-header" id="CD006086-abs-0001" lang="en"> <h2 class="title section-collapse-title"> Abstract <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD006086-abs-0001">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD006086-abs-0016">Español</a> </li> <li class="section-language"> <a class="" href="full/fa#CD006086-abs-0018">فارسی</a> </li> <li class="section-language"> <a class="" href="full/fr#CD006086-abs-0005">Français</a> </li> <li class="section-language"> <a class="" href="full/ja#CD006086-abs-0004">日本語</a> </li> <li class="section-language"> <a class="" href="full/ko#CD006086-abs-0003">한국어</a> </li> <li class="section-language"> <a class="" href="full/pt#CD006086-abs-0002">Português</a> </li> </nav> </div> </div> <div class="abstract full_abstract" id="CD006086-abs-0001" lang="en"> <section id="CD006086-sec-0001"> <h3 class="title" id="CD006086-sec-0001">Background</h3> <p>Tuberculosis and malnutrition are linked in a complex relationship. Tuberculosis may cause undernutrition through increased metabolic demands and decreased intake, and nutritional deficiencies may worsen the disease, or delay recovery by depressing important immune functions. At present, there is no evidence‐based nutritional guidance for adults and children being treated for tuberculosis. </p> </section> <section id="CD006086-sec-0002"> <h3 class="title" id="CD006086-sec-0002">Objectives</h3> <p>To assess the effects of oral nutritional supplements in people being treated with antituberculous drug therapy for active tuberculosis. </p> </section> <section id="CD006086-sec-0003"> <h3 class="title" id="CD006086-sec-0003">Search methods</h3> <p>We searched the Cochrane Infectious Disease Group Specialized Register, Cochrane Central Register of Controlled Trials (CENTRAL; Issue 1, 2016), MEDLINE (from 1946 to 4 February 2016), EMBASE (from 1980 to 4 February 2016), LILACS (from 1982 to 4 February 2016), the <i>meta</i> Register of Controlled Trials (<i>m</i> RCT), the World Health Organization (WHO) International Clinical Trials Registry Platform (ICTRP), and the <i>Indian Journal of Tuberculosis</i> up to 4 February 2016, and checked the reference lists of all included studies. </p> </section> <section id="CD006086-sec-0004"> <h3 class="title" id="CD006086-sec-0004">Selection criteria</h3> <p>Randomized controlled trials that compared any oral nutritional supplement given for at least four weeks with no nutritional intervention, placebo, or dietary advice only for people being treated for active tuberculosis. The primary outcomes of interest were all‐cause death, and cure at six and 12 months. </p> </section> <section id="CD006086-sec-0005"> <h3 class="title" id="CD006086-sec-0005">Data collection and analysis</h3> <p>Two review authors independently selected trials for inclusion, and extracted data and assessed the risk of bias in the included trials. We presented the results as risk ratios (RR) for dichotomous variables, and mean differences (MD) for continuous variables, with 95% confidence intervals (CIs). Where appropriate, we pooled data from trials with similar interventions and outcomes. We assessed the quality of the evidence using the Grading of Recommendation Assessment, Development and Evaluation (GRADE) approach. </p> </section> <section id="CD006086-sec-0006"> <h3 class="title" id="CD006086-sec-0006">Main results</h3> <p>Thirty‐five trials, including 8283 participants, met the inclusion criteria of this review. </p> <p><b>Macronutrient supplementation</b> </p> <p>Six trials assessed the provision of free food, or high‐energy supplements. Only two trials measured total dietary intake, and in both trials the intervention increased calorie consumption compared to controls. </p> <p>The available trials were too small to reliably prove or exclude clinically important benefits on mortality (RR 0.34, 95% CI 0.10 to 1.20; four trials, 567 participants, <i>very low quality evidence</i> ), cure (RR 0.91, 95% CI 0.59 to 1.41; one trial, 102 participants, <i>very low quality evidence</i> ), or treatment completion (data not pooled; two trials, 365 participants, <i>very low quality evidence</i>). </p> <p>Supplementation probably produces a modest increase in weight gain during treatment for active tuberculosis, although this was not seen consistently across all trials (data not pooled; five trials, 883 participants, <i>moderate quality evidence</i> ). Two small studies provide some evidence that quality of life may also be improved but the trials were too small to have much confidence in the result (data not pooled; two trials, 134 participants, <i>low quality evidence</i>). </p> <p><b>Micronutrient supplementation</b> </p> <p>Six trials assessed multi‐micronutrient supplementation in doses up to 10 times the dietary reference intake, and 18 trials assessed single or dual micronutrient supplementation. </p> <p>Routine multi‐micronutrient supplementation may have little or no effect on mortality in HIV‐negative people with tuberculosis (RR 0.86, 95% CI 0.46 to 1.6; four trials, 1219 participants, <i>low quality evidence</i> ), or HIV‐positive people who are not taking antiretroviral therapy (RR 0.92, 95% CI 0.69 to 1.23; three trials, 1429 participants, <i>moderate quality evidence</i> ). There is insufficient evidence to know if supplementation improves cure (no trials), treatment completion (RR 0.99, 95% CI 0.95 to 1.04; one trial, 302 participants, <i>very low quality evidence</i> ), or the proportion of people who remain sputum positive during the first eight weeks (RR 0.92, 95% CI 0.63 to 1.35; two trials, 1020 participants, <i>very low quality evidence</i> ). However, supplementation may have little or no effect on weight gain during treatment (data not pooled; five trials, 2940 participants, <i>low quality evidence</i>), and no studies have assessed the effect on quality of life. </p> <p>Plasma levels of vitamin A appear to increase following initiation of tuberculosis treatment regardless of supplementation. In contrast, supplementation probably does improve plasma levels of zinc, vitamin D, vitamin E, and selenium, but this has not been shown to have clinically important benefits. Of note, despite multiple studies of vitamin D supplementation in different doses, statistically significant benefits on sputum conversion have not been demonstrated. </p> </section> <section id="CD006086-sec-0007"> <h3 class="title" id="CD006086-sec-0007">Authors' conclusions</h3> <p>There is currently insufficient research to know whether routinely providing free food, or energy supplements improves tuberculosis treatment outcomes, but it probably improves weight gain in some settings. </p> <p>Although blood levels of some vitamins may be low in people starting treatment for active tuberculosis, there is currently no reliable evidence that routinely supplementing above recommended daily amounts has clinical benefits. </p> </section> </div> </section> <section class="pico-section" id="pico"> <h2 class="title section-collapse-title">PICOs <i class="icon fa fa-info-circle" title="The PICO model is widely used and taught in evidence-based health care as a strategy for formulating questions and search strategies and for characterizing clinical studies or meta-analyses. PICO stands for four different potential components of a clinical question: Patient, Population or Problem; Intervention; Comparison; Outcome."></i> <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-content" style="display: block;"> <h3 class="keyword-heading">PICOs</h3> <div class="pico-table"> <div class="pico-column Population"> <h6>Population<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Intervention"> <h6>Intervention<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Comparison"> <h6>Comparison<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Outcome"> <h6>Outcome<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> </div> <div class="pico-information"> <p><i class="icon fa fa-info-circle"></i> The PICO model is widely used and taught in evidence-based health care as a strategy for formulating questions and search strategies and for characterizing clinical studies or meta-analyses. PICO stands for four different potential components of a clinical question: Patient, Population or Problem; Intervention; Comparison; Outcome.</p> <p>See more on using PICO in the <a href="https://training.cochrane.org/handbook/current/chapter-02#section-2-3">Cochrane Handbook</a>.</p> </div> </div> </section> <section class="pls"> <div class="section-header section-collapse-header" id="CD006086-abs-0006" lang="en"> <h2 class="title section-collapse-title"> Plain language summary <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD006086-abs-0006">English</a> </li> <li class="section-language"> <a class="" href="full/de#CD006086-abs-0007">Deutsch</a> </li> <li class="section-language"> <a class="" href="full/es#CD006086-abs-0017">Español</a> </li> <li class="section-language"> <a class="" href="full/fa#CD006086-abs-0019">فارسی</a> </li> <li class="section-language"> <a class="" href="full/fr#CD006086-abs-0013">Français</a> </li> <li class="section-language"> <a class="" href="full/hr#CD006086-abs-0012">Hrvatski</a> </li> <li class="section-language"> <a class="" href="full/ja#CD006086-abs-0011">日本語</a> </li> <li class="section-language"> <a class="" href="full/ko#CD006086-abs-0009">한국어</a> </li> <li class="section-language"> <a class="" href="full/ms#CD006086-abs-0010">Bahasa Malaysia</a> </li> <li class="section-language"> <a class="" href="full/pl#CD006086-abs-0014">Polski</a> </li> <li class="section-language"> <a class="" href="full/pt#CD006086-abs-0008">Português</a> </li> <li class="section-language"> <a class="" href="full/ta#CD006086-abs-0015">தமிழ்</a> </li> <li class="section-language"> <a class="" href="full/zh_HANT#CD006086-abs-0020">繁體中文</a> </li> </nav> </div> </div> <div class="abstract abstract_plainLanguageSummary" id="CD006086-abs-0006" lang="en"> <h3>Nutritional supplements for people being treated for active tuberculosis</h3> <p>Cochrane researchers conducted a review of the effects of nutritional supplements for people being treated for tuberculosis. After searching for relevant studies up to 4 February 2016, they included 35 relevant studies with 8283 participants. Their findings are summarized below. </p> <p><b>What is active tuberculosis and how might nutritional supplements work?</b> </p> <p>Tuberculosis is a bacterial infection which most commonly affects the lungs. Most people who get infected never develop symptoms as their immune system manages to control the bacteria. Active tuberculosis occurs when the infection is no longer contained by the immune system, and typical symptoms are cough, chest pain, fever, night sweats, weight loss, and sometimes coughing up blood. Treatment is with a combination of antibiotic drugs, which must be taken for at least six months. </p> <p>People with tuberculosis are often malnourished, and malnourished people are at higher risk of developing tuberculosis as their immune system is weakened. Nutritional supplements could help people recover from the illness by strengthening their immune system, and by improving weight gain, and muscle strength, allowing them to return to an active life. Good nutrition requires a daily intake of macronutrients (carbohydrate, protein, and fat), and micronutrients (essential vitamins and minerals). </p> <p><b>What the research says</b> </p> <p><i><b>Effect of providing nutritional supplements to people being treated for tuberculosis</b> </i> </p> <p>We currently don't know if providing free food to tuberculosis patients, as hot meals or ration parcels, reduces death or improves cure (<i>very low quality evidence</i> ). However, it probably does improve weight gain in some settings (<i>moderate quality evidence</i> ), and may improve quality of life (<i>low quality evidence</i>). </p> <p>Routinely providing multi‐micronutrient supplements may have little or no effect on deaths in HIV‐negative people with tuberculosis (<i>low quality evidence</i> ), or HIV‐positive people who are not taking anti‐retroviral therapy (<i>moderate quality evidence</i> ). We currently don't know if micronutrient supplements have any effect on tuberculosis treatment outcomes (<i>very low quality evidence</i> ), but they may have no effect on weight gain (<i>low quality evidence</i>). No studies have assessed the effect on quality of life. </p> <p>Plasma levels of vitamin A appear to increase after starting tuberculosis treatment regardless of supplementation. In contrast, supplementation probably does improve plasma levels of zinc, vitamin D, vitamin E, and selenium, but this has not been shown to have clinically important benefits. Despite multiple studies of vitamin D supplementation in different doses, statistically significant benefits on sputum conversion have not been demonstrated. </p> <p><b>Authors' conclusions</b> </p> <p>Food or energy supplements may improve weight gain during recovery from tuberculosis in some settings, but there is currently no evidence that they improve tuberculosis treatment outcomes. There is also currently no reliable evidence that routinely supplementing above recommended daily amounts has clinical benefits. </p> </div> </section> <section id="vls" style="display: none"> <div class="section-header section-collapse-header"> <h2 class="title section-collapse-title">Visual summary<i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i></h2> </div> <a href="" target="_blank"><img alt="visual summary" src=""/></a> </section> <section class="conclusions"> <div class="section-header section-collapse-header" id="CD006086-sec-0152" lang="en"> <h2 class="title section-collapse-title"> Authors' conclusions <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="authorsConclusions" lang="en"> <div class="section-header" id="CD006086-sec-0152"></div> <h3 class="title" id="CD006086-sec-0153">Implications for practice</h3> <section id="CD006086-sec-0153"> <p>There is insufficient research to know whether routinely providing free food or energy supplements results in better tuberculosis treatment outcomes, but limited evidence suggests it probably improves weight gain. </p> <p>Although blood levels of some vitamins may be low in patients starting treatment for active tuberculosis, there is currently no reliable evidence that routinely supplementing above recommended daily amounts has clinical benefits. </p> </section> <h3 class="title" id="CD006086-sec-0154">Implications for research</h3> <section id="CD006086-sec-0154"> <p>High quality studies of food provision to tuberculosis patients in food‐insecure settings are urgently needed to support the continued expenditure on food support to tuberculosis programmes. In designing these studies, researchers, and programme managers need to be clear about the aim of food provision. Whilst an effect on mortality would provide strong advocacy for continued financial support, if the primary aim is to promote adherence, or to mitigate the catastrophic financial consequences of the illness, then these are the outcomes that should be measured, and appropriate comparison interventions should be selected. If the primary aim is to reduce mortality, then future trials must be large enough to reliably detect or exclude an effect. </p> <p>The failure to demonstrate a beneficial effect with micronutrient supplementation does not imply that one does not exist. Further studies, perhaps using higher doses, would still be beneficial but should have adequate sample sizes to reliably detect or exclude clinically important benefits. It would also be useful if some standardization of outcome measurements could be made. </p> <p>For nutritional recovery it seems important to assess changes in weight and lean body mass during the first two months of treatment rather than as a single measure at the end of treatment. It is also essential that measures of how this translates into improved quality of life and physical functioning are made, as weight gain on its own is of little interest. </p> </section> </section> </section> <section class="summaryOfFindings"> <div class="section-header section-collapse-header" id="CD006086-sec-0051" lang="en"> <h2 class="title section-collapse-title"> Summary of findings <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="summaryOfFindings" lang="en"> <div class="section-header" id="CD006086-sec-0051"></div> <div class="table" id="CD006086-tbl-0001"> <table class="summary-of-findings framed"><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Summary of findings for the main comparison.</span> <span class="table-title">'Summary of findings' table 1</span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Food provision compared with nutritional advice or no intervention for patients with active tuberculosis</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Patient or population:</b> adults and children with active tuberculosis </p> <p><b>Settings:</b> low‐ and middle‐income countries </p> <p><b>Intervention:</b> calorie supplementation as food or energy dense supplements </p> <p><b>Comparison:</b> nutritional advice, micronutrient supplement, or no intervention </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="center" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Illustrative comparative risks* (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Number of participants<br/> (trials)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Quality of the evidence<br/> (GRADE)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Comments</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Assumed risk</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Corresponding risk</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Standard care</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Increased calorie intake</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Death</b> </p> <p>(at 6 months)</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>3 per 100</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>1 per 100</b> <br/> (0 to 4) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>RR 0.34</b> <br/> (0.10 to 1.20) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>567<br/> (4 trials) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/> <b>very low</b><sup>1,2,3</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>We don't know if food supplementation reduces mortality from tuberculosis in food‐insecure settings </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Cured</b> </p> <p>(at 6 months)</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>48 per 100</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>44 per 100</b> <br/> (28 to 68) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>RR 0.91</b> <br/> (0.59 to 1.41) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>102<br/> (1 trial) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/> <b>very low</b><sup>2,3,4</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>We don't know if food supplementation increases cure in tuberculosis patients</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Treatment completion</b> <br/> (at 6 months) </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>79 per 100</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>85 per 100</b> <br/> (70 to 100) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not pooled</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>365<br/> (2 trials) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/> <b>very low</b><sup>3,5,6</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>We don't know if food supplementation increases treatment completion in tuberculosis patients </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Sputum negative</b> </p> <p>(at 8 weeks)</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>76 per 100</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>82 per 100</b> <br/> (65 to 100) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>RR 1.08</b> <br/> (0.86 to 1.37) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>222<br/> (3 trials) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/> <b>very low</b><sup>3,5,6</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>We don't know if food supplementation reduces the duration of sputum positivity in tuberculosis patients </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Mean weight gain</b> </p> <p>(At 8 weeks)</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not pooled</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>883<br/> (5 trials) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊝<br/> <b>moderate</b><sup>7,8</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Supplementation probably increases weight gain during treatment</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Quality of life</b> <br/> (At 8 weeks) </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not pooled</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>134<br/> (2 trials) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/> <b>low</b><sup>9,10</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Supplementation may increase quality of life scores during the first 2 months of treatment</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*The <b>assumed risk</b> is taken from the mean risk in the control groups in the included studies. The <b>corresponding risk</b> (and its 95% CI) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/> <b>Abbreviations:</b> CI = confidence interval; RR = risk ratio; GRADE = Grading of Recommendations Assessment, Development and Evaluation. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>GRADE Working Group grades of evidence<br/> <b>High quality:</b> further research is very unlikely to change our confidence in the estimate of effect.<br/> <b>Moderate quality:</b> further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.<br/> <b>Low quality:</b> further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.<br/> <b>Very low quality:</b> we are very uncertain about the estimate. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>1</sup>Three trials reported some deaths during the 6 months of treatment (<a href="./references#CD006086-bbs2-0006" title="JahnaviG , SudhaCH . Randomised controlled trial of food supplements in patients with newly diagnosed tuberculosis and wasting. Singapore Medical Journal2010;51(12):957‐62. ">Jahnavi 2010 IND</a>; <a href="./references#CD006086-bbs2-0007" title="JeremiahK , DentiP , ChigutsaE , Faurholt‐JepsenD , PrayGodG , RangeN , et al. Nutritional supplementation increases rifampin exposure among tuberculosis patients co‐infected with HIV. Antimicrobial Agents and Chemotherapy2014;58(6):3468‐74. ">Jeremiah 2014 TZA</a>; <a href="./references#CD006086-bbs2-0031" title="SudarsanamTD , JohnJ , KangG , MahendriV , GerriorJ , FranciosaM , et al. Pilot randomized trial of nutritional supplementation in patients with tuberculosis and HIV‐tuberculosis coinfection receiving directly observed short‐course chemotherapy for tuberculosis. Tropical Medicine and International Health2011;16(6):699‐706. ">Sudarsanam 2010 IND</a>), and 1 reported that no deaths occurred (<a href="./references#CD006086-bbs2-0013" title="MartinsN , MorrisP , KellyPM . Food incentives to improve completion of tuberculosis treatment: randomised controlled trial in Dili, Timor‐Leste. BMJ2009;229:b4248. ">Martins 2009 TLS</a>). The trials were conducted in Tanzania, Timor‐Leste, and India in participants with signs of undernutrition. <a href="./references#CD006086-bbs2-0013" title="MartinsN , MorrisP , KellyPM . Food incentives to improve completion of tuberculosis treatment: randomised controlled trial in Dili, Timor‐Leste. BMJ2009;229:b4248. ">Martins 2009 TLS</a> gave a daily hot meal, <a href="./references#CD006086-bbs2-0031" title="SudarsanamTD , JohnJ , KangG , MahendriV , GerriorJ , FranciosaM , et al. Pilot randomized trial of nutritional supplementation in patients with tuberculosis and HIV‐tuberculosis coinfection receiving directly observed short‐course chemotherapy for tuberculosis. Tropical Medicine and International Health2011;16(6):699‐706. ">Sudarsanam 2010 IND</a> gave monthly ration packs, <a href="./references#CD006086-bbs2-0006" title="JahnaviG , SudhaCH . Randomised controlled trial of food supplements in patients with newly diagnosed tuberculosis and wasting. Singapore Medical Journal2010;51(12):957‐62. ">Jahnavi 2010 IND</a> gave daily locally appropriate supplements, and <a href="./references#CD006086-bbs2-0007" title="JeremiahK , DentiP , ChigutsaE , Faurholt‐JepsenD , PrayGodG , RangeN , et al. Nutritional supplementation increases rifampin exposure among tuberculosis patients co‐infected with HIV. Antimicrobial Agents and Chemotherapy2014;58(6):3468‐74. ">Jeremiah 2014 TZA</a> gave high energy multivitamin enriched biscuits.<br/> <sup>2</sup>Downgraded by 1 for indirectness: trials are only available from limited settings. Food supplementation would plausibly have its biggest effect in highly food‐insecure or emergency settings which are not reflected in these trials.<br/> <sup>3</sup>Downgraded by 2 for imprecision: the trials and meta‐analysis are significantly underpowered to either detect or exclude an effect if it exists.<br/> <sup>4</sup>Data on successful cure at 6 months is only available from <a href="./references#CD006086-bbs2-0031" title="SudarsanamTD , JohnJ , KangG , MahendriV , GerriorJ , FranciosaM , et al. Pilot randomized trial of nutritional supplementation in patients with tuberculosis and HIV‐tuberculosis coinfection receiving directly observed short‐course chemotherapy for tuberculosis. Tropical Medicine and International Health2011;16(6):699‐706. ">Sudarsanam 2010 IND</a> which randomized tuberculosis patients in India to monthly ration packs or advice only.<br/> <sup>5</sup>Two trials report on tuberculosis treatment completion at 6 months (<a href="./references#CD006086-bbs2-0006" title="JahnaviG , SudhaCH . Randomised controlled trial of food supplements in patients with newly diagnosed tuberculosis and wasting. Singapore Medical Journal2010;51(12):957‐62. ">Jahnavi 2010 IND</a>; <a href="./references#CD006086-bbs2-0013" title="MartinsN , MorrisP , KellyPM . Food incentives to improve completion of tuberculosis treatment: randomised controlled trial in Dili, Timor‐Leste. BMJ2009;229:b4248. ">Martins 2009 TLS</a>). One trial was conducted in India and 1 in Timor‐Leste in participants with signs of undernutrition. Both trials gave daily locally appropriate supplements.<br/> <sup>6</sup>Downgraded by 1 for inconsistency. <a href="./references#CD006086-bbs2-0006" title="JahnaviG , SudhaCH . Randomised controlled trial of food supplements in patients with newly diagnosed tuberculosis and wasting. Singapore Medical Journal2010;51(12):957‐62. ">Jahnavi 2010 IND</a> found a statistically significant benefit while the larger trial, <a href="./references#CD006086-bbs2-0013" title="MartinsN , MorrisP , KellyPM . Food incentives to improve completion of tuberculosis treatment: randomised controlled trial in Dili, Timor‐Leste. BMJ2009;229:b4248. ">Martins 2009 TLS</a>, did not.<br/> <sup>7</sup>Five studies reported measures of weight gain but at different time‐points, which prevented meta‐analysis.<br/> <sup>8</sup>Downgraded by 1 for inconsistency. <a href="./references#CD006086-bbs2-0023" title="PraygodG , RangeN , Faurholt‐JepsenD , JeremiahK , Faurholt‐JepsenM , AabyeMG , et al. Daily multi‐micronutrient supplementation during tuberculosis treatment increases weight and grip strength among HIV‐uninfected but not HIV‐infected patients in Mwanza, Tanzania. The Journal of Nutrition2011;141:685‐91. PraygodG , RangeN , Faurholt‐JepsenD , JeremiahK , Faurholt‐JepsenM , AabyeMG , et al. The effect of energy‐protein supplementation on weight, body composition and handgrip strength among pulmonary tuberculosis HIV‐co‐infected patients: randomised controlled trial in Mwanza, Tanzania. The British Journal of Nutrition2012;107(2):263‐71. ">Praygod 2011b TZA</a> included only HIV‐positive patients and although the trend was towards a benefit this did not reach statistical significance. <a href="./references#CD006086-bbs2-0007" title="JeremiahK , DentiP , ChigutsaE , Faurholt‐JepsenD , PrayGodG , RangeN , et al. Nutritional supplementation increases rifampin exposure among tuberculosis patients co‐infected with HIV. Antimicrobial Agents and Chemotherapy2014;58(6):3468‐74. ">Jeremiah 2014 TZA</a> noted a greater increase in mean weight gain in the supplemented group compared to the non‐supplemented group after 8 weeks; however the difference was not appreciable (1.09 kg, P &lt; 0.6, authors' own figures). The 3 other trials all demonstrated clinically important benefits.<br/> <sup>9</sup>Downgraded by 1 for indirectness. Only 2 small trials, 1 from Singapore (<a href="./references#CD006086-bbs2-0020" title="PatonNI , ChuaYK , EarnestA , CheeCB . Randomized controlled trial of nutritional supplementation in patients with newly diagnosed tuberculosis and wasting. American Journal of Clinical Nutrition2004;80(2):460‐5. ">Paton 2004 SGP</a>) and 1 from India (<a href="./references#CD006086-bbs2-0006" title="JahnaviG , SudhaCH . Randomised controlled trial of food supplements in patients with newly diagnosed tuberculosis and wasting. Singapore Medical Journal2010;51(12):957‐62. ">Jahnavi 2010 IND</a>) report quality of life scores. The results can not be generalized to other populations or settings with any certainty.<br/> <sup>10</sup>Downgraded by 1 for imprecision. The presented data appear highly skewed and could not be pooled. </p> </div> </td> </tr> </tfoot> </table> </div> <div class="table" id="CD006086-tbl-0002"> <table class="summary-of-findings framed"><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Summary of findings 2.</span> <span class="table-title">'Summary of findings' table 2</span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Multi‐micronutrient supplementation compared with placebo for patients with active tuberculosis</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Patient or population:</b> adults and children with active tuberculosis </p> <p><b>Settings:</b> low‐ and middle‐income countries </p> <p><b>Intervention:</b> multi‐micronutrient supplements </p> <p><b>Comparison:</b> placebo or no intervention </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="center" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Illustrative comparative risks* (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Number of participants<br/> (studies)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Quality of the evidence<br/> (GRADE)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Comments</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Assumed risk</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Corresponding risk</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Placebo</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Multi‐micronutrients</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p><b>Death</b> </p> </td> <td align="center" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>HIV‐negative participants</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>RR 0.86</b> <br/> (0.46 to 1.6) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>1219<br/> (4 trials) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊝⊝<br/> <b>low</b><sup>1,2,3</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Multi‐micronutrient supplements may have little or no effect on mortality in HIV‐negative tuberculosis patients </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>40 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>34 per 1000</b> <br/> (18 to 64) </p> </td> </tr> <tr class="separated"> <td align="center" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>HIV‐positive participants</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>RR 0.92</b> <br/> (0.69 to 1.23) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>1429<br/> (3 trials) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊕⊝<br/> <b>moderate</b><sup>4,5</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Multi‐micronutrients probably have little or no effect on mortality in HIV‐positive tuberculosis patients not on ARV therapy </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>357 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>328 per 1000</b> <br/> (246 to 439) </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Cure rate</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>(0 trials)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>We don't know if multi‐micronutrients improve cure in tuberculosis patients</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Treatment completion</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>970 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>960 per 1000</b> </p> <p>(920 to 101)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>RR 0.99</b> (0.95 to 1.04) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>302</p> <p>(1 trial)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/> <b>very low</b><sup>6,7</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>We don't know if multi‐micronutrients improve treatment completion in tuberculosis patients </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Remaining sputum positive</b> <br/> (at 4 weeks) </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>309 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>312 per 1000</b> <br/> (263 to 371) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>RR 0.92</b> <br/> (0.63 to 1.35) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1020<br/> (2 studies) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/> <b>very low</b><sup>8,9,10</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>We don't know if multi‐micronutrients reduce the proportion of patients still sputum positive at 4 weeks </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Weight gain</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not pooled</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2940<br/> (5 trials) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/> <b>low</b><sup>11</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Multi‐micronutrient supplements may not improve weight gain in tuberculosis patients</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Quality of life</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>(0 trials)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>We don't know if multi‐micronutrients improve quality of life in tuberculosis patients</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*The <b>assumed risk</b> is taken from the risk in the control groups of the included studies. The <b>corresponding risk</b> (and its 95% CI) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/> <b>Abbreviations:</b> CI = confidence interval; RR = risk ratio; GRADE = Grading of Recommendations Assessment, Development and Evaluation. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>GRADE Working Group grades of evidence<br/> <b>High quality:</b> further research is very unlikely to change our confidence in the estimate of effect.<br/> <b>Moderate quality:</b> further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.<br/> <b>Low quality:</b> further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.<br/> <b>Very low quality:</b> we are very uncertain about the estimate. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>1</sup>Five RCTs comparing multi‐micronutrient supplementation with placebo in adults (<a href="./references#CD006086-bbs2-0025" title="RangeN , AndersenAB , MagnussenP , MugomelaA , FriisH . The effect of micronutrient supplementation on treatment outcome in patients with pulmonary tuberculosis: a randomised controlled trial in Mwanza, Tanzania. Tropical Medicine and International Health2005;10(9):826‐32. RangeN , ChangaluchaJ , KrarupH , MagnussenP , AndersenAB , FriisH . The effect of multi‐vitamin/mineral supplementation on mortality during treatment of pulmonary tuberculosis: a randomised two‐by‐two factorial trial in Mwanza, Tanzania. British Journal of Nutrition2006;95(4):762‐70. ">Range 2005 TZA</a>; <a href="./references#CD006086-bbs2-0028" title="SembaRD , KumwendaJ , ZijlstraE , RicksMO , vanLettowM , WhalenC , et al. Micronutrient supplements and mortality of HIV‐infected adults with pulmonary TB: a controlled clinical trial. International Journal of Tuberculosis and Lung Disease2007;11(8):854‐9. ">Semba 2007 MWI</a>; <a href="./references#CD006086-bbs2-0033" title="VillamorE , MugusiF , UrassaW , BoschR J , SaathoffE , MatsumotoK , et al. A trial of the effect of micronutrient supplementation on treatment outcome, T cell counts, morbidity, and mortality in adults with pulmonary tuberculosis. The Journal of Infectious Diseases2008;197(11):1499‐505. ">Villamor 2008 TZA</a>) and children (<a href="./references#CD006086-bbs2-0011" title="LodhaR , MukherjeeA , SinghV , SinghS , FriisH , Faurholt‐JepsenD , et al. Effect of micronutrient supplementation on treatment outcomes in children with intrathoracic tuberculosis: a randomized controlled trial. American Journal of Clinical Nutrition2014;100(5):1287‐97. ">Lodha 2014 IND</a>; <a href="./references#CD006086-bbs2-0014" title="MehtaS , MugusiFM , BoschRJ , AboudS , ChatterjeeA , FinkelsteinJL , et al. A randomized trial of multivitamin supplementation in children with tuberculosis in Tanzania. Nutrition Journal2011;10:120. NCT00145184 . Effect of Multivitamin Supplements on Clinical and Immunological Response in Childhood Tuberculosis. https://clinicaltrials.gov/ct2/show/NCT00145184 (accessed 4 February 2016). ">Mehta 2011 TZA</a>), reported deaths during treatment. The exact composition of nutrients varied from 1 to 10 times the DRI. Three studies are from Tanzania, 1 from Malawi, and 1 from India. There is evidence of participants being significantly undernourished at baseline.<br/> <sup>2</sup>No serious inconsistency: statistical heterogeneity was low. Although the estimate of effect is trending towards a benefit this is due to 1 trial (<a href="./references#CD006086-bbs2-0033" title="VillamorE , MugusiF , UrassaW , BoschR J , SaathoffE , MatsumotoK , et al. A trial of the effect of micronutrient supplementation on treatment outcome, T cell counts, morbidity, and mortality in adults with pulmonary tuberculosis. The Journal of Infectious Diseases2008;197(11):1499‐505. ">Villamor 2008 TZA</a>), the remaining trials found non significant trends in the opposite direction. Not downgraded.<br/> <sup>3</sup>Downgraded by 2 for imprecision: the 95% CI of the pooled effect crosses 1 and includes a 2% absolute reduction in death which might be considered beneficial given the low cost of the intervention. The optimal information size to reliably detect a clinically beneficial effect if there is 1 is greater than 2000.<br/> <sup>4</sup>Downgraded by 1 for indirectness: none of the participants in these trials were receiving antiretroviral therapy (<a href="./references#CD006086-bbs2-0025" title="RangeN , AndersenAB , MagnussenP , MugomelaA , FriisH . The effect of micronutrient supplementation on treatment outcome in patients with pulmonary tuberculosis: a randomised controlled trial in Mwanza, Tanzania. Tropical Medicine and International Health2005;10(9):826‐32. RangeN , ChangaluchaJ , KrarupH , MagnussenP , AndersenAB , FriisH . The effect of multi‐vitamin/mineral supplementation on mortality during treatment of pulmonary tuberculosis: a randomised two‐by‐two factorial trial in Mwanza, Tanzania. British Journal of Nutrition2006;95(4):762‐70. ">Range 2005 TZA</a>; <a href="./references#CD006086-bbs2-0028" title="SembaRD , KumwendaJ , ZijlstraE , RicksMO , vanLettowM , WhalenC , et al. Micronutrient supplements and mortality of HIV‐infected adults with pulmonary TB: a controlled clinical trial. International Journal of Tuberculosis and Lung Disease2007;11(8):854‐9. ">Semba 2007 MWI</a>; <a href="./references#CD006086-bbs2-0033" title="VillamorE , MugusiF , UrassaW , BoschR J , SaathoffE , MatsumotoK , et al. A trial of the effect of micronutrient supplementation on treatment outcome, T cell counts, morbidity, and mortality in adults with pulmonary tuberculosis. The Journal of Infectious Diseases2008;197(11):1499‐505. ">Villamor 2008 TZA</a>). The exact composition of nutrients varied from 1 to 10 times the DRI. Two studies are from Tanzania and 1 in Malawi. There is evidence of participants being significantly undernourished at baseline.<br/> <sup>5</sup>No serious imprecision: the 95% CI of the pooled effect crosses 1 and does includes a 5% absolute reduction in death which might be considered beneficial given the low cost of the intervention. However, the effect estimate is of no difference between the treatments and the optimal information size to reliably detect a clinically beneficial effect is met.<br/> <sup>6</sup>Downgraded by 2 for indirectness: current evidence is limited to 1 small trial (<a href="./references#CD006086-bbs2-0011" title="LodhaR , MukherjeeA , SinghV , SinghS , FriisH , Faurholt‐JepsenD , et al. Effect of micronutrient supplementation on treatment outcomes in children with intrathoracic tuberculosis: a randomized controlled trial. American Journal of Clinical Nutrition2014;100(5):1287‐97. ">Lodha 2014 IND</a>) conducted in moderately undernourished, HIV‐negative children in India, where treatment completion was very high in both groups. The result is not easily generalized to other settings.<br/> <sup>7</sup>Downgraded by 1 for imprecision: although this trial approaches adequate power to detect a result, the fact that treatment completion was so high in both arm renders the result irrelevant to settings where treatment completion is lower.<br/> <sup>8</sup>Downgraded by 1 for inconsistency. Statistical heterogeneity is high; 1 study found a non‐significant trend in favour of supplementation, and 1 study in favour of placebo.<br/> <sup>9</sup>Downgraded by 1 for indirectness. Both studies were conducted in Tanzania. Different populations may differ in their micronutrient deficiency or requirement.<br/> <sup>10</sup>Downgraded by 1 for imprecision. The 95% CI is wide and includes what may be clinically important effects.<br/> <sup>11</sup>Downgraded by 2 for inconsistency: Statistical heterogeneity is very high. Four studies from Tanzania and India found no evidence of improved weight gain with supplements, while 1 study from Tanzania found large increases in weight with micronutrients at 8 months. </p> </div> </td> </tr> </tfoot> </table> </div> </section> </section> <section class="background"> <div class="section-header section-collapse-header" id="CD006086-sec-0052" lang="en"> <h2 class="title section-collapse-title"> Background <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="background" lang="en"> <div class="section-header" id="CD006086-sec-0052"></div> <section id="CD006086-sec-0053"> <h3 class="title" id="CD006086-sec-0053">Description of the condition</h3> <p>Tuberculosis is an infection caused by the bacterium <i>Mycobacterium tuberculosis,</i> which is spread from person to person by inhalation of respiratory droplets (<a href="./references#CD006086-bbs2-0082" title="HarriesAD , DyeC . Tuberculosis. Annals of Tropical Medicine and Parasitology2006;100(5‐6):415‐31. ">Harries 2006</a>). In 2013, the World Health Organization (WHO) estimated that there were nine million new cases of active tuberculosis worldwide, and 1.5 million deaths (<a href="./references#CD006086-bbs2-0106" title="World Health Organization. Global Tuberculosis Report 2014. Geneva: World Health Organization, 2014. ">WHO 2014</a>). </p> <p>Most people who are infected with <i>M. tuberculosis</i> develop what is known as latent tuberculosis. People with latent tuberculosis are infected with the bacterium <i>Mycobacterium tuberculosis</i>, but the infection is contained by their immune system. These people remain well and do not exhibit any clinical signs or symptoms of illness (<a href="./references#CD006086-bbs2-0076" title="BarryCE3rd , BoshoffHI , DartoisV , DickT , EhrtS , FlynnJ , et al. The spectrum of latent tuberculosis: rethinking the biology and intervention strategies. Nature Reviews. Microbiology2009;7(12):845‐55. ">Barry 2009</a>). The immune response to infection is complex, it initially involves the uptake of the bacterium into macrophage cells as part of the non‐specific 'innate' immune response, and later recruitment of both B‐ and T‐lymphocytes of the cellular immune response (<a href="./references#CD006086-bbs2-0096" title="SchlugerNW , RomWN . The host immune response to tuberculosis. American Journal of Respiratory Critical Care Medicine1998;157(3 Pt 1):679‐91. ">Schluger 1998</a>). These cells isolate the bacterium as a granuloma, typically in the lung (<a href="./references#CD006086-bbs2-0095" title="SaundersBM , BrittonWJ . Life and death in the granuloma: immunopathology of tuberculosis. Immunology and Cell Biology2007;85(2):103‐11. ">Saunders 2007</a>). </p> <p>Active tuberculosis occurs when the infection is no longer contained by the immune system, and can occur at any time following infection. The lifetime risk of conversion from latent to active tuberculosis is around 5% to 10% in an otherwise healthy population (<a href="./references#CD006086-bbs2-0082" title="HarriesAD , DyeC . Tuberculosis. Annals of Tropical Medicine and Parasitology2006;100(5‐6):415‐31. ">Harries 2006</a>), but this can rise to around 50% in people with severe impairment of their immune system, such as occurs with human immunodeficiency virus (HIV) infection (<a href="./references#CD006086-bbs2-0110" title="ZumlaA , MalonP , HendersonJ , GrangeJM . Impact of HIV infection on tuberculosis. Postgraduate Medical Journal2000;76(895):259‐68. ">Zumla 2000</a>; <a href="./references#CD006086-bbs2-0074" title="AaronL , SaadounD , CalatroniI , LaunayO , MémainN , VincentV , et al. Tuberculosis in HIV‐infected patients: a comprehensive review. Clinical Microbiology and Infection2004;10(5):388‐98. ">Aaron 2004</a>). </p> <p>Tuberculosis most commonly affects the lungs (pulmonary tuberculosis), but can also spread to affect the central nervous system, lymphatic system, circulatory system, genitourinary system, and bones and joints. The symptoms of active pulmonary tuberculosis include cough, chest pain, fever, night sweats, weight loss, and sometimes coughing up blood (<a href="./references#CD006086-bbs2-0082" title="HarriesAD , DyeC . Tuberculosis. Annals of Tropical Medicine and Parasitology2006;100(5‐6):415‐31. ">Harries 2006</a>). </p> <p>Tuberculosis is treated with a combination of antibiotic drugs (antituberculous therapy), which must be taken for a period of at least six months to ensure success (<a href="./references#CD006086-bbs2-0105" title="World Health Organization. Treatment of Tuberculosis Guidelines. 4th Edition. Geneva: World Health Organization, 2010. ">WHO 2010</a>). If left untreated, around half of those with active tuberculosis will die of the disease (<a href="./references#CD006086-bbs2-0079" title="CorbettEL , WattCJ , WalkerN , MaherD , WilliamsBG , RaviglioneMC , et al. The growing burden of tuberculosis: global trends and interactions with the HIV epidemic. Archives of Internal Medicine2003;163(9):1009‐21. ">Corbett 2003</a>). With adequate treatment the mortality is around 5% globally (<a href="./references#CD006086-bbs2-0104" title="World Health Organization. Global Tuberculosis Control. A short update to the 2009 report. Geneva: World Health Organization, 2009. ">WHO 2009</a>), although this may be higher in HIV‐positive people (<a href="./references#CD006086-bbs2-0074" title="AaronL , SaadounD , CalatroniI , LaunayO , MémainN , VincentV , et al. Tuberculosis in HIV‐infected patients: a comprehensive review. Clinical Microbiology and Infection2004;10(5):388‐98. ">Aaron 2004</a>). The WHO target for successful cure in national tuberculosis control programmes is 85% (<a href="./references#CD006086-bbs2-0104" title="World Health Organization. Global Tuberculosis Control. A short update to the 2009 report. Geneva: World Health Organization, 2009. ">WHO 2009</a>). </p> <p>Throughout the world, poor nutritional status is more common in people with active tuberculosis than in people without tuberculosis (<a href="./references#CD006086-bbs2-0101" title="vanLettowM , FawziWW , SembaRD . Triple trouble: the role of malnutrition in tuberculosis and human immunodeficiency virus coinfection. Nutrition Reviews2003;61(3):81‐90. ">van Lettow 2003</a>), and weight loss, including loss of lean body mass, is a well‐recognized symptom of the disease. Cohort and cross‐sectional studies have suggested that active tuberculosis is commonly associated with low serum levels of important micronutrients such as zinc (<a href="./references#CD006086-bbs2-0100" title="TanejaDP . Observations of serum zinc in patients with pulmonary tuberculosis. Journal of the Indian Medical Association1990;88(10):280‐1. ">Taneja 1990</a>), and vitamins A, C, D, and E (<a href="./references#CD006086-bbs2-0080" title="DaviesPD , BrownRC , WoodheadJS . Serum concentrations of vitamin D metabolites in untreated tuberculosis. Thorax1985;40(3):187‐90. ">Davies 1985</a>; <a href="./references#CD006086-bbs2-0093" title="PlitMl , TheronAJ , FicklH , vanRensburgCE , PendelS , AndersonR . Influence of antimicrobial chemotherapy and smoking status on plasma concentrations of vitamin C, vitamin E, beta‐carotene, acute phase reactants, iron and lipid peroxides in patients with pulmonary tuberculosis. International Journal of Tuberculosis and Lung Disease1998;2(7):590‐9. ">Plit 1998</a>; <a href="./references#CD006086-bbs2-0092" title="NnoahamKE , ClarkeA . Low serum vitamin D levels and tuberculosis: a systematic review and meta‐analysis. International Journal of Epidemiology2008;37(1):113‐9. ">Nnoaham 2008</a>). However, the measurement of serum vitamin levels during an acute infection, such as tuberculosis, is known to be unreliable, as transient abnormalities can occur (<a href="./references#CD006086-bbs2-0087" title="LouwJA , WerbeckA , LouwMEJ , KotzeTJvW , CooperR , LabadariosD . Blood vitamin concentrations during the acute phase response. Critical Care Medicine1992;20(7):934‐41. ">Louw 1992</a>). </p> <p>The daily nutritional requirements for healthy individuals of all age groups are well described (<a href="./references#CD006086-bbs2-0090" title="National Academy of Sciences. Dietary Reference Intakes: The Essential Guide to Nutrient Requirements. 6th Edition. Washington DC: National Academies Press, 2006. ">Meyers 2006</a>), and it is unlikely that people with active tuberculosis would require less than these recommended amounts. The two important questions are therefore whether tuberculosis patients require more, and whether these increased requirements should be provided as part of routine health care. </p> <p>The effects of supplementation in people with HIV (but without tuberculosis) is covered in two other Cochrane Reviews (<a href="./references#CD006086-bbs2-0083" title="IrlamJH , VisserMME , RollinsNN , SiegfriedN . Micronutrient supplementation in children and adults with HIV infection. Cochrane Database of Systematic Reviews2010, Issue 12. [DOI: 10.1002/14651858.CD003650.pub3] ">Irlam 2010</a>; <a href="./references#CD006086-bbs2-0081" title="GroblerL , SiegfriedN , VisserME , MahlunguluSS , VolminkJ . Nutritional interventions for reducing morbidity and mortality in people with HIV. Cochrane Database of Systematic Reviews2013, Issue 2. [DOI: 10.1002/14651858.CD004536.pub3] ">Grobler 2013</a>). </p> </section> <section id="CD006086-sec-0054"> <h3 class="title" id="CD006086-sec-0054">Description of the intervention</h3> <p>Nutritional requirements can be broadly divided into macronutrients (carbohydrate, protein, and fat) and micronutrients (essential vitamins and trace elements). </p> <section id="CD006086-sec-0055"> <h4 class="title">Macronutrients</h4> <p>Each day the average 70 kg male requires approximately 2500 kilocalories (kcal) of energy to maintain body weight and composition; ideally consumed as 55% carbohydrate, 15% protein, and 30% fat (<a href="./references#CD006086-bbs2-0090" title="National Academy of Sciences. Dietary Reference Intakes: The Essential Guide to Nutrient Requirements. 6th Edition. Washington DC: National Academies Press, 2006. ">Meyers 2006</a>). </p> <p>If it was shown that patients with active tuberculosis required additional macronutrients; these could be purchased and consumed by the patient simply following nutritional advice. However, in many situations, especially in low‐ and middle‐income countries, the patient may not be able to acquire this additional food due to economic hardship through illness and loss of work, or due to local food insecurity (<a href="./references#CD006086-bbs2-0084" title="KamolratanakulP , SawertH , KongsinS , LertmaharitS , SriwongsaJ , Na‐SongkhlaS , et al. Economic impact of tuberculosis at the household level. International Journal of Tuberculosis and Lung Disease1999;3(7):596‐602. ">Kamolratanakul 1999</a>; <a href="./references#CD006086-bbs2-0108" title="WyssK , KilimaP , LorenzN . Costs of tuberculosis for households and health care providers in Dar es Salaam, Tanzania. Tropical Medicine &amp; International Health2001;6(1):60‐8. ">Wyss 2001</a>). In these situations healthcare services might provide increased nutrients through free provision of meals, take home rations, or specific high energy supplements. In many crisis or low‐income settings this already happens and the World Food Programme (WFP) in particular is involved in many food support programmes for tuberculosis patients (<a href="./references#CD006086-bbs2-0103" title="BaM , StraussA . Getting started: WFP food assistance in the context of tuberculosis care and treatment. World Food Programme, 2007. ">WFP 2007</a>). </p> </section> <section id="CD006086-sec-0056"> <h4 class="title">Micronutrients</h4> <p>The daily micronutrient requirements for an adult male are given in <a href="./appendices#CD006086-sec-0158">Appendix 1</a>. These are usually expressed as the 'dietary reference intake' (DRI), and this is different for each individual micronutrient (<a href="./references#CD006086-bbs2-0090" title="National Academy of Sciences. Dietary Reference Intakes: The Essential Guide to Nutrient Requirements. 6th Edition. Washington DC: National Academies Press, 2006. ">Meyers 2006</a>). </p> <p>These requirements can be gained from the consumption of a healthy, and varied diet, or through pharmaceutical supplementation as tablets, capsules, or powders. Any additional requirements could be gained through increased consumption following dietary advice, or through pharmaceutical provision via the health service or tuberculosis programme. </p> <p>In trials of macronutrient and micronutrient interventions two important factors should be noted. </p> <p> <ul id="CD006086-list-0001"> <li> <p>The intervention is a supplement and does not represent the total daily intake of that nutrient. </p> </li> <li> <p>Any benefit derived from the intervention is likely to be dependant on the initial nutritional status of the patient. </p> </li> </ul> </p> <p>In order to accurately interpret data it is therefore essential to consider both the baseline nutritional status, and the overall nutritional intake of the patients. </p> </section> </section> <section id="CD006086-sec-0057"> <h3 class="title" id="CD006086-sec-0057">How the intervention might work</h3> <p>Tuberculosis and undernutrition interact in a two‐way process. Tuberculosis can lead to weight loss and micronutrient deficiencies by increasing nutritional requirements, by changing metabolic processes, or by decreasing appetite and causing a reduction in food intake (<a href="./references#CD006086-bbs2-0089" title="MacallanDC . Malnutrition in tuberculosis. Diagnostic Microbiology and Infectious Disease1999;34(2):153‐7. ">Macallan 1999</a>). Alternatively, low body mass index (BMI; a measure of weight for height that is indicative of nutritional status) and some micronutrient deficiencies can depress cell‐mediated immunity, the key host defence against tuberculosis, increasing the susceptibility to active tuberculosis and delaying recovery (<a href="./references#CD006086-bbs2-0078" title="ChandraRK . Nutrition, immunity and infection: from basic knowledge of dietary manipulation of immune responses to practical application of ameliorating suffering and improving survival. Proceedings of the National Academy of Sciences of the United States of America1996;93(25):14304‐7. ">Chandra 1996</a>; <a href="./references#CD006086-bbs2-0109" title="ZachariahR , SpielmannMP , HarriesAD , SalaniponiFM . Moderate to severe malnutrition in patients with tuberculosis is a risk factor associated with early death. Transactions of the Royal Society of Tropical Medicine and Hygiene2002;96(3):291‐4. ">Zachariah 2002</a>; <a href="./references#CD006086-bbs2-0077" title="CegielskiJP , McMurrayDN . The relationship between malnutrition and tuberculosis, evidence from studies in humans and experimental animals. International Journal of Tuberculosis and Lung Disease2004;8(3):286‐98. ">Cegielski 2004</a>). </p> <p>The micronutrients which have received the most attention are the following.</p> <p> <ul id="CD006086-list-0002"> <li> <p>Vitamin A, which is involved in both T‐ and B‐lymphocyte function, macrophage activity and the generation of antibody responses (<a href="./references#CD006086-bbs2-0097" title="SembaRD . The role of vitamin A and related retinoids in immune function. Nutrition Reviews1998;56(1 Pt 2):S38‐48. ">Semba 1998</a>; <a href="./references#CD006086-bbs2-0099" title="StephensenCB . Vitamin A, infection, and immune function. Annual Review of Nutrition2001;21:167‐92. ">Stephensen 2001</a>). </p> </li> <li> <p>Vitamin D, which is involved in the function of macrophages, a key component of the immune response to tuberculosis (<a href="./references#CD006086-bbs2-0107" title="WintergerstES , MagginiS , HornigDH . Contribution of Selected Vitamins andTrace Elements to Immune Function. Annals of Nutrition &amp; Metabolism2007;51(4):301‐23. ">Wintergerst 2007</a>). </p> </li> <li> <p>Vitamin E, which has anti‐oxidant properties and may protect against T‐lympocyte failure due to oxidative stress (<a href="./references#CD006086-bbs2-0107" title="WintergerstES , MagginiS , HornigDH . Contribution of Selected Vitamins andTrace Elements to Immune Function. Annals of Nutrition &amp; Metabolism2007;51(4):301‐23. ">Wintergerst 2007</a>). </p> </li> <li> <p>Zinc, which is necessary for adequate functioning of many aspects of human immunity (<a href="./references#CD006086-bbs2-0098" title="ShankarAH , PrasadAS . Zinc and immune function: the biological basis of altered resistance to infection. American Journal of Clinical Nutrition1998;68(2 Suppl):447S‐63S. ">Shankar 1998</a>). </p> </li> <li> <p>Selenium; which is essential for both cell‐mediated and humoral immunity (<a href="./references#CD006086-bbs2-0075" title="ArthurJR , McKenzieyRC , BeckettGJ . Selenium in the Immune System. The Journal of Nutrition2003;133(5 Suppl 1):1457S‐9S. ">Arthur 2003</a>). </p> </li> </ul> </p> <p>Nutritional interventions, in people with active tuberculosis, therefore have the potential to do the following. </p> <p> <ul id="CD006086-list-0003"> <li> <p>Improve tuberculosis treatment outcomes; through restoration of cell‐mediated immunity, increasing the individuals' ability to fight the infection and hastening recovery from the illness. </p> </li> <li> <p>Promote nutritional recovery; with improved weight gain, restoration of muscle strength, function, and quality of life. Nutritional recovery is of great importance in tuberculosis treatment, allowing the patient to return to work, and recover economically as well as physically. </p> </li> </ul> </p> <p>Food may also be given to people with tuberculosis for quite different reasons, such as; to promote adherence to treatment, or to mitigate the financial consequences of prolonged illness. Another Cochrane Review is addressing the use of food to promote adherence (<a href="./references#CD006086-bbs2-0088" title="LutgeEE , KnightSE , VolminkJ . Incentives for improving patient adherence to anti‐tuberculosis treatment. Cochrane Database of Systematic Reviews2009, Issue 3. [DOI: 10.1002/14651858.CD007952] ">Lutge 2009</a>). </p> <p>In addition, it is important to note that pathogens such as tuberculosis also require certain micronutrients for their own metabolism, and greater availability of these nutrients through supplementation could encourage their growth. There is some evidence for this in the case of iron (<a href="./references#CD006086-bbs2-0086" title="LounisN , Truffot‐PernotC , GrossetJ , GordeukVR , BoelaertJR . Iron and Mycobacterium tuberculosis infection. Journal of Clinical Virology2001;20(3):123‐6. ">Lounis 2001</a>), and so nutritional interventions cannot be considered entirely benign. </p> </section> <section id="CD006086-sec-0058"> <h3 class="title" id="CD006086-sec-0058">Why it is important to do this review</h3> <p>There is currently no evidence‐based guidance on food provision or supplementation for adults or children being treated for tuberculosis, with or without concurrent HIV infection. This Cochrane Review seeks to assess the evidence for the effectiveness of different food and nutritional supplements in helping people to gain weight and recover from tuberculosis, and highlight where more research might be needed. </p> </section> </section> </section> <section class="objectives"> <div class="section-header section-collapse-header" id="CD006086-sec-0059" lang="en"> <h2 class="title section-collapse-title"> Objectives <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="objectives" lang="en"> <div class="section-header" id="CD006086-sec-0059"></div> <p>To assess the effects of oral nutritional supplements in people being treated with antituberculous drug therapy for active tuberculosis. </p> </section> </section> <section class="methods"> <div class="section-header section-collapse-header" id="CD006086-sec-0060" lang="en"> <h2 class="title section-collapse-title"> Methods <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="methods" lang="en"> <div class="section-header" id="CD006086-sec-0060"></div> <section id="CD006086-sec-0061"> <h3 class="title">Criteria for considering studies for this review</h3> <section id="CD006086-sec-0062"> <h4 class="title">Types of studies</h4> <p>Randomized controlled trials (RCTs).</p> </section> <section id="CD006086-sec-0063"> <h4 class="title">Types of participants</h4> <p>Children or adults being treated for active tuberculosis with or without concurrent HIV infection, and with or without a diagnosis of being underweight, malnourished, or nutrient deficient. </p> </section> <section id="CD006086-sec-0064"> <h4 class="title">Types of interventions</h4> <section id="CD006086-sec-0065"> <h5 class="title">Intervention</h5> <p>Any oral macro or micronutrient supplement given for at least four weeks.</p> <p>We excluded trials that assessed tube feeding or parenteral nutrition, and trials that assessed dietary advice alone without the actual provision of supplements. </p> </section> <section id="CD006086-sec-0066"> <h5 class="title">Control</h5> <p>No nutritional intervention, placebo, or dietary advice alone.</p> </section> </section> <section id="CD006086-sec-0067"> <h4 class="title">Types of outcome measures</h4> <section id="CD006086-sec-0068"> <h5 class="title">Primary outcomes</h5> <p> <ul id="CD006086-list-0004"> <li> <p>All‐cause death.</p> </li> <li> <p>Cure (completed treatment and sputum‐smear or sputum‐culture negative) at six and 12 months. </p> </li> </ul> </p> </section> <section id="CD006086-sec-0069"> <h5 class="title">Secondary outcomes</h5> <p> <ul id="CD006086-list-0005"> <li> <p>Completion of treatment.</p> </li> <li> <p>Sputum positive at follow‐up.</p> </li> <li> <p>Self‐reported recovery from illness or resolution of symptoms.</p> </li> <li> <p>Change in weight, skinfold thickness, or other measure of lean or total mass.</p> </li> <li> <p>Any measure of growth in children.</p> </li> <li> <p>Any measures of physical functioning, quality of life, or ability to return to work.</p> </li> <li> <p>Total calorie intake.</p> </li> <li> <p>Micronutrient levels before and after supplementation.</p> </li> </ul> </p> <p>We intended to include cure assessed at six and 12 months, as is customary. For other outcome measures, we accepted data presented at any time point. </p> </section> </section> </section> <section id="CD006086-sec-0070"> <h3 class="title">Search methods for identification of studies</h3> <p>We attempted to identify all relevant trials regardless of language or publication status (published or unpublished, in press, or in progress). </p> <section id="CD006086-sec-0071"> <h4 class="title">Electronic searches</h4> <p>We searched the following databases using the search terms and strategy described in <a href="./appendices#CD006086-sec-0159">Appendix 2</a>. </p> <p> <ul id="CD006086-list-0006"> <li> <p>Cochrane Infectious Disease Group Specialized Register.</p> </li> <li> <p>Cochrane Central Register of Controlled Trials (CENTRAL; Issue 1, 2016).</p> </li> <li> <p>MEDLINE (from 1946 to 4 February 2016).</p> </li> <li> <p>EMBASE (from 1980 to 4 February 2016).</p> </li> <li> <p>LILACS (from 1982 to 4 February 2016).</p> </li> </ul> </p> <p>We checked the <i>meta</i> Register of Controlled Trials (<i>m</i>RCT) and the World Health Organization (WHO) International Clinical Trials Registry Platform (ICTRP) (<a href="http://www.who.int/ictrp/search/en" target="_blank">www.who.int/ictrp/search/en</a>) up to 4 February 2016, using 'tuberculosis' and 'supplementation' as search terms. </p> <p>In addition we searched the <i>Indian Journal of Tuberculosis</i> using the keywords given in the search strategy (<a href="./appendices#CD006086-sec-0159">Appendix 2</a>) on 4 February 2016. </p> </section> <section id="CD006086-sec-0072"> <h4 class="title">Searching other resources</h4> <p>We also checked the reference lists of all studies identified by the above methods.</p> </section> </section> <section id="CD006086-sec-0073"> <h3 class="title" id="CD006086-sec-0073">Data collection and analysis</h3> <section id="CD006086-sec-0074"> <h4 class="title">Selection of studies</h4> <p>Two review authors (Liesl Grobler (LG) and Sukrti Nagpal (SN)/Thambu Sudarsanam (TS)) independently screened all citations and abstracts identified in the search for potentially eligible studies. Full reports of potentially eligible studies were obtained and assessed for inclusion in the review by the same authors using a pre‐designed eligibility form based on the inclusion criteria. Where it was unclear whether a study was eligible for the review, we attempted to contact the authors for clarification. We resolved differences in opinion by discussion and, where necessary, by discussion with a fourth author (David Sinclair). We screened all papers for multiple publications. We excluded studies that did not meet the criteria and documented the reasons for their exclusion. </p> </section> <section id="CD006086-sec-0075"> <h4 class="title">Data extraction and management</h4> <p>Two review authors (LG and SN) independently extracted data using a tailored data extraction form. We extracted data on study design, participant characteristics, interventions, and outcomes. </p> <p>For dichotomous data, we extracted the number of participants with the outcome and the total number analysed. For continuous data, we extracted the arithmetic mean and standard deviation (SD) for each group. If medians were used, we also extracted the ranges where possible. If there was skewed continuous data, we planned to extract geometric means where presented by the trial author(s). We resolved any discrepancies regarding extracted data by discussion between the review authors. </p> </section> <section id="CD006086-sec-0076"> <h4 class="title">Assessment of risk of bias in included studies</h4> <p>Two review authors (LG and SN) independently assessed components of risk of bias of the included trials using the Cochrane 'Risk of bias' assessment tool (<a href="./references#CD006086-bbs2-0094" title="The Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager (RevMan). Version 5.3. Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration, 2014. ">RevMan 2014</a>), and discussed any differences of opinion. We followed the guidance to assess whether adequate steps were taken to reduce the risk of bias across six domains: sequence generation, allocation concealment, blinding (of participants, personnel, and outcome assessors), incomplete outcome data, selective outcome reporting, and other sources of bias. We categorized our judgements as either 'low', 'high', or 'unclear' risk of bias. Where our judgment was 'unclear', we attempted to contact the trial authors for clarification. </p> </section> <section id="CD006086-sec-0077"> <h4 class="title">Measures of treatment effect</h4> <p>We compared interventions using risk ratios (RR) for dichotomous data, and mean difference (MD) values for continuous data. We presented all results with 95% confidence intervals (CIs). </p> </section> <section id="CD006086-sec-0078"> <h4 class="title">Unit of analysis issues</h4> <p>We split trials that included more than two comparison groups and analysed them as individual pair‐wise comparisons. When we conducted meta‐analysis we ensured that we did not count participants and cases in the placebo group more than once, by dividing the placebo cases and participants evenly between the intervention groups. </p> </section> <section id="CD006086-sec-0079"> <h4 class="title">Dealing with missing data</h4> <p>If data from the trial reports were insufficient, unclear, or missing, we attempted to contact the trial authors for additional information. </p> </section> <section id="CD006086-sec-0080"> <h4 class="title">Assessment of heterogeneity</h4> <p>We assessed heterogeneity amongst trials by inspection of the forest plots (to detect overlapping CIs), the I² statistic with a level of 50% to denote moderate levels of heterogeneity, and application of the Chi² test with a P value of 0.10 to indicate appreciable heterogeneity. </p> </section> <section id="CD006086-sec-0081"> <h4 class="title">Assessment of reporting biases</h4> <p>We planned to assess the likelihood of publication bias by examining the funnel plots for asymmetry. However, there were too few trials to make this assessment meaningful. </p> </section> <section id="CD006086-sec-0082"> <h4 class="title">Data synthesis</h4> <p>We analysed the data using Review Manager (RevMan) (<a href="./references#CD006086-bbs2-0094" title="The Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager (RevMan). Version 5.3. Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration, 2014. ">RevMan 2014</a>). Using pair‐wise meta‐analyses we compared the treatments. We stratified meta‐analyses by time‐point or HIV status where appropriate. </p> <p>When there was no statistically significant heterogeneity we used the fixed‐effect meta‐analysis model. When we observed moderate statistically significant heterogeneity within groups that we could not explain by subgroup or sensitivity analyses we used a random‐effects meta‐analysis model to synthesize the data. When a pooled meta‐analysis result was considered to be meaningless because of clinical or substantial statistical heterogeneity the results are presented in a forest plot without a pooled estimate of effect. </p> <p>Data presented as medians and ranges are presented in tables and described in the narrative. Highly skewed continuous data (where the SDs were larger than the means) are only presented in tables. </p> </section> <section id="CD006086-sec-0083"> <h4 class="title">Subgroup analysis and investigation of heterogeneity</h4> <p>Due to the small number of included trials or each comparison, the investigation of heterogeneity was not necessary or possible. In future updates of this Cochrane review we may perform subgroup analyses by: HIV status, nutritional status at baseline, presence of co‐morbidities, and specific micronutrient level at baseline. </p> </section> <section id="CD006086-sec-0084"> <h4 class="title">Sensitivity analysis</h4> <p>We have planned to perform a sensitivity analysis to investigate the robustness of the results to the 'Risk of bias' components. However, there were too few included trials for each comparison for this to be possible. </p> </section> </section> </section> </section> <section class="results"> <div class="section-header section-collapse-header" id="CD006086-sec-0085" lang="en"> <h2 class="title section-collapse-title"> Results <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="results" lang="en"> <div class="section-header" id="CD006086-sec-0085"></div> <section id="CD006086-sec-0086"> <h3 class="title">Description of studies</h3> <section id="CD006086-sec-0087"> <h4 class="title">Results of the search</h4> <p>The original search (June 2008) identified 47 articles, and the updated search (July 2011) identified a further 17 articles. The searches conducted in December 2014 and updated in February 2016 identified 48 published articles and 16 ongoing studies. In total the current review includes data from 39 reports, covering 35 individually randomized controlled trials (RCTs) (see <a href="#CD006086-fig-0001">Figure 1</a>). </p> <div class="figure" id="CD006086-fig-0001"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 1</div> </div> <hr class="top"/><img alt="Study flow diagram." data-id="CD006086-fig-0001" src="/cdsr/doi/10.1002/14651858.CD006086.pub4/media/CDSR/CD006086/image_n/nCD006086-AFig-FIG01.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Study flow diagram.</p> </div> </div> </div> </section> <section id="CD006086-sec-0088"> <h4 class="title">Included studies</h4> <section id="CD006086-sec-0089"> <h5 class="title">Participants</h5> <p>The 35 trials included 8285 participants. Twenty‐eight trials included only adults being treated for pulmonary tuberculosis, and three trials also included adults with extrapulmonary tuberculosis (<a href="./references#CD006086-bbs2-0035" title="WejseC , GomesVF , RabnaP , GustafsonP , AabyP , LisseIM , et al. Vitamin D as supplementary treatment for tuberculosis ‐ a double‐blind randomised placebo‐controlled trial. American Journal of Respiratory and Critical Care Medicine2009;179(9):843‐50. ">Wejse 2008 GNB</a>; <a href="./references#CD006086-bbs2-0006" title="JahnaviG , SudhaCH . Randomised controlled trial of food supplements in patients with newly diagnosed tuberculosis and wasting. Singapore Medical Journal2010;51(12):957‐62. ">Jahnavi 2010 IND</a>; <a href="./references#CD006086-bbs2-0031" title="SudarsanamTD , JohnJ , KangG , MahendriV , GerriorJ , FranciosaM , et al. Pilot randomized trial of nutritional supplementation in patients with tuberculosis and HIV‐tuberculosis coinfection receiving directly observed short‐course chemotherapy for tuberculosis. Tropical Medicine and International Health2011;16(6):699‐706. ">Sudarsanam 2010 IND</a>). Likewise of four studies in children, one included only pulmonary tuberculosis (<a href="./references#CD006086-bbs2-0005" title="HanekomWA , PotgeiterS , HughesEJ , MalanH , KessowG , HusseyGD . Vitamin A status and therapy in childhood pulmonary tuberculosis. Journal of Pediatrics1997;131(6):925‐7. ">Hanekom 1997 ZAF</a>), and three also included extrapulmonary tuberculosis (<a href="./references#CD006086-bbs2-0016" title="MorcosMM , GabrAA , SamualS , KamelM , elBazM , elBeshryM , et al. Vitamin D administration to tuberculous children and its value. Bollettino Chimico Farmaceutico1998;137(5):157‐64. ">Morcos 1998 EGY</a>; <a href="./references#CD006086-bbs2-0014" title="MehtaS , MugusiFM , BoschRJ , AboudS , ChatterjeeA , FinkelsteinJL , et al. A randomized trial of multivitamin supplementation in children with tuberculosis in Tanzania. Nutrition Journal2011;10:120. NCT00145184 . Effect of Multivitamin Supplements on Clinical and Immunological Response in Childhood Tuberculosis. https://clinicaltrials.gov/ct2/show/NCT00145184 (accessed 4 February 2016). ">Mehta 2011 TZA</a>; <a href="./references#CD006086-bbs2-0011" title="LodhaR , MukherjeeA , SinghV , SinghS , FriisH , Faurholt‐JepsenD , et al. Effect of micronutrient supplementation on treatment outcomes in children with intrathoracic tuberculosis: a randomized controlled trial. American Journal of Clinical Nutrition2014;100(5):1287‐97. ">Lodha 2014 IND</a>). </p> </section> <section id="CD006086-sec-0090"> <h5 class="title">HIV status</h5> <p>Eleven trials specifically included people with HIV, and presented some results separately for HIV positive and HIV negative participants (<a href="./references#CD006086-bbs2-0026" title="SchönT , EliasD , MogesF , MeleseE , TessemaT , StendahlO , et al. Arginine as an adjuvant to chemotherapy improves clinical outcomes in active tuberculosis. European Respiratory Journal2003;21(3):483‐8. ">Schön 2003 ETH</a>; <a href="./references#CD006086-bbs2-0025" title="RangeN , AndersenAB , MagnussenP , MugomelaA , FriisH . The effect of micronutrient supplementation on treatment outcome in patients with pulmonary tuberculosis: a randomised controlled trial in Mwanza, Tanzania. Tropical Medicine and International Health2005;10(9):826‐32. RangeN , ChangaluchaJ , KrarupH , MagnussenP , AndersenAB , FriisH . The effect of multi‐vitamin/mineral supplementation on mortality during treatment of pulmonary tuberculosis: a randomised two‐by‐two factorial trial in Mwanza, Tanzania. British Journal of Nutrition2006;95(4):762‐70. ">Range 2005 TZA</a>; <a href="./references#CD006086-bbs2-0028" title="SembaRD , KumwendaJ , ZijlstraE , RicksMO , vanLettowM , WhalenC , et al. Micronutrient supplements and mortality of HIV‐infected adults with pulmonary TB: a controlled clinical trial. International Journal of Tuberculosis and Lung Disease2007;11(8):854‐9. ">Semba 2007 MWI</a>; <a href="./references#CD006086-bbs2-0033" title="VillamorE , MugusiF , UrassaW , BoschR J , SaathoffE , MatsumotoK , et al. A trial of the effect of micronutrient supplementation on treatment outcome, T cell counts, morbidity, and mortality in adults with pulmonary tuberculosis. The Journal of Infectious Diseases2008;197(11):1499‐505. ">Villamor 2008 TZA</a>; <a href="./references#CD006086-bbs2-0035" title="WejseC , GomesVF , RabnaP , GustafsonP , AabyP , LisseIM , et al. Vitamin D as supplementary treatment for tuberculosis ‐ a double‐blind randomised placebo‐controlled trial. American Journal of Respiratory and Critical Care Medicine2009;179(9):843‐50. ">Wejse 2008 GNB</a>; <a href="./references#CD006086-bbs2-0010" title="LawsonL , ThacherTD , YassinMA , OnuohaNA , UsmanA , EmenyonuNE , et al. Randomized controlled trial of zinc and vitamin A as co‐adjuvants for the treatment of pulmonary tuberculosis. Tropical Medicine and International Health2010;15(12):1481‐90. ">Lawson 2010 NGA</a>; <a href="./references#CD006086-bbs2-0014" title="MehtaS , MugusiFM , BoschRJ , AboudS , ChatterjeeA , FinkelsteinJL , et al. A randomized trial of multivitamin supplementation in children with tuberculosis in Tanzania. Nutrition Journal2011;10:120. NCT00145184 . Effect of Multivitamin Supplements on Clinical and Immunological Response in Childhood Tuberculosis. https://clinicaltrials.gov/ct2/show/NCT00145184 (accessed 4 February 2016). ">Mehta 2011 TZA</a>; <a href="./references#CD006086-bbs2-0031" title="SudarsanamTD , JohnJ , KangG , MahendriV , GerriorJ , FranciosaM , et al. Pilot randomized trial of nutritional supplementation in patients with tuberculosis and HIV‐tuberculosis coinfection receiving directly observed short‐course chemotherapy for tuberculosis. Tropical Medicine and International Health2011;16(6):699‐706. ">Sudarsanam 2010 IND</a>; <a href="./references#CD006086-bbs2-0027" title="SchönT , IdhJ , WestmanA , EliasD , AbateE , DiroE , et al. Effects of a food supplement rich in arginine in patients with smear positive pulmonary tuberculosis ‐ a randomised trial. Tuberculosis2011;91(5):370‐7. ">Schön 2011 ETH</a>; <a href="./references#CD006086-bbs2-0024" title="RalphAP , WaramoriG , PontororingGJ , KenangalemE , WigunaA , TjitraE , et al. L‐arginine and vitamin D adjunctive therapies in pulmonary tuberculosis: a randomised, double‐blind, placebo‐controlled trial. PLoS One2013;8(8):e70032. ">Ralph 2013 IDN</a>; <a href="./references#CD006086-bbs2-0007" title="JeremiahK , DentiP , ChigutsaE , Faurholt‐JepsenD , PrayGodG , RangeN , et al. Nutritional supplementation increases rifampin exposure among tuberculosis patients co‐infected with HIV. Antimicrobial Agents and Chemotherapy2014;58(6):3468‐74. ">Jeremiah 2014 TZA</a>). Four of the trials that presented results for HIV‐positive and HIV‐negative participants separately used stratified randomization (<a href="./references#CD006086-bbs2-0033" title="VillamorE , MugusiF , UrassaW , BoschR J , SaathoffE , MatsumotoK , et al. A trial of the effect of micronutrient supplementation on treatment outcome, T cell counts, morbidity, and mortality in adults with pulmonary tuberculosis. The Journal of Infectious Diseases2008;197(11):1499‐505. ">Villamor 2008 TZA</a>; <a href="./references#CD006086-bbs2-0035" title="WejseC , GomesVF , RabnaP , GustafsonP , AabyP , LisseIM , et al. Vitamin D as supplementary treatment for tuberculosis ‐ a double‐blind randomised placebo‐controlled trial. American Journal of Respiratory and Critical Care Medicine2009;179(9):843‐50. ">Wejse 2008 GNB</a>; <a href="./references#CD006086-bbs2-0031" title="SudarsanamTD , JohnJ , KangG , MahendriV , GerriorJ , FranciosaM , et al. Pilot randomized trial of nutritional supplementation in patients with tuberculosis and HIV‐tuberculosis coinfection receiving directly observed short‐course chemotherapy for tuberculosis. Tropical Medicine and International Health2011;16(6):699‐706. ">Sudarsanam 2010 IND</a>; <a href="./references#CD006086-bbs2-0007" title="JeremiahK , DentiP , ChigutsaE , Faurholt‐JepsenD , PrayGodG , RangeN , et al. Nutritional supplementation increases rifampin exposure among tuberculosis patients co‐infected with HIV. Antimicrobial Agents and Chemotherapy2014;58(6):3468‐74. ">Jeremiah 2014 TZA</a>), but six tested participants for HIV following randomization (<a href="./references#CD006086-bbs2-0026" title="SchönT , EliasD , MogesF , MeleseE , TessemaT , StendahlO , et al. Arginine as an adjuvant to chemotherapy improves clinical outcomes in active tuberculosis. European Respiratory Journal2003;21(3):483‐8. ">Schön 2003 ETH</a>; <a href="./references#CD006086-bbs2-0025" title="RangeN , AndersenAB , MagnussenP , MugomelaA , FriisH . The effect of micronutrient supplementation on treatment outcome in patients with pulmonary tuberculosis: a randomised controlled trial in Mwanza, Tanzania. Tropical Medicine and International Health2005;10(9):826‐32. RangeN , ChangaluchaJ , KrarupH , MagnussenP , AndersenAB , FriisH . The effect of multi‐vitamin/mineral supplementation on mortality during treatment of pulmonary tuberculosis: a randomised two‐by‐two factorial trial in Mwanza, Tanzania. British Journal of Nutrition2006;95(4):762‐70. ">Range 2005 TZA</a>; <a href="./references#CD006086-bbs2-0028" title="SembaRD , KumwendaJ , ZijlstraE , RicksMO , vanLettowM , WhalenC , et al. Micronutrient supplements and mortality of HIV‐infected adults with pulmonary TB: a controlled clinical trial. International Journal of Tuberculosis and Lung Disease2007;11(8):854‐9. ">Semba 2007 MWI</a>; <a href="./references#CD006086-bbs2-0010" title="LawsonL , ThacherTD , YassinMA , OnuohaNA , UsmanA , EmenyonuNE , et al. Randomized controlled trial of zinc and vitamin A as co‐adjuvants for the treatment of pulmonary tuberculosis. Tropical Medicine and International Health2010;15(12):1481‐90. ">Lawson 2010 NGA</a>; <a href="./references#CD006086-bbs2-0014" title="MehtaS , MugusiFM , BoschRJ , AboudS , ChatterjeeA , FinkelsteinJL , et al. A randomized trial of multivitamin supplementation in children with tuberculosis in Tanzania. Nutrition Journal2011;10:120. NCT00145184 . Effect of Multivitamin Supplements on Clinical and Immunological Response in Childhood Tuberculosis. https://clinicaltrials.gov/ct2/show/NCT00145184 (accessed 4 February 2016). ">Mehta 2011 TZA</a>; <a href="./references#CD006086-bbs2-0027" title="SchönT , IdhJ , WestmanA , EliasD , AbateE , DiroE , et al. Effects of a food supplement rich in arginine in patients with smear positive pulmonary tuberculosis ‐ a randomised trial. Tuberculosis2011;91(5):370‐7. ">Schön 2011 ETH</a>), and therefore the subgroup analyses by HIV status cannot be said to be truly randomized. Four trials included both HIV‐positive and HIV‐negative individuals and reported on numbers but did not present results separately (<a href="./references#CD006086-bbs2-0012" title="MartineauAR , TimmsPM , BothamleyGH , HanifaY , IslamK , ClaxtonAP , et al. High‐dose vitamin D3 during intensive‐phase antimicrobial treatment for pulmonary tuberculosis: a double‐blind randomised controlled trial. Lancet2011;377(9761):242‐50. ">Martineau 2011 GBR</a>; <a href="./references#CD006086-bbs2-0022" title="PraygodG , RangeN , Faurholt‐JepsenD , JeremiahK , Faurholt‐JepsenM , AabyeMG , et al. Daily multi‐micronutrient supplementation during tuberculosis treatment increases weight and grip strength among HIV‐uninfected but not HIV‐infected patients in Mwanza, Tanzania. The Journal of Nutrition2011;141(4):685‐91. ">Praygod 2011a TZA</a>; <a href="./references#CD006086-bbs2-0034" title="VisserME , GrewalHMS , SwartEC , DhansayMA , WalzlG , SwanevelderS , et al. The effect of vitamin A and zinc supplementation on treatment outcomes in pulmonary tuberculosis: a randomized controlled trial. American Journal of Clinical Nutrition2011;93(1):93‐100. ">Visser 2011 ZAF</a>; <a href="./references#CD006086-bbs2-0032" title="FredianiJ , TukvadzeN , SanikidzeE , KipianiM , HebbarG , TangprichaV , et al. Drug susceptibility influences macronutrient intake and body composition in tuberculosis patients. The FASEB Journal2014;28(Supplement 1):1014.4. TukvadzeN , SanikidzeE , KipianiM , HebbarG , EasleyKA , ShenviN , et al. High‐dose vitamin D3 in adults with pulmonary tuberculosis: a double‐blind randomised controlled trial. American Journal of Clinical Nutrition2015;102(5):1059‐69. ">Tukvadze 2015 GEO</a>). One trial included only HIV‐positive participants (<a href="./references#CD006086-bbs2-0023" title="PraygodG , RangeN , Faurholt‐JepsenD , JeremiahK , Faurholt‐JepsenM , AabyeMG , et al. Daily multi‐micronutrient supplementation during tuberculosis treatment increases weight and grip strength among HIV‐uninfected but not HIV‐infected patients in Mwanza, Tanzania. The Journal of Nutrition2011;141:685‐91. PraygodG , RangeN , Faurholt‐JepsenD , JeremiahK , Faurholt‐JepsenM , AabyeMG , et al. The effect of energy‐protein supplementation on weight, body composition and handgrip strength among pulmonary tuberculosis HIV‐co‐infected patients: randomised controlled trial in Mwanza, Tanzania. The British Journal of Nutrition2012;107(2):263‐71. ">Praygod 2011b TZA</a>). None of the HIV‐positive participants were receiving antiretroviral treatment. One trial was stopped early when antiretrovirals became locally available (<a href="./references#CD006086-bbs2-0028" title="SembaRD , KumwendaJ , ZijlstraE , RicksMO , vanLettowM , WhalenC , et al. Micronutrient supplements and mortality of HIV‐infected adults with pulmonary TB: a controlled clinical trial. International Journal of Tuberculosis and Lung Disease2007;11(8):854‐9. ">Semba 2007 MWI</a>). Eleven trials excluded people with HIV infection (<a href="./references#CD006086-bbs2-0005" title="HanekomWA , PotgeiterS , HughesEJ , MalanH , KessowG , HusseyGD . Vitamin A status and therapy in childhood pulmonary tuberculosis. Journal of Pediatrics1997;131(6):925‐7. ">Hanekom 1997 ZAF</a>; <a href="./references#CD006086-bbs2-0020" title="PatonNI , ChuaYK , EarnestA , CheeCB . Randomized controlled trial of nutritional supplementation in patients with newly diagnosed tuberculosis and wasting. American Journal of Clinical Nutrition2004;80(2):460‐5. ">Paton 2004 SGP</a>; <a href="./references#CD006086-bbs2-0021" title="Pérez‐GuzmánC , VargasMH , QuiñonezF , BazavilvazoN , AguilarA . A cholesterol‐rich diet accelerates bacteriologic sterilization in pulmonary tuberculosis. Chest2005;127(2):643‐51. ">Pérez‐Guzmán 2005 MEX</a>; <a href="./references#CD006086-bbs2-0017" title="NursyamEW , AminZ , RumendeCA . The effects of vitamin D as supplementary treatment in patients with moderately advanced pulmonary tuberculosis lesion. Acta Medica Indonesiana2006;38(1):3‐5. ">Nursyam 2006 IDN</a>; <a href="./references#CD006086-bbs2-0001" title="ArmijosRX , WeigelMM , ChaconR , FloresL , CamposA . Adjunctive micronutrient supplementation for pulmonary tuberculosis. Salud Pública de México2010;52(3):185‐9. ">Armijos 2010 MEX</a>; <a href="./references#CD006086-bbs2-0006" title="JahnaviG , SudhaCH . Randomised controlled trial of food supplements in patients with newly diagnosed tuberculosis and wasting. Singapore Medical Journal2010;51(12):957‐62. ">Jahnavi 2010 IND</a>; <a href="./references#CD006086-bbs2-0019" title="PaliliewuN , DatauEA , MatheosJC , SurachmantoEE . Channa striatus capsules induces cytokine conversion in pulmonary tuberculosis patients. Journal of Experimental and Integrative Medicine2013;3(3):237‐42. ">Paliliewu 2013 IDN</a>; <a href="./references#CD006086-bbs2-0011" title="LodhaR , MukherjeeA , SinghV , SinghS , FriisH , Faurholt‐JepsenD , et al. Effect of micronutrient supplementation on treatment outcomes in children with intrathoracic tuberculosis: a randomized controlled trial. American Journal of Clinical Nutrition2014;100(5):1287‐97. ">Lodha 2014 IND</a>; <a href="./references#CD006086-bbs2-0002" title="DaleyP , JagannathanV , JohnKR , SarojiniJ , LathaA , ViethR , et al. Adjunctive vitamin D for treatment of active tuberculosis in India: a randomised, double‐blind, placebo‐controlled trial. The Lancet. Infectious Diseases2015;15(5):528‐34. ">Daley 2015 IND</a>; <a href="./references#CD006086-bbs2-0003" title="FaraziA , ShafaatO , SofianM , KahbaziM . Arginine adjunctive therapy in active tuberculosis. Tuberculosis Research and Treatment2015;2015:205016. [DOI: 10.1155/2015/205016] ">Farazi 2015 IRN</a>; <a href="./references#CD006086-bbs2-0015" title="MilyA , RekhaRS , KamalSM , ArifuzzamanAS , RahimZ , KhanL , et al. Significant effects of oral phenylbutyrate and vitamin D3 adjunctive therapy in pulmonary tuberculosis: a randomized controlled trial. PLoS One2015;10(9):e0138340. [DOI: 10.1371/journal.pone.0138340] ">Mily 2015 BGD</a>), and eight trials did not mention HIV infection (<a href="./references#CD006086-bbs2-0016" title="MorcosMM , GabrAA , SamualS , KamelM , elBazM , elBeshryM , et al. Vitamin D administration to tuberculous children and its value. Bollettino Chimico Farmaceutico1998;137(5):157‐64. ">Morcos 1998 EGY</a>; <a href="./references#CD006086-bbs2-0008" title="KaryadiE , WestCE , SchultinkW , NelwanRH , GrossR , AminZ , et al. A double‐blind, placebo‐controlled study of vitamin A and zinc supplementation in persons with tuberculosis in Indonesia: effects on clinical response and nutritional status. American Journal of Clinical Nutrition2002;75(4):720‐7. ">Karyadi 2002 IDN</a>; <a href="./references#CD006086-bbs2-0029" title="SeyedrezazadehE , OstadrahimiA , MahboobS , AsadiY , GhaemmagamiJ , PourmogaddamM . Effect of vitamin E and selenium supplementation on oxidative stress status in pulmonary tuberculosis patients. Respirology2008;13(2):294‐8. SeyedrezazadehE , OstradrahimiAR , MahboobSA , AssadiY , AnsarinK , SakooriP , et al. Vitamin E‐selenium supplement and clinical responses of active pulmonary tuberculosis. Tanaffos2006;5(2):49‐55. ">Seyedrezazadeh 2006 IRN</a>; <a href="./references#CD006086-bbs2-0013" title="MartinsN , MorrisP , KellyPM . Food incentives to improve completion of tuberculosis treatment: randomised controlled trial in Dili, Timor‐Leste. BMJ2009;229:b4248. ">Martins 2009 TLS</a>; <a href="./references#CD006086-bbs2-0018" title="PakasiTA , KaryadiE , SuratihNMD , SaleanM , DarmawidjajaN , BorH , et al. Zinc and vitamin A supplementation fails to reduce sputum conversion time in severely malnourished pulmonary tuberculosis patients in Indonesia. Nutrition Journal2010;9:41. ">Pakasi 2010 IDN</a>; <a href="./references#CD006086-bbs2-0009" title="KotaSK , JammulaS , KotaSK , TripathyPR , PandaS , ModiKD . Effect of vitamin D supplementation in type 2 diabetes patients with pulmonary tuberculosis. Diabetes and Metabolic Syndrome: Clinical Research &amp; Reviews2011;5(2):85‐9. ">Kota 2011 IND</a>; <a href="./references#CD006086-bbs2-0004" title="GinawiIA , AhmedMQ , AhmadI , Al‐HazimiAM . Effect of zinc and vitamin a supplementation along with inter‐tubercular treatment in pulmonary tuberculosis in north Indian patients. International Journal of Pharmaceutical Sciences and Research2013;4(9):3426‐31. ">Ginawi 2013 IND</a>; <a href="./references#CD006086-bbs2-0030" title="SinghAKr , GogoiJB , PantNC , MittalP , JuyalV , MukherjeeS . A study on the role of vitamins and minerals supplementation in the treatment of tuberculosis. Indian Journal of Public Health Research and Development2013;4(2):26‐30. ">Singh 2013 IND</a>). </p> </section> <section id="CD006086-sec-0091"> <h5 class="title">Study site</h5> <p>Trials were undertaken in the following locations.</p> <p> <ul id="CD006086-list-0007"> <li> <p>Africa: Egypt (<a href="./references#CD006086-bbs2-0016" title="MorcosMM , GabrAA , SamualS , KamelM , elBazM , elBeshryM , et al. Vitamin D administration to tuberculous children and its value. Bollettino Chimico Farmaceutico1998;137(5):157‐64. ">Morcos 1998 EGY</a>), Guinnea‐Bissau (<a href="./references#CD006086-bbs2-0035" title="WejseC , GomesVF , RabnaP , GustafsonP , AabyP , LisseIM , et al. Vitamin D as supplementary treatment for tuberculosis ‐ a double‐blind randomised placebo‐controlled trial. American Journal of Respiratory and Critical Care Medicine2009;179(9):843‐50. ">Wejse 2008 GNB</a>), Ethiopia (<a href="./references#CD006086-bbs2-0026" title="SchönT , EliasD , MogesF , MeleseE , TessemaT , StendahlO , et al. Arginine as an adjuvant to chemotherapy improves clinical outcomes in active tuberculosis. European Respiratory Journal2003;21(3):483‐8. ">Schön 2003 ETH</a>; <a href="./references#CD006086-bbs2-0027" title="SchönT , IdhJ , WestmanA , EliasD , AbateE , DiroE , et al. Effects of a food supplement rich in arginine in patients with smear positive pulmonary tuberculosis ‐ a randomised trial. Tuberculosis2011;91(5):370‐7. ">Schön 2011 ETH</a>), Tanzania (<a href="./references#CD006086-bbs2-0025" title="RangeN , AndersenAB , MagnussenP , MugomelaA , FriisH . The effect of micronutrient supplementation on treatment outcome in patients with pulmonary tuberculosis: a randomised controlled trial in Mwanza, Tanzania. Tropical Medicine and International Health2005;10(9):826‐32. RangeN , ChangaluchaJ , KrarupH , MagnussenP , AndersenAB , FriisH . The effect of multi‐vitamin/mineral supplementation on mortality during treatment of pulmonary tuberculosis: a randomised two‐by‐two factorial trial in Mwanza, Tanzania. British Journal of Nutrition2006;95(4):762‐70. ">Range 2005 TZA</a>; <a href="./references#CD006086-bbs2-0033" title="VillamorE , MugusiF , UrassaW , BoschR J , SaathoffE , MatsumotoK , et al. A trial of the effect of micronutrient supplementation on treatment outcome, T cell counts, morbidity, and mortality in adults with pulmonary tuberculosis. The Journal of Infectious Diseases2008;197(11):1499‐505. ">Villamor 2008 TZA</a>; <a href="./references#CD006086-bbs2-0014" title="MehtaS , MugusiFM , BoschRJ , AboudS , ChatterjeeA , FinkelsteinJL , et al. A randomized trial of multivitamin supplementation in children with tuberculosis in Tanzania. Nutrition Journal2011;10:120. NCT00145184 . Effect of Multivitamin Supplements on Clinical and Immunological Response in Childhood Tuberculosis. https://clinicaltrials.gov/ct2/show/NCT00145184 (accessed 4 February 2016). ">Mehta 2011 TZA</a>; <a href="./references#CD006086-bbs2-0023" title="PraygodG , RangeN , Faurholt‐JepsenD , JeremiahK , Faurholt‐JepsenM , AabyeMG , et al. Daily multi‐micronutrient supplementation during tuberculosis treatment increases weight and grip strength among HIV‐uninfected but not HIV‐infected patients in Mwanza, Tanzania. The Journal of Nutrition2011;141:685‐91. PraygodG , RangeN , Faurholt‐JepsenD , JeremiahK , Faurholt‐JepsenM , AabyeMG , et al. The effect of energy‐protein supplementation on weight, body composition and handgrip strength among pulmonary tuberculosis HIV‐co‐infected patients: randomised controlled trial in Mwanza, Tanzania. The British Journal of Nutrition2012;107(2):263‐71. ">Praygod 2011b TZA</a>; <a href="./references#CD006086-bbs2-0022" title="PraygodG , RangeN , Faurholt‐JepsenD , JeremiahK , Faurholt‐JepsenM , AabyeMG , et al. Daily multi‐micronutrient supplementation during tuberculosis treatment increases weight and grip strength among HIV‐uninfected but not HIV‐infected patients in Mwanza, Tanzania. The Journal of Nutrition2011;141(4):685‐91. ">Praygod 2011a TZA</a>; <a href="./references#CD006086-bbs2-0007" title="JeremiahK , DentiP , ChigutsaE , Faurholt‐JepsenD , PrayGodG , RangeN , et al. Nutritional supplementation increases rifampin exposure among tuberculosis patients co‐infected with HIV. Antimicrobial Agents and Chemotherapy2014;58(6):3468‐74. ">Jeremiah 2014 TZA</a>), Malawi (<a href="./references#CD006086-bbs2-0028" title="SembaRD , KumwendaJ , ZijlstraE , RicksMO , vanLettowM , WhalenC , et al. Micronutrient supplements and mortality of HIV‐infected adults with pulmonary TB: a controlled clinical trial. International Journal of Tuberculosis and Lung Disease2007;11(8):854‐9. ">Semba 2007 MWI</a>), Nigeria (<a href="./references#CD006086-bbs2-0010" title="LawsonL , ThacherTD , YassinMA , OnuohaNA , UsmanA , EmenyonuNE , et al. Randomized controlled trial of zinc and vitamin A as co‐adjuvants for the treatment of pulmonary tuberculosis. Tropical Medicine and International Health2010;15(12):1481‐90. ">Lawson 2010 NGA</a>), and South Africa (<a href="./references#CD006086-bbs2-0005" title="HanekomWA , PotgeiterS , HughesEJ , MalanH , KessowG , HusseyGD . Vitamin A status and therapy in childhood pulmonary tuberculosis. Journal of Pediatrics1997;131(6):925‐7. ">Hanekom 1997 ZAF</a>; <a href="./references#CD006086-bbs2-0034" title="VisserME , GrewalHMS , SwartEC , DhansayMA , WalzlG , SwanevelderS , et al. The effect of vitamin A and zinc supplementation on treatment outcomes in pulmonary tuberculosis: a randomized controlled trial. American Journal of Clinical Nutrition2011;93(1):93‐100. ">Visser 2011 ZAF</a>). </p> </li> <li> <p>Asia: Singapore (<a href="./references#CD006086-bbs2-0020" title="PatonNI , ChuaYK , EarnestA , CheeCB . Randomized controlled trial of nutritional supplementation in patients with newly diagnosed tuberculosis and wasting. American Journal of Clinical Nutrition2004;80(2):460‐5. ">Paton 2004 SGP</a>), Indonesia (<a href="./references#CD006086-bbs2-0008" title="KaryadiE , WestCE , SchultinkW , NelwanRH , GrossR , AminZ , et al. A double‐blind, placebo‐controlled study of vitamin A and zinc supplementation in persons with tuberculosis in Indonesia: effects on clinical response and nutritional status. American Journal of Clinical Nutrition2002;75(4):720‐7. ">Karyadi 2002 IDN</a>; <a href="./references#CD006086-bbs2-0017" title="NursyamEW , AminZ , RumendeCA . The effects of vitamin D as supplementary treatment in patients with moderately advanced pulmonary tuberculosis lesion. Acta Medica Indonesiana2006;38(1):3‐5. ">Nursyam 2006 IDN</a>; <a href="./references#CD006086-bbs2-0018" title="PakasiTA , KaryadiE , SuratihNMD , SaleanM , DarmawidjajaN , BorH , et al. Zinc and vitamin A supplementation fails to reduce sputum conversion time in severely malnourished pulmonary tuberculosis patients in Indonesia. Nutrition Journal2010;9:41. ">Pakasi 2010 IDN</a>; <a href="./references#CD006086-bbs2-0019" title="PaliliewuN , DatauEA , MatheosJC , SurachmantoEE . Channa striatus capsules induces cytokine conversion in pulmonary tuberculosis patients. Journal of Experimental and Integrative Medicine2013;3(3):237‐42. ">Paliliewu 2013 IDN</a>; <a href="./references#CD006086-bbs2-0024" title="RalphAP , WaramoriG , PontororingGJ , KenangalemE , WigunaA , TjitraE , et al. L‐arginine and vitamin D adjunctive therapies in pulmonary tuberculosis: a randomised, double‐blind, placebo‐controlled trial. PLoS One2013;8(8):e70032. ">Ralph 2013 IDN</a>), Iran (<a href="./references#CD006086-bbs2-0029" title="SeyedrezazadehE , OstadrahimiA , MahboobS , AsadiY , GhaemmagamiJ , PourmogaddamM . Effect of vitamin E and selenium supplementation on oxidative stress status in pulmonary tuberculosis patients. Respirology2008;13(2):294‐8. SeyedrezazadehE , OstradrahimiAR , MahboobSA , AssadiY , AnsarinK , SakooriP , et al. Vitamin E‐selenium supplement and clinical responses of active pulmonary tuberculosis. Tanaffos2006;5(2):49‐55. ">Seyedrezazadeh 2006 IRN</a>; <a href="./references#CD006086-bbs2-0003" title="FaraziA , ShafaatO , SofianM , KahbaziM . Arginine adjunctive therapy in active tuberculosis. Tuberculosis Research and Treatment2015;2015:205016. [DOI: 10.1155/2015/205016] ">Farazi 2015 IRN</a>), Bangladesh (<a href="./references#CD006086-bbs2-0015" title="MilyA , RekhaRS , KamalSM , ArifuzzamanAS , RahimZ , KhanL , et al. Significant effects of oral phenylbutyrate and vitamin D3 adjunctive therapy in pulmonary tuberculosis: a randomized controlled trial. PLoS One2015;10(9):e0138340. [DOI: 10.1371/journal.pone.0138340] ">Mily 2015 BGD</a>), and India (<a href="./references#CD006086-bbs2-0006" title="JahnaviG , SudhaCH . Randomised controlled trial of food supplements in patients with newly diagnosed tuberculosis and wasting. Singapore Medical Journal2010;51(12):957‐62. ">Jahnavi 2010 IND</a>; <a href="./references#CD006086-bbs2-0031" title="SudarsanamTD , JohnJ , KangG , MahendriV , GerriorJ , FranciosaM , et al. Pilot randomized trial of nutritional supplementation in patients with tuberculosis and HIV‐tuberculosis coinfection receiving directly observed short‐course chemotherapy for tuberculosis. Tropical Medicine and International Health2011;16(6):699‐706. ">Sudarsanam 2010 IND</a>; <a href="./references#CD006086-bbs2-0009" title="KotaSK , JammulaS , KotaSK , TripathyPR , PandaS , ModiKD . Effect of vitamin D supplementation in type 2 diabetes patients with pulmonary tuberculosis. Diabetes and Metabolic Syndrome: Clinical Research &amp; Reviews2011;5(2):85‐9. ">Kota 2011 IND</a>; <a href="./references#CD006086-bbs2-0004" title="GinawiIA , AhmedMQ , AhmadI , Al‐HazimiAM . Effect of zinc and vitamin a supplementation along with inter‐tubercular treatment in pulmonary tuberculosis in north Indian patients. International Journal of Pharmaceutical Sciences and Research2013;4(9):3426‐31. ">Ginawi 2013 IND</a>; <a href="./references#CD006086-bbs2-0030" title="SinghAKr , GogoiJB , PantNC , MittalP , JuyalV , MukherjeeS . A study on the role of vitamins and minerals supplementation in the treatment of tuberculosis. Indian Journal of Public Health Research and Development2013;4(2):26‐30. ">Singh 2013 IND</a>; <a href="./references#CD006086-bbs2-0011" title="LodhaR , MukherjeeA , SinghV , SinghS , FriisH , Faurholt‐JepsenD , et al. Effect of micronutrient supplementation on treatment outcomes in children with intrathoracic tuberculosis: a randomized controlled trial. American Journal of Clinical Nutrition2014;100(5):1287‐97. ">Lodha 2014 IND</a>; <a href="./references#CD006086-bbs2-0002" title="DaleyP , JagannathanV , JohnKR , SarojiniJ , LathaA , ViethR , et al. Adjunctive vitamin D for treatment of active tuberculosis in India: a randomised, double‐blind, placebo‐controlled trial. The Lancet. Infectious Diseases2015;15(5):528‐34. ">Daley 2015 IND</a>). </p> </li> <li> <p>Oceania: Timor Leste (<a href="./references#CD006086-bbs2-0013" title="MartinsN , MorrisP , KellyPM . Food incentives to improve completion of tuberculosis treatment: randomised controlled trial in Dili, Timor‐Leste. BMJ2009;229:b4248. ">Martins 2009 TLS</a>). </p> </li> <li> <p>North America: Mexico (<a href="./references#CD006086-bbs2-0021" title="Pérez‐GuzmánC , VargasMH , QuiñonezF , BazavilvazoN , AguilarA . A cholesterol‐rich diet accelerates bacteriologic sterilization in pulmonary tuberculosis. Chest2005;127(2):643‐51. ">Pérez‐Guzmán 2005 MEX</a>; <a href="./references#CD006086-bbs2-0001" title="ArmijosRX , WeigelMM , ChaconR , FloresL , CamposA . Adjunctive micronutrient supplementation for pulmonary tuberculosis. Salud Pública de México2010;52(3):185‐9. ">Armijos 2010 MEX</a>). </p> </li> <li> <p>Europe: UK (<a href="./references#CD006086-bbs2-0012" title="MartineauAR , TimmsPM , BothamleyGH , HanifaY , IslamK , ClaxtonAP , et al. High‐dose vitamin D3 during intensive‐phase antimicrobial treatment for pulmonary tuberculosis: a double‐blind randomised controlled trial. Lancet2011;377(9761):242‐50. ">Martineau 2011 GBR</a>) and Georgia (<a href="./references#CD006086-bbs2-0032" title="FredianiJ , TukvadzeN , SanikidzeE , KipianiM , HebbarG , TangprichaV , et al. Drug susceptibility influences macronutrient intake and body composition in tuberculosis patients. The FASEB Journal2014;28(Supplement 1):1014.4. TukvadzeN , SanikidzeE , KipianiM , HebbarG , EasleyKA , ShenviN , et al. High‐dose vitamin D3 in adults with pulmonary tuberculosis: a double‐blind randomised controlled trial. American Journal of Clinical Nutrition2015;102(5):1059‐69. ">Tukvadze 2015 GEO</a>). </p> </li> </ul> </p> </section> <section id="CD006086-sec-0092"> <h5 class="title">Interventions</h5> <p>Seven trials assessed macronutrient supplementation (<a href="./references#CD006086-bbs2-0020" title="PatonNI , ChuaYK , EarnestA , CheeCB . Randomized controlled trial of nutritional supplementation in patients with newly diagnosed tuberculosis and wasting. American Journal of Clinical Nutrition2004;80(2):460‐5. ">Paton 2004 SGP</a>; <a href="./references#CD006086-bbs2-0021" title="Pérez‐GuzmánC , VargasMH , QuiñonezF , BazavilvazoN , AguilarA . A cholesterol‐rich diet accelerates bacteriologic sterilization in pulmonary tuberculosis. Chest2005;127(2):643‐51. ">Pérez‐Guzmán 2005 MEX</a>; <a href="./references#CD006086-bbs2-0013" title="MartinsN , MorrisP , KellyPM . Food incentives to improve completion of tuberculosis treatment: randomised controlled trial in Dili, Timor‐Leste. BMJ2009;229:b4248. ">Martins 2009 TLS</a>; <a href="./references#CD006086-bbs2-0006" title="JahnaviG , SudhaCH . Randomised controlled trial of food supplements in patients with newly diagnosed tuberculosis and wasting. Singapore Medical Journal2010;51(12):957‐62. ">Jahnavi 2010 IND</a>; <a href="./references#CD006086-bbs2-0031" title="SudarsanamTD , JohnJ , KangG , MahendriV , GerriorJ , FranciosaM , et al. Pilot randomized trial of nutritional supplementation in patients with tuberculosis and HIV‐tuberculosis coinfection receiving directly observed short‐course chemotherapy for tuberculosis. Tropical Medicine and International Health2011;16(6):699‐706. ">Sudarsanam 2010 IND</a>; <a href="./references#CD006086-bbs2-0023" title="PraygodG , RangeN , Faurholt‐JepsenD , JeremiahK , Faurholt‐JepsenM , AabyeMG , et al. Daily multi‐micronutrient supplementation during tuberculosis treatment increases weight and grip strength among HIV‐uninfected but not HIV‐infected patients in Mwanza, Tanzania. The Journal of Nutrition2011;141:685‐91. PraygodG , RangeN , Faurholt‐JepsenD , JeremiahK , Faurholt‐JepsenM , AabyeMG , et al. The effect of energy‐protein supplementation on weight, body composition and handgrip strength among pulmonary tuberculosis HIV‐co‐infected patients: randomised controlled trial in Mwanza, Tanzania. The British Journal of Nutrition2012;107(2):263‐71. ">Praygod 2011b TZA</a>; <a href="./references#CD006086-bbs2-0007" title="JeremiahK , DentiP , ChigutsaE , Faurholt‐JepsenD , PrayGodG , RangeN , et al. Nutritional supplementation increases rifampin exposure among tuberculosis patients co‐infected with HIV. Antimicrobial Agents and Chemotherapy2014;58(6):3468‐74. ">Jeremiah 2014 TZA</a>), six trials assessed multi‐micronutrient supplementation (<a href="./references#CD006086-bbs2-0025" title="RangeN , AndersenAB , MagnussenP , MugomelaA , FriisH . The effect of micronutrient supplementation on treatment outcome in patients with pulmonary tuberculosis: a randomised controlled trial in Mwanza, Tanzania. Tropical Medicine and International Health2005;10(9):826‐32. RangeN , ChangaluchaJ , KrarupH , MagnussenP , AndersenAB , FriisH . The effect of multi‐vitamin/mineral supplementation on mortality during treatment of pulmonary tuberculosis: a randomised two‐by‐two factorial trial in Mwanza, Tanzania. British Journal of Nutrition2006;95(4):762‐70. ">Range 2005 TZA</a>; <a href="./references#CD006086-bbs2-0028" title="SembaRD , KumwendaJ , ZijlstraE , RicksMO , vanLettowM , WhalenC , et al. Micronutrient supplements and mortality of HIV‐infected adults with pulmonary TB: a controlled clinical trial. International Journal of Tuberculosis and Lung Disease2007;11(8):854‐9. ">Semba 2007 MWI</a>; <a href="./references#CD006086-bbs2-0033" title="VillamorE , MugusiF , UrassaW , BoschR J , SaathoffE , MatsumotoK , et al. A trial of the effect of micronutrient supplementation on treatment outcome, T cell counts, morbidity, and mortality in adults with pulmonary tuberculosis. The Journal of Infectious Diseases2008;197(11):1499‐505. ">Villamor 2008 TZA</a>; <a href="./references#CD006086-bbs2-0014" title="MehtaS , MugusiFM , BoschRJ , AboudS , ChatterjeeA , FinkelsteinJL , et al. A randomized trial of multivitamin supplementation in children with tuberculosis in Tanzania. Nutrition Journal2011;10:120. NCT00145184 . Effect of Multivitamin Supplements on Clinical and Immunological Response in Childhood Tuberculosis. https://clinicaltrials.gov/ct2/show/NCT00145184 (accessed 4 February 2016). ">Mehta 2011 TZA</a>; <a href="./references#CD006086-bbs2-0022" title="PraygodG , RangeN , Faurholt‐JepsenD , JeremiahK , Faurholt‐JepsenM , AabyeMG , et al. Daily multi‐micronutrient supplementation during tuberculosis treatment increases weight and grip strength among HIV‐uninfected but not HIV‐infected patients in Mwanza, Tanzania. The Journal of Nutrition2011;141(4):685‐91. ">Praygod 2011a TZA</a>; <a href="./references#CD006086-bbs2-0011" title="LodhaR , MukherjeeA , SinghV , SinghS , FriisH , Faurholt‐JepsenD , et al. Effect of micronutrient supplementation on treatment outcomes in children with intrathoracic tuberculosis: a randomized controlled trial. American Journal of Clinical Nutrition2014;100(5):1287‐97. ">Lodha 2014 IND</a>), and 21 trials assessed single or dual micronutrient supplementation. The remaining trial assessed the effect of supplementation with <i>Channa striata</i> capsules (<a href="./references#CD006086-bbs2-0019" title="PaliliewuN , DatauEA , MatheosJC , SurachmantoEE . Channa striatus capsules induces cytokine conversion in pulmonary tuberculosis patients. Journal of Experimental and Integrative Medicine2013;3(3):237‐42. ">Paliliewu 2013 IDN</a>). <i>C. striata</i> is a fresh‐water fish found in most tropical and subtropical countries. </p> </section> <section id="CD006086-sec-0093"> <h5 class="title">Sample size</h5> <p>Eleven of the 35 trials included less than 100 participants in their final analysis. To aid interpretation and inform future research we have calculated the optimal sample size to reliably demonstrate some suggested clinically important results (<a href="./appendices#CD006086-sec-0160">Appendix 3</a>; <a href="./appendices#CD006086-sec-0161">Appendix 4</a>). </p> <p>As micronutrients are a cheap and easily administered intervention, even a small effect on tuberculosis treatment outcomes might be considered clinically important. For example, to demonstrate a reduction in death from the worldwide average of 5% to just 4% (a relative risk reduction of 20%); a sample size of over 13,000 participants would be necessary. This is far above the data included in this Cochrane Review. Similarly an increase in successful cure rate from 80% to 84% would require almost 3000 participants. </p> <p>For full details of the included trials see the '<a href="./references#CD006086-sec-0175" title="">Characteristics of included studies</a>' table. </p> </section> </section> <section id="CD006086-sec-0094"> <h4 class="title">Excluded studies</h4> <p>We excluded 17 studies that we had thought were eligible after initial screening for the reasons we have given in the '<a href="./references#CD006086-sec-0176" title="">Characteristics of excluded studies</a>' table. Five trials are currently awaiting classification pending further information from the author (<a href="./references#CD006086-bbs2-0054" title="ChandraRK . Nutrient supplementation as adjunct therapy in pulmonary tuberculosis. International Journal for Vitamin and Nutritional Research2004;74(2):144‐6. ">Chandra 2004</a>; <a href="./references#CD006086-bbs2-0055" title="Guzman‐RiveroM , SejasE , MedinaM , Verduguez‐OrellanaA , AkessonB . Changes in clinical status, nutritional and biochemical biomarkers in pulmonary tuberculosis patients receiving zinc supplementation in addition to conventional treatment (Abstract). Annals of Nutrition and Metabolism2013;63(Supplement 1):1104. ">Guzman‐Rivero 2013</a>; <a href="./references#CD006086-bbs2-0056" title="NagraleD , MahakalkarS , GaurS . Supplementation of N‐acetylcysteine as an adjuvant in treatment of newly diagnosed pulmonary tuberculosis patients: A prospective, randomized double blind, placebo controlled study (Abstract). European Respiratory Journal2013;42(Suppl 57):P2833. ">Nagrale 2013</a>; <a href="./references#CD006086-bbs2-0057" title="NawasMA , BurhanE , SoepandiP , IsbaniahF , AgustinH . Double blind randomized placebo‐controlled trial in tuberculosis patients with tuberculosis treatment supplemented with morrinda‐zinger extract: The speed of sputum conversion (Abstract). Respirology2013;18(Supplement 4):9. ">Nawas 2013</a>; <a href="./references#CD006086-bbs2-0053" title="Al MamunSMA . Effects and rationale of micronutrients supplementation in the treatment of smear positive pulmonary tuberculosis patients. Chest Journal2014; Vol. 145, issue 3_Meeting Abstracts. ">Al Mamun 2014</a>). In addition we are aware of 17 potentially relevant ongoing or unpublished trials; see the '<a href="./references#CD006086-sec-0178" title="">Characteristics of ongoing studies</a>' table. </p> </section> </section> <section id="CD006086-sec-0095"> <h3 class="title">Risk of bias in included studies</h3> <p>We have displayed the 'Risk of bias' assessments in a table and summarised these results in <a href="#CD006086-fig-0002">Figure 2</a>. </p> <div class="figure" id="CD006086-fig-0002"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 2</div> </div> <hr class="top"/><img alt="'Risk of bias' summary: review authors' judgements about each 'Risk of bias' item for each included study." data-id="CD006086-fig-0002" src="/cdsr/doi/10.1002/14651858.CD006086.pub4/media/CDSR/CD006086/image_n/nCD006086-AFig-FIG02.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>'Risk of bias' summary: review authors' judgements about each 'Risk of bias' item for each included study. </p> </div> </div> </div> <section id="CD006086-sec-0096"> <h4 class="title">Allocation</h4> <p>Twenty‐four trials described an adequate method of generating a truly random allocation sequence (<a href="./references#CD006086-bbs2-0008" title="KaryadiE , WestCE , SchultinkW , NelwanRH , GrossR , AminZ , et al. A double‐blind, placebo‐controlled study of vitamin A and zinc supplementation in persons with tuberculosis in Indonesia: effects on clinical response and nutritional status. American Journal of Clinical Nutrition2002;75(4):720‐7. ">Karyadi 2002 IDN</a>; <a href="./references#CD006086-bbs2-0026" title="SchönT , EliasD , MogesF , MeleseE , TessemaT , StendahlO , et al. Arginine as an adjuvant to chemotherapy improves clinical outcomes in active tuberculosis. European Respiratory Journal2003;21(3):483‐8. ">Schön 2003 ETH</a>; <a href="./references#CD006086-bbs2-0020" title="PatonNI , ChuaYK , EarnestA , CheeCB . Randomized controlled trial of nutritional supplementation in patients with newly diagnosed tuberculosis and wasting. American Journal of Clinical Nutrition2004;80(2):460‐5. ">Paton 2004 SGP</a>; <a href="./references#CD006086-bbs2-0025" title="RangeN , AndersenAB , MagnussenP , MugomelaA , FriisH . The effect of micronutrient supplementation on treatment outcome in patients with pulmonary tuberculosis: a randomised controlled trial in Mwanza, Tanzania. Tropical Medicine and International Health2005;10(9):826‐32. RangeN , ChangaluchaJ , KrarupH , MagnussenP , AndersenAB , FriisH . The effect of multi‐vitamin/mineral supplementation on mortality during treatment of pulmonary tuberculosis: a randomised two‐by‐two factorial trial in Mwanza, Tanzania. British Journal of Nutrition2006;95(4):762‐70. ">Range 2005 TZA</a>; <a href="./references#CD006086-bbs2-0028" title="SembaRD , KumwendaJ , ZijlstraE , RicksMO , vanLettowM , WhalenC , et al. Micronutrient supplements and mortality of HIV‐infected adults with pulmonary TB: a controlled clinical trial. International Journal of Tuberculosis and Lung Disease2007;11(8):854‐9. ">Semba 2007 MWI</a>; <a href="./references#CD006086-bbs2-0033" title="VillamorE , MugusiF , UrassaW , BoschR J , SaathoffE , MatsumotoK , et al. A trial of the effect of micronutrient supplementation on treatment outcome, T cell counts, morbidity, and mortality in adults with pulmonary tuberculosis. The Journal of Infectious Diseases2008;197(11):1499‐505. ">Villamor 2008 TZA</a>; <a href="./references#CD006086-bbs2-0035" title="WejseC , GomesVF , RabnaP , GustafsonP , AabyP , LisseIM , et al. Vitamin D as supplementary treatment for tuberculosis ‐ a double‐blind randomised placebo‐controlled trial. American Journal of Respiratory and Critical Care Medicine2009;179(9):843‐50. ">Wejse 2008 GNB</a>; <a href="./references#CD006086-bbs2-0013" title="MartinsN , MorrisP , KellyPM . Food incentives to improve completion of tuberculosis treatment: randomised controlled trial in Dili, Timor‐Leste. BMJ2009;229:b4248. ">Martins 2009 TLS</a>; <a href="./references#CD006086-bbs2-0010" title="LawsonL , ThacherTD , YassinMA , OnuohaNA , UsmanA , EmenyonuNE , et al. Randomized controlled trial of zinc and vitamin A as co‐adjuvants for the treatment of pulmonary tuberculosis. Tropical Medicine and International Health2010;15(12):1481‐90. ">Lawson 2010 NGA</a>; <a href="./references#CD006086-bbs2-0018" title="PakasiTA , KaryadiE , SuratihNMD , SaleanM , DarmawidjajaN , BorH , et al. Zinc and vitamin A supplementation fails to reduce sputum conversion time in severely malnourished pulmonary tuberculosis patients in Indonesia. Nutrition Journal2010;9:41. ">Pakasi 2010 IDN</a>; <a href="./references#CD006086-bbs2-0031" title="SudarsanamTD , JohnJ , KangG , MahendriV , GerriorJ , FranciosaM , et al. Pilot randomized trial of nutritional supplementation in patients with tuberculosis and HIV‐tuberculosis coinfection receiving directly observed short‐course chemotherapy for tuberculosis. Tropical Medicine and International Health2011;16(6):699‐706. ">Sudarsanam 2010 IND</a>; <a href="./references#CD006086-bbs2-0012" title="MartineauAR , TimmsPM , BothamleyGH , HanifaY , IslamK , ClaxtonAP , et al. High‐dose vitamin D3 during intensive‐phase antimicrobial treatment for pulmonary tuberculosis: a double‐blind randomised controlled trial. Lancet2011;377(9761):242‐50. ">Martineau 2011 GBR</a>; <a href="./references#CD006086-bbs2-0014" title="MehtaS , MugusiFM , BoschRJ , AboudS , ChatterjeeA , FinkelsteinJL , et al. A randomized trial of multivitamin supplementation in children with tuberculosis in Tanzania. Nutrition Journal2011;10:120. NCT00145184 . Effect of Multivitamin Supplements on Clinical and Immunological Response in Childhood Tuberculosis. https://clinicaltrials.gov/ct2/show/NCT00145184 (accessed 4 February 2016). ">Mehta 2011 TZA</a>; <a href="./references#CD006086-bbs2-0022" title="PraygodG , RangeN , Faurholt‐JepsenD , JeremiahK , Faurholt‐JepsenM , AabyeMG , et al. Daily multi‐micronutrient supplementation during tuberculosis treatment increases weight and grip strength among HIV‐uninfected but not HIV‐infected patients in Mwanza, Tanzania. The Journal of Nutrition2011;141(4):685‐91. ">Praygod 2011a TZA</a>; <a href="./references#CD006086-bbs2-0023" title="PraygodG , RangeN , Faurholt‐JepsenD , JeremiahK , Faurholt‐JepsenM , AabyeMG , et al. Daily multi‐micronutrient supplementation during tuberculosis treatment increases weight and grip strength among HIV‐uninfected but not HIV‐infected patients in Mwanza, Tanzania. The Journal of Nutrition2011;141:685‐91. PraygodG , RangeN , Faurholt‐JepsenD , JeremiahK , Faurholt‐JepsenM , AabyeMG , et al. The effect of energy‐protein supplementation on weight, body composition and handgrip strength among pulmonary tuberculosis HIV‐co‐infected patients: randomised controlled trial in Mwanza, Tanzania. The British Journal of Nutrition2012;107(2):263‐71. ">Praygod 2011b TZA</a>; <a href="./references#CD006086-bbs2-0027" title="SchönT , IdhJ , WestmanA , EliasD , AbateE , DiroE , et al. Effects of a food supplement rich in arginine in patients with smear positive pulmonary tuberculosis ‐ a randomised trial. Tuberculosis2011;91(5):370‐7. ">Schön 2011 ETH</a>; <a href="./references#CD006086-bbs2-0034" title="VisserME , GrewalHMS , SwartEC , DhansayMA , WalzlG , SwanevelderS , et al. The effect of vitamin A and zinc supplementation on treatment outcomes in pulmonary tuberculosis: a randomized controlled trial. American Journal of Clinical Nutrition2011;93(1):93‐100. ">Visser 2011 ZAF</a>; <a href="./references#CD006086-bbs2-0024" title="RalphAP , WaramoriG , PontororingGJ , KenangalemE , WigunaA , TjitraE , et al. L‐arginine and vitamin D adjunctive therapies in pulmonary tuberculosis: a randomised, double‐blind, placebo‐controlled trial. PLoS One2013;8(8):e70032. ">Ralph 2013 IDN</a>; <a href="./references#CD006086-bbs2-0007" title="JeremiahK , DentiP , ChigutsaE , Faurholt‐JepsenD , PrayGodG , RangeN , et al. Nutritional supplementation increases rifampin exposure among tuberculosis patients co‐infected with HIV. Antimicrobial Agents and Chemotherapy2014;58(6):3468‐74. ">Jeremiah 2014 TZA</a>; <a href="./references#CD006086-bbs2-0011" title="LodhaR , MukherjeeA , SinghV , SinghS , FriisH , Faurholt‐JepsenD , et al. Effect of micronutrient supplementation on treatment outcomes in children with intrathoracic tuberculosis: a randomized controlled trial. American Journal of Clinical Nutrition2014;100(5):1287‐97. ">Lodha 2014 IND</a>; <a href="./references#CD006086-bbs2-0002" title="DaleyP , JagannathanV , JohnKR , SarojiniJ , LathaA , ViethR , et al. Adjunctive vitamin D for treatment of active tuberculosis in India: a randomised, double‐blind, placebo‐controlled trial. The Lancet. Infectious Diseases2015;15(5):528‐34. ">Daley 2015 IND</a>; <a href="./references#CD006086-bbs2-0003" title="FaraziA , ShafaatO , SofianM , KahbaziM . Arginine adjunctive therapy in active tuberculosis. Tuberculosis Research and Treatment2015;2015:205016. [DOI: 10.1155/2015/205016] ">Farazi 2015 IRN</a>; <a href="./references#CD006086-bbs2-0015" title="MilyA , RekhaRS , KamalSM , ArifuzzamanAS , RahimZ , KhanL , et al. Significant effects of oral phenylbutyrate and vitamin D3 adjunctive therapy in pulmonary tuberculosis: a randomized controlled trial. PLoS One2015;10(9):e0138340. [DOI: 10.1371/journal.pone.0138340] ">Mily 2015 BGD</a>; <a href="./references#CD006086-bbs2-0032" title="FredianiJ , TukvadzeN , SanikidzeE , KipianiM , HebbarG , TangprichaV , et al. Drug susceptibility influences macronutrient intake and body composition in tuberculosis patients. The FASEB Journal2014;28(Supplement 1):1014.4. TukvadzeN , SanikidzeE , KipianiM , HebbarG , EasleyKA , ShenviN , et al. High‐dose vitamin D3 in adults with pulmonary tuberculosis: a double‐blind randomised controlled trial. American Journal of Clinical Nutrition2015;102(5):1059‐69. ">Tukvadze 2015 GEO</a>). The other trials did not report how the random sequences were generated although all were described as "randomized". </p> <p>Eighteen trials described an adequate method of ensuring allocation concealment (<a href="./references#CD006086-bbs2-0026" title="SchönT , EliasD , MogesF , MeleseE , TessemaT , StendahlO , et al. Arginine as an adjuvant to chemotherapy improves clinical outcomes in active tuberculosis. European Respiratory Journal2003;21(3):483‐8. ">Schön 2003 ETH</a>; <a href="./references#CD006086-bbs2-0028" title="SembaRD , KumwendaJ , ZijlstraE , RicksMO , vanLettowM , WhalenC , et al. Micronutrient supplements and mortality of HIV‐infected adults with pulmonary TB: a controlled clinical trial. International Journal of Tuberculosis and Lung Disease2007;11(8):854‐9. ">Semba 2007 MWI</a>; <a href="./references#CD006086-bbs2-0035" title="WejseC , GomesVF , RabnaP , GustafsonP , AabyP , LisseIM , et al. Vitamin D as supplementary treatment for tuberculosis ‐ a double‐blind randomised placebo‐controlled trial. American Journal of Respiratory and Critical Care Medicine2009;179(9):843‐50. ">Wejse 2008 GNB</a>; <a href="./references#CD006086-bbs2-0013" title="MartinsN , MorrisP , KellyPM . Food incentives to improve completion of tuberculosis treatment: randomised controlled trial in Dili, Timor‐Leste. BMJ2009;229:b4248. ">Martins 2009 TLS</a>; <a href="./references#CD006086-bbs2-0010" title="LawsonL , ThacherTD , YassinMA , OnuohaNA , UsmanA , EmenyonuNE , et al. Randomized controlled trial of zinc and vitamin A as co‐adjuvants for the treatment of pulmonary tuberculosis. Tropical Medicine and International Health2010;15(12):1481‐90. ">Lawson 2010 NGA</a>; <a href="./references#CD006086-bbs2-0031" title="SudarsanamTD , JohnJ , KangG , MahendriV , GerriorJ , FranciosaM , et al. Pilot randomized trial of nutritional supplementation in patients with tuberculosis and HIV‐tuberculosis coinfection receiving directly observed short‐course chemotherapy for tuberculosis. Tropical Medicine and International Health2011;16(6):699‐706. ">Sudarsanam 2010 IND</a>; <a href="./references#CD006086-bbs2-0012" title="MartineauAR , TimmsPM , BothamleyGH , HanifaY , IslamK , ClaxtonAP , et al. High‐dose vitamin D3 during intensive‐phase antimicrobial treatment for pulmonary tuberculosis: a double‐blind randomised controlled trial. Lancet2011;377(9761):242‐50. ">Martineau 2011 GBR</a>; <a href="./references#CD006086-bbs2-0014" title="MehtaS , MugusiFM , BoschRJ , AboudS , ChatterjeeA , FinkelsteinJL , et al. A randomized trial of multivitamin supplementation in children with tuberculosis in Tanzania. Nutrition Journal2011;10:120. NCT00145184 . Effect of Multivitamin Supplements on Clinical and Immunological Response in Childhood Tuberculosis. https://clinicaltrials.gov/ct2/show/NCT00145184 (accessed 4 February 2016). ">Mehta 2011 TZA</a>; <a href="./references#CD006086-bbs2-0022" title="PraygodG , RangeN , Faurholt‐JepsenD , JeremiahK , Faurholt‐JepsenM , AabyeMG , et al. Daily multi‐micronutrient supplementation during tuberculosis treatment increases weight and grip strength among HIV‐uninfected but not HIV‐infected patients in Mwanza, Tanzania. The Journal of Nutrition2011;141(4):685‐91. ">Praygod 2011a TZA</a>; <a href="./references#CD006086-bbs2-0023" title="PraygodG , RangeN , Faurholt‐JepsenD , JeremiahK , Faurholt‐JepsenM , AabyeMG , et al. Daily multi‐micronutrient supplementation during tuberculosis treatment increases weight and grip strength among HIV‐uninfected but not HIV‐infected patients in Mwanza, Tanzania. The Journal of Nutrition2011;141:685‐91. PraygodG , RangeN , Faurholt‐JepsenD , JeremiahK , Faurholt‐JepsenM , AabyeMG , et al. The effect of energy‐protein supplementation on weight, body composition and handgrip strength among pulmonary tuberculosis HIV‐co‐infected patients: randomised controlled trial in Mwanza, Tanzania. The British Journal of Nutrition2012;107(2):263‐71. ">Praygod 2011b TZA</a>; <a href="./references#CD006086-bbs2-0027" title="SchönT , IdhJ , WestmanA , EliasD , AbateE , DiroE , et al. Effects of a food supplement rich in arginine in patients with smear positive pulmonary tuberculosis ‐ a randomised trial. Tuberculosis2011;91(5):370‐7. ">Schön 2011 ETH</a>; <a href="./references#CD006086-bbs2-0034" title="VisserME , GrewalHMS , SwartEC , DhansayMA , WalzlG , SwanevelderS , et al. The effect of vitamin A and zinc supplementation on treatment outcomes in pulmonary tuberculosis: a randomized controlled trial. American Journal of Clinical Nutrition2011;93(1):93‐100. ">Visser 2011 ZAF</a>; <a href="./references#CD006086-bbs2-0024" title="RalphAP , WaramoriG , PontororingGJ , KenangalemE , WigunaA , TjitraE , et al. L‐arginine and vitamin D adjunctive therapies in pulmonary tuberculosis: a randomised, double‐blind, placebo‐controlled trial. PLoS One2013;8(8):e70032. ">Ralph 2013 IDN</a>; <a href="./references#CD006086-bbs2-0011" title="LodhaR , MukherjeeA , SinghV , SinghS , FriisH , Faurholt‐JepsenD , et al. Effect of micronutrient supplementation on treatment outcomes in children with intrathoracic tuberculosis: a randomized controlled trial. American Journal of Clinical Nutrition2014;100(5):1287‐97. ">Lodha 2014 IND</a>; <a href="./references#CD006086-bbs2-0002" title="DaleyP , JagannathanV , JohnKR , SarojiniJ , LathaA , ViethR , et al. Adjunctive vitamin D for treatment of active tuberculosis in India: a randomised, double‐blind, placebo‐controlled trial. The Lancet. Infectious Diseases2015;15(5):528‐34. ">Daley 2015 IND</a>; <a href="./references#CD006086-bbs2-0003" title="FaraziA , ShafaatO , SofianM , KahbaziM . Arginine adjunctive therapy in active tuberculosis. Tuberculosis Research and Treatment2015;2015:205016. [DOI: 10.1155/2015/205016] ">Farazi 2015 IRN</a>; <a href="./references#CD006086-bbs2-0015" title="MilyA , RekhaRS , KamalSM , ArifuzzamanAS , RahimZ , KhanL , et al. Significant effects of oral phenylbutyrate and vitamin D3 adjunctive therapy in pulmonary tuberculosis: a randomized controlled trial. PLoS One2015;10(9):e0138340. [DOI: 10.1371/journal.pone.0138340] ">Mily 2015 BGD</a>; <a href="./references#CD006086-bbs2-0032" title="FredianiJ , TukvadzeN , SanikidzeE , KipianiM , HebbarG , TangprichaV , et al. Drug susceptibility influences macronutrient intake and body composition in tuberculosis patients. The FASEB Journal2014;28(Supplement 1):1014.4. TukvadzeN , SanikidzeE , KipianiM , HebbarG , EasleyKA , ShenviN , et al. High‐dose vitamin D3 in adults with pulmonary tuberculosis: a double‐blind randomised controlled trial. American Journal of Clinical Nutrition2015;102(5):1059‐69. ">Tukvadze 2015 GEO</a>). The other trials did not provide sufficient information to determine if the allocation sequence was truly concealed from the person allocating participants to the treatment groups. </p> </section> <section id="CD006086-sec-0097"> <h4 class="title">Blinding</h4> <p>It is generally not possible to blind patients to macronutrient supplementation. However, it is possible to blind the outcome assessors but only one of the six studies reports an attempt to do this (<a href="./references#CD006086-bbs2-0013" title="MartinsN , MorrisP , KellyPM . Food incentives to improve completion of tuberculosis treatment: randomised controlled trial in Dili, Timor‐Leste. BMJ2009;229:b4248. ">Martins 2009 TLS</a>). </p> <p>Twenty‐one of the 27 trials assessing micronutrients used placebos and adequately blinded participants and study staff to be considered at low risk of bias. </p> </section> <section id="CD006086-sec-0098"> <h4 class="title">Incomplete outcome data</h4> <p>We considered 12 studies at high risk of bias for some outcomes due to high losses to follow‐up (that is, loss to follow‐up &gt; 10% overall, between groups or within a group (<a href="./references#CD006086-bbs2-0005" title="HanekomWA , PotgeiterS , HughesEJ , MalanH , KessowG , HusseyGD . Vitamin A status and therapy in childhood pulmonary tuberculosis. Journal of Pediatrics1997;131(6):925‐7. ">Hanekom 1997 ZAF</a>; <a href="./references#CD006086-bbs2-0008" title="KaryadiE , WestCE , SchultinkW , NelwanRH , GrossR , AminZ , et al. A double‐blind, placebo‐controlled study of vitamin A and zinc supplementation in persons with tuberculosis in Indonesia: effects on clinical response and nutritional status. American Journal of Clinical Nutrition2002;75(4):720‐7. ">Karyadi 2002 IDN</a>; <a href="./references#CD006086-bbs2-0020" title="PatonNI , ChuaYK , EarnestA , CheeCB . Randomized controlled trial of nutritional supplementation in patients with newly diagnosed tuberculosis and wasting. American Journal of Clinical Nutrition2004;80(2):460‐5. ">Paton 2004 SGP</a>; <a href="./references#CD006086-bbs2-0025" title="RangeN , AndersenAB , MagnussenP , MugomelaA , FriisH . The effect of micronutrient supplementation on treatment outcome in patients with pulmonary tuberculosis: a randomised controlled trial in Mwanza, Tanzania. Tropical Medicine and International Health2005;10(9):826‐32. RangeN , ChangaluchaJ , KrarupH , MagnussenP , AndersenAB , FriisH . The effect of multi‐vitamin/mineral supplementation on mortality during treatment of pulmonary tuberculosis: a randomised two‐by‐two factorial trial in Mwanza, Tanzania. British Journal of Nutrition2006;95(4):762‐70. ">Range 2005 TZA</a>; <a href="./references#CD006086-bbs2-0028" title="SembaRD , KumwendaJ , ZijlstraE , RicksMO , vanLettowM , WhalenC , et al. Micronutrient supplements and mortality of HIV‐infected adults with pulmonary TB: a controlled clinical trial. International Journal of Tuberculosis and Lung Disease2007;11(8):854‐9. ">Semba 2007 MWI</a>; <a href="./references#CD006086-bbs2-0013" title="MartinsN , MorrisP , KellyPM . Food incentives to improve completion of tuberculosis treatment: randomised controlled trial in Dili, Timor‐Leste. BMJ2009;229:b4248. ">Martins 2009 TLS</a>; <a href="./references#CD006086-bbs2-0018" title="PakasiTA , KaryadiE , SuratihNMD , SaleanM , DarmawidjajaN , BorH , et al. Zinc and vitamin A supplementation fails to reduce sputum conversion time in severely malnourished pulmonary tuberculosis patients in Indonesia. Nutrition Journal2010;9:41. ">Pakasi 2010 IDN</a>; <a href="./references#CD006086-bbs2-0031" title="SudarsanamTD , JohnJ , KangG , MahendriV , GerriorJ , FranciosaM , et al. Pilot randomized trial of nutritional supplementation in patients with tuberculosis and HIV‐tuberculosis coinfection receiving directly observed short‐course chemotherapy for tuberculosis. Tropical Medicine and International Health2011;16(6):699‐706. ">Sudarsanam 2010 IND</a>; <a href="./references#CD006086-bbs2-0034" title="VisserME , GrewalHMS , SwartEC , DhansayMA , WalzlG , SwanevelderS , et al. The effect of vitamin A and zinc supplementation on treatment outcomes in pulmonary tuberculosis: a randomized controlled trial. American Journal of Clinical Nutrition2011;93(1):93‐100. ">Visser 2011 ZAF</a>; <a href="./references#CD006086-bbs2-0004" title="GinawiIA , AhmedMQ , AhmadI , Al‐HazimiAM . Effect of zinc and vitamin a supplementation along with inter‐tubercular treatment in pulmonary tuberculosis in north Indian patients. International Journal of Pharmaceutical Sciences and Research2013;4(9):3426‐31. ">Ginawi 2013 IND</a>; <a href="./references#CD006086-bbs2-0007" title="JeremiahK , DentiP , ChigutsaE , Faurholt‐JepsenD , PrayGodG , RangeN , et al. Nutritional supplementation increases rifampin exposure among tuberculosis patients co‐infected with HIV. Antimicrobial Agents and Chemotherapy2014;58(6):3468‐74. ">Jeremiah 2014 TZA</a>; <a href="./references#CD006086-bbs2-0032" title="FredianiJ , TukvadzeN , SanikidzeE , KipianiM , HebbarG , TangprichaV , et al. Drug susceptibility influences macronutrient intake and body composition in tuberculosis patients. The FASEB Journal2014;28(Supplement 1):1014.4. TukvadzeN , SanikidzeE , KipianiM , HebbarG , EasleyKA , ShenviN , et al. High‐dose vitamin D3 in adults with pulmonary tuberculosis: a double‐blind randomised controlled trial. American Journal of Clinical Nutrition2015;102(5):1059‐69. ">Tukvadze 2015 GEO</a>). </p> </section> <section id="CD006086-sec-0099"> <h4 class="title">Selective reporting</h4> <p>Although treatment outcomes in tuberculosis such as cure, and treatment completion are well established in tuberculosis programmes only one trial reported cure (<a href="./references#CD006086-bbs2-0031" title="SudarsanamTD , JohnJ , KangG , MahendriV , GerriorJ , FranciosaM , et al. Pilot randomized trial of nutritional supplementation in patients with tuberculosis and HIV‐tuberculosis coinfection receiving directly observed short‐course chemotherapy for tuberculosis. Tropical Medicine and International Health2011;16(6):699‐706. ">Sudarsanam 2010 IND</a>), and five reported treatment completion (<a href="./references#CD006086-bbs2-0013" title="MartinsN , MorrisP , KellyPM . Food incentives to improve completion of tuberculosis treatment: randomised controlled trial in Dili, Timor‐Leste. BMJ2009;229:b4248. ">Martins 2009 TLS</a>; <a href="./references#CD006086-bbs2-0006" title="JahnaviG , SudhaCH . Randomised controlled trial of food supplements in patients with newly diagnosed tuberculosis and wasting. Singapore Medical Journal2010;51(12):957‐62. ">Jahnavi 2010 IND</a>; <a href="./references#CD006086-bbs2-0018" title="PakasiTA , KaryadiE , SuratihNMD , SaleanM , DarmawidjajaN , BorH , et al. Zinc and vitamin A supplementation fails to reduce sputum conversion time in severely malnourished pulmonary tuberculosis patients in Indonesia. Nutrition Journal2010;9:41. ">Pakasi 2010 IDN</a>; <a href="./references#CD006086-bbs2-0031" title="SudarsanamTD , JohnJ , KangG , MahendriV , GerriorJ , FranciosaM , et al. Pilot randomized trial of nutritional supplementation in patients with tuberculosis and HIV‐tuberculosis coinfection receiving directly observed short‐course chemotherapy for tuberculosis. Tropical Medicine and International Health2011;16(6):699‐706. ">Sudarsanam 2010 IND</a>; <a href="./references#CD006086-bbs2-0003" title="FaraziA , ShafaatO , SofianM , KahbaziM . Arginine adjunctive therapy in active tuberculosis. Tuberculosis Research and Treatment2015;2015:205016. [DOI: 10.1155/2015/205016] ">Farazi 2015 IRN</a>). We were unable to retrieve trial protocols. </p> </section> <section id="CD006086-sec-0100"> <h4 class="title">Other potential sources of bias</h4> <p>One trial did not adequately describe baseline nutritional status (<a href="./references#CD006086-bbs2-0016" title="MorcosMM , GabrAA , SamualS , KamelM , elBazM , elBeshryM , et al. Vitamin D administration to tuberculous children and its value. Bollettino Chimico Farmaceutico1998;137(5):157‐64. ">Morcos 1998 EGY</a>), one trial had a large imbalance in HIV status at baseline (<a href="./references#CD006086-bbs2-0014" title="MehtaS , MugusiFM , BoschRJ , AboudS , ChatterjeeA , FinkelsteinJL , et al. A randomized trial of multivitamin supplementation in children with tuberculosis in Tanzania. Nutrition Journal2011;10:120. NCT00145184 . Effect of Multivitamin Supplements on Clinical and Immunological Response in Childhood Tuberculosis. https://clinicaltrials.gov/ct2/show/NCT00145184 (accessed 4 February 2016). ">Mehta 2011 TZA</a>), and one trial had appreciable difference in both HIV status and severity of chest X‐ray at baseline (<a href="./references#CD006086-bbs2-0024" title="RalphAP , WaramoriG , PontororingGJ , KenangalemE , WigunaA , TjitraE , et al. L‐arginine and vitamin D adjunctive therapies in pulmonary tuberculosis: a randomised, double‐blind, placebo‐controlled trial. PLoS One2013;8(8):e70032. ">Ralph 2013 IDN</a>). </p> </section> </section> <section id="CD006086-sec-0101"> <h3 class="title" id="CD006086-sec-0101">Effects of interventions</h3> <p>See: <a href="./full#CD006086-tbl-0001"><b>Summary of findings for the main comparison</b> 'Summary of findings' table 1</a>; <a href="./full#CD006086-tbl-0002"><b>Summary of findings 2</b> 'Summary of findings' table 2</a> </p> <section id="CD006086-sec-0102"> <h4 class="title">1. Macronutrients</h4> <section id="CD006086-sec-0103"> <h5 class="title">1.1 Increased energy supplementation (average daily requirement for a male adult: 2500 kcal) </h5> <p>Six trials examined the effects of providing macronutrient supplements through the health service. </p> <p> <ul id="CD006086-list-0008"> <li> <p>In Timor Leste, adults with pulmonary tuberculosis and a mean weight of 43.3 kg (31% of participants had a BMI of less than 16 kg/m²) were randomized to nutritional advice plus a daily cooked meal or nutritional advice alone (<a href="./references#CD006086-bbs2-0013" title="MartinsN , MorrisP , KellyPM . Food incentives to improve completion of tuberculosis treatment: randomised controlled trial in Dili, Timor‐Leste. BMJ2009;229:b4248. ">Martins 2009 TLS</a>). The daily midday meal (administered for two months during the intensive phase) consisted of a bowl of meat, kidney beans, and vegetable stew with rice. During the continuation phase participants in the supplement group also received a weekly food parcel containing unprepared red kidney beans, rice, and oil adequate for one meal per day. </p> </li> <li> <p>In India, adults with pulmonary tuberculosis and a BMI of less than 19 kg/m² were randomized to receive a macronutrient and micronutrient supplement plus standard care versus standard care alone (<a href="./references#CD006086-bbs2-0031" title="SudarsanamTD , JohnJ , KangG , MahendriV , GerriorJ , FranciosaM , et al. Pilot randomized trial of nutritional supplementation in patients with tuberculosis and HIV‐tuberculosis coinfection receiving directly observed short‐course chemotherapy for tuberculosis. Tropical Medicine and International Health2011;16(6):699‐706. ">Sudarsanam 2010 IND</a>). The supplement consisted of three daily servings of a cereal and lentil mixture (providing 930 kcal and 31.5 g protein) and a once‐a‐day multivitamin tablet. Participants were given a month's supply of supplement at a time. </p> </li> <li> <p>The remaining four trials compared daily high energy supplements with: nutritional advice alone (<a href="./references#CD006086-bbs2-0020" title="PatonNI , ChuaYK , EarnestA , CheeCB . Randomized controlled trial of nutritional supplementation in patients with newly diagnosed tuberculosis and wasting. American Journal of Clinical Nutrition2004;80(2):460‐5. ">Paton 2004 SGP</a>; <a href="./references#CD006086-bbs2-0006" title="JahnaviG , SudhaCH . Randomised controlled trial of food supplements in patients with newly diagnosed tuberculosis and wasting. Singapore Medical Journal2010;51(12):957‐62. ">Jahnavi 2010 IND</a>); a single multi‐micronutrient biscuit (<a href="./references#CD006086-bbs2-0023" title="PraygodG , RangeN , Faurholt‐JepsenD , JeremiahK , Faurholt‐JepsenM , AabyeMG , et al. Daily multi‐micronutrient supplementation during tuberculosis treatment increases weight and grip strength among HIV‐uninfected but not HIV‐infected patients in Mwanza, Tanzania. The Journal of Nutrition2011;141:685‐91. PraygodG , RangeN , Faurholt‐JepsenD , JeremiahK , Faurholt‐JepsenM , AabyeMG , et al. The effect of energy‐protein supplementation on weight, body composition and handgrip strength among pulmonary tuberculosis HIV‐co‐infected patients: randomised controlled trial in Mwanza, Tanzania. The British Journal of Nutrition2012;107(2):263‐71. ">Praygod 2011b TZA</a>); or no supplement (<a href="./references#CD006086-bbs2-0007" title="JeremiahK , DentiP , ChigutsaE , Faurholt‐JepsenD , PrayGodG , RangeN , et al. Nutritional supplementation increases rifampin exposure among tuberculosis patients co‐infected with HIV. Antimicrobial Agents and Chemotherapy2014;58(6):3468‐74. ">Jeremiah 2014 TZA</a>). The supplements were described as 'sweetballs' (made from wheat flour, caramel, ground nuts, and vegetable ghee) (<a href="./references#CD006086-bbs2-0006" title="JahnaviG , SudhaCH . Randomised controlled trial of food supplements in patients with newly diagnosed tuberculosis and wasting. Singapore Medical Journal2010;51(12):957‐62. ">Jahnavi 2010 IND</a>), high energy 'packets' (<a href="./references#CD006086-bbs2-0020" title="PatonNI , ChuaYK , EarnestA , CheeCB . Randomized controlled trial of nutritional supplementation in patients with newly diagnosed tuberculosis and wasting. American Journal of Clinical Nutrition2004;80(2):460‐5. ">Paton 2004 SGP</a>), and high energy 'biscuits' (<a href="./references#CD006086-bbs2-0023" title="PraygodG , RangeN , Faurholt‐JepsenD , JeremiahK , Faurholt‐JepsenM , AabyeMG , et al. Daily multi‐micronutrient supplementation during tuberculosis treatment increases weight and grip strength among HIV‐uninfected but not HIV‐infected patients in Mwanza, Tanzania. The Journal of Nutrition2011;141:685‐91. PraygodG , RangeN , Faurholt‐JepsenD , JeremiahK , Faurholt‐JepsenM , AabyeMG , et al. The effect of energy‐protein supplementation on weight, body composition and handgrip strength among pulmonary tuberculosis HIV‐co‐infected patients: randomised controlled trial in Mwanza, Tanzania. The British Journal of Nutrition2012;107(2):263‐71. ">Praygod 2011b TZA</a>; <a href="./references#CD006086-bbs2-0007" title="JeremiahK , DentiP , ChigutsaE , Faurholt‐JepsenD , PrayGodG , RangeN , et al. Nutritional supplementation increases rifampin exposure among tuberculosis patients co‐infected with HIV. Antimicrobial Agents and Chemotherapy2014;58(6):3468‐74. ">Jeremiah 2014 TZA</a>) (see <a href="./appendices#CD006086-sec-0162">Appendix 5</a>). None of the studies estimated the total daily energy intake, but the supplement provided between 600 and 3690 kcal per day on top of the regular diet. All four studies recruited people with mean BMI below 20 kg/m². </p> </li> </ul> </p> <p>Only two trials measured total dietary intake. Both trials confirmed that supplementation had increased nutritional intake compared to dietary advice alone, and not simply substituted food that patients might have obtained elsewhere (<a href="./references#CD006086-bbs2-0020" title="PatonNI , ChuaYK , EarnestA , CheeCB . Randomized controlled trial of nutritional supplementation in patients with newly diagnosed tuberculosis and wasting. American Journal of Clinical Nutrition2004;80(2):460‐5. ">Paton 2004 SGP</a>; <a href="./references#CD006086-bbs2-0031" title="SudarsanamTD , JohnJ , KangG , MahendriV , GerriorJ , FranciosaM , et al. Pilot randomized trial of nutritional supplementation in patients with tuberculosis and HIV‐tuberculosis coinfection receiving directly observed short‐course chemotherapy for tuberculosis. Tropical Medicine and International Health2011;16(6):699‐706. ">Sudarsanam 2010 IND</a>). </p> <section id="CD006086-sec-0104"> <h6 class="title">Tuberculosis treatment outcomes</h6> <p>The number of deaths reported from these trials was very low, and trials were too small to reliably detect or exclude important differences in mortality (risk ratio (RR) 0.34, 95% confidence interval (CI) 0.10 to 1.20; four trials, 567 participants; <a href="./references#CD006086-fig-0003" title="">Analysis 1.1</a>), or cure (RR 0.91, 95% CI 0.59 to 1.41; one trial, 102 participants; <a href="./references#CD006086-fig-0004" title="">Analysis 1.2</a>). <a href="./references#CD006086-bbs2-0006" title="JahnaviG , SudhaCH . Randomised controlled trial of food supplements in patients with newly diagnosed tuberculosis and wasting. Singapore Medical Journal2010;51(12):957‐62. ">Jahnavi 2010 IND</a> found a statistically significant difference in treatment completion in favour of supplementation, but this was not seen in the larger trial conducted in Timor Leste (two trials, 365 participants, <a href="./references#CD006086-fig-0005" title="">Analysis 1.3</a>). </p> <p><a href="./references#CD006086-bbs2-0006" title="JahnaviG , SudhaCH . Randomised controlled trial of food supplements in patients with newly diagnosed tuberculosis and wasting. Singapore Medical Journal2010;51(12):957‐62. ">Jahnavi 2010 IND</a> also found that more participants given supplements were smear negative at eight weeks, while <a href="./references#CD006086-bbs2-0013" title="MartinsN , MorrisP , KellyPM . Food incentives to improve completion of tuberculosis treatment: randomised controlled trial in Dili, Timor‐Leste. BMJ2009;229:b4248. ">Martins 2009 TLS</a> and <a href="./references#CD006086-bbs2-0007" title="JeremiahK , DentiP , ChigutsaE , Faurholt‐JepsenD , PrayGodG , RangeN , et al. Nutritional supplementation increases rifampin exposure among tuberculosis patients co‐infected with HIV. Antimicrobial Agents and Chemotherapy2014;58(6):3468‐74. ">Jeremiah 2014 TZA</a> found no statistically significant difference (RR 1.08, 95% CI 0.86 to 1.37; three trials, 222 participants; <a href="./references#CD006086-fig-0006" title="">Analysis 1.4</a>). </p> </section> <section id="CD006086-sec-0105"> <h6 class="title">Nutritional recovery and quality of life</h6> <p>Effects on weight gain were mixed (five trials, 689 participants, <a href="./references#CD006086-fig-0007" title="">Analysis 1.5</a>). The daily hot meal was associated with an extra 1.7 kg weight gain at eight weeks (95% CI 0.1 to 3.2; P = 0.04; authors' own figures), and 2.6 kg at eight months (95% CI 0.1 to 5.2; P = 0.04; authors' own figures; <a href="./references#CD006086-bbs2-0013" title="MartinsN , MorrisP , KellyPM . Food incentives to improve completion of tuberculosis treatment: randomised controlled trial in Dili, Timor‐Leste. BMJ2009;229:b4248. ">Martins 2009 TLS</a>), whereas the monthly ration pack was not associated with important differences (change in lean body mass, and percentage body fat were not significantly different between groups; P = 0.479 and P = 0.573 respectively; authors' own figures; <a href="./references#CD006086-bbs2-0031" title="SudarsanamTD , JohnJ , KangG , MahendriV , GerriorJ , FranciosaM , et al. Pilot randomized trial of nutritional supplementation in patients with tuberculosis and HIV‐tuberculosis coinfection receiving directly observed short‐course chemotherapy for tuberculosis. Tropical Medicine and International Health2011;16(6):699‐706. ">Sudarsanam 2010 IND</a>). </p> <p>Of the trials evaluating high energy supplements, the two smaller trials in HIV‐negative participants found that supplementation resulted in significantly more weight gain than advice alone at six weeks (MD 1.73 kg, 95% CI 0.81 to 2.65; one trial, 34 participants; <a href="./references#CD006086-fig-0007" title="">Analysis 1.5</a>) and 12 weeks, respectively (MD 2.6 kg, 95% CI 1.74 to 3.46; one trial, 100 participants; <a href="./references#CD006086-fig-0007" title="">Analysis 1.5</a>). <a href="./references#CD006086-bbs2-0020" title="PatonNI , ChuaYK , EarnestA , CheeCB . Randomized controlled trial of nutritional supplementation in patients with newly diagnosed tuberculosis and wasting. American Journal of Clinical Nutrition2004;80(2):460‐5. ">Paton 2004 SGP</a> further quantified this as an increase in lean body mass (MD 1.13 kg, 95% CI 0.37 to 1.89; one trial, 34 participants), with no significant difference in total fat mass. However, in Tanzania <a href="./references#CD006086-bbs2-0023" title="PraygodG , RangeN , Faurholt‐JepsenD , JeremiahK , Faurholt‐JepsenM , AabyeMG , et al. Daily multi‐micronutrient supplementation during tuberculosis treatment increases weight and grip strength among HIV‐uninfected but not HIV‐infected patients in Mwanza, Tanzania. The Journal of Nutrition2011;141:685‐91. PraygodG , RangeN , Faurholt‐JepsenD , JeremiahK , Faurholt‐JepsenM , AabyeMG , et al. The effect of energy‐protein supplementation on weight, body composition and handgrip strength among pulmonary tuberculosis HIV‐co‐infected patients: randomised controlled trial in Mwanza, Tanzania. The British Journal of Nutrition2012;107(2):263‐71. ">Praygod 2011b TZA</a> found no significant difference in weight gain with supplementation in HIV‐positive participants at eight or 20 weeks (one trial, 332 participants, <a href="./references#CD006086-fig-0007" title="">Analysis 1.5</a>). Similarly, <a href="./references#CD006086-bbs2-0007" title="JeremiahK , DentiP , ChigutsaE , Faurholt‐JepsenD , PrayGodG , RangeN , et al. Nutritional supplementation increases rifampin exposure among tuberculosis patients co‐infected with HIV. Antimicrobial Agents and Chemotherapy2014;58(6):3468‐74. ">Jeremiah 2014 TZA</a> found no difference in final mean weight between the supplement and no supplement group after two months of supplementation (one trial, 92 participants, <a href="./references#CD006086-fig-0007" title="">Analysis 1.5</a>). </p> <p>Three trials of high energy supplements (<a href="./references#CD006086-bbs2-0020" title="PatonNI , ChuaYK , EarnestA , CheeCB . Randomized controlled trial of nutritional supplementation in patients with newly diagnosed tuberculosis and wasting. American Journal of Clinical Nutrition2004;80(2):460‐5. ">Paton 2004 SGP</a>; <a href="./references#CD006086-bbs2-0006" title="JahnaviG , SudhaCH . Randomised controlled trial of food supplements in patients with newly diagnosed tuberculosis and wasting. Singapore Medical Journal2010;51(12):957‐62. ">Jahnavi 2010 IND</a>; <a href="./references#CD006086-bbs2-0023" title="PraygodG , RangeN , Faurholt‐JepsenD , JeremiahK , Faurholt‐JepsenM , AabyeMG , et al. Daily multi‐micronutrient supplementation during tuberculosis treatment increases weight and grip strength among HIV‐uninfected but not HIV‐infected patients in Mwanza, Tanzania. The Journal of Nutrition2011;141:685‐91. PraygodG , RangeN , Faurholt‐JepsenD , JeremiahK , Faurholt‐JepsenM , AabyeMG , et al. The effect of energy‐protein supplementation on weight, body composition and handgrip strength among pulmonary tuberculosis HIV‐co‐infected patients: randomised controlled trial in Mwanza, Tanzania. The British Journal of Nutrition2012;107(2):263‐71. ">Praygod 2011b TZA</a>) report changes in maximum grip strength, and again a statistically significant benefit was seen in the small trials of HIV‐negative participants but not the larger trial of HIV‐positive participants although the data appear skewed (three trials, 466 participants, <a href="./references#CD006086-fig-0008" title="">Analysis 1.6</a>). </p> <p><a href="./references#CD006086-bbs2-0006" title="JahnaviG , SudhaCH . Randomised controlled trial of food supplements in patients with newly diagnosed tuberculosis and wasting. Singapore Medical Journal2010;51(12):957‐62. ">Jahnavi 2010 IND</a> and <a href="./references#CD006086-bbs2-0020" title="PatonNI , ChuaYK , EarnestA , CheeCB . Randomized controlled trial of nutritional supplementation in patients with newly diagnosed tuberculosis and wasting. American Journal of Clinical Nutrition2004;80(2):460‐5. ">Paton 2004 SGP</a> also reported that the benefits on weight gain and grip strength were accompanied by improvements in some quality of life scores. It was not possible to assess whether these difference were statistically significant because the data appeared highly skewed (the SDs were larger than the means for most outcomes); see <a href="./references#CD006086-fig-0009" title="">Analysis 1.7</a> and <a href="./appendices#CD006086-sec-0163">Appendix 6</a>. </p> </section> </section> <section id="CD006086-sec-0106"> <h5 class="title">1.2 Altered dietary composition</h5> <p>One very small trial of 21 participants compared a high cholesterol diet (2500 kcal per day with 800 mg cholesterol per day) with a diet with a similar nutritional profile but lower in cholesterol (2500 kcal per day with 250 mg cholesterol per day) for eight weeks in adults being treated for sputum‐culture positive pulmonary tuberculosis (<a href="./references#CD006086-bbs2-0021" title="Pérez‐GuzmánC , VargasMH , QuiñonezF , BazavilvazoN , AguilarA . A cholesterol‐rich diet accelerates bacteriologic sterilization in pulmonary tuberculosis. Chest2005;127(2):643‐51. ">Pérez‐Guzmán 2005 MEX</a>). </p> <section id="CD006086-sec-0107"> <h6 class="title">Tuberculosis treatment outcomes</h6> <p>This trial did not report on death, cure, or treatment completion.</p> <p>Fewer participants in the high cholesterol group were still sputum‐culture positive at two weeks compared with those in the normal cholesterol group (RR of remaining sputum positive at two weeks 0.22, 95% CI 0.06 to 0.77; one trial, 20 participants, <a href="./references#CD006086-fig-0010" title="">Analysis 2.1</a>), the difference was not significant at four weeks, and at eight weeks all participants in both groups were sputum‐culture negative. Self reported cough and dyspnoea are reported to have decreased at the same rate in both groups (figures not given). </p> </section> <section id="CD006086-sec-0108"> <h6 class="title">Nutritional recovery and quality of life</h6> <p>This trial did not report on any aspect of the participant's nutritional recovery or quality of life. </p> </section> </section> </section> <section id="CD006086-sec-0109"> <h4 class="title">2. Micronutrients</h4> <section id="CD006086-sec-0110"> <h5 class="title">2.1 Multivitamins and trace elements</h5> <p>Four trials in adults being treated for sputum test positive or negative pulmonary tuberculosis (<a href="./references#CD006086-bbs2-0025" title="RangeN , AndersenAB , MagnussenP , MugomelaA , FriisH . The effect of micronutrient supplementation on treatment outcome in patients with pulmonary tuberculosis: a randomised controlled trial in Mwanza, Tanzania. Tropical Medicine and International Health2005;10(9):826‐32. RangeN , ChangaluchaJ , KrarupH , MagnussenP , AndersenAB , FriisH . The effect of multi‐vitamin/mineral supplementation on mortality during treatment of pulmonary tuberculosis: a randomised two‐by‐two factorial trial in Mwanza, Tanzania. British Journal of Nutrition2006;95(4):762‐70. ">Range 2005 TZA</a>; <a href="./references#CD006086-bbs2-0028" title="SembaRD , KumwendaJ , ZijlstraE , RicksMO , vanLettowM , WhalenC , et al. Micronutrient supplements and mortality of HIV‐infected adults with pulmonary TB: a controlled clinical trial. International Journal of Tuberculosis and Lung Disease2007;11(8):854‐9. ">Semba 2007 MWI</a>; <a href="./references#CD006086-bbs2-0033" title="VillamorE , MugusiF , UrassaW , BoschR J , SaathoffE , MatsumotoK , et al. A trial of the effect of micronutrient supplementation on treatment outcome, T cell counts, morbidity, and mortality in adults with pulmonary tuberculosis. The Journal of Infectious Diseases2008;197(11):1499‐505. ">Villamor 2008 TZA</a>; <a href="./references#CD006086-bbs2-0022" title="PraygodG , RangeN , Faurholt‐JepsenD , JeremiahK , Faurholt‐JepsenM , AabyeMG , et al. Daily multi‐micronutrient supplementation during tuberculosis treatment increases weight and grip strength among HIV‐uninfected but not HIV‐infected patients in Mwanza, Tanzania. The Journal of Nutrition2011;141(4):685‐91. ">Praygod 2011a TZA</a>) and two trials in children (<a href="./references#CD006086-bbs2-0014" title="MehtaS , MugusiFM , BoschRJ , AboudS , ChatterjeeA , FinkelsteinJL , et al. A randomized trial of multivitamin supplementation in children with tuberculosis in Tanzania. Nutrition Journal2011;10:120. NCT00145184 . Effect of Multivitamin Supplements on Clinical and Immunological Response in Childhood Tuberculosis. https://clinicaltrials.gov/ct2/show/NCT00145184 (accessed 4 February 2016). ">Mehta 2011 TZA</a>; <a href="./references#CD006086-bbs2-0011" title="LodhaR , MukherjeeA , SinghV , SinghS , FriisH , Faurholt‐JepsenD , et al. Effect of micronutrient supplementation on treatment outcomes in children with intrathoracic tuberculosis: a randomized controlled trial. American Journal of Clinical Nutrition2014;100(5):1287‐97. ">Lodha 2014 IND</a>) compared daily multiple micronutrient supplements (containing a range of vitamins and trace elements), with placebo. The exact doses of the individual constituents ranged from one to 10 times the dietary reference intake (DRI), and are given in <a href="./appendices#CD006086-sec-0158">Appendix 1</a>. In summary: vitamin A (1 to 3 x DRI), B vitamins (1 to 10 x DRI), vitamin C (1 to 5 x DRI), vitamin D (approximately 1 x DRI), vitamin E (1 to 10 x DRI), zinc (1 to 5 x DRI), and selenium (1 to 4 x DRI). </p> <p>In two trials participants received daily supplements for two months (<a href="./references#CD006086-bbs2-0014" title="MehtaS , MugusiFM , BoschRJ , AboudS , ChatterjeeA , FinkelsteinJL , et al. A randomized trial of multivitamin supplementation in children with tuberculosis in Tanzania. Nutrition Journal2011;10:120. NCT00145184 . Effect of Multivitamin Supplements on Clinical and Immunological Response in Childhood Tuberculosis. https://clinicaltrials.gov/ct2/show/NCT00145184 (accessed 4 February 2016). ">Mehta 2011 TZA</a>; <a href="./references#CD006086-bbs2-0022" title="PraygodG , RangeN , Faurholt‐JepsenD , JeremiahK , Faurholt‐JepsenM , AabyeMG , et al. Daily multi‐micronutrient supplementation during tuberculosis treatment increases weight and grip strength among HIV‐uninfected but not HIV‐infected patients in Mwanza, Tanzania. The Journal of Nutrition2011;141(4):685‐91. ">Praygod 2011a TZA</a>), one trial for six months (<a href="./references#CD006086-bbs2-0011" title="LodhaR , MukherjeeA , SinghV , SinghS , FriisH , Faurholt‐JepsenD , et al. Effect of micronutrient supplementation on treatment outcomes in children with intrathoracic tuberculosis: a randomized controlled trial. American Journal of Clinical Nutrition2014;100(5):1287‐97. ">Lodha 2014 IND</a>), one trial for eight months (<a href="./references#CD006086-bbs2-0025" title="RangeN , AndersenAB , MagnussenP , MugomelaA , FriisH . The effect of micronutrient supplementation on treatment outcome in patients with pulmonary tuberculosis: a randomised controlled trial in Mwanza, Tanzania. Tropical Medicine and International Health2005;10(9):826‐32. RangeN , ChangaluchaJ , KrarupH , MagnussenP , AndersenAB , FriisH . The effect of multi‐vitamin/mineral supplementation on mortality during treatment of pulmonary tuberculosis: a randomised two‐by‐two factorial trial in Mwanza, Tanzania. British Journal of Nutrition2006;95(4):762‐70. ">Range 2005 TZA</a>), and in two trials they received daily supplements for 24 months (<a href="./references#CD006086-bbs2-0028" title="SembaRD , KumwendaJ , ZijlstraE , RicksMO , vanLettowM , WhalenC , et al. Micronutrient supplements and mortality of HIV‐infected adults with pulmonary TB: a controlled clinical trial. International Journal of Tuberculosis and Lung Disease2007;11(8):854‐9. ">Semba 2007 MWI</a>; <a href="./references#CD006086-bbs2-0033" title="VillamorE , MugusiF , UrassaW , BoschR J , SaathoffE , MatsumotoK , et al. A trial of the effect of micronutrient supplementation on treatment outcome, T cell counts, morbidity, and mortality in adults with pulmonary tuberculosis. The Journal of Infectious Diseases2008;197(11):1499‐505. ">Villamor 2008 TZA</a>). </p> <section id="CD006086-sec-0111"> <h6 class="title">Tuberculosis treatment outcomes</h6> <p>In trials with HIV negative people the number of deaths from tuberculosis was low and the trials substantially underpowered to demonstrate an effect, Consequently, the 95% CI is wide and includes clinically important benefit and harm (RR 0.86, 95% CI 0.46 to 1.60, four trials, 1219 participants, <a href="./references#CD006086-fig-0011" title="">Analysis 3.1</a>). Deaths were more common in trials with HIV positive people not taking antiretroviral therapy, but again no differences between micronutrients and placebo were demonstrated (RR 0.92, 95% CI 0.69 to 1.23, three trials, 1429 participants, <a href="./references#CD006086-fig-0011" title="">Analysis 3.1</a>). </p> <p><a href="./references#CD006086-bbs2-0011" title="LodhaR , MukherjeeA , SinghV , SinghS , FriisH , Faurholt‐JepsenD , et al. Effect of micronutrient supplementation on treatment outcomes in children with intrathoracic tuberculosis: a randomized controlled trial. American Journal of Clinical Nutrition2014;100(5):1287‐97. ">Lodha 2014 IND</a> reported no difference in tuberculosis treatment completion at six months between micronutrients (with and without zinc) and placebo (one trial, 302 participants, <a href="./references#CD006086-fig-0012" title="">Analysis 3.2</a>). </p> <p>There was no statistically significant difference between the supplement and control groups in the numbers of participants who remained sputum‐culture or sputum‐smear positive at one month (two trials, 1020 participants, <a href="./references#CD006086-fig-0013" title="">Analysis 3.3</a>) or two months (two trials, 731 participants, <a href="./references#CD006086-fig-0014" title="">Analysis 3.4</a>). </p> <p><a href="./references#CD006086-bbs2-0011" title="LodhaR , MukherjeeA , SinghV , SinghS , FriisH , Faurholt‐JepsenD , et al. Effect of micronutrient supplementation on treatment outcomes in children with intrathoracic tuberculosis: a randomized controlled trial. American Journal of Clinical Nutrition2014;100(5):1287‐97. ">Lodha 2014 IND</a> and <a href="./references#CD006086-bbs2-0014" title="MehtaS , MugusiFM , BoschRJ , AboudS , ChatterjeeA , FinkelsteinJL , et al. A randomized trial of multivitamin supplementation in children with tuberculosis in Tanzania. Nutrition Journal2011;10:120. NCT00145184 . Effect of Multivitamin Supplements on Clinical and Immunological Response in Childhood Tuberculosis. https://clinicaltrials.gov/ct2/show/NCT00145184 (accessed 4 February 2016). ">Mehta 2011 TZA</a> reported no appreciable difference in chest x‐ray clearance (after two or six months of supplementation) between the supplemented children and the placebo children at follow‐up (two trials, 497 participants, <a href="./references#CD006086-fig-0015" title="">Analysis 3.5</a>). </p> </section> <section id="CD006086-sec-0112"> <h6 class="title">Nutritional recovery and quality of life</h6> <p>Five trials reported changes in weight or body mass using a variety of parameters, and only <a href="./references#CD006086-bbs2-0025" title="RangeN , AndersenAB , MagnussenP , MugomelaA , FriisH . The effect of micronutrient supplementation on treatment outcome in patients with pulmonary tuberculosis: a randomised controlled trial in Mwanza, Tanzania. Tropical Medicine and International Health2005;10(9):826‐32. RangeN , ChangaluchaJ , KrarupH , MagnussenP , AndersenAB , FriisH . The effect of multi‐vitamin/mineral supplementation on mortality during treatment of pulmonary tuberculosis: a randomised two‐by‐two factorial trial in Mwanza, Tanzania. British Journal of Nutrition2006;95(4):762‐70. ">Range 2005 TZA</a> reported statistically significant effects (see <a href="#CD006086-tbl-0003">Table 1</a>). </p> <div class="table" id="CD006086-tbl-0003"> <table><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Table 1.</span> <span class="table-title">Effect of multi‐micronutrient supplementation on nutritional recovery</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Trial ID</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Population</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Weight measurement</b> </p> </td> <td align="center" bgcolor="#ffffff" colspan="2" rowspan="1" valign="top"> <p><b>Baseline nutritional status</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Duration of supplement and follow‐up</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Comment</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Supplement</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Placebo</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD006086-bbs2-0014" title="MehtaS , MugusiFM , BoschRJ , AboudS , ChatterjeeA , FinkelsteinJL , et al. A randomized trial of multivitamin supplementation in children with tuberculosis in Tanzania. Nutrition Journal2011;10:120. NCT00145184 . Effect of Multivitamin Supplements on Clinical and Immunological Response in Childhood Tuberculosis. https://clinicaltrials.gov/ct2/show/NCT00145184 (accessed 4 February 2016). ">Mehta 2011 TZA</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>HIV‐positive and HIV‐negative children</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Weight gain median (IQR)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>MUAC (cm)</p> <p>13.0 (11.9 to 14.25)</p> <p>Weight: 8.48kg (NR)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>MUAC (cm)</p> <p>13.0 (11.2 to 14.0)</p> <p>Weight kg: 7.95 kg (NR)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Supplement and follow‐up 2 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>The trial authors reported no effect of supplement on median weight, height, or mid‐upper arm circumference at 2 months </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD006086-bbs2-0011" title="LodhaR , MukherjeeA , SinghV , SinghS , FriisH , Faurholt‐JepsenD , et al. Effect of micronutrient supplementation on treatment outcomes in children with intrathoracic tuberculosis: a randomized controlled trial. American Journal of Clinical Nutrition2014;100(5):1287‐97. ">Lodha 2014 IND</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>HIV‐negative children</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Change in weight‐for‐age z score</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Weight‐for‐age z score (SD):</p> <p>−2.72 (1.85, MN+Z group);</p> <p>−2.8 (1.6, MN group)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Weight‐for‐age z score (SD): −2.8 (1.6)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Supplement and follow‐up 6 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>The trial authors reported no difference in weight (kg), weight‐for‐age z score, height‐for‐age z score, or BMI z score after 2 or 6 months supplementation with micronutrients with or without zinc (1 trial, 302 participants, <a href="./references#CD006086-fig-0017" title="">Analysis 3.7</a>) </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD006086-bbs2-0022" title="PraygodG , RangeN , Faurholt‐JepsenD , JeremiahK , Faurholt‐JepsenM , AabyeMG , et al. Daily multi‐micronutrient supplementation during tuberculosis treatment increases weight and grip strength among HIV‐uninfected but not HIV‐infected patients in Mwanza, Tanzania. The Journal of Nutrition2011;141(4):685‐91. ">Praygod 2011a TZA</a><sup>1</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>HIV‐positive and negative adults</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Mean weight gain (SD)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Mean BMI (SD): 18.9 kg/m² (2.8)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>mean BMI (SD): 18.9 kg/m² (3.1)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Supplement for 2 months</p> <p>Follow‐up at 2 and 5 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>There was no statistically significant difference in weight gain at 2 or 5 months. Subgroup analysis by HIV status found a statistically significant difference in weight gain in favour of supplements in HIV‐negative participants, and in favour of placebo in HIV‐positive participants (trial authors' own figures) </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD006086-bbs2-0033" title="VillamorE , MugusiF , UrassaW , BoschR J , SaathoffE , MatsumotoK , et al. A trial of the effect of micronutrient supplementation on treatment outcome, T cell counts, morbidity, and mortality in adults with pulmonary tuberculosis. The Journal of Infectious Diseases2008;197(11):1499‐505. ">Villamor 2008 TZA</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>HIV‐positive and negative adults</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Mean BMI (SD)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>HIV‐negative mean BMI (SD): 18.9 kg/m² (2.5)</p> <p>HIV‐positive mean BMI (SD): 19.3 kg/m² (2.8)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>HIV‐negative mean BMI (SD): 18.9 kg/m² (2.5)</p> <p>HIV‐positive mean BMI (SD): 19.6 kg/m² (2.9)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Supplement for 24 months and follow‐up at 8 and 24 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>The trial authors reported no statistically significant effect of supplement on BMI, mid‐upper arm circumference, fat mass, or fat free mass at 8 or 24 months, regardless of HIV status (no figures reported) </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD006086-bbs2-0025" title="RangeN , AndersenAB , MagnussenP , MugomelaA , FriisH . The effect of micronutrient supplementation on treatment outcome in patients with pulmonary tuberculosis: a randomised controlled trial in Mwanza, Tanzania. Tropical Medicine and International Health2005;10(9):826‐32. RangeN , ChangaluchaJ , KrarupH , MagnussenP , AndersenAB , FriisH . The effect of multi‐vitamin/mineral supplementation on mortality during treatment of pulmonary tuberculosis: a randomised two‐by‐two factorial trial in Mwanza, Tanzania. British Journal of Nutrition2006;95(4):762‐70. ">Range 2005 TZA</a><sup>2</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>HIV‐positive and negative adults</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Mean weight gain (SD)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Mean BMI (SD): 18.3 kg/m² (2.5) zinc + MMN group</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Mean BMI (SD): 18.7 kg/m² (2.7)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Supplement for 8 months and follow‐up 8 weeks and 7 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>There was a statistically significantly greater weight gain in supplemented group at 7 months. While the difference in weight was appreciable in both treatment (zinc + MMN and MMN groups) arms compared to placebo, the weight gain in the zinc + MMN arm appeared to be clinically important </p> </td> </tr> </tbody> </table> <div class="table-footnote"> <p>Abbreviations: SD = standard deviation; BMI = body mass index; MMN = multi‐micronutrient; HIV = human immunodeficiency virus; IQR = interquartile range; MUAC = mid‐upper arm circumference; NR = not reported;<br/> <sup>1</sup>The supplement administered by <a href="./references#CD006086-bbs2-0022" title="PraygodG , RangeN , Faurholt‐JepsenD , JeremiahK , Faurholt‐JepsenM , AabyeMG , et al. Daily multi‐micronutrient supplementation during tuberculosis treatment increases weight and grip strength among HIV‐uninfected but not HIV‐infected patients in Mwanza, Tanzania. The Journal of Nutrition2011;141(4):685‐91. ">Praygod 2011a TZA</a> included a similar dose of zinc to that used by <a href="./references#CD006086-bbs2-0025" title="RangeN , AndersenAB , MagnussenP , MugomelaA , FriisH . The effect of micronutrient supplementation on treatment outcome in patients with pulmonary tuberculosis: a randomised controlled trial in Mwanza, Tanzania. Tropical Medicine and International Health2005;10(9):826‐32. RangeN , ChangaluchaJ , KrarupH , MagnussenP , AndersenAB , FriisH . The effect of multi‐vitamin/mineral supplementation on mortality during treatment of pulmonary tuberculosis: a randomised two‐by‐two factorial trial in Mwanza, Tanzania. British Journal of Nutrition2006;95(4):762‐70. ">Range 2005 TZA</a>.<br/> <sup>2</sup>2 X 2 factorial design; Group 1: zinc plus placebo; Group 2: multivitamin and mineral tablet plus placebo; Group 3: zinc plus multivitamin and mineral tablet; Group 4: placebo plus placebo. </p> </div> </div> <p><a href="./references#CD006086-bbs2-0025" title="RangeN , AndersenAB , MagnussenP , MugomelaA , FriisH . The effect of micronutrient supplementation on treatment outcome in patients with pulmonary tuberculosis: a randomised controlled trial in Mwanza, Tanzania. Tropical Medicine and International Health2005;10(9):826‐32. RangeN , ChangaluchaJ , KrarupH , MagnussenP , AndersenAB , FriisH . The effect of multi‐vitamin/mineral supplementation on mortality during treatment of pulmonary tuberculosis: a randomised two‐by‐two factorial trial in Mwanza, Tanzania. British Journal of Nutrition2006;95(4):762‐70. ">Range 2005 TZA</a> found that participants receiving multiple micronutrients had gained significantly more weight at seven months than those in the placebo group. This was a 2 x 2 factorial study and the difference in weight was appreciable in both treatment groups compared to placebo. In the treatment arm that received both high dose multivitamins and high dose zinc, the weight gain appeared clinically important (MD 2.37 kg, 95% CI 2.21 to 2.53; one trial, 192 participants, <a href="./references#CD006086-fig-0016" title="">Analysis 3.6</a>). However, in the treatment arm that received high‐dose multivitamins alone, the weight gain was minimal (MD 0.30 kg, 95% CI 0.17 to 0.43; one trial, 198 participants, <a href="./references#CD006086-fig-0016" title="">Analysis 3.6</a>). In <a href="./references#CD006086-bbs2-0011" title="LodhaR , MukherjeeA , SinghV , SinghS , FriisH , Faurholt‐JepsenD , et al. Effect of micronutrient supplementation on treatment outcomes in children with intrathoracic tuberculosis: a randomized controlled trial. American Journal of Clinical Nutrition2014;100(5):1287‐97. ">Lodha 2014 IND</a>, multi‐micronutrient supplementation with or without zinc did not consistently alter children's weight, BMI‐for‐age z score or height‐for‐age z score (one trial, 198 participants; <a href="./references#CD006086-fig-0017" title="">Analysis 3.7</a>). </p> <p>One study, <a href="./references#CD006086-bbs2-0022" title="PraygodG , RangeN , Faurholt‐JepsenD , JeremiahK , Faurholt‐JepsenM , AabyeMG , et al. Daily multi‐micronutrient supplementation during tuberculosis treatment increases weight and grip strength among HIV‐uninfected but not HIV‐infected patients in Mwanza, Tanzania. The Journal of Nutrition2011;141(4):685‐91. ">Praygod 2011a TZA</a>, found an appreciable improvement in mean handgrip strength at two months but not five months (mean difference (change in handgrip strength) 1.22 kg, 95% CI 0.49 to 1.95; one trial, 771 participants; <a href="./references#CD006086-fig-0018" title="">Analysis 3.8</a>). The clinical importance of this difference is unclear. Consistent with the change in weight, this increase was only present in HIV‐negative participants. </p> </section> </section> <section id="CD006086-sec-0113"> <h5 class="title">2.2 Individual micronutrients</h5> <section id="CD006086-sec-0114"> <h6 class="title">Vitamin A (DRI: 900 µg/3000 IU per day)</h6> <section id="CD006086-sec-0115"> <p><b>Supplement dosing regimes</b></p> <p>Three trials directly compared vitamin A given alone versus placebo (<a href="./references#CD006086-bbs2-0004" title="GinawiIA , AhmedMQ , AhmadI , Al‐HazimiAM . Effect of zinc and vitamin a supplementation along with inter‐tubercular treatment in pulmonary tuberculosis in north Indian patients. International Journal of Pharmaceutical Sciences and Research2013;4(9):3426‐31. ">Ginawi 2013 IND</a>: vitamin A 5000 IU; <a href="./references#CD006086-bbs2-0005" title="HanekomWA , PotgeiterS , HughesEJ , MalanH , KessowG , HusseyGD . Vitamin A status and therapy in childhood pulmonary tuberculosis. Journal of Pediatrics1997;131(6):925‐7. ">Hanekom 1997 ZAF</a>: vitamin A 200,000 IU on Day 0 and Day 1; <a href="./references#CD006086-bbs2-0018" title="PakasiTA , KaryadiE , SuratihNMD , SaleanM , DarmawidjajaN , BorH , et al. Zinc and vitamin A supplementation fails to reduce sputum conversion time in severely malnourished pulmonary tuberculosis patients in Indonesia. Nutrition Journal2010;9:41. ">Pakasi 2010 IDN</a>: vitamin A 5000 IU daily). In addition, seven trials combined vitamin A with zinc (see Comparison 6: Zinc plus vitamin A versus placebo), and five studies gave vitamin A as part of a multi‐micronutrient supplement (see Comparison 3: Multivitamin and trace element tablets versus placebo). </p> </section> <section id="CD006086-sec-0116"> <p><b>Serum vitamin A concentrations at baseline and follow‐up</b></p> <p>Seven studies report on measures of vitamin A status, but <a href="./references#CD006086-bbs2-0018" title="PakasiTA , KaryadiE , SuratihNMD , SaleanM , DarmawidjajaN , BorH , et al. Zinc and vitamin A supplementation fails to reduce sputum conversion time in severely malnourished pulmonary tuberculosis patients in Indonesia. Nutrition Journal2010;9:41. ">Pakasi 2010 IDN</a> and <a href="./references#CD006086-bbs2-0034" title="VisserME , GrewalHMS , SwartEC , DhansayMA , WalzlG , SwanevelderS , et al. The effect of vitamin A and zinc supplementation on treatment outcomes in pulmonary tuberculosis: a randomized controlled trial. American Journal of Clinical Nutrition2011;93(1):93‐100. ">Visser 2011 ZAF</a> reported data as median plasma levels so could not be included in the meta‐analysis, and <a href="./references#CD006086-bbs2-0028" title="SembaRD , KumwendaJ , ZijlstraE , RicksMO , vanLettowM , WhalenC , et al. Micronutrient supplements and mortality of HIV‐infected adults with pulmonary TB: a controlled clinical trial. International Journal of Tuberculosis and Lung Disease2007;11(8):854‐9. ">Semba 2007 MWI</a> only presented data graphically (see <a href="#CD006086-tbl-0004">Table 2</a>). Only <a href="./references#CD006086-bbs2-0028" title="SembaRD , KumwendaJ , ZijlstraE , RicksMO , vanLettowM , WhalenC , et al. Micronutrient supplements and mortality of HIV‐infected adults with pulmonary TB: a controlled clinical trial. International Journal of Tuberculosis and Lung Disease2007;11(8):854‐9. ">Semba 2007 MWI</a> reports a difference that was statistically significant in favour of supplements, but this difference (at eight months) is unlikely to be of clinical significance. </p> <div class="table" id="CD006086-tbl-0004"> <table><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Table 2.</span> <span class="table-title">Effects of vitamin A supplementation on serum vitamin A levels</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Trial ID</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Supplement dose</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Measure</b> </p> </td> <td align="center" bgcolor="#ffffff" colspan="2" rowspan="1" valign="top"> <p><b>Baseline</b> </p> </td> <td align="center" bgcolor="#ffffff" colspan="2" rowspan="1" valign="top"> <p><b>Follow‐up</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Follow‐up</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Comment</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Supplement</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Control</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Supplement</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Control</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD006086-bbs2-0005" title="HanekomWA , PotgeiterS , HughesEJ , MalanH , KessowG , HusseyGD . Vitamin A status and therapy in childhood pulmonary tuberculosis. Journal of Pediatrics1997;131(6):925‐7. ">Hanekom 1997 ZAF</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>200 000 IU vitamin A 2 doses at baseline</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Mean µg/L</p> <p>(SD)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>17.6</p> <p>(10.1)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>18.6</p> <p>(10.5)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>34.8</p> <p>(10.1)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>33.5</p> <p>(14.2)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>6 weeks</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No statistically significant difference in serum vitamin A levels at 6 weeks or 2 months </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD006086-bbs2-0004" title="GinawiIA , AhmedMQ , AhmadI , Al‐HazimiAM . Effect of zinc and vitamin a supplementation along with inter‐tubercular treatment in pulmonary tuberculosis in north Indian patients. International Journal of Pharmaceutical Sciences and Research2013;4(9):3426‐31. ">Ginawi 2013 IND</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>5000 IU vitamin A daily</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Mean µmol/L</p> <p>(SD)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.77</p> <p>(0.21)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.82</p> <p>(0.29)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1.2</p> <p>(0.27)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1.13</p> <p>(0.34)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No statistically significant difference in serum vitamin A levels at 2 or 6 months</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD006086-bbs2-0018" title="PakasiTA , KaryadiE , SuratihNMD , SaleanM , DarmawidjajaN , BorH , et al. Zinc and vitamin A supplementation fails to reduce sputum conversion time in severely malnourished pulmonary tuberculosis patients in Indonesia. Nutrition Journal2010;9:41. ">Pakasi 2010 IDN</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>5000 IU vitamin A daily for 6 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Median µmol/L</p> <p>(IQR)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.7</p> <p>(0.5 to 1.5)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.7</p> <p>(0.5 to 1.0)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1.5</p> <p>(1.0 to 2.0)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1.2</p> <p>(0.9 to 1.6)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No statistically significant difference at 2 or 6 months</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD006086-bbs2-0001" title="ArmijosRX , WeigelMM , ChaconR , FloresL , CamposA . Adjunctive micronutrient supplementation for pulmonary tuberculosis. Salud Pública de México2010;52(3):185‐9. ">Armijos 2010 MEX</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>5000 IU vitamin A plus</p> <p>50 mg zinc daily for 4 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Mean µmol/L</p> <p>(SD)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1.03</p> <p>(0.46)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1.04</p> <p>(0.48)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1.4</p> <p>(0.47)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1.29</p> <p>(0.35)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No statistically significant difference in serum vitamin A levels at 2 or 6 months</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD006086-bbs2-0008" title="KaryadiE , WestCE , SchultinkW , NelwanRH , GrossR , AminZ , et al. A double‐blind, placebo‐controlled study of vitamin A and zinc supplementation in persons with tuberculosis in Indonesia: effects on clinical response and nutritional status. American Journal of Clinical Nutrition2002;75(4):720‐7. ">Karyadi 2002 IDN</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>5000 IU vitamin A plus 15 mg zinc daily for 6 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Mean µmol/L</p> <p>(SD)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.82</p> <p>(0.25)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.9</p> <p>(0.25)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1.14</p> <p>(0.32)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1.08</p> <p>(0.25)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No statistically significant difference in serum vitamin A levels at 2 or 6 months</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD006086-bbs2-0004" title="GinawiIA , AhmedMQ , AhmadI , Al‐HazimiAM . Effect of zinc and vitamin a supplementation along with inter‐tubercular treatment in pulmonary tuberculosis in north Indian patients. International Journal of Pharmaceutical Sciences and Research2013;4(9):3426‐31. ">Ginawi 2013 IND</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>5000 IU vitamin A plus 15 mg zinc sulphate daily</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Mean µmol/L</p> <p>(SD)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.78</p> <p>(0.23)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.82</p> <p>(0.29)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1.14</p> <p>(0.25)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1.13</p> <p>(0.34)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No statistically significant difference in serum vitamin A levels at 2 or 6 months</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD006086-bbs2-0018" title="PakasiTA , KaryadiE , SuratihNMD , SaleanM , DarmawidjajaN , BorH , et al. Zinc and vitamin A supplementation fails to reduce sputum conversion time in severely malnourished pulmonary tuberculosis patients in Indonesia. Nutrition Journal2010;9:41. ">Pakasi 2010 IDN</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>5000 IU vitamin A plus 15 mg zinc sulphate daily for 6 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Median µmol/L</p> <p>(IQR)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.7</p> <p>(0.4 to 1.1)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.7</p> <p>(0.5 to 1.0)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1.3</p> <p>(1.0 to 1.9)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1.2</p> <p>(0.9 to 1.6)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No statistically significant difference in serum vitamin A levels at 2 or 6 months</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD006086-bbs2-0034" title="VisserME , GrewalHMS , SwartEC , DhansayMA , WalzlG , SwanevelderS , et al. The effect of vitamin A and zinc supplementation on treatment outcomes in pulmonary tuberculosis: a randomized controlled trial. American Journal of Clinical Nutrition2011;93(1):93‐100. ">Visser 2011 ZAF</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>200,000 IU vitamin A once plus 15 mg zinc sulphate 5 days per week for 8 weeks</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Median µd/dL</p> <p>(IQR)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>21.1 (15.1 to 27.8)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>21.2 (15.7 to 28.9)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>40.3 (28.7 to 48.5)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>35.8 (27.7 to 43.2)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No statistically significant difference in serum vitamin A levels at 2 or 8 weeks</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD006086-bbs2-0028" title="SembaRD , KumwendaJ , ZijlstraE , RicksMO , vanLettowM , WhalenC , et al. Micronutrient supplements and mortality of HIV‐infected adults with pulmonary TB: a controlled clinical trial. International Journal of Tuberculosis and Lung Disease2007;11(8):854‐9. ">Semba 2007 MWI</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>8000 IU vitamin A daily as part of a multi‐micronutrient supplement</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Geometric mean µmol/L (95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.60 (0.54 to 0.66)<sup>1</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.69 (0.63 to 0.75)<sup>1</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>NR</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>NR</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>8 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Presented graphically with an increase in serum vitamin A levels in both groups</p> </td> </tr> </tbody> </table> <div class="table-footnote"> <p>Abbreviations: IU = international units; IQR = interquartile range; CI = confidence interval; SD = standard deviation.<br/> <sup>1</sup>Serum vitamin A levels for HIV‐negative participants. </p> </div> </div> <p>In four trials in adults and one in children, mean serum vitamin A level substantially increased in both intervention and control arms regardless of supplementation, and there was no statistically significant difference between the groups (one trial, 85 participants; <a href="./references#CD006086-fig-0019" title="">Analysis 4.1</a>; three trials, 242 participants; <a href="./references#CD006086-fig-0020" title="">Analysis 4.2</a>; <a href="#CD006086-tbl-0004">Table 2</a>). </p> </section> <section id="CD006086-sec-0117"> <p><b>Tuberculosis treatment outcomes</b></p> <p>Supplementation with vitamin A alone or in combination with other micronutrients appears to have little or no effect on mortality (eight trials, 3308 participants; <a href="./references#CD006086-fig-0021" title="">Analysis 4.3</a>), but these trials, even the larger ones, were significantly underpowered to rule out a clinically important effect. </p> <p>Only <a href="./references#CD006086-bbs2-0018" title="PakasiTA , KaryadiE , SuratihNMD , SaleanM , DarmawidjajaN , BorH , et al. Zinc and vitamin A supplementation fails to reduce sputum conversion time in severely malnourished pulmonary tuberculosis patients in Indonesia. Nutrition Journal2010;9:41. ">Pakasi 2010 IDN</a> reported on treatment completion and found no statistically significant effect (one trial, 158 participants, <a href="./references#CD006086-fig-0022" title="">Analysis 4.4</a>). <a href="./references#CD006086-bbs2-0005" title="HanekomWA , PotgeiterS , HughesEJ , MalanH , KessowG , HusseyGD . Vitamin A status and therapy in childhood pulmonary tuberculosis. Journal of Pediatrics1997;131(6):925‐7. ">Hanekom 1997 ZAF</a> reported that more children in the supplement group remained symptomatic after six weeks of tuberculosis treatment than in the control group, but this was not statistically significant (one trial, 76 participants, <a href="./references#CD006086-fig-0023" title="">Analysis 4.5</a>). The trial authors also reported no statistically significant differences in respiratory symptoms at three months, or in chest x‐ray resolution; but specific data on these outcomes were not provided. </p> <p>Supplementation with vitamin A alone had no effect on the number of participants who were sputum smear negative after two weeks, one month, or two months (two trials, 224 participants, <a href="./references#CD006086-fig-0024" title="">Analysis 4.6</a>). <a href="./references#CD006086-bbs2-0018" title="PakasiTA , KaryadiE , SuratihNMD , SaleanM , DarmawidjajaN , BorH , et al. Zinc and vitamin A supplementation fails to reduce sputum conversion time in severely malnourished pulmonary tuberculosis patients in Indonesia. Nutrition Journal2010;9:41. ">Pakasi 2010 IDN</a> reported that all participants in the vitamin A and placebo arm were smear negative at two months. </p> </section> <section id="CD006086-sec-0118"> <p><b>Nutritional recovery and quality of life</b></p> <p><a href="./references#CD006086-bbs2-0005" title="HanekomWA , PotgeiterS , HughesEJ , MalanH , KessowG , HusseyGD . Vitamin A status and therapy in childhood pulmonary tuberculosis. Journal of Pediatrics1997;131(6):925‐7. ">Hanekom 1997 ZAF</a> reported that the mean weight z score at baseline was −1.41 (SD 1.41) in the supplement group, and −1.44 (SD 1.34) in the placebo group (it is unclear whether this is weight for age or weight for height). The trial authors also reported that no statistically significant differences in change‐in‐weight z scores were recorded at any time‐point, but the specific data for this outcome was not provided. </p> <p><a href="./references#CD006086-bbs2-0018" title="PakasiTA , KaryadiE , SuratihNMD , SaleanM , DarmawidjajaN , BorH , et al. Zinc and vitamin A supplementation fails to reduce sputum conversion time in severely malnourished pulmonary tuberculosis patients in Indonesia. Nutrition Journal2010;9:41. ">Pakasi 2010 IDN</a> reports that the mean BMI at baseline was 16.5 kg/m² (SD 2.2) in the supplement group and 16.4 kg/m² (SD 2.5) in the placebo group. There was no statistically significant difference in mean BMI between groups at two or six months (one trial, 158 participants, <a href="./references#CD006086-fig-0025" title="">Analysis 4.7</a>). <a href="./references#CD006086-bbs2-0018" title="PakasiTA , KaryadiE , SuratihNMD , SaleanM , DarmawidjajaN , BorH , et al. Zinc and vitamin A supplementation fails to reduce sputum conversion time in severely malnourished pulmonary tuberculosis patients in Indonesia. Nutrition Journal2010;9:41. ">Pakasi 2010 IDN</a> also reported that there were no statistically significant differences in mid upper arm circumference (MUAC) or percentage body fat (<a href="./references#CD006086-fig-0026" title="">Analysis 4.8</a>). </p> </section> </section> <section id="CD006086-sec-0119"> <h6 class="title">Zinc (DRI: 11 mg/day)</h6> <section id="CD006086-sec-0120"> <p><b>Supplement dosing regimes</b></p> <p>Five trials directly compared daily zinc given alone versus placebo (<a href="./references#CD006086-bbs2-0004" title="GinawiIA , AhmedMQ , AhmadI , Al‐HazimiAM . Effect of zinc and vitamin a supplementation along with inter‐tubercular treatment in pulmonary tuberculosis in north Indian patients. International Journal of Pharmaceutical Sciences and Research2013;4(9):3426‐31. ">Ginawi 2013 IND</a>: 15 mg zinc sulphate; <a href="./references#CD006086-bbs2-0011" title="LodhaR , MukherjeeA , SinghV , SinghS , FriisH , Faurholt‐JepsenD , et al. Effect of micronutrient supplementation on treatment outcomes in children with intrathoracic tuberculosis: a randomized controlled trial. American Journal of Clinical Nutrition2014;100(5):1287‐97. ">Lodha 2014 IND</a>: 20 mg elemental zinc; <a href="./references#CD006086-bbs2-0025" title="RangeN , AndersenAB , MagnussenP , MugomelaA , FriisH . The effect of micronutrient supplementation on treatment outcome in patients with pulmonary tuberculosis: a randomised controlled trial in Mwanza, Tanzania. Tropical Medicine and International Health2005;10(9):826‐32. RangeN , ChangaluchaJ , KrarupH , MagnussenP , AndersenAB , FriisH . The effect of multi‐vitamin/mineral supplementation on mortality during treatment of pulmonary tuberculosis: a randomised two‐by‐two factorial trial in Mwanza, Tanzania. British Journal of Nutrition2006;95(4):762‐70. ">Range 2005 TZA</a>: zinc 45 mg daily; <a href="./references#CD006086-bbs2-0010" title="LawsonL , ThacherTD , YassinMA , OnuohaNA , UsmanA , EmenyonuNE , et al. Randomized controlled trial of zinc and vitamin A as co‐adjuvants for the treatment of pulmonary tuberculosis. Tropical Medicine and International Health2010;15(12):1481‐90. ">Lawson 2010 NGA</a>: 90 mg elemental zinc weekly; <a href="./references#CD006086-bbs2-0018" title="PakasiTA , KaryadiE , SuratihNMD , SaleanM , DarmawidjajaN , BorH , et al. Zinc and vitamin A supplementation fails to reduce sputum conversion time in severely malnourished pulmonary tuberculosis patients in Indonesia. Nutrition Journal2010;9:41. ">Pakasi 2010 IDN</a>: 15 mg zinc sulphate daily). In addition, seven trials combined vitamin A with zinc (see Comparison 6: zinc plus vitamin A versus placebo), and four trials gave zinc as part of a multi‐micronutrient supplement (see comparison 3: Multivitamin and trace element tablets versus placebo). </p> </section> <section id="CD006086-sec-0121"> <p><b>Serum zinc concentrations at baseline and follow‐up</b></p> <p>Five studies report mean plasma zinc levels at baseline and during follow‐up (see <a href="#CD006086-tbl-0005">Table 3</a>). <a href="./references#CD006086-bbs2-0018" title="PakasiTA , KaryadiE , SuratihNMD , SaleanM , DarmawidjajaN , BorH , et al. Zinc and vitamin A supplementation fails to reduce sputum conversion time in severely malnourished pulmonary tuberculosis patients in Indonesia. Nutrition Journal2010;9:41. ">Pakasi 2010 IDN</a> and <a href="./references#CD006086-bbs2-0001" title="ArmijosRX , WeigelMM , ChaconR , FloresL , CamposA . Adjunctive micronutrient supplementation for pulmonary tuberculosis. Salud Pública de México2010;52(3):185‐9. ">Armijos 2010 MEX</a> report mean zinc levels within the normal range at baseline. <a href="./references#CD006086-bbs2-0004" title="GinawiIA , AhmedMQ , AhmadI , Al‐HazimiAM . Effect of zinc and vitamin a supplementation along with inter‐tubercular treatment in pulmonary tuberculosis in north Indian patients. International Journal of Pharmaceutical Sciences and Research2013;4(9):3426‐31. ">Ginawi 2013 IND</a> and <a href="./references#CD006086-bbs2-0008" title="KaryadiE , WestCE , SchultinkW , NelwanRH , GrossR , AminZ , et al. A double‐blind, placebo‐controlled study of vitamin A and zinc supplementation in persons with tuberculosis in Indonesia: effects on clinical response and nutritional status. American Journal of Clinical Nutrition2002;75(4):720‐7. ">Karyadi 2002 IDN</a> reported that 30% of the participants had low zinc levels (less than 10.7 µmol/L) and in <a href="./references#CD006086-bbs2-0011" title="LodhaR , MukherjeeA , SinghV , SinghS , FriisH , Faurholt‐JepsenD , et al. Effect of micronutrient supplementation on treatment outcomes in children with intrathoracic tuberculosis: a randomized controlled trial. American Journal of Clinical Nutrition2014;100(5):1287‐97. ">Lodha 2014 IND</a> approximately 50% of the participants had zinc levels greater than 65 µg/dL. </p> <div class="table" id="CD006086-tbl-0005"> <table><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Table 3.</span> <span class="table-title">Effects of zinc supplementation on serum zinc levels</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Trial ID</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Supplement dose</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Measure</b> </p> </td> <td align="center" bgcolor="#ffffff" colspan="2" rowspan="1" valign="top"> <p><b>Baseline</b> </p> </td> <td align="center" bgcolor="#ffffff" colspan="2" rowspan="1" valign="top"> <p><b>Follow‐up</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Follow‐up</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Comment</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Supplement</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Control</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Supplement</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Control</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD006086-bbs2-0004" title="GinawiIA , AhmedMQ , AhmadI , Al‐HazimiAM . Effect of zinc and vitamin a supplementation along with inter‐tubercular treatment in pulmonary tuberculosis in north Indian patients. International Journal of Pharmaceutical Sciences and Research2013;4(9):3426‐31. ">Ginawi 2013 IND</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>15 mg zinc sulphate daily</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Mean µmol/L</p> <p>(SD)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>9.86</p> <p>(0.87)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>9.88</p> <p>(1.44)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>12.23</p> <p>(1.12)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>11.23</p> <p>(1.34)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Statistically significant increase in serum zinc levels in the zinc group at 2 and 6 months </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD006086-bbs2-0018" title="PakasiTA , KaryadiE , SuratihNMD , SaleanM , DarmawidjajaN , BorH , et al. Zinc and vitamin A supplementation fails to reduce sputum conversion time in severely malnourished pulmonary tuberculosis patients in Indonesia. Nutrition Journal2010;9:41. ">Pakasi 2010 IDN</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>15 mg zinc sulphate daily for 6 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Mean µmol/L</p> <p>(SD)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>11.6</p> <p>(2.2)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>11.8</p> <p>(2.4)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>11.7</p> <p>(2.43)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>11.7</p> <p>(2.33)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No statistically significant difference in serum zinc levels at 2 months</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD006086-bbs2-0001" title="ArmijosRX , WeigelMM , ChaconR , FloresL , CamposA . Adjunctive micronutrient supplementation for pulmonary tuberculosis. Salud Pública de México2010;52(3):185‐9. ">Armijos 2010 MEX</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>50 mg zinc plus 5000 IU vitamin A daily for 4 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Mean µmol/L</p> <p>(SD)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>11.29</p> <p>(2.57)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>11.69</p> <p>(2.1)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>12.85</p> <p>(3.4)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>10.13</p> <p>(1.61)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Statistically significant increase in serum zinc levels in zinc plus vitamin A group at 2 months. Increase not sustained post supplementation. </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD006086-bbs2-0008" title="KaryadiE , WestCE , SchultinkW , NelwanRH , GrossR , AminZ , et al. A double‐blind, placebo‐controlled study of vitamin A and zinc supplementation in persons with tuberculosis in Indonesia: effects on clinical response and nutritional status. American Journal of Clinical Nutrition2002;75(4):720‐7. ">Karyadi 2002 IDN</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>15 mg zinc plus 5000 IU vitamin A daily for 6 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Mean µmol/L</p> <p>(SD)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>11.52</p> <p>(1.64)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>11.15</p> <p>(1.77)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>11.22</p> <p>(2.4)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>10.22</p> <p>(2.28)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No statistically significant difference in serum zinc levels at 2 months</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD006086-bbs2-0004" title="GinawiIA , AhmedMQ , AhmadI , Al‐HazimiAM . Effect of zinc and vitamin a supplementation along with inter‐tubercular treatment in pulmonary tuberculosis in north Indian patients. International Journal of Pharmaceutical Sciences and Research2013;4(9):3426‐31. ">Ginawi 2013 IND</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>15 mg zinc sulphate plus 5000 IU vitamin A daily</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Mean µmol/L</p> <p>(SD)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>9.56</p> <p>(0.77)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>9.88</p> <p>(1.4)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>11.17</p> <p>(0.86)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>11.23</p> <p>(1.34)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No statistically significant difference in serum zinc levels at 2 months</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD006086-bbs2-0018" title="PakasiTA , KaryadiE , SuratihNMD , SaleanM , DarmawidjajaN , BorH , et al. Zinc and vitamin A supplementation fails to reduce sputum conversion time in severely malnourished pulmonary tuberculosis patients in Indonesia. Nutrition Journal2010;9:41. ">Pakasi 2010 IDN</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>15 mg zinc sulphate plus 5000 IU vitamin A daily for 6 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Mean µmol/L</p> <p>(SD)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>12.1</p> <p>(3.0)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>11.8</p> <p>(2.4)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>12.5</p> <p>(2.33)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>11.7</p> <p>(2.33)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No statistically significant difference in serum zinc levels at 2 months</p> </td> </tr> </tbody> </table> <div class="table-footnote"> <p>Abbreviations: IU = international unit; SD = standard deviation.</p> </div> </div> <p>Overall, daily supplementation with zinc sulphate increased serum zinc concentrations after two months and six months compared to placebo (four trials, 472 participants, <a href="./references#CD006086-fig-0027" title="">Analysis 5.1</a>; <a href="#CD006086-tbl-0005">Table 3</a>), with more consistent effects at six months. </p> </section> <section id="CD006086-sec-0122"> <p><b>Tuberculosis treatment outcomes</b></p> <p>No effect on mortality has been seen with zinc alone or in combination with other micronutrients (seven trials, 2862 participants, <a href="./references#CD006086-fig-0028" title="">Analysis 5.2</a>, <a href="./references#CD006086-fig-0029" title="">Analysis 5.3</a>). These trials, even the larger ones, are significantly underpowered to rule out a clinically important effect. </p> <p>There was no appreciable differences in treatment completion between the zinc alone and placebo groups (two trials, 353 participants, <a href="./references#CD006086-fig-0030" title="">Analysis 5.4</a>), and there were no differences between the groups in the numbers who remained sputum‐culture positive at four weeks (three trials, 783 participants, <a href="./references#CD006086-fig-0031" title="">Analysis 5.5</a>) or eight weeks (five trials, 1076 participants, <a href="./references#CD006086-fig-0031" title="">Analysis 5.5</a>). Furthermore, <a href="./references#CD006086-bbs2-0011" title="LodhaR , MukherjeeA , SinghV , SinghS , FriisH , Faurholt‐JepsenD , et al. Effect of micronutrient supplementation on treatment outcomes in children with intrathoracic tuberculosis: a randomized controlled trial. American Journal of Clinical Nutrition2014;100(5):1287‐97. ">Lodha 2014 IND</a> reports no difference in chest X‐ray clearance after six months between the zinc and placebo groups (one trial, 201 participants, <a href="./references#CD006086-fig-0032" title="">Analysis 5.6</a>). </p> </section> <section id="CD006086-sec-0123"> <p><b>Nutritional recovery and quality of life</b></p> <p>One trial in children in India found no difference in mean weight (kg), weight‐for‐age z score, BMI‐for‐age z score or height‐for‐age z score after two months or six months supplementation with zinc alone (one trial, 201 participants, <a href="./references#CD006086-fig-0033" title="">Analysis 5.7</a>; <a href="./references#CD006086-fig-0036" title="">Analysis 5.10</a>; <a href="./references#CD006086-fig-0037" title="">Analysis 5.11</a>; <a href="./references#CD006086-fig-0038" title="">Analysis 5.12</a>). Similarly, <a href="./references#CD006086-bbs2-0018" title="PakasiTA , KaryadiE , SuratihNMD , SaleanM , DarmawidjajaN , BorH , et al. Zinc and vitamin A supplementation fails to reduce sputum conversion time in severely malnourished pulmonary tuberculosis patients in Indonesia. Nutrition Journal2010;9:41. ">Pakasi 2010 IDN</a> found no difference in BMI or body fat (%) in adults at two or six months (one trial, 162 participants, <a href="./references#CD006086-fig-0034" title="">Analysis 5.8</a> and <a href="./references#CD006086-fig-0035" title="">Analysis 5.9</a>; <a href="./references#CD006086-bbs2-0018" title="PakasiTA , KaryadiE , SuratihNMD , SaleanM , DarmawidjajaN , BorH , et al. Zinc and vitamin A supplementation fails to reduce sputum conversion time in severely malnourished pulmonary tuberculosis patients in Indonesia. Nutrition Journal2010;9:41. ">Pakasi 2010 IDN</a>), and <a href="./references#CD006086-bbs2-0010" title="LawsonL , ThacherTD , YassinMA , OnuohaNA , UsmanA , EmenyonuNE , et al. Randomized controlled trial of zinc and vitamin A as co‐adjuvants for the treatment of pulmonary tuberculosis. Tropical Medicine and International Health2010;15(12):1481‐90. ">Lawson 2010 NGA</a> presented data on changes in BMI graphically, and BMI appeared to improve at the same rate in all groups (<a href="./references#CD006086-bbs2-0010" title="LawsonL , ThacherTD , YassinMA , OnuohaNA , UsmanA , EmenyonuNE , et al. Randomized controlled trial of zinc and vitamin A as co‐adjuvants for the treatment of pulmonary tuberculosis. Tropical Medicine and International Health2010;15(12):1481‐90. ">Lawson 2010 NGA</a>). </p> <p><a href="./references#CD006086-bbs2-0025" title="RangeN , AndersenAB , MagnussenP , MugomelaA , FriisH . The effect of micronutrient supplementation on treatment outcome in patients with pulmonary tuberculosis: a randomised controlled trial in Mwanza, Tanzania. Tropical Medicine and International Health2005;10(9):826‐32. RangeN , ChangaluchaJ , KrarupH , MagnussenP , AndersenAB , FriisH . The effect of multi‐vitamin/mineral supplementation on mortality during treatment of pulmonary tuberculosis: a randomised two‐by‐two factorial trial in Mwanza, Tanzania. British Journal of Nutrition2006;95(4):762‐70. ">Range 2005 TZA</a> reported a very small but statistically significant decrease in weight gain with supplementation compared to placebo (MD −0.21 kg, 95% CI −0.36 to −0.06; one trial 183 participants; <a href="./references#CD006086-fig-0033" title="">Analysis 5.7</a>). </p> </section> </section> <section id="CD006086-sec-0124"> <h6 class="title">Vitamin A plus zinc (DRI: vitamin A 900 µg/3000 IU, zinc 11 mg per day)</h6> <section id="CD006086-sec-0125"> <p><b>Supplement dosing regimes</b></p> <p>Seven studies in adults with sputum positive pulmonary tuberculosis compared the combination of vitamin A and zinc versus placebo (<a href="./references#CD006086-bbs2-0004" title="GinawiIA , AhmedMQ , AhmadI , Al‐HazimiAM . Effect of zinc and vitamin a supplementation along with inter‐tubercular treatment in pulmonary tuberculosis in north Indian patients. International Journal of Pharmaceutical Sciences and Research2013;4(9):3426‐31. ">Ginawi 2013 IND</a>: vitamin A 5000 IU and 15 mg zinc sulphate; <a href="./references#CD006086-bbs2-0030" title="SinghAKr , GogoiJB , PantNC , MittalP , JuyalV , MukherjeeS . A study on the role of vitamins and minerals supplementation in the treatment of tuberculosis. Indian Journal of Public Health Research and Development2013;4(2):26‐30. ">Singh 2013 IND</a>: 25000 IU vitamin A and 50 mg zinc sulphate, once daily for 10 days and then thrice weekly until six months; <a href="./references#CD006086-bbs2-0008" title="KaryadiE , WestCE , SchultinkW , NelwanRH , GrossR , AminZ , et al. A double‐blind, placebo‐controlled study of vitamin A and zinc supplementation in persons with tuberculosis in Indonesia: effects on clinical response and nutritional status. American Journal of Clinical Nutrition2002;75(4):720‐7. ">Karyadi 2002 IDN</a>: vitamin A 5000 IU and zinc 15 mg daily for six months; <a href="./references#CD006086-bbs2-0001" title="ArmijosRX , WeigelMM , ChaconR , FloresL , CamposA . Adjunctive micronutrient supplementation for pulmonary tuberculosis. Salud Pública de México2010;52(3):185‐9. ">Armijos 2010 MEX</a>: vitamin A 5000 IU plus zinc 50 mg daily for four months; <a href="./references#CD006086-bbs2-0010" title="LawsonL , ThacherTD , YassinMA , OnuohaNA , UsmanA , EmenyonuNE , et al. Randomized controlled trial of zinc and vitamin A as co‐adjuvants for the treatment of pulmonary tuberculosis. Tropical Medicine and International Health2010;15(12):1481‐90. ">Lawson 2010 NGA</a>: vitamin A 5000 IU/day plus 90 mg elemental zinc/week for six months; <a href="./references#CD006086-bbs2-0018" title="PakasiTA , KaryadiE , SuratihNMD , SaleanM , DarmawidjajaN , BorH , et al. Zinc and vitamin A supplementation fails to reduce sputum conversion time in severely malnourished pulmonary tuberculosis patients in Indonesia. Nutrition Journal2010;9:41. ">Pakasi 2010 IDN</a>: vitamin A 5000 IU plus 15 mg zinc sulphate daily for six months; <a href="./references#CD006086-bbs2-0034" title="VisserME , GrewalHMS , SwartEC , DhansayMA , WalzlG , SwanevelderS , et al. The effect of vitamin A and zinc supplementation on treatment outcomes in pulmonary tuberculosis: a randomized controlled trial. American Journal of Clinical Nutrition2011;93(1):93‐100. ">Visser 2011 ZAF</a>: vitamin A 100,000 IU at baseline plus zinc 15 mg for five days per week for two months). </p> </section> <section id="CD006086-sec-0126"> <p><b>Tuberculosis treatment outcomes</b></p> <p>Four trials reported on deaths that occurred during the trial. In HIV negative participants there were no statistically significant differences in risk of death between those who received zinc and vitamin A or placebo (four trials, 430 participants, <a href="./references#CD006086-fig-0039" title="">Analysis 6.1</a>), but in HIV‐positive participants the effect did reach statistical significance (RR 5.94, 95% CI 1.07 to 32.96; two trials, 136 participants; <a href="./references#CD006086-fig-0039" title="">Analysis 6.1</a>). However, both of these analyses are substantially underpowered to have confidence in these effects. </p> <p>Only <a href="./references#CD006086-bbs2-0018" title="PakasiTA , KaryadiE , SuratihNMD , SaleanM , DarmawidjajaN , BorH , et al. Zinc and vitamin A supplementation fails to reduce sputum conversion time in severely malnourished pulmonary tuberculosis patients in Indonesia. Nutrition Journal2010;9:41. ">Pakasi 2010 IDN</a> reported on treatment completion and found no statistically significant difference between the groups (one trial, 152 participants; <a href="./references#CD006086-fig-0040" title="">Analysis 6.2</a>). Overall, there is no statistically significant difference between supplementation and placebo in the number of participants who remain sputum‐smear positive at one month or two months (seven trials, 726 participants, <a href="./references#CD006086-fig-0041" title="">Analysis 6.3</a>). One study, <a href="./references#CD006086-bbs2-0001" title="ArmijosRX , WeigelMM , ChaconR , FloresL , CamposA . Adjunctive micronutrient supplementation for pulmonary tuberculosis. Salud Pública de México2010;52(3):185‐9. ">Armijos 2010 MEX</a>, did find a statistically significant difference in sputum positivity at three months in favour of supplementation (RR 0.12, 95% CI 0.02 to 0.84; one trial, 33 participants; <a href="./references#CD006086-fig-0041" title="">Analysis 6.3</a>), but the difference was not significant at two or four months. <a href="./references#CD006086-bbs2-0034" title="VisserME , GrewalHMS , SwartEC , DhansayMA , WalzlG , SwanevelderS , et al. The effect of vitamin A and zinc supplementation on treatment outcomes in pulmonary tuberculosis: a randomized controlled trial. American Journal of Clinical Nutrition2011;93(1):93‐100. ">Visser 2011 ZAF</a> found no statistically significant difference in time to smear or culture conversion (one trial, 154 participants; P = 0.15 and P = 0.38 respectively, authors' own figures). </p> </section> <section id="CD006086-sec-0127"> <p><b>Nutritional recovery and quality of life</b></p> <p><a href="./references#CD006086-bbs2-0008" title="KaryadiE , WestCE , SchultinkW , NelwanRH , GrossR , AminZ , et al. A double‐blind, placebo‐controlled study of vitamin A and zinc supplementation in persons with tuberculosis in Indonesia: effects on clinical response and nutritional status. American Journal of Clinical Nutrition2002;75(4):720‐7. ">Karyadi 2002 IDN</a> reported a statistically significant increase in mean body weight at six months (MD 3.10 kg, 95% CI 0.74 to 5.46; one trial, 80 participants; <a href="./references#CD006086-fig-0042" title="">Analysis 6.4</a>), but there were no differences in any other nutritional parameters (see <a href="#CD006086-tbl-0006">Table 4</a> and <a href="./references#CD006086-fig-0043" title="">Analysis 6.5</a>; <a href="./references#CD006086-fig-0044" title="">Analysis 6.6</a>; <a href="./references#CD006086-fig-0045" title="">Analysis 6.7</a>; <a href="./references#CD006086-fig-0046" title="">Analysis 6.8</a>; <a href="./references#CD006086-fig-0047" title="">Analysis 6.9</a>; <a href="./references#CD006086-fig-0048" title="">Analysis 6.10</a>; <a href="./references#CD006086-fig-0049" title="">Analysis 6.11</a>; <a href="./references#CD006086-fig-0050" title="">Analysis 6.12</a>). There was no statistically significant differences between intervention and control arms in any of the other three trials that reported changes in BMI or weight. </p> <div class="table" id="CD006086-tbl-0006"> <table><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Table 4.</span> <span class="table-title">Effect of vitamin A plus zinc supplementation on nutritional recovery</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Trial ID</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Population</b> </p> </td> <td align="center" bgcolor="#ffffff" colspan="2" rowspan="1" valign="top"> <p><b>Baseline nutritional status</b> </p> <p><b>Mean BMI (SD) kg/m²</b> </p> </td> <td align="center" bgcolor="#ffffff" colspan="2" rowspan="1" valign="top"> <p><b>Endpoint nutritional status</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Comments</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Vitamin A plus zinc</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Placebo</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Vitamin A plus zinc</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Placebo</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD006086-bbs2-0008" title="KaryadiE , WestCE , SchultinkW , NelwanRH , GrossR , AminZ , et al. A double‐blind, placebo‐controlled study of vitamin A and zinc supplementation in persons with tuberculosis in Indonesia: effects on clinical response and nutritional status. American Journal of Clinical Nutrition2002;75(4):720‐7. ">Karyadi 2002 IDN</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Adults HIV status unknown</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>17.6 (1.9)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>18.1 (3.2)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Mean BMI (SD) 6 months: 19.4 (2.5)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Mean BMI (SD) 6 months: 20.0 (3.2)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Statistically significantly greater body weight (kg) in supplemented group at 6 months (3.10 kg, 95% CI 0.74 to 5.46). No statistically significant differences in BMI, mid‐upper arm circumference, biceps skinfold thickness, triceps skinfold thickness, subscapular skinfold thickness, supra‐iliac skinfold thickness, body fat (%), or fat mass (kg) between groups at 2 or 6 months </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD006086-bbs2-0010" title="LawsonL , ThacherTD , YassinMA , OnuohaNA , UsmanA , EmenyonuNE , et al. Randomized controlled trial of zinc and vitamin A as co‐adjuvants for the treatment of pulmonary tuberculosis. Tropical Medicine and International Health2010;15(12):1481‐90. ">Lawson 2010 NGA</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Adults HIV‐positive and HIV‐negative</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>19.6 (3.5)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>19.8 (3.3)</p> </td> <td align="" bgcolor="#ffffff" colspan="2" rowspan="1" valign="top"> <p>BMI data reported graphically</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>BMI appears to increase along a similar trajectory for both supplemented and placebo groups at 2 and 6 months </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD006086-bbs2-0018" title="PakasiTA , KaryadiE , SuratihNMD , SaleanM , DarmawidjajaN , BorH , et al. Zinc and vitamin A supplementation fails to reduce sputum conversion time in severely malnourished pulmonary tuberculosis patients in Indonesia. Nutrition Journal2010;9:41. ">Pakasi 2010 IDN</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Adults HIV status unknown</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>16.6 (2.1)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>16.4 (2.5)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Mean BMI (SD) 6 months: 18.3 (2.0)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Mean BMI (SD) 6 months: 18.4 (2.6)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No statistically significant differences in BMI between the supplement and placebo group at 2 or 6 months </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD006086-bbs2-0034" title="VisserME , GrewalHMS , SwartEC , DhansayMA , WalzlG , SwanevelderS , et al. The effect of vitamin A and zinc supplementation on treatment outcomes in pulmonary tuberculosis: a randomized controlled trial. American Journal of Clinical Nutrition2011;93(1):93‐100. ">Visser 2011 ZAF</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Adults HIV‐positive and HIV‐negative</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Male: 18.9 (2.7)</p> <p>Female: 23.0 (4.3)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Male: 19.0 (2)</p> <p>Female: 21.6 (4.8)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Mean weight gain 2.3 kg</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Mean weight gain 2.2 kg</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No statistically significant difference in weight gain during the first 2 months of treatment (P = 0.68, trial authors' own figures) </p> </td> </tr> </tbody> </table> <div class="table-footnote"> <p>Abbreviations: HIV = human immunodeficiency virus; BMI = body mass index; SD = standard deviation. </p> </div> </div> <p>Two trials reported on changes in Karnofsy score, a rating scale of a person's ability to perform activities of daily living ranging from 0 (dead) to 100 (normal). <a href="./references#CD006086-bbs2-0008" title="KaryadiE , WestCE , SchultinkW , NelwanRH , GrossR , AminZ , et al. A double‐blind, placebo‐controlled study of vitamin A and zinc supplementation in persons with tuberculosis in Indonesia: effects on clinical response and nutritional status. American Journal of Clinical Nutrition2002;75(4):720‐7. ">Karyadi 2002 IDN</a> reported that supplementation resulted in a small but statistically significant difference in Karnofsky score at six months (MD 2.5%, 95% CI 0.91 to 4.09; one trial 80 participants; <a href="./references#CD006086-fig-0051" title="">Analysis 6.13</a>), while <a href="./references#CD006086-bbs2-0010" title="LawsonL , ThacherTD , YassinMA , OnuohaNA , UsmanA , EmenyonuNE , et al. Randomized controlled trial of zinc and vitamin A as co‐adjuvants for the treatment of pulmonary tuberculosis. Tropical Medicine and International Health2010;15(12):1481‐90. ">Lawson 2010 NGA</a> found no difference at two or six months but only presented data graphically (one trial, 233 participants). A difference in Karnofsky score of 2.5% is unlikely to be of clinical significance. </p> </section> </section> <section id="CD006086-sec-0128"> <h6 class="title">Vitamin D (DRI for adults: 5 to 15 µg/200 to 600 IU per day)</h6> <section id="CD006086-sec-0129"> <p><b>Supplement dosing regimes</b></p> <p>Eight trials evaluated vitamin D supplementation versus placebo: <a href="./references#CD006086-bbs2-0016" title="MorcosMM , GabrAA , SamualS , KamelM , elBazM , elBeshryM , et al. Vitamin D administration to tuberculous children and its value. Bollettino Chimico Farmaceutico1998;137(5):157‐64. ">Morcos 1998 EGY</a>: 1000 IU daily for eight weeks; <a href="./references#CD006086-bbs2-0017" title="NursyamEW , AminZ , RumendeCA . The effects of vitamin D as supplementary treatment in patients with moderately advanced pulmonary tuberculosis lesion. Acta Medica Indonesiana2006;38(1):3‐5. ">Nursyam 2006 IDN</a>: 250 µg daily for six weeks; <a href="./references#CD006086-bbs2-0024" title="RalphAP , WaramoriG , PontororingGJ , KenangalemE , WigunaA , TjitraE , et al. L‐arginine and vitamin D adjunctive therapies in pulmonary tuberculosis: a randomised, double‐blind, placebo‐controlled trial. PLoS One2013;8(8):e70032. ">Ralph 2013 IDN</a>: 50,000 IU daily for eight weeks; <a href="./references#CD006086-bbs2-0015" title="MilyA , RekhaRS , KamalSM , ArifuzzamanAS , RahimZ , KhanL , et al. Significant effects of oral phenylbutyrate and vitamin D3 adjunctive therapy in pulmonary tuberculosis: a randomized controlled trial. PLoS One2015;10(9):e0138340. [DOI: 10.1371/journal.pone.0138340] ">Mily 2015 BGD</a>: 5000 IU daily for eight weeks; <a href="./references#CD006086-bbs2-0032" title="FredianiJ , TukvadzeN , SanikidzeE , KipianiM , HebbarG , TangprichaV , et al. Drug susceptibility influences macronutrient intake and body composition in tuberculosis patients. The FASEB Journal2014;28(Supplement 1):1014.4. TukvadzeN , SanikidzeE , KipianiM , HebbarG , EasleyKA , ShenviN , et al. High‐dose vitamin D3 in adults with pulmonary tuberculosis: a double‐blind randomised controlled trial. American Journal of Clinical Nutrition2015;102(5):1059‐69. ">Tukvadze 2015 GEO</a>: 50000 IU three times a week for eight weeks, then every two weeks for eight weeks; <a href="./references#CD006086-bbs2-0035" title="WejseC , GomesVF , RabnaP , GustafsonP , AabyP , LisseIM , et al. Vitamin D as supplementary treatment for tuberculosis ‐ a double‐blind randomised placebo‐controlled trial. American Journal of Respiratory and Critical Care Medicine2009;179(9):843‐50. ">Wejse 2008 GNB</a>: 100,000 IU at 0, 5, and 8 months; <a href="./references#CD006086-bbs2-0002" title="DaleyP , JagannathanV , JohnKR , SarojiniJ , LathaA , ViethR , et al. Adjunctive vitamin D for treatment of active tuberculosis in India: a randomised, double‐blind, placebo‐controlled trial. The Lancet. Infectious Diseases2015;15(5):528‐34. ">Daley 2015 IND</a> and <a href="./references#CD006086-bbs2-0012" title="MartineauAR , TimmsPM , BothamleyGH , HanifaY , IslamK , ClaxtonAP , et al. High‐dose vitamin D3 during intensive‐phase antimicrobial treatment for pulmonary tuberculosis: a double‐blind randomised controlled trial. Lancet2011;377(9761):242‐50. ">Martineau 2011 GBR</a>: 2.5 mg on days 0, 14, 28, and 42). </p> <p>In addition, one trial evaluated vitamin D combined with arginine (<a href="./references#CD006086-bbs2-0024" title="RalphAP , WaramoriG , PontororingGJ , KenangalemE , WigunaA , TjitraE , et al. L‐arginine and vitamin D adjunctive therapies in pulmonary tuberculosis: a randomised, double‐blind, placebo‐controlled trial. PLoS One2013;8(8):e70032. ">Ralph 2013 IDN</a>: 50,000 IU plus arginine 6 g daily for eight weeks), two trials evaluated vitamin D combined with calcium (<a href="./references#CD006086-bbs2-0030" title="SinghAKr , GogoiJB , PantNC , MittalP , JuyalV , MukherjeeS . A study on the role of vitamins and minerals supplementation in the treatment of tuberculosis. Indian Journal of Public Health Research and Development2013;4(2):26‐30. ">Singh 2013 IND</a>: 250 IU plus calcium 500 mg daily for 10 days then three times a week; <a href="./references#CD006086-bbs2-0009" title="KotaSK , JammulaS , KotaSK , TripathyPR , PandaS , ModiKD . Effect of vitamin D supplementation in type 2 diabetes patients with pulmonary tuberculosis. Diabetes and Metabolic Syndrome: Clinical Research &amp; Reviews2011;5(2):85‐9. ">Kota 2011 IND</a>: 60,000 IU per week plus calcium 1000 mg per day for 3 months), and four trials of multi‐micronutrients included vitamin D in standard daily doses (see comparison 3). </p> </section> <section id="CD006086-sec-0130"> <p><b>Vitamin D levels at baseline and follow‐up (deficient ≤ 50 nmol/L, and insufficient ≤ 75 nmol/L)</b></p> <p>Seven trials reported vitamin D status at baseline and during follow‐up, although only four trials provided data that we could include in a meta‐analysis of the effect of Vitamin D supplementation on Vitamin D levels at follow‐up (see <a href="./references#CD006086-fig-0052" title="">Analysis 7.1</a>; <a href="#CD006086-tbl-0007">Table 5</a>). </p> <div class="table" id="CD006086-tbl-0007"> <table><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Table 5.</span> <span class="table-title">Effects of vitamin D supplementation on serum vitamin D levels</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Trial ID</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Supplement dose</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Measure</b> </p> </td> <td align="center" bgcolor="#ffffff" colspan="2" rowspan="1" valign="top"> <p><b>Baseline</b> </p> </td> <td align="center" bgcolor="#ffffff" colspan="2" rowspan="1" valign="top"> <p><b>Follow‐up</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Follow‐up</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Comment</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Supplement</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Control</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Supplement</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Control</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD006086-bbs2-0015" title="MilyA , RekhaRS , KamalSM , ArifuzzamanAS , RahimZ , KhanL , et al. Significant effects of oral phenylbutyrate and vitamin D3 adjunctive therapy in pulmonary tuberculosis: a randomized controlled trial. PLoS One2015;10(9):e0138340. [DOI: 10.1371/journal.pone.0138340] ">Mily 2015 BGD</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>5000 IU daily for 8 weeks</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Mean nmol/L</p> <p>(SD)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>28.0</p> <p>(17.5)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>28.1</p> <p>(16.2)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>102</p> <p>(NR)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>30</p> <p>(NR)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>8 weeks</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>The follow‐up mean values inserted here have been approximated from a graph in the published paper. The trial authors reported that the group receiving vitamin D<sub>3</sub> supplementation exhibited significantly higher concentration of plasma 25‐hydroxyvitamin D<b>[</b>25(OH) D<sub>3</sub>] at week 8 compared to placebo after initiation of therapy (P &lt; 0.000) </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD006086-bbs2-0032" title="FredianiJ , TukvadzeN , SanikidzeE , KipianiM , HebbarG , TangprichaV , et al. Drug susceptibility influences macronutrient intake and body composition in tuberculosis patients. The FASEB Journal2014;28(Supplement 1):1014.4. TukvadzeN , SanikidzeE , KipianiM , HebbarG , EasleyKA , ShenviN , et al. High‐dose vitamin D3 in adults with pulmonary tuberculosis: a double‐blind randomised controlled trial. American Journal of Clinical Nutrition2015;102(5):1059‐69. ">Tukvadze 2015 GEO</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>50000 IU 3 times a week for 8 weeks, then every 2 weeks for 8 weeks</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Mean nmol/L</p> <p>(SD)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>30</p> <p>(NR)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>30</p> <p>(NR)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>250</p> <p>(NR)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>40</p> <p>(NR)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>8 weeks</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>The mean values inserted here have been approximated from a graph in the published paper. The trial authors reported that high‐dose vitamin D<sub>3</sub> resulted in a significant increase in plasma 25(OH)D concentrations to 250 nmol/L at study week 8 </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD006086-bbs2-0002" title="DaleyP , JagannathanV , JohnKR , SarojiniJ , LathaA , ViethR , et al. Adjunctive vitamin D for treatment of active tuberculosis in India: a randomised, double‐blind, placebo‐controlled trial. The Lancet. Infectious Diseases2015;15(5):528‐34. ">Daley 2015 IND</a><sup>1</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2.5 mg vitamin D<sub>3</sub> on days 0, 14, 28, and 42 </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Mean nmol/L</p> <p>(SD)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>63.1</p> <p>(46.6)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>62.2 (51.0)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>72.2</p> <p>(NR)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>60.4</p> <p>(NR)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>26 weeks</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Authors reported significant increase serum vitamin D levels in supplement group (P = 0.001) but not in the placebo group (P = 0.15). No difference in serum vitamin D levels between groups at week 26 (P = 0.24) </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD006086-bbs2-0009" title="KotaSK , JammulaS , KotaSK , TripathyPR , PandaS , ModiKD . Effect of vitamin D supplementation in type 2 diabetes patients with pulmonary tuberculosis. Diabetes and Metabolic Syndrome: Clinical Research &amp; Reviews2011;5(2):85‐9. ">Kota 2011 IND</a><sup>2</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>60,000 IU vitamin D<sub>3</sub> per week plus 1000 mg calcium carbonate per day </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Mean ng/ml</p> <p>(SD)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>12.8</p> <p>(4.5)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>11.1 (4.7)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>22.3</p> <p>(5.9)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>11.1</p> <p>(1.6)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>8 weeks</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Statistically significant increase in serum vitamin D level in the supplement group (P = 0.0001) at 4, 8, and 12 weeks </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD006086-bbs2-0012" title="MartineauAR , TimmsPM , BothamleyGH , HanifaY , IslamK , ClaxtonAP , et al. High‐dose vitamin D3 during intensive‐phase antimicrobial treatment for pulmonary tuberculosis: a double‐blind randomised controlled trial. Lancet2011;377(9761):242‐50. ">Martineau 2011 GBR</a><sup>3</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2.5 mg on days 0, 14, 28, and 42</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Mean nmol/L</p> <p>(SD)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>21.1</p> <p>(20.0)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>21.3 (19.0)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>101.4</p> <p>(NR)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>22.8</p> <p>(NR)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>8 weeks</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Statistically significant increase in serum vitamin D level in the supplement group (P &lt; 0.001) </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD006086-bbs2-0035" title="WejseC , GomesVF , RabnaP , GustafsonP , AabyP , LisseIM , et al. Vitamin D as supplementary treatment for tuberculosis ‐ a double‐blind randomised placebo‐controlled trial. American Journal of Respiratory and Critical Care Medicine2009;179(9):843‐50. ">Wejse 2008 GNB</a><sup>4</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>100,000 IU vitamin D<sub>3</sub> at 0, 5, and 8 months </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Mean nmol/L</p> <p>(SD)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>77.5</p> <p>(23.8)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>79.1 (21.8)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>105</p> <p>(95% CI 99 to 110)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>103</p> <p>(95% CI 96 to 110)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>8 weeks</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>There was no statistically significant difference in serum vitamin D levels at 8 weeks or 8 months between the groups </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD006086-bbs2-0016" title="MorcosMM , GabrAA , SamualS , KamelM , elBazM , elBeshryM , et al. Vitamin D administration to tuberculous children and its value. Bollettino Chimico Farmaceutico1998;137(5):157‐64. ">Morcos 1998 EGY</a><sup>5</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1000 IU daily for 8 weeks</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>NR</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>NR</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>NR</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>NR</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>NR</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>16 weeks</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>The trial authors reported that the serum vitamin D level rose in both groups and was not statistically different between groups (P &gt; 0.05). </p> </td> </tr> </tbody> </table> <div class="table-footnote"> <p>Abbreviations: NR = not reported; IU = international units; SD = standard deviation; 25(OH) D<sub>3</sub> = 25‐hydroxyvitamin D.<br/> <sup>1</sup><a href="./references#CD006086-bbs2-0002" title="DaleyP , JagannathanV , JohnKR , SarojiniJ , LathaA , ViethR , et al. Adjunctive vitamin D for treatment of active tuberculosis in India: a randomised, double‐blind, placebo‐controlled trial. The Lancet. Infectious Diseases2015;15(5):528‐34. ">Daley 2015 IND</a> only included HIV‐negative participants.<br/> <sup>2</sup><a href="./references#CD006086-bbs2-0009" title="KotaSK , JammulaS , KotaSK , TripathyPR , PandaS , ModiKD . Effect of vitamin D supplementation in type 2 diabetes patients with pulmonary tuberculosis. Diabetes and Metabolic Syndrome: Clinical Research &amp; Reviews2011;5(2):85‐9. ">Kota 2011 IND</a> only enrolled newly diagnosed tuberculosis cases with uncontrolled diabetes and serum vitamin D &lt; 20 ng/mL.<br/> <sup>3</sup><a href="./references#CD006086-bbs2-0012" title="MartineauAR , TimmsPM , BothamleyGH , HanifaY , IslamK , ClaxtonAP , et al. High‐dose vitamin D3 during intensive‐phase antimicrobial treatment for pulmonary tuberculosis: a double‐blind randomised controlled trial. Lancet2011;377(9761):242‐50. ">Martineau 2011 GBR</a> reported that at baseline almost all participants had serum vitamin D levels below the definition of insufficiency used by <a href="./references#CD006086-bbs2-0035" title="WejseC , GomesVF , RabnaP , GustafsonP , AabyP , LisseIM , et al. Vitamin D as supplementary treatment for tuberculosis ‐ a double‐blind randomised placebo‐controlled trial. American Journal of Respiratory and Critical Care Medicine2009;179(9):843‐50. ">Wejse 2008 GNB</a> (95% supplement group versus 98% control group).<br/> <sup>4</sup><a href="./references#CD006086-bbs2-0035" title="WejseC , GomesVF , RabnaP , GustafsonP , AabyP , LisseIM , et al. Vitamin D as supplementary treatment for tuberculosis ‐ a double‐blind randomised placebo‐controlled trial. American Journal of Respiratory and Critical Care Medicine2009;179(9):843‐50. ">Wejse 2008 GNB</a> reports that at baseline approximately 10% of participants were defined as being vitamin D deficient (serum 25 (OH)D<sub>3</sub>&lt; 50 nmol/L), and 45% as vitamin D insufficient (serum 25(OH)D<sub>3</sub> &lt; 75 nmol/L).<br/> <sup>5</sup><a href="./references#CD006086-bbs2-0016" title="MorcosMM , GabrAA , SamualS , KamelM , elBazM , elBeshryM , et al. Vitamin D administration to tuberculous children and its value. Bollettino Chimico Farmaceutico1998;137(5):157‐64. ">Morcos 1998 EGY</a> reported a mean vitamin D level of 17.91 pg/mL at baseline which is below the normal reference range (20 to 42 pg/mL). </p> </div> </div> <p>In four studies where the mean serum vitamin D levels were in the deficient range at baseline, there were large improvements at eight weeks with vitamin D compared to placebo (<a href="./references#CD006086-bbs2-0012" title="MartineauAR , TimmsPM , BothamleyGH , HanifaY , IslamK , ClaxtonAP , et al. High‐dose vitamin D3 during intensive‐phase antimicrobial treatment for pulmonary tuberculosis: a double‐blind randomised controlled trial. Lancet2011;377(9761):242‐50. ">Martineau 2011 GBR</a>: MD 78.60, 95% CI 54.17 to 103.03; <a href="./references#CD006086-bbs2-0009" title="KotaSK , JammulaS , KotaSK , TripathyPR , PandaS , ModiKD . Effect of vitamin D supplementation in type 2 diabetes patients with pulmonary tuberculosis. Diabetes and Metabolic Syndrome: Clinical Research &amp; Reviews2011;5(2):85‐9. ">Kota 2011 IND</a>: MD 28.00, 95% CI 20.29 to 35.71; <a href="./references#CD006086-bbs2-0015" title="MilyA , RekhaRS , KamalSM , ArifuzzamanAS , RahimZ , KhanL , et al. Significant effects of oral phenylbutyrate and vitamin D3 adjunctive therapy in pulmonary tuberculosis: a randomized controlled trial. PLoS One2015;10(9):e0138340. [DOI: 10.1371/journal.pone.0138340] ">Mily 2015 BGD</a> and <a href="./references#CD006086-bbs2-0032" title="FredianiJ , TukvadzeN , SanikidzeE , KipianiM , HebbarG , TangprichaV , et al. Drug susceptibility influences macronutrient intake and body composition in tuberculosis patients. The FASEB Journal2014;28(Supplement 1):1014.4. TukvadzeN , SanikidzeE , KipianiM , HebbarG , EasleyKA , ShenviN , et al. High‐dose vitamin D3 in adults with pulmonary tuberculosis: a double‐blind randomised controlled trial. American Journal of Clinical Nutrition2015;102(5):1059‐69. ">Tukvadze 2015 GEO</a> presented graphically, see <a href="#CD006086-tbl-0007">Table 5</a>). In two additional studies where the mean serum vitamin D levels were in the normal or insufficient range at baseline, there were no statistically significant differences at eight weeks (<a href="./references#CD006086-bbs2-0035" title="WejseC , GomesVF , RabnaP , GustafsonP , AabyP , LisseIM , et al. Vitamin D as supplementary treatment for tuberculosis ‐ a double‐blind randomised placebo‐controlled trial. American Journal of Respiratory and Critical Care Medicine2009;179(9):843‐50. ">Wejse 2008 GNB</a>: MD 2.00, 95% CI −7.76 to 11.76), or six months (<a href="./references#CD006086-bbs2-0002" title="DaleyP , JagannathanV , JohnKR , SarojiniJ , LathaA , ViethR , et al. Adjunctive vitamin D for treatment of active tuberculosis in India: a randomised, double‐blind, placebo‐controlled trial. The Lancet. Infectious Diseases2015;15(5):528‐34. ">Daley 2015 IND</a>: MD 8.60, 95%CI −6.29 to 23.49). </p> </section> <section id="CD006086-sec-0131"> <p><b>Tuberculosis treatment outcomes</b></p> <p>There were no statistically significant differences in the number of deaths between those receiving vitamin D (any formulation) or placebo regardless of HIV status (seven trials, 2649 participants, <a href="./references#CD006086-fig-0053" title="">Analysis 7.2</a>; <a href="./references#CD006086-fig-0054" title="">Analysis 7.3</a>). </p> <p>Only <a href="./references#CD006086-bbs2-0024" title="RalphAP , WaramoriG , PontororingGJ , KenangalemE , WigunaA , TjitraE , et al. L‐arginine and vitamin D adjunctive therapies in pulmonary tuberculosis: a randomised, double‐blind, placebo‐controlled trial. PLoS One2013;8(8):e70032. ">Ralph 2013 IDN</a> reported on cure, for which there was no statistically significant difference between the vitamin D and the placebo groups (one trial, 76 participants, <a href="./references#CD006086-fig-0055" title="">Analysis 7.4</a>). <a href="./references#CD006086-bbs2-0035" title="WejseC , GomesVF , RabnaP , GustafsonP , AabyP , LisseIM , et al. Vitamin D as supplementary treatment for tuberculosis ‐ a double‐blind randomised placebo‐controlled trial. American Journal of Respiratory and Critical Care Medicine2009;179(9):843‐50. ">Wejse 2008 GNB</a> also found no statistically significant difference in recovery, as defined by a newly developed tuberculosis scoring system (one trial, 348 participants, <a href="./references#CD006086-fig-0056" title="">Analysis 7.5</a>). This system rates the patient's condition on a scale of zero to 13, based on signs and symptoms and anthropometric measurements (<a href="./references#CD006086-bbs2-0102" title="WesjeC , GustafsonP , NielsonJ , GomesVF , AabyP , AndersonPL , et al. TB score: Signs and symptoms from tuberculosis patients in a low‐resource setting have predictive value and may be used to assess clinical course. Scandinavian Journal of Infectious Diseases2008;40(2):111‐20. ">Wesje 2008</a>). </p> <p>Overall, there were no statistically significant differences in the proportion of people that remained sputum positive at any time point from four weeks to eight months (seven trials, 1197 participants, <a href="./references#CD006086-fig-0057" title="">Analysis 7.6</a>). One trial of daily supplementation, <a href="./references#CD006086-bbs2-0017" title="NursyamEW , AminZ , RumendeCA . The effects of vitamin D as supplementary treatment in patients with moderately advanced pulmonary tuberculosis lesion. Acta Medica Indonesiana2006;38(1):3‐5. ">Nursyam 2006 IDN</a>, showed a statistically significant difference in the proportion of participants who remained sputum positive at six weeks (RR 0.06, 95% CI 0.00 to 0.95; one trial, 67 participants, <a href="./references#CD006086-fig-0057" title="">Analysis 7.6</a>); but the difference was not significant two weeks later. One additional trial, <a href="./references#CD006086-bbs2-0009" title="KotaSK , JammulaS , KotaSK , TripathyPR , PandaS , ModiKD . Effect of vitamin D supplementation in type 2 diabetes patients with pulmonary tuberculosis. Diabetes and Metabolic Syndrome: Clinical Research &amp; Reviews2011;5(2):85‐9. ">Kota 2011 IND</a>, also reported finding a statistically significant difference but only presented the P value (P = 0.067). </p> </section> <section id="CD006086-sec-0132"> <p><b>Nutritional <i>recovery and quality of life</i> </b></p> <p>There were no statistically significant differences in mean BMI after six to eight weeks of supplementation (four trials, 430 participants, <a href="./references#CD006086-fig-0058" title="">Analysis 7.7</a>), or in mean body weight (two trials, 150 participants, <a href="./references#CD006086-fig-0059" title="">Analysis 7.8</a>). <a href="./references#CD006086-bbs2-0035" title="WejseC , GomesVF , RabnaP , GustafsonP , AabyP , LisseIM , et al. Vitamin D as supplementary treatment for tuberculosis ‐ a double‐blind randomised placebo‐controlled trial. American Journal of Respiratory and Critical Care Medicine2009;179(9):843‐50. ">Wejse 2008 GNB</a> also reported no statistically significant difference in weight gain at eight months but only reported the P value (one trial, 359 participants, P = 0.9, authors' own figures), and <a href="./references#CD006086-bbs2-0024" title="RalphAP , WaramoriG , PontororingGJ , KenangalemE , WigunaA , TjitraE , et al. L‐arginine and vitamin D adjunctive therapies in pulmonary tuberculosis: a randomised, double‐blind, placebo‐controlled trial. PLoS One2013;8(8):e70032. ">Ralph 2013 IDN</a> reported no statistically significant difference in the proportions gaining less than 5%, 5% to 9.9%, or greater than 10% weight. </p> <p><a href="./references#CD006086-bbs2-0002" title="DaleyP , JagannathanV , JohnKR , SarojiniJ , LathaA , ViethR , et al. Adjunctive vitamin D for treatment of active tuberculosis in India: a randomised, double‐blind, placebo‐controlled trial. The Lancet. Infectious Diseases2015;15(5):528‐34. ">Daley 2015 IND</a> reported that mean Karnofsky score increased in both groups, with no statistically significant difference at eight weeks (one trial, 212 participants, <a href="./references#CD006086-fig-0060" title="">Analysis 7.9</a>). </p> </section> <section id="CD006086-sec-0133"> <p><b>Adverse events</b></p> <p>Five trials reported adverse events, which we have summarized in <a href="#CD006086-tbl-0008">Table 6</a>. There were no important differences in reported adverse events between the supplemented and the placebo groups. </p> <div class="table" id="CD006086-tbl-0008"> <table><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Table 6.</span> <span class="table-title">Adverse effects of vitamin D</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Trial ID</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Dose</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Severe adverse events</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Effects on calcium</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Other</b> </p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD006086-bbs2-0015" title="MilyA , RekhaRS , KamalSM , ArifuzzamanAS , RahimZ , KhanL , et al. Significant effects of oral phenylbutyrate and vitamin D3 adjunctive therapy in pulmonary tuberculosis: a randomized controlled trial. PLoS One2015;10(9):e0138340. [DOI: 10.1371/journal.pone.0138340] ">Mily 2015 BGD</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>5000 IU daily for 8 weeks</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>None in the vitamin D group</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Hypercalcemia: none</p> <p>Hypocalcemia: common but no differences between groups</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No differences between study arms</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD006086-bbs2-0032" title="FredianiJ , TukvadzeN , SanikidzeE , KipianiM , HebbarG , TangprichaV , et al. Drug susceptibility influences macronutrient intake and body composition in tuberculosis patients. The FASEB Journal2014;28(Supplement 1):1014.4. TukvadzeN , SanikidzeE , KipianiM , HebbarG , EasleyKA , ShenviN , et al. High‐dose vitamin D3 in adults with pulmonary tuberculosis: a double‐blind randomised controlled trial. American Journal of Clinical Nutrition2015;102(5):1059‐69. ">Tukvadze 2015 GEO</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>50,000 IU 3 times a week for 8 weeks, then every 2 weeks for 8 weeks</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>5/100 vitamin D versus 15/99 placebo</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Hypercalcemia: 3/100 vitamin D versus 7/99 placebo</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No differences between study arms</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD006086-bbs2-0002" title="DaleyP , JagannathanV , JohnKR , SarojiniJ , LathaA , ViethR , et al. Adjunctive vitamin D for treatment of active tuberculosis in India: a randomised, double‐blind, placebo‐controlled trial. The Lancet. Infectious Diseases2015;15(5):528‐34. ">Daley 2015 IND</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2.5 mg vitamin D<sub>3</sub> on days 0, 14, 28, and 42 </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>None in the vitamin D group</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Hypercalcaemia: none</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>4/121 vitamin D versus 3/126 placebo</p> <p>(none required a change in medical therapy)</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD006086-bbs2-0012" title="MartineauAR , TimmsPM , BothamleyGH , HanifaY , IslamK , ClaxtonAP , et al. High‐dose vitamin D3 during intensive‐phase antimicrobial treatment for pulmonary tuberculosis: a double‐blind randomised controlled trial. Lancet2011;377(9761):242‐50. ">Martineau 2011 GBR</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2.5 mg on days 0, 14, 28, and 42</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>7/71 vitamin D versus 2/70 placebo</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Hypercalcemia: 2/71 vitamin D versus 0/70 placebo</p> <p>Hypocalcaemia: 5/71 vitamin D versus 2/70 placebo</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No differences between study arms</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD006086-bbs2-0035" title="WejseC , GomesVF , RabnaP , GustafsonP , AabyP , LisseIM , et al. Vitamin D as supplementary treatment for tuberculosis ‐ a double‐blind randomised placebo‐controlled trial. American Journal of Respiratory and Critical Care Medicine2009;179(9):843‐50. ">Wejse 2008 GNB</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>100,000 IU vitamin D<sub>3</sub> at 0, 5, and 8 months </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No comment</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Hypercalcemia: at 2 months: 1/157 vitamin D versus 2/147 placebo</p> <p>At 8 months: none</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>At 2 months: only 24 reported any symptom, most commonly excessive thirst: 10/157 vitamin D versus 14/147 placebo (P = 0.31) </p> </td> </tr> </tbody> </table> <div class="table-footnote"> <p>Abbreviations: IU = international units.</p> </div> </div> </section> </section> <section id="CD006086-sec-0134"> <h6 class="title">Vitamin E and selenium capsules (DRI: vitamin E 15 mg, selenium 55 µg per day)</h6> <p>One trial compared a daily vitamin E (140 mg) and selenium (200 µg) supplement with placebo in adults being treated for sputum‐smear positive pulmonary tuberculosis (<a href="./references#CD006086-bbs2-0029" title="SeyedrezazadehE , OstadrahimiA , MahboobS , AsadiY , GhaemmagamiJ , PourmogaddamM . Effect of vitamin E and selenium supplementation on oxidative stress status in pulmonary tuberculosis patients. Respirology2008;13(2):294‐8. SeyedrezazadehE , OstradrahimiAR , MahboobSA , AssadiY , AnsarinK , SakooriP , et al. Vitamin E‐selenium supplement and clinical responses of active pulmonary tuberculosis. Tanaffos2006;5(2):49‐55. ">Seyedrezazadeh 2006 IRN</a>). </p> <p>The trial authors reported the median plasma vitamin E and selenium levels at baseline and at eight weeks. They reported that the median level of both micronutrients rose in the supplement group and decreased in the placebo group. We were unable to assess whether these differences between groups were statistically significant (<a href="./appendices#CD006086-sec-0165">Appendix 8</a>). In addition, one study that gave multi‐micronutrients, including vitamin E (133 mg) and selenium (65 µg), measured the vitamin E and selenium levels at baseline and during follow‐up (<a href="./references#CD006086-bbs2-0028" title="SembaRD , KumwendaJ , ZijlstraE , RicksMO , vanLettowM , WhalenC , et al. Micronutrient supplements and mortality of HIV‐infected adults with pulmonary TB: a controlled clinical trial. International Journal of Tuberculosis and Lung Disease2007;11(8):854‐9. ">Semba 2007 MWI</a>). The trial authors reported that both vitamin E and selenium levels were "significantly higher" in the supplement group after eight months, but only presented the data graphically. </p> <section id="CD006086-sec-0135"> <p><b>Tuberculosis treatment outcomes</b></p> <p>No deaths were reported and this trial did not report cure or treatment completion.</p> <p>There was no statistically significant difference between the supplement and placebo groups in the numbers of participants who were sputum‐smear positive at 15, 30, 45, and 60 days after the start of antituberculous treatment (one trial, 35 participants, <a href="./references#CD006086-fig-0066" title="">Analysis 9.1</a>). </p> </section> <section id="CD006086-sec-0136"> <p><b>Nutritional <i>recovery and quality of life</i> </b></p> <p>The trial authors reported a 'constant increment' in BMI for the two months of treatment with no statistically significant differences between the groups, but did not present these data. </p> </section> </section> <section id="CD006086-sec-0137"> <h6 class="title">Arginine (currently considered a conditionally essential amino acid, depending on the developmental stage and health status of the individual) </h6> <p>Four trials compared daily supplementation with arginine (1 mg daily: <a href="./references#CD006086-bbs2-0026" title="SchönT , EliasD , MogesF , MeleseE , TessemaT , StendahlO , et al. Arginine as an adjuvant to chemotherapy improves clinical outcomes in active tuberculosis. European Respiratory Journal2003;21(3):483‐8. ">Schön 2003 ETH</a> and <a href="./references#CD006086-bbs2-0027" title="SchönT , IdhJ , WestmanA , EliasD , AbateE , DiroE , et al. Effects of a food supplement rich in arginine in patients with smear positive pulmonary tuberculosis ‐ a randomised trial. Tuberculosis2011;91(5):370‐7. ">Schön 2011 ETH</a>; 1000 mg twice daily for 30 days: <a href="./references#CD006086-bbs2-0003" title="FaraziA , ShafaatO , SofianM , KahbaziM . Arginine adjunctive therapy in active tuberculosis. Tuberculosis Research and Treatment2015;2015:205016. [DOI: 10.1155/2015/205016] ">Farazi 2015 IRN</a>; and 6 mg daily for eight weeks: <a href="./references#CD006086-bbs2-0024" title="RalphAP , WaramoriG , PontororingGJ , KenangalemE , WigunaA , TjitraE , et al. L‐arginine and vitamin D adjunctive therapies in pulmonary tuberculosis: a randomised, double‐blind, placebo‐controlled trial. PLoS One2013;8(8):e70032. ">Ralph 2013 IDN</a>) with either placebo (<a href="./references#CD006086-bbs2-0026" title="SchönT , EliasD , MogesF , MeleseE , TessemaT , StendahlO , et al. Arginine as an adjuvant to chemotherapy improves clinical outcomes in active tuberculosis. European Respiratory Journal2003;21(3):483‐8. ">Schön 2003 ETH</a>; <a href="./references#CD006086-bbs2-0024" title="RalphAP , WaramoriG , PontororingGJ , KenangalemE , WigunaA , TjitraE , et al. L‐arginine and vitamin D adjunctive therapies in pulmonary tuberculosis: a randomised, double‐blind, placebo‐controlled trial. PLoS One2013;8(8):e70032. ">Ralph 2013 IDN</a>; <a href="./references#CD006086-bbs2-0003" title="FaraziA , ShafaatO , SofianM , KahbaziM . Arginine adjunctive therapy in active tuberculosis. Tuberculosis Research and Treatment2015;2015:205016. [DOI: 10.1155/2015/205016] ">Farazi 2015 IRN</a>) or a biscuit that contained trace amounts of arginine (0.1 mg arginine, <a href="./references#CD006086-bbs2-0027" title="SchönT , IdhJ , WestmanA , EliasD , AbateE , DiroE , et al. Effects of a food supplement rich in arginine in patients with smear positive pulmonary tuberculosis ‐ a randomised trial. Tuberculosis2011;91(5):370‐7. ">Schön 2011 ETH</a>). The trials were all conducted in adults being treated for smear‐positive pulmonary tuberculosis. <a href="./references#CD006086-bbs2-0003" title="FaraziA , ShafaatO , SofianM , KahbaziM . Arginine adjunctive therapy in active tuberculosis. Tuberculosis Research and Treatment2015;2015:205016. [DOI: 10.1155/2015/205016] ">Farazi 2015 IRN</a> only included HIV‐negative participants. The percentage of HIV‐positive participants in the other three trials ranged from 13% (<a href="./references#CD006086-bbs2-0024" title="RalphAP , WaramoriG , PontororingGJ , KenangalemE , WigunaA , TjitraE , et al. L‐arginine and vitamin D adjunctive therapies in pulmonary tuberculosis: a randomised, double‐blind, placebo‐controlled trial. PLoS One2013;8(8):e70032. ">Ralph 2013 IDN</a>) to 52% (<a href="./references#CD006086-bbs2-0026" title="SchönT , EliasD , MogesF , MeleseE , TessemaT , StendahlO , et al. Arginine as an adjuvant to chemotherapy improves clinical outcomes in active tuberculosis. European Respiratory Journal2003;21(3):483‐8. ">Schön 2003 ETH</a>). </p> <section id="CD006086-sec-0138"> <p><b>Tuberculosis treatment outcomes</b></p> <p>The included trials reported a total of 12 deaths. There was no significant difference in the risk of death between the arginine supplemented group and the placebo group (three trials, 394 participants, <a href="./references#CD006086-fig-0061" title="">Analysis 8.1</a>). There was also no significant difference in the proportion of participants who were cured (two trials, 279 participants, <a href="./references#CD006086-fig-0062" title="">Analysis 8.2</a>), or sputum smear or culture positive at four or eight weeks of follow‐up (four trials, 464 participants, <a href="./references#CD006086-fig-0063" title="">Analysis 8.3</a>). <a href="./references#CD006086-bbs2-0026" title="SchönT , EliasD , MogesF , MeleseE , TessemaT , StendahlO , et al. Arginine as an adjuvant to chemotherapy improves clinical outcomes in active tuberculosis. European Respiratory Journal2003;21(3):483‐8. ">Schön 2003 ETH</a> reported a statistically significant increase in sputum‐smear conversion in HIV‐negative participants receiving arginine; however, our analysis of the data showed a non‐significant difference between groups in the numbers of participants still sputum‐smear positive at eight weeks (one trial, 56 participants, <a href="./references#CD006086-fig-0063" title="">Analysis 8.3</a>). </p> <p>At two weeks <a href="./references#CD006086-bbs2-0026" title="SchönT , EliasD , MogesF , MeleseE , TessemaT , StendahlO , et al. Arginine as an adjuvant to chemotherapy improves clinical outcomes in active tuberculosis. European Respiratory Journal2003;21(3):483‐8. ">Schön 2003 ETH</a> reported that compared to the placebo group, fewer HIV‐negative participants in the arginine group reported cough (RR 0.71, 95% CI 0.53 to 0.96; one trial, 56 participants, <a href="./references#CD006086-fig-0064" title="">Analysis 8.4</a>). Similarly, at eight weeks significantly fewer participants in the arginine group reported cough compared to those in the placebo group (RR 0.78, 95% CI 0.61 to 0.99; three trials, 348 participants, <a href="./references#CD006086-fig-0064" title="">Analysis 8.4</a>); this difference should be viewed with caution as only <a href="./references#CD006086-bbs2-0003" title="FaraziA , ShafaatO , SofianM , KahbaziM . Arginine adjunctive therapy in active tuberculosis. Tuberculosis Research and Treatment2015;2015:205016. [DOI: 10.1155/2015/205016] ">Farazi 2015 IRN</a> provided baseline data that showed no difference in cough symptoms between groups. </p> </section> <section id="CD006086-sec-0139"> <p><b>Nutritional recovery and quality of life</b></p> <p>In two studies there was no significant difference in weight gain (<a href="./references#CD006086-bbs2-0026" title="SchönT , EliasD , MogesF , MeleseE , TessemaT , StendahlO , et al. Arginine as an adjuvant to chemotherapy improves clinical outcomes in active tuberculosis. European Respiratory Journal2003;21(3):483‐8. ">Schön 2003 ETH</a> only presented the data graphically) or the proportion of participants with weight gain greater than 10% (<a href="./references#CD006086-bbs2-0027" title="SchönT , IdhJ , WestmanA , EliasD , AbateE , DiroE , et al. Effects of a food supplement rich in arginine in patients with smear positive pulmonary tuberculosis ‐ a randomised trial. Tuberculosis2011;91(5):370‐7. ">Schön 2011 ETH</a>; one trial, 170 participants, <a href="./references#CD006086-fig-0065" title="">Analysis 8.5</a>) between the arginine and placebo or low arginine groups. In a recent study, arginine supplementation significantly reduced the number of participants with a BMI of less than 18.5 after one (P = 0.032) and two (P = 0.04) months of antituberculous treatment compared to placebo (<a href="./references#CD006086-bbs2-0003" title="FaraziA , ShafaatO , SofianM , KahbaziM . Arginine adjunctive therapy in active tuberculosis. Tuberculosis Research and Treatment2015;2015:205016. [DOI: 10.1155/2015/205016] ">Farazi 2015 IRN</a>). </p> </section> </section> </section> </section> <section id="CD006086-sec-0140"> <h4 class="title">3. Other trials</h4> <p>One small trial compared supplementation with <i>C. striata</i> capsules (6 g per day), for four months, with organoleptically‐matched placebo on sputum and cytokine conversion in 36 HIV‐negative participants with sputum smear positive pulmonary tuberculosis (<a href="./references#CD006086-bbs2-0019" title="PaliliewuN , DatauEA , MatheosJC , SurachmantoEE . Channa striatus capsules induces cytokine conversion in pulmonary tuberculosis patients. Journal of Experimental and Integrative Medicine2013;3(3):237‐42. ">Paliliewu 2013 IDN</a>). </p> <section id="CD006086-sec-0141"> <h5 class="title">Tuberculosis treatment outcomes</h5> <p>This trial did not report on death, cure, or treatment completion. The rate of sputum smear conversion was greater in the supplemented group compared to placebo group. However, these differences were not statistically significant at any of the time points measured. </p> </section> <section id="CD006086-sec-0142"> <h5 class="title">Nutritional recovery and quality of life</h5> <p>This outcome was not reported.</p> </section> </section> </section> </section> </section> <section class="discussion"> <div class="section-header section-collapse-header" id="CD006086-sec-0143" lang="en"> <h2 class="title section-collapse-title"> Discussion <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="discussion" lang="en"> <div class="section-header" id="CD006086-sec-0143"></div> <section id="CD006086-sec-0144"> <h3 class="title" id="CD006086-sec-0144">Summary of main results</h3> <section id="CD006086-sec-0145"> <h4 class="title">Macronutrient supplementation</h4> <p>The included trials were too small to reliably prove or exclude clinically important benefits on mortality, cure, or treatment completion (<i>very low quality evidence</i>). One small trial from India did find a statistically significant benefit on treatment completion, and clearance of the bacteria from the sputum, but these findings have not been confirmed in larger trials elsewhere. </p> <p>The provision of free food or high‐energy nutritional products probably does produce a modest increase in weight gain during treatment for active tuberculosis, although this was not consistent across all included trials (<i>moderate quality evidence</i> ). Two small studies provide some evidence that quality of life may also be improved but the trials were too small to have much confidence in the result (<i>low quality evidence</i>). </p> </section> <section id="CD006086-sec-0146"> <h4 class="title">Micronutrient supplementation</h4> <p>Multi‐micronutrients may have little or no effect on mortality in HIV‐negative people with tuberculosis (<i>low quality evidence</i> ), and probably have little or no effect on mortality in HIV‐positive patients who are not taking anti‐retroviral therapy (<i>moderate quality evidence</i> ). There is insufficient evidence to know if multi‐micronutrients improve cure, treatment completion, or the proportion of tuberculosis patients remaining sputum positive during the first eight weeks (<i>very low quality evidence</i>). </p> <p>Multi‐micronutrients may have little or no effect on weight gain during treatment (<i>low quality evidence</i>), although one of the three studies did find a substantial benefit in one study arm. No studies assessed the effect of multi‐micronutrient supplementation on quality of life. </p> </section> <section id="CD006086-sec-0147"> <h4 class="title">Individual micronutrients</h4> <p>Although low vitamin A levels are common in tuberculosis, plasma levels probably increase following initiation of tuberculosis treatment regardless of supplementation. There is no evidence that supplementation in doses up to three times the DRI has a beneficial effect on tuberculosis treatment outcomes, or nutritional recovery. </p> <p>B vitamins have been given in doses up to 10 times the DRI as part of multi‐micronutrient supplementation. There is no evidence of an effect on mortality from tuberculosis. Due to the paucity of trials we cannot make any further conclusions about the effect of this vitamin on other tuberculosis outcomes. </p> <p>Vitamin C has only been evaluated as part of multi‐micronutrient supplements. Doses of vitamin C up to five times the DRI had no effect on tuberculosis mortality. Due to the paucity of trials we cannot make any further conclusions about the effect of this vitamin on other tuberculosis outcomes. </p> <p>Vitamin D supplementation appears to improve plasma levels compared to placebo when participants are deficient at the start of supplementation, but may not have any clinically important effects on early sputum conversion. </p> <p>Vitamin E has only been assessed in combination with other vitamins or selenium. The dose used was up to 10 times the DRI. None of these trials show any significant benefit or harm with supplementation, but supplementation probably does improve blood levels of both vitamin E and selenium. </p> <p>There is some evidence that plasma zinc levels increase during the first six months of supplementation, but no convincing evidence of other benefits. </p> </section> </section> <section id="CD006086-sec-0148"> <h3 class="title" id="CD006086-sec-0148">Overall completeness and applicability of evidence</h3> <p>The included studies were generally too small and too limited to make broad conclusions on the presence or absence of clinically important benefits of nutritional supplementation on tuberculosis treatment outcomes. </p> <p>Although the included studies are from low‐ and middle‐income countries, they may not reflect the food‐insecure settings where most supplementation programmes take place, and where the benefit may plausibly be greatest. </p> <p>Where a supplement has so far not shown any benefit, this may also be an issue relating to the dose used as people recovering from tuberculosis may have micronutrient requirements which are higher than healthy people, however there is currently no evidence to support this. </p> <p>In addition, it should be noted that most of the HIV‐positive participants in these trials were not taking antiretroviral therapy. </p> </section> <section id="CD006086-sec-0149"> <h3 class="title" id="CD006086-sec-0149">Quality of the evidence</h3> <p>We assessed the quality of evidence using the GRADE methodology, and displayed the results in two 'Summary of findings' tables (<a href="./full#CD006086-tbl-0001">summary of findings Table for the main comparison</a>; <a href="./full#CD006086-tbl-0002">summary of findings Table 2</a>). 'Moderate' quality evidence implies we can have some confidence in the result, but further research evidence would still be helpful. 'Low' and 'very low' quality reflect decreasing levels of confidence in the result. </p> <p>The quality of evidence was mainly downgraded under 'directness' and 'precision'. Directness is an assessment of how well the evidence matches the PICO question being asked (population, intervention, control, outcome). Because nutritional deficiencies are likely to differ widely among populations, it is difficult to generalize the results of one or two trials to other settings or subgroups. Precision involves an assessment of the statistical and clinical significance of the result, and also whether the sample size of the trials is adequate to reliably detect an effect. Most of these trials were small and well below the optimal information size for the outcomes that were being measured. </p> </section> <section id="CD006086-sec-0150"> <h3 class="title" id="CD006086-sec-0150">Potential biases in the review process</h3> <p>We minimized biases in the review process by performing a comprehensive search of the literature for relevant published, unpublished, and ongoing trials and by independently selecting and appraising the studies, and extracting the data in duplicate. Where data was missing, we sought additional information and data directly from the study authors where this was possible to do so. We did not conduct an extensive hand‐search for grey literature. Therefore, the review is at risk of publication bias from less prominent trials. We attempted to reduce this risk by identifying relevant conference abstracts and registered ongoing trials. The search of the trials registry to identify trial protocols and ongoing trials yielded 16 potentially relevant trial protocols. These will require further assessment and exploration to either: 1) link them to trials already included in the review; or 2) if not included, to attempt to obtain the completed trial reports. This task is time‐consuming and has to be balanced against feasibility and time constraints. </p> </section> <section id="CD006086-sec-0151"> <h3 class="title" id="CD006086-sec-0151">Agreements and disagreements with other studies or reviews</h3> <p>Nutritional supplementation in HIV‐positive patients without tuberculosis has been assessed by two further Cochrane reviews (<a href="./references#CD006086-bbs2-0083" title="IrlamJH , VisserMME , RollinsNN , SiegfriedN . Micronutrient supplementation in children and adults with HIV infection. Cochrane Database of Systematic Reviews2010, Issue 12. [DOI: 10.1002/14651858.CD003650.pub3] ">Irlam 2010</a>; <a href="./references#CD006086-bbs2-0081" title="GroblerL , SiegfriedN , VisserME , MahlunguluSS , VolminkJ . Nutritional interventions for reducing morbidity and mortality in people with HIV. Cochrane Database of Systematic Reviews2013, Issue 2. [DOI: 10.1002/14651858.CD004536.pub3] ">Grobler 2013</a>). </p> <p><a href="./references#CD006086-bbs2-0081" title="GroblerL , SiegfriedN , VisserME , MahlunguluSS , VolminkJ . Nutritional interventions for reducing morbidity and mortality in people with HIV. Cochrane Database of Systematic Reviews2013, Issue 2. [DOI: 10.1002/14651858.CD004536.pub3] ">Grobler 2013</a> found 14 small trials that compared macronutrient supplementation with no supplementation and concluded that although there was evidence that supplementation increased both energy and protein intake, there was no evidence of a clinical benefit on either nutritional‐ or HIV‐related outcomes. </p> <p><a href="./references#CD006086-bbs2-0083" title="IrlamJH , VisserMME , RollinsNN , SiegfriedN . Micronutrient supplementation in children and adults with HIV infection. Cochrane Database of Systematic Reviews2010, Issue 12. [DOI: 10.1002/14651858.CD003650.pub3] ">Irlam 2010</a> assessed 30 trials that compared micronutrients with placebo from both developed and developing countries. The authors concluded that multi‐micronutrient supplements have significant benefits in HIV‐positive pregnant women and children. In children there was also evidence of a reduction in mortality with vitamin A, and a reduction in diarrhoeal morbidity with zinc. </p> </section> </section> </section> <div class="figures-list"> <div class="figure" id="CD006086-fig-0001"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006086.pub4/media/CDSR/CD006086/urn:x-wiley:14651858:media:CD006086:CD006086-AFig-FIG01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006086.pub4/media/CDSR/CD006086/image_t/tCD006086-AFig-FIG01.png" target="_blank"><b></b></a></p> </div><img alt="Study flow diagram." data-id="CD006086-fig-0001" src="/cdsr/doi/10.1002/14651858.CD006086.pub4/media/CDSR/CD006086/image_n/nCD006086-AFig-FIG01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 1</div> <div class="figure-caption"> <p>Study flow diagram.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006086.pub4/full#CD006086-fig-0001">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006086.pub4/media/CDSR/CD006086/image_n/nCD006086-AFig-FIG01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006086-fig-0002"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006086.pub4/media/CDSR/CD006086/urn:x-wiley:14651858:media:CD006086:CD006086-AFig-FIG02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006086.pub4/media/CDSR/CD006086/image_t/tCD006086-AFig-FIG02.png" target="_blank"><b></b></a></p> </div><img alt="'Risk of bias' summary: review authors' judgements about each 'Risk of bias' item for each included study." data-id="CD006086-fig-0002" src="/cdsr/doi/10.1002/14651858.CD006086.pub4/media/CDSR/CD006086/image_n/nCD006086-AFig-FIG02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 2</div> <div class="figure-caption"> <p>'Risk of bias' summary: review authors' judgements about each 'Risk of bias' item for each included study. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006086.pub4/full#CD006086-fig-0002">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006086.pub4/media/CDSR/CD006086/image_n/nCD006086-AFig-FIG02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006086-fig-0003"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006086.pub4/media/CDSR/CD006086/urn:x-wiley:14651858:media:CD006086:CD006086-CMP-001-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006086.pub4/media/CDSR/CD006086/image_t/tCD006086-CMP-001-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Macronutrient supplementation, Outcome 1 Death (1 year of follow‐up)." data-id="CD006086-fig-0003" src="/cdsr/doi/10.1002/14651858.CD006086.pub4/media/CDSR/CD006086/image_n/nCD006086-CMP-001-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.1</div> <div class="figure-caption"> <p>Comparison 1 Macronutrient supplementation, Outcome 1 Death (1 year of follow‐up).</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006086.pub4/references#CD006086-fig-0003">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006086.pub4/media/CDSR/CD006086/image_n/nCD006086-CMP-001-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006086-fig-0004"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006086.pub4/media/CDSR/CD006086/urn:x-wiley:14651858:media:CD006086:CD006086-CMP-001-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006086.pub4/media/CDSR/CD006086/image_t/tCD006086-CMP-001-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Macronutrient supplementation, Outcome 2 Cured (at 6 months)." data-id="CD006086-fig-0004" src="/cdsr/doi/10.1002/14651858.CD006086.pub4/media/CDSR/CD006086/image_n/nCD006086-CMP-001-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.2</div> <div class="figure-caption"> <p>Comparison 1 Macronutrient supplementation, Outcome 2 Cured (at 6 months).</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006086.pub4/references#CD006086-fig-0004">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006086.pub4/media/CDSR/CD006086/image_n/nCD006086-CMP-001-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006086-fig-0005"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006086.pub4/media/CDSR/CD006086/urn:x-wiley:14651858:media:CD006086:CD006086-CMP-001-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006086.pub4/media/CDSR/CD006086/image_t/tCD006086-CMP-001-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Macronutrient supplementation, Outcome 3 Treatment completion." data-id="CD006086-fig-0005" src="/cdsr/doi/10.1002/14651858.CD006086.pub4/media/CDSR/CD006086/image_n/nCD006086-CMP-001-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.3</div> <div class="figure-caption"> <p>Comparison 1 Macronutrient supplementation, Outcome 3 Treatment completion.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006086.pub4/references#CD006086-fig-0005">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006086.pub4/media/CDSR/CD006086/image_n/nCD006086-CMP-001-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006086-fig-0006"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006086.pub4/media/CDSR/CD006086/urn:x-wiley:14651858:media:CD006086:CD006086-CMP-001-04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006086.pub4/media/CDSR/CD006086/image_t/tCD006086-CMP-001-04.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Macronutrient supplementation, Outcome 4 Sputum negative at 8 weeks." data-id="CD006086-fig-0006" src="/cdsr/doi/10.1002/14651858.CD006086.pub4/media/CDSR/CD006086/image_n/nCD006086-CMP-001-04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.4</div> <div class="figure-caption"> <p>Comparison 1 Macronutrient supplementation, Outcome 4 Sputum negative at 8 weeks.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006086.pub4/references#CD006086-fig-0006">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006086.pub4/media/CDSR/CD006086/image_n/nCD006086-CMP-001-04.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006086-fig-0007"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006086.pub4/media/CDSR/CD006086/urn:x-wiley:14651858:media:CD006086:CD006086-CMP-001-05" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006086.pub4/media/CDSR/CD006086/image_t/tCD006086-CMP-001-05.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Macronutrient supplementation, Outcome 5 Mean weight gain." data-id="CD006086-fig-0007" src="/cdsr/doi/10.1002/14651858.CD006086.pub4/media/CDSR/CD006086/image_n/nCD006086-CMP-001-05.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.5</div> <div class="figure-caption"> <p>Comparison 1 Macronutrient supplementation, Outcome 5 Mean weight gain.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006086.pub4/references#CD006086-fig-0007">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006086.pub4/media/CDSR/CD006086/image_n/nCD006086-CMP-001-05.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006086-fig-0008"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006086.pub4/media/CDSR/CD006086/urn:x-wiley:14651858:media:CD006086:CD006086-CMP-001-06" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006086.pub4/media/CDSR/CD006086/image_t/tCD006086-CMP-001-06.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Macronutrient supplementation, Outcome 6 Change in maximum grip strength (kg)." data-id="CD006086-fig-0008" src="/cdsr/doi/10.1002/14651858.CD006086.pub4/media/CDSR/CD006086/image_n/nCD006086-CMP-001-06.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.6</div> <div class="figure-caption"> <p>Comparison 1 Macronutrient supplementation, Outcome 6 Change in maximum grip strength (kg). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006086.pub4/references#CD006086-fig-0008">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006086.pub4/media/CDSR/CD006086/image_n/nCD006086-CMP-001-06.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006086-fig-0009"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006086.pub4/media/CDSR/CD006086/urn:x-wiley:14651858:media:CD006086:CD006086-CMP-001-07" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006086.pub4/media/CDSR/CD006086/image_t/tCD006086-CMP-001-07.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Macronutrient supplementation, Outcome 7 Change in quality of life score." data-id="CD006086-fig-0009" src="/cdsr/doi/10.1002/14651858.CD006086.pub4/media/CDSR/CD006086/image_n/nCD006086-CMP-001-07.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.7</div> <div class="figure-caption"> <p>Comparison 1 Macronutrient supplementation, Outcome 7 Change in quality of life score.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006086.pub4/references#CD006086-fig-0009">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006086.pub4/media/CDSR/CD006086/image_n/nCD006086-CMP-001-07.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006086-fig-0010"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006086.pub4/media/CDSR/CD006086/urn:x-wiley:14651858:media:CD006086:CD006086-CMP-002-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006086.pub4/media/CDSR/CD006086/image_t/tCD006086-CMP-002-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 High cholesterol (850 mg/day) versus low cholesterol (250 mg/day) diet, Outcome 1 Sputum‐culture positive." data-id="CD006086-fig-0010" src="/cdsr/doi/10.1002/14651858.CD006086.pub4/media/CDSR/CD006086/image_n/nCD006086-CMP-002-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.1</div> <div class="figure-caption"> <p>Comparison 2 High cholesterol (850 mg/day) versus low cholesterol (250 mg/day) diet, Outcome 1 Sputum‐culture positive. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006086.pub4/references#CD006086-fig-0010">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006086.pub4/media/CDSR/CD006086/image_n/nCD006086-CMP-002-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006086-fig-0011"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006086.pub4/media/CDSR/CD006086/urn:x-wiley:14651858:media:CD006086:CD006086-CMP-003-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006086.pub4/media/CDSR/CD006086/image_t/tCD006086-CMP-003-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 Multivitamin and trace element tablets versus placebo, Outcome 1 Death during follow‐up in adults and children." data-id="CD006086-fig-0011" src="/cdsr/doi/10.1002/14651858.CD006086.pub4/media/CDSR/CD006086/image_n/nCD006086-CMP-003-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.1</div> <div class="figure-caption"> <p>Comparison 3 Multivitamin and trace element tablets versus placebo, Outcome 1 Death during follow‐up in adults and children. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006086.pub4/references#CD006086-fig-0011">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006086.pub4/media/CDSR/CD006086/image_n/nCD006086-CMP-003-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006086-fig-0012"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006086.pub4/media/CDSR/CD006086/urn:x-wiley:14651858:media:CD006086:CD006086-CMP-003-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006086.pub4/media/CDSR/CD006086/image_t/tCD006086-CMP-003-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 Multivitamin and trace element tablets versus placebo, Outcome 2 Tuberculosis treatment completion." data-id="CD006086-fig-0012" src="/cdsr/doi/10.1002/14651858.CD006086.pub4/media/CDSR/CD006086/image_n/nCD006086-CMP-003-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.2</div> <div class="figure-caption"> <p>Comparison 3 Multivitamin and trace element tablets versus placebo, Outcome 2 Tuberculosis treatment completion. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006086.pub4/references#CD006086-fig-0012">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006086.pub4/media/CDSR/CD006086/image_n/nCD006086-CMP-003-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006086-fig-0013"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006086.pub4/media/CDSR/CD006086/urn:x-wiley:14651858:media:CD006086:CD006086-CMP-003-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006086.pub4/media/CDSR/CD006086/image_t/tCD006086-CMP-003-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 Multivitamin and trace element tablets versus placebo, Outcome 3 Sputum‐smear or sputum‐culture positive at 1 month." data-id="CD006086-fig-0013" src="/cdsr/doi/10.1002/14651858.CD006086.pub4/media/CDSR/CD006086/image_n/nCD006086-CMP-003-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.3</div> <div class="figure-caption"> <p>Comparison 3 Multivitamin and trace element tablets versus placebo, Outcome 3 Sputum‐smear or sputum‐culture positive at 1 month. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006086.pub4/references#CD006086-fig-0013">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006086.pub4/media/CDSR/CD006086/image_n/nCD006086-CMP-003-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006086-fig-0014"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006086.pub4/media/CDSR/CD006086/urn:x-wiley:14651858:media:CD006086:CD006086-CMP-003-04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006086.pub4/media/CDSR/CD006086/image_t/tCD006086-CMP-003-04.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 Multivitamin and trace element tablets versus placebo, Outcome 4 Sputum‐smear or sputum‐culture positive at 2 months." data-id="CD006086-fig-0014" src="/cdsr/doi/10.1002/14651858.CD006086.pub4/media/CDSR/CD006086/image_n/nCD006086-CMP-003-04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.4</div> <div class="figure-caption"> <p>Comparison 3 Multivitamin and trace element tablets versus placebo, Outcome 4 Sputum‐smear or sputum‐culture positive at 2 months. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006086.pub4/references#CD006086-fig-0014">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006086.pub4/media/CDSR/CD006086/image_n/nCD006086-CMP-003-04.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006086-fig-0015"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006086.pub4/media/CDSR/CD006086/urn:x-wiley:14651858:media:CD006086:CD006086-CMP-003-05" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006086.pub4/media/CDSR/CD006086/image_t/tCD006086-CMP-003-05.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 Multivitamin and trace element tablets versus placebo, Outcome 5 Clearance of chest X‐ray at 6 months." data-id="CD006086-fig-0015" src="/cdsr/doi/10.1002/14651858.CD006086.pub4/media/CDSR/CD006086/image_n/nCD006086-CMP-003-05.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.5</div> <div class="figure-caption"> <p>Comparison 3 Multivitamin and trace element tablets versus placebo, Outcome 5 Clearance of chest X‐ray at 6 months. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006086.pub4/references#CD006086-fig-0015">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006086.pub4/media/CDSR/CD006086/image_n/nCD006086-CMP-003-05.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006086-fig-0016"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006086.pub4/media/CDSR/CD006086/urn:x-wiley:14651858:media:CD006086:CD006086-CMP-003-06" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006086.pub4/media/CDSR/CD006086/image_t/tCD006086-CMP-003-06.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 Multivitamin and trace element tablets versus placebo, Outcome 6 Weight." data-id="CD006086-fig-0016" src="/cdsr/doi/10.1002/14651858.CD006086.pub4/media/CDSR/CD006086/image_n/nCD006086-CMP-003-06.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.6</div> <div class="figure-caption"> <p>Comparison 3 Multivitamin and trace element tablets versus placebo, Outcome 6 Weight.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006086.pub4/references#CD006086-fig-0016">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006086.pub4/media/CDSR/CD006086/image_n/nCD006086-CMP-003-06.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006086-fig-0017"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006086.pub4/media/CDSR/CD006086/urn:x-wiley:14651858:media:CD006086:CD006086-CMP-003-07" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006086.pub4/media/CDSR/CD006086/image_t/tCD006086-CMP-003-07.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 Multivitamin and trace element tablets versus placebo, Outcome 7 Anthropometrical changes at follow‐up." data-id="CD006086-fig-0017" src="/cdsr/doi/10.1002/14651858.CD006086.pub4/media/CDSR/CD006086/image_n/nCD006086-CMP-003-07.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.7</div> <div class="figure-caption"> <p>Comparison 3 Multivitamin and trace element tablets versus placebo, Outcome 7 Anthropometrical changes at follow‐up. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006086.pub4/references#CD006086-fig-0017">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006086.pub4/media/CDSR/CD006086/image_n/nCD006086-CMP-003-07.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006086-fig-0018"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006086.pub4/media/CDSR/CD006086/urn:x-wiley:14651858:media:CD006086:CD006086-CMP-003-08" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006086.pub4/media/CDSR/CD006086/image_t/tCD006086-CMP-003-08.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 Multivitamin and trace element tablets versus placebo, Outcome 8 Mean change in handgrip strength (kg)." data-id="CD006086-fig-0018" src="/cdsr/doi/10.1002/14651858.CD006086.pub4/media/CDSR/CD006086/image_n/nCD006086-CMP-003-08.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.8</div> <div class="figure-caption"> <p>Comparison 3 Multivitamin and trace element tablets versus placebo, Outcome 8 Mean change in handgrip strength (kg). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006086.pub4/references#CD006086-fig-0018">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006086.pub4/media/CDSR/CD006086/image_n/nCD006086-CMP-003-08.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006086-fig-0019"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006086.pub4/media/CDSR/CD006086/urn:x-wiley:14651858:media:CD006086:CD006086-CMP-004-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006086.pub4/media/CDSR/CD006086/image_t/tCD006086-CMP-004-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 4 Vitamin A versus placebo, Outcome 1 Children: mean serum retinol (normal range &gt; 20 µg/L)." data-id="CD006086-fig-0019" src="/cdsr/doi/10.1002/14651858.CD006086.pub4/media/CDSR/CD006086/image_n/nCD006086-CMP-004-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.1</div> <div class="figure-caption"> <p>Comparison 4 Vitamin A versus placebo, Outcome 1 Children: mean serum retinol (normal range &gt; 20 µg/L). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006086.pub4/references#CD006086-fig-0019">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006086.pub4/media/CDSR/CD006086/image_n/nCD006086-CMP-004-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006086-fig-0020"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006086.pub4/media/CDSR/CD006086/urn:x-wiley:14651858:media:CD006086:CD006086-CMP-004-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006086.pub4/media/CDSR/CD006086/image_t/tCD006086-CMP-004-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 4 Vitamin A versus placebo, Outcome 2 Adults: mean serum retinol (normal range &gt; 70 µmol/L)." data-id="CD006086-fig-0020" src="/cdsr/doi/10.1002/14651858.CD006086.pub4/media/CDSR/CD006086/image_n/nCD006086-CMP-004-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.2</div> <div class="figure-caption"> <p>Comparison 4 Vitamin A versus placebo, Outcome 2 Adults: mean serum retinol (normal range &gt; 70 µmol/L). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006086.pub4/references#CD006086-fig-0020">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006086.pub4/media/CDSR/CD006086/image_n/nCD006086-CMP-004-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006086-fig-0021"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006086.pub4/media/CDSR/CD006086/urn:x-wiley:14651858:media:CD006086:CD006086-CMP-004-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006086.pub4/media/CDSR/CD006086/image_t/tCD006086-CMP-004-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 4 Vitamin A versus placebo, Outcome 3 Death." data-id="CD006086-fig-0021" src="/cdsr/doi/10.1002/14651858.CD006086.pub4/media/CDSR/CD006086/image_n/nCD006086-CMP-004-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.3</div> <div class="figure-caption"> <p>Comparison 4 Vitamin A versus placebo, Outcome 3 Death.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006086.pub4/references#CD006086-fig-0021">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006086.pub4/media/CDSR/CD006086/image_n/nCD006086-CMP-004-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006086-fig-0022"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006086.pub4/media/CDSR/CD006086/urn:x-wiley:14651858:media:CD006086:CD006086-CMP-004-04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006086.pub4/media/CDSR/CD006086/image_t/tCD006086-CMP-004-04.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 4 Vitamin A versus placebo, Outcome 4 Treatment completion." data-id="CD006086-fig-0022" src="/cdsr/doi/10.1002/14651858.CD006086.pub4/media/CDSR/CD006086/image_n/nCD006086-CMP-004-04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.4</div> <div class="figure-caption"> <p>Comparison 4 Vitamin A versus placebo, Outcome 4 Treatment completion.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006086.pub4/references#CD006086-fig-0022">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006086.pub4/media/CDSR/CD006086/image_n/nCD006086-CMP-004-04.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006086-fig-0023"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006086.pub4/media/CDSR/CD006086/urn:x-wiley:14651858:media:CD006086:CD006086-CMP-004-05" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006086.pub4/media/CDSR/CD006086/image_t/tCD006086-CMP-004-05.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 4 Vitamin A versus placebo, Outcome 5 Symptomatic at 6 weeks." data-id="CD006086-fig-0023" src="/cdsr/doi/10.1002/14651858.CD006086.pub4/media/CDSR/CD006086/image_n/nCD006086-CMP-004-05.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.5</div> <div class="figure-caption"> <p>Comparison 4 Vitamin A versus placebo, Outcome 5 Symptomatic at 6 weeks.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006086.pub4/references#CD006086-fig-0023">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006086.pub4/media/CDSR/CD006086/image_n/nCD006086-CMP-004-05.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006086-fig-0024"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006086.pub4/media/CDSR/CD006086/urn:x-wiley:14651858:media:CD006086:CD006086-CMP-004-06" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006086.pub4/media/CDSR/CD006086/image_t/tCD006086-CMP-004-06.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 4 Vitamin A versus placebo, Outcome 6 Sputum‐smear and sputum‐culture positive during follow‐up." data-id="CD006086-fig-0024" src="/cdsr/doi/10.1002/14651858.CD006086.pub4/media/CDSR/CD006086/image_n/nCD006086-CMP-004-06.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.6</div> <div class="figure-caption"> <p>Comparison 4 Vitamin A versus placebo, Outcome 6 Sputum‐smear and sputum‐culture positive during follow‐up. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006086.pub4/references#CD006086-fig-0024">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006086.pub4/media/CDSR/CD006086/image_n/nCD006086-CMP-004-06.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006086-fig-0025"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006086.pub4/media/CDSR/CD006086/urn:x-wiley:14651858:media:CD006086:CD006086-CMP-004-07" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006086.pub4/media/CDSR/CD006086/image_t/tCD006086-CMP-004-07.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 4 Vitamin A versus placebo, Outcome 7 BMI (kg/m²)." data-id="CD006086-fig-0025" src="/cdsr/doi/10.1002/14651858.CD006086.pub4/media/CDSR/CD006086/image_n/nCD006086-CMP-004-07.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.7</div> <div class="figure-caption"> <p>Comparison 4 Vitamin A versus placebo, Outcome 7 BMI (kg/m²).</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006086.pub4/references#CD006086-fig-0025">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006086.pub4/media/CDSR/CD006086/image_n/nCD006086-CMP-004-07.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006086-fig-0026"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006086.pub4/media/CDSR/CD006086/urn:x-wiley:14651858:media:CD006086:CD006086-CMP-004-08" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006086.pub4/media/CDSR/CD006086/image_t/tCD006086-CMP-004-08.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 4 Vitamin A versus placebo, Outcome 8 Body fat (%)." data-id="CD006086-fig-0026" src="/cdsr/doi/10.1002/14651858.CD006086.pub4/media/CDSR/CD006086/image_n/nCD006086-CMP-004-08.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.8</div> <div class="figure-caption"> <p>Comparison 4 Vitamin A versus placebo, Outcome 8 Body fat (%).</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006086.pub4/references#CD006086-fig-0026">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006086.pub4/media/CDSR/CD006086/image_n/nCD006086-CMP-004-08.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006086-fig-0027"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006086.pub4/media/CDSR/CD006086/urn:x-wiley:14651858:media:CD006086:CD006086-CMP-005-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006086.pub4/media/CDSR/CD006086/image_t/tCD006086-CMP-005-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 5 Zinc versus placebo, Outcome 1 Serum zinc level (normal range &gt; 10.7 µmol/L)." data-id="CD006086-fig-0027" src="/cdsr/doi/10.1002/14651858.CD006086.pub4/media/CDSR/CD006086/image_n/nCD006086-CMP-005-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 5.1</div> <div class="figure-caption"> <p>Comparison 5 Zinc versus placebo, Outcome 1 Serum zinc level (normal range &gt; 10.7 µmol/L). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006086.pub4/references#CD006086-fig-0027">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006086.pub4/media/CDSR/CD006086/image_n/nCD006086-CMP-005-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006086-fig-0028"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006086.pub4/media/CDSR/CD006086/urn:x-wiley:14651858:media:CD006086:CD006086-CMP-005-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006086.pub4/media/CDSR/CD006086/image_t/tCD006086-CMP-005-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 5 Zinc versus placebo, Outcome 2 Death by 6 to 8 months." data-id="CD006086-fig-0028" src="/cdsr/doi/10.1002/14651858.CD006086.pub4/media/CDSR/CD006086/image_n/nCD006086-CMP-005-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 5.2</div> <div class="figure-caption"> <p>Comparison 5 Zinc versus placebo, Outcome 2 Death by 6 to 8 months.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006086.pub4/references#CD006086-fig-0028">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006086.pub4/media/CDSR/CD006086/image_n/nCD006086-CMP-005-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006086-fig-0029"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006086.pub4/media/CDSR/CD006086/urn:x-wiley:14651858:media:CD006086:CD006086-CMP-005-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006086.pub4/media/CDSR/CD006086/image_t/tCD006086-CMP-005-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 5 Zinc versus placebo, Outcome 3 Death by 6 to 8 months (subgrouped by HIV status)." data-id="CD006086-fig-0029" src="/cdsr/doi/10.1002/14651858.CD006086.pub4/media/CDSR/CD006086/image_n/nCD006086-CMP-005-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 5.3</div> <div class="figure-caption"> <p>Comparison 5 Zinc versus placebo, Outcome 3 Death by 6 to 8 months (subgrouped by HIV status). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006086.pub4/references#CD006086-fig-0029">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006086.pub4/media/CDSR/CD006086/image_n/nCD006086-CMP-005-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006086-fig-0030"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006086.pub4/media/CDSR/CD006086/urn:x-wiley:14651858:media:CD006086:CD006086-CMP-005-04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006086.pub4/media/CDSR/CD006086/image_t/tCD006086-CMP-005-04.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 5 Zinc versus placebo, Outcome 4 Treatment completion at 6 months." data-id="CD006086-fig-0030" src="/cdsr/doi/10.1002/14651858.CD006086.pub4/media/CDSR/CD006086/image_n/nCD006086-CMP-005-04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 5.4</div> <div class="figure-caption"> <p>Comparison 5 Zinc versus placebo, Outcome 4 Treatment completion at 6 months.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006086.pub4/references#CD006086-fig-0030">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006086.pub4/media/CDSR/CD006086/image_n/nCD006086-CMP-005-04.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006086-fig-0031"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006086.pub4/media/CDSR/CD006086/urn:x-wiley:14651858:media:CD006086:CD006086-CMP-005-05" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006086.pub4/media/CDSR/CD006086/image_t/tCD006086-CMP-005-05.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 5 Zinc versus placebo, Outcome 5 Sputum‐smear or sputum‐culture positive during follow‐up." data-id="CD006086-fig-0031" src="/cdsr/doi/10.1002/14651858.CD006086.pub4/media/CDSR/CD006086/image_n/nCD006086-CMP-005-05.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 5.5</div> <div class="figure-caption"> <p>Comparison 5 Zinc versus placebo, Outcome 5 Sputum‐smear or sputum‐culture positive during follow‐up. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006086.pub4/references#CD006086-fig-0031">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006086.pub4/media/CDSR/CD006086/image_n/nCD006086-CMP-005-05.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006086-fig-0032"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006086.pub4/media/CDSR/CD006086/urn:x-wiley:14651858:media:CD006086:CD006086-CMP-005-06" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006086.pub4/media/CDSR/CD006086/image_t/tCD006086-CMP-005-06.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 5 Zinc versus placebo, Outcome 6 Clearance of chest X‐ray at 6 months." data-id="CD006086-fig-0032" src="/cdsr/doi/10.1002/14651858.CD006086.pub4/media/CDSR/CD006086/image_n/nCD006086-CMP-005-06.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 5.6</div> <div class="figure-caption"> <p>Comparison 5 Zinc versus placebo, Outcome 6 Clearance of chest X‐ray at 6 months.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006086.pub4/references#CD006086-fig-0032">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006086.pub4/media/CDSR/CD006086/image_n/nCD006086-CMP-005-06.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006086-fig-0033"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006086.pub4/media/CDSR/CD006086/urn:x-wiley:14651858:media:CD006086:CD006086-CMP-005-07" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006086.pub4/media/CDSR/CD006086/image_t/tCD006086-CMP-005-07.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 5 Zinc versus placebo, Outcome 7 Weight at follow‐up." data-id="CD006086-fig-0033" src="/cdsr/doi/10.1002/14651858.CD006086.pub4/media/CDSR/CD006086/image_n/nCD006086-CMP-005-07.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 5.7</div> <div class="figure-caption"> <p>Comparison 5 Zinc versus placebo, Outcome 7 Weight at follow‐up.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006086.pub4/references#CD006086-fig-0033">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006086.pub4/media/CDSR/CD006086/image_n/nCD006086-CMP-005-07.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006086-fig-0034"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006086.pub4/media/CDSR/CD006086/urn:x-wiley:14651858:media:CD006086:CD006086-CMP-005-08" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006086.pub4/media/CDSR/CD006086/image_t/tCD006086-CMP-005-08.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 5 Zinc versus placebo, Outcome 8 BMI (kg/m²)." data-id="CD006086-fig-0034" src="/cdsr/doi/10.1002/14651858.CD006086.pub4/media/CDSR/CD006086/image_n/nCD006086-CMP-005-08.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 5.8</div> <div class="figure-caption"> <p>Comparison 5 Zinc versus placebo, Outcome 8 BMI (kg/m²).</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006086.pub4/references#CD006086-fig-0034">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006086.pub4/media/CDSR/CD006086/image_n/nCD006086-CMP-005-08.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006086-fig-0035"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006086.pub4/media/CDSR/CD006086/urn:x-wiley:14651858:media:CD006086:CD006086-CMP-005-09" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006086.pub4/media/CDSR/CD006086/image_t/tCD006086-CMP-005-09.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 5 Zinc versus placebo, Outcome 9 Body fat (%)." data-id="CD006086-fig-0035" src="/cdsr/doi/10.1002/14651858.CD006086.pub4/media/CDSR/CD006086/image_n/nCD006086-CMP-005-09.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 5.9</div> <div class="figure-caption"> <p>Comparison 5 Zinc versus placebo, Outcome 9 Body fat (%).</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006086.pub4/references#CD006086-fig-0035">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006086.pub4/media/CDSR/CD006086/image_n/nCD006086-CMP-005-09.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006086-fig-0036"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006086.pub4/media/CDSR/CD006086/urn:x-wiley:14651858:media:CD006086:CD006086-CMP-005-10" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006086.pub4/media/CDSR/CD006086/image_t/tCD006086-CMP-005-10.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 5 Zinc versus placebo, Outcome 10 Weight‐for‐age z score." data-id="CD006086-fig-0036" src="/cdsr/doi/10.1002/14651858.CD006086.pub4/media/CDSR/CD006086/image_n/nCD006086-CMP-005-10.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 5.10</div> <div class="figure-caption"> <p>Comparison 5 Zinc versus placebo, Outcome 10 Weight‐for‐age z score.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006086.pub4/references#CD006086-fig-0036">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006086.pub4/media/CDSR/CD006086/image_n/nCD006086-CMP-005-10.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006086-fig-0037"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006086.pub4/media/CDSR/CD006086/urn:x-wiley:14651858:media:CD006086:CD006086-CMP-005-11" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006086.pub4/media/CDSR/CD006086/image_t/tCD006086-CMP-005-11.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 5 Zinc versus placebo, Outcome 11 BMI‐for‐age z score." data-id="CD006086-fig-0037" src="/cdsr/doi/10.1002/14651858.CD006086.pub4/media/CDSR/CD006086/image_n/nCD006086-CMP-005-11.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 5.11</div> <div class="figure-caption"> <p>Comparison 5 Zinc versus placebo, Outcome 11 BMI‐for‐age z score.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006086.pub4/references#CD006086-fig-0037">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006086.pub4/media/CDSR/CD006086/image_n/nCD006086-CMP-005-11.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006086-fig-0038"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006086.pub4/media/CDSR/CD006086/urn:x-wiley:14651858:media:CD006086:CD006086-CMP-005-12" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006086.pub4/media/CDSR/CD006086/image_t/tCD006086-CMP-005-12.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 5 Zinc versus placebo, Outcome 12 Height‐for‐age z score at follow‐up." data-id="CD006086-fig-0038" src="/cdsr/doi/10.1002/14651858.CD006086.pub4/media/CDSR/CD006086/image_n/nCD006086-CMP-005-12.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 5.12</div> <div class="figure-caption"> <p>Comparison 5 Zinc versus placebo, Outcome 12 Height‐for‐age z score at follow‐up.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006086.pub4/references#CD006086-fig-0038">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006086.pub4/media/CDSR/CD006086/image_n/nCD006086-CMP-005-12.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006086-fig-0039"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006086.pub4/media/CDSR/CD006086/urn:x-wiley:14651858:media:CD006086:CD006086-CMP-006-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006086.pub4/media/CDSR/CD006086/image_t/tCD006086-CMP-006-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 6 Zinc plus vitamin A versus placebo, Outcome 1 Death by 6 months." data-id="CD006086-fig-0039" src="/cdsr/doi/10.1002/14651858.CD006086.pub4/media/CDSR/CD006086/image_n/nCD006086-CMP-006-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 6.1</div> <div class="figure-caption"> <p>Comparison 6 Zinc plus vitamin A versus placebo, Outcome 1 Death by 6 months.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006086.pub4/references#CD006086-fig-0039">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006086.pub4/media/CDSR/CD006086/image_n/nCD006086-CMP-006-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006086-fig-0040"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006086.pub4/media/CDSR/CD006086/urn:x-wiley:14651858:media:CD006086:CD006086-CMP-006-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006086.pub4/media/CDSR/CD006086/image_t/tCD006086-CMP-006-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 6 Zinc plus vitamin A versus placebo, Outcome 2 Treatment completion at 6 months." data-id="CD006086-fig-0040" src="/cdsr/doi/10.1002/14651858.CD006086.pub4/media/CDSR/CD006086/image_n/nCD006086-CMP-006-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 6.2</div> <div class="figure-caption"> <p>Comparison 6 Zinc plus vitamin A versus placebo, Outcome 2 Treatment completion at 6 months. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006086.pub4/references#CD006086-fig-0040">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006086.pub4/media/CDSR/CD006086/image_n/nCD006086-CMP-006-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006086-fig-0041"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006086.pub4/media/CDSR/CD006086/urn:x-wiley:14651858:media:CD006086:CD006086-CMP-006-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006086.pub4/media/CDSR/CD006086/image_t/tCD006086-CMP-006-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 6 Zinc plus vitamin A versus placebo, Outcome 3 Sputum‐smear and sputum‐culture positive during follow‐up." data-id="CD006086-fig-0041" src="/cdsr/doi/10.1002/14651858.CD006086.pub4/media/CDSR/CD006086/image_n/nCD006086-CMP-006-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 6.3</div> <div class="figure-caption"> <p>Comparison 6 Zinc plus vitamin A versus placebo, Outcome 3 Sputum‐smear and sputum‐culture positive during follow‐up. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006086.pub4/references#CD006086-fig-0041">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006086.pub4/media/CDSR/CD006086/image_n/nCD006086-CMP-006-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006086-fig-0042"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006086.pub4/media/CDSR/CD006086/urn:x-wiley:14651858:media:CD006086:CD006086-CMP-006-04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006086.pub4/media/CDSR/CD006086/image_t/tCD006086-CMP-006-04.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 6 Zinc plus vitamin A versus placebo, Outcome 4 Body weight (kg)." data-id="CD006086-fig-0042" src="/cdsr/doi/10.1002/14651858.CD006086.pub4/media/CDSR/CD006086/image_n/nCD006086-CMP-006-04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 6.4</div> <div class="figure-caption"> <p>Comparison 6 Zinc plus vitamin A versus placebo, Outcome 4 Body weight (kg).</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006086.pub4/references#CD006086-fig-0042">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006086.pub4/media/CDSR/CD006086/image_n/nCD006086-CMP-006-04.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006086-fig-0043"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006086.pub4/media/CDSR/CD006086/urn:x-wiley:14651858:media:CD006086:CD006086-CMP-006-05" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006086.pub4/media/CDSR/CD006086/image_t/tCD006086-CMP-006-05.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 6 Zinc plus vitamin A versus placebo, Outcome 5 BMI (kg/m²)." data-id="CD006086-fig-0043" src="/cdsr/doi/10.1002/14651858.CD006086.pub4/media/CDSR/CD006086/image_n/nCD006086-CMP-006-05.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 6.5</div> <div class="figure-caption"> <p>Comparison 6 Zinc plus vitamin A versus placebo, Outcome 5 BMI (kg/m²).</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006086.pub4/references#CD006086-fig-0043">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006086.pub4/media/CDSR/CD006086/image_n/nCD006086-CMP-006-05.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006086-fig-0044"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006086.pub4/media/CDSR/CD006086/urn:x-wiley:14651858:media:CD006086:CD006086-CMP-006-06" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006086.pub4/media/CDSR/CD006086/image_t/tCD006086-CMP-006-06.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 6 Zinc plus vitamin A versus placebo, Outcome 6 Mid upper arm circumference (cm)." data-id="CD006086-fig-0044" src="/cdsr/doi/10.1002/14651858.CD006086.pub4/media/CDSR/CD006086/image_n/nCD006086-CMP-006-06.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 6.6</div> <div class="figure-caption"> <p>Comparison 6 Zinc plus vitamin A versus placebo, Outcome 6 Mid upper arm circumference (cm). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006086.pub4/references#CD006086-fig-0044">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006086.pub4/media/CDSR/CD006086/image_n/nCD006086-CMP-006-06.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006086-fig-0045"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006086.pub4/media/CDSR/CD006086/urn:x-wiley:14651858:media:CD006086:CD006086-CMP-006-07" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006086.pub4/media/CDSR/CD006086/image_t/tCD006086-CMP-006-07.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 6 Zinc plus vitamin A versus placebo, Outcome 7 Biceps skinfold thickness (mm)." data-id="CD006086-fig-0045" src="/cdsr/doi/10.1002/14651858.CD006086.pub4/media/CDSR/CD006086/image_n/nCD006086-CMP-006-07.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 6.7</div> <div class="figure-caption"> <p>Comparison 6 Zinc plus vitamin A versus placebo, Outcome 7 Biceps skinfold thickness (mm). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006086.pub4/references#CD006086-fig-0045">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006086.pub4/media/CDSR/CD006086/image_n/nCD006086-CMP-006-07.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006086-fig-0046"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006086.pub4/media/CDSR/CD006086/urn:x-wiley:14651858:media:CD006086:CD006086-CMP-006-08" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006086.pub4/media/CDSR/CD006086/image_t/tCD006086-CMP-006-08.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 6 Zinc plus vitamin A versus placebo, Outcome 8 Triceps skinfold thickness (mm)." data-id="CD006086-fig-0046" src="/cdsr/doi/10.1002/14651858.CD006086.pub4/media/CDSR/CD006086/image_n/nCD006086-CMP-006-08.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 6.8</div> <div class="figure-caption"> <p>Comparison 6 Zinc plus vitamin A versus placebo, Outcome 8 Triceps skinfold thickness (mm). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006086.pub4/references#CD006086-fig-0046">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006086.pub4/media/CDSR/CD006086/image_n/nCD006086-CMP-006-08.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006086-fig-0047"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006086.pub4/media/CDSR/CD006086/urn:x-wiley:14651858:media:CD006086:CD006086-CMP-006-09" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006086.pub4/media/CDSR/CD006086/image_t/tCD006086-CMP-006-09.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 6 Zinc plus vitamin A versus placebo, Outcome 9 Subscapular skinfold thickness (mm)." data-id="CD006086-fig-0047" src="/cdsr/doi/10.1002/14651858.CD006086.pub4/media/CDSR/CD006086/image_n/nCD006086-CMP-006-09.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 6.9</div> <div class="figure-caption"> <p>Comparison 6 Zinc plus vitamin A versus placebo, Outcome 9 Subscapular skinfold thickness (mm). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006086.pub4/references#CD006086-fig-0047">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006086.pub4/media/CDSR/CD006086/image_n/nCD006086-CMP-006-09.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006086-fig-0048"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006086.pub4/media/CDSR/CD006086/urn:x-wiley:14651858:media:CD006086:CD006086-CMP-006-10" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006086.pub4/media/CDSR/CD006086/image_t/tCD006086-CMP-006-10.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 6 Zinc plus vitamin A versus placebo, Outcome 10 Suprailiac skinfold thickness (mm)." data-id="CD006086-fig-0048" src="/cdsr/doi/10.1002/14651858.CD006086.pub4/media/CDSR/CD006086/image_n/nCD006086-CMP-006-10.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 6.10</div> <div class="figure-caption"> <p>Comparison 6 Zinc plus vitamin A versus placebo, Outcome 10 Suprailiac skinfold thickness (mm). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006086.pub4/references#CD006086-fig-0048">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006086.pub4/media/CDSR/CD006086/image_n/nCD006086-CMP-006-10.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006086-fig-0049"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006086.pub4/media/CDSR/CD006086/urn:x-wiley:14651858:media:CD006086:CD006086-CMP-006-11" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006086.pub4/media/CDSR/CD006086/image_t/tCD006086-CMP-006-11.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 6 Zinc plus vitamin A versus placebo, Outcome 11 Body fat (%)." data-id="CD006086-fig-0049" src="/cdsr/doi/10.1002/14651858.CD006086.pub4/media/CDSR/CD006086/image_n/nCD006086-CMP-006-11.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 6.11</div> <div class="figure-caption"> <p>Comparison 6 Zinc plus vitamin A versus placebo, Outcome 11 Body fat (%).</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006086.pub4/references#CD006086-fig-0049">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006086.pub4/media/CDSR/CD006086/image_n/nCD006086-CMP-006-11.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006086-fig-0050"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006086.pub4/media/CDSR/CD006086/urn:x-wiley:14651858:media:CD006086:CD006086-CMP-006-12" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006086.pub4/media/CDSR/CD006086/image_t/tCD006086-CMP-006-12.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 6 Zinc plus vitamin A versus placebo, Outcome 12 Fat mass (kg)." data-id="CD006086-fig-0050" src="/cdsr/doi/10.1002/14651858.CD006086.pub4/media/CDSR/CD006086/image_n/nCD006086-CMP-006-12.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 6.12</div> <div class="figure-caption"> <p>Comparison 6 Zinc plus vitamin A versus placebo, Outcome 12 Fat mass (kg).</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006086.pub4/references#CD006086-fig-0050">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006086.pub4/media/CDSR/CD006086/image_n/nCD006086-CMP-006-12.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006086-fig-0051"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006086.pub4/media/CDSR/CD006086/urn:x-wiley:14651858:media:CD006086:CD006086-CMP-006-13" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006086.pub4/media/CDSR/CD006086/image_t/tCD006086-CMP-006-13.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 6 Zinc plus vitamin A versus placebo, Outcome 13 Karnofsky score." data-id="CD006086-fig-0051" src="/cdsr/doi/10.1002/14651858.CD006086.pub4/media/CDSR/CD006086/image_n/nCD006086-CMP-006-13.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 6.13</div> <div class="figure-caption"> <p>Comparison 6 Zinc plus vitamin A versus placebo, Outcome 13 Karnofsky score.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006086.pub4/references#CD006086-fig-0051">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006086.pub4/media/CDSR/CD006086/image_n/nCD006086-CMP-006-13.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006086-fig-0052"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006086.pub4/media/CDSR/CD006086/urn:x-wiley:14651858:media:CD006086:CD006086-CMP-007-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006086.pub4/media/CDSR/CD006086/image_t/tCD006086-CMP-007-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 7 Vitamin D versus placebo or no supplement, Outcome 1 Serum vitamin D levels (nmol/L)." data-id="CD006086-fig-0052" src="/cdsr/doi/10.1002/14651858.CD006086.pub4/media/CDSR/CD006086/image_n/nCD006086-CMP-007-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 7.1</div> <div class="figure-caption"> <p>Comparison 7 Vitamin D versus placebo or no supplement, Outcome 1 Serum vitamin D levels (nmol/L). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006086.pub4/references#CD006086-fig-0052">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006086.pub4/media/CDSR/CD006086/image_n/nCD006086-CMP-007-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006086-fig-0053"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006086.pub4/media/CDSR/CD006086/urn:x-wiley:14651858:media:CD006086:CD006086-CMP-007-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006086.pub4/media/CDSR/CD006086/image_t/tCD006086-CMP-007-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 7 Vitamin D versus placebo or no supplement, Outcome 2 Death during follow‐up (2 to 12 months)." data-id="CD006086-fig-0053" src="/cdsr/doi/10.1002/14651858.CD006086.pub4/media/CDSR/CD006086/image_n/nCD006086-CMP-007-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 7.2</div> <div class="figure-caption"> <p>Comparison 7 Vitamin D versus placebo or no supplement, Outcome 2 Death during follow‐up (2 to 12 months). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006086.pub4/references#CD006086-fig-0053">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006086.pub4/media/CDSR/CD006086/image_n/nCD006086-CMP-007-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006086-fig-0054"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006086.pub4/media/CDSR/CD006086/urn:x-wiley:14651858:media:CD006086:CD006086-CMP-007-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006086.pub4/media/CDSR/CD006086/image_t/tCD006086-CMP-007-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 7 Vitamin D versus placebo or no supplement, Outcome 3 Death during follow‐up (2 to 12 months)." data-id="CD006086-fig-0054" src="/cdsr/doi/10.1002/14651858.CD006086.pub4/media/CDSR/CD006086/image_n/nCD006086-CMP-007-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 7.3</div> <div class="figure-caption"> <p>Comparison 7 Vitamin D versus placebo or no supplement, Outcome 3 Death during follow‐up (2 to 12 months). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006086.pub4/references#CD006086-fig-0054">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006086.pub4/media/CDSR/CD006086/image_n/nCD006086-CMP-007-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006086-fig-0055"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006086.pub4/media/CDSR/CD006086/urn:x-wiley:14651858:media:CD006086:CD006086-CMP-007-04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006086.pub4/media/CDSR/CD006086/image_t/tCD006086-CMP-007-04.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 7 Vitamin D versus placebo or no supplement, Outcome 4 Cure at 6 months." data-id="CD006086-fig-0055" src="/cdsr/doi/10.1002/14651858.CD006086.pub4/media/CDSR/CD006086/image_n/nCD006086-CMP-007-04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 7.4</div> <div class="figure-caption"> <p>Comparison 7 Vitamin D versus placebo or no supplement, Outcome 4 Cure at 6 months.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006086.pub4/references#CD006086-fig-0055">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006086.pub4/media/CDSR/CD006086/image_n/nCD006086-CMP-007-04.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006086-fig-0056"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006086.pub4/media/CDSR/CD006086/urn:x-wiley:14651858:media:CD006086:CD006086-CMP-007-05" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006086.pub4/media/CDSR/CD006086/image_t/tCD006086-CMP-007-05.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 7 Vitamin D versus placebo or no supplement, Outcome 5 Tuberculosis score." data-id="CD006086-fig-0056" src="/cdsr/doi/10.1002/14651858.CD006086.pub4/media/CDSR/CD006086/image_n/nCD006086-CMP-007-05.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 7.5</div> <div class="figure-caption"> <p>Comparison 7 Vitamin D versus placebo or no supplement, Outcome 5 Tuberculosis score.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006086.pub4/references#CD006086-fig-0056">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006086.pub4/media/CDSR/CD006086/image_n/nCD006086-CMP-007-05.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006086-fig-0057"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006086.pub4/media/CDSR/CD006086/urn:x-wiley:14651858:media:CD006086:CD006086-CMP-007-06" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006086.pub4/media/CDSR/CD006086/image_t/tCD006086-CMP-007-06.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 7 Vitamin D versus placebo or no supplement, Outcome 6 Sputum‐smear or sputum‐culture positive." data-id="CD006086-fig-0057" src="/cdsr/doi/10.1002/14651858.CD006086.pub4/media/CDSR/CD006086/image_n/nCD006086-CMP-007-06.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 7.6</div> <div class="figure-caption"> <p>Comparison 7 Vitamin D versus placebo or no supplement, Outcome 6 Sputum‐smear or sputum‐culture positive. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006086.pub4/references#CD006086-fig-0057">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006086.pub4/media/CDSR/CD006086/image_n/nCD006086-CMP-007-06.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006086-fig-0058"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006086.pub4/media/CDSR/CD006086/urn:x-wiley:14651858:media:CD006086:CD006086-CMP-007-07" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006086.pub4/media/CDSR/CD006086/image_t/tCD006086-CMP-007-07.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 7 Vitamin D versus placebo or no supplement, Outcome 7 Body mass index." data-id="CD006086-fig-0058" src="/cdsr/doi/10.1002/14651858.CD006086.pub4/media/CDSR/CD006086/image_n/nCD006086-CMP-007-07.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 7.7</div> <div class="figure-caption"> <p>Comparison 7 Vitamin D versus placebo or no supplement, Outcome 7 Body mass index.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006086.pub4/references#CD006086-fig-0058">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006086.pub4/media/CDSR/CD006086/image_n/nCD006086-CMP-007-07.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006086-fig-0059"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006086.pub4/media/CDSR/CD006086/urn:x-wiley:14651858:media:CD006086:CD006086-CMP-007-08" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006086.pub4/media/CDSR/CD006086/image_t/tCD006086-CMP-007-08.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 7 Vitamin D versus placebo or no supplement, Outcome 8 Body weight (kg)." data-id="CD006086-fig-0059" src="/cdsr/doi/10.1002/14651858.CD006086.pub4/media/CDSR/CD006086/image_n/nCD006086-CMP-007-08.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 7.8</div> <div class="figure-caption"> <p>Comparison 7 Vitamin D versus placebo or no supplement, Outcome 8 Body weight (kg).</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006086.pub4/references#CD006086-fig-0059">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006086.pub4/media/CDSR/CD006086/image_n/nCD006086-CMP-007-08.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006086-fig-0060"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006086.pub4/media/CDSR/CD006086/urn:x-wiley:14651858:media:CD006086:CD006086-CMP-007-09" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006086.pub4/media/CDSR/CD006086/image_t/tCD006086-CMP-007-09.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 7 Vitamin D versus placebo or no supplement, Outcome 9 Karnofsky score at 8 weeks." data-id="CD006086-fig-0060" src="/cdsr/doi/10.1002/14651858.CD006086.pub4/media/CDSR/CD006086/image_n/nCD006086-CMP-007-09.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 7.9</div> <div class="figure-caption"> <p>Comparison 7 Vitamin D versus placebo or no supplement, Outcome 9 Karnofsky score at 8 weeks. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006086.pub4/references#CD006086-fig-0060">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006086.pub4/media/CDSR/CD006086/image_n/nCD006086-CMP-007-09.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006086-fig-0061"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006086.pub4/media/CDSR/CD006086/urn:x-wiley:14651858:media:CD006086:CD006086-CMP-008-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006086.pub4/media/CDSR/CD006086/image_t/tCD006086-CMP-008-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 8 Arginine versus placebo, Outcome 1 Death during treatment." data-id="CD006086-fig-0061" src="/cdsr/doi/10.1002/14651858.CD006086.pub4/media/CDSR/CD006086/image_n/nCD006086-CMP-008-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 8.1</div> <div class="figure-caption"> <p>Comparison 8 Arginine versus placebo, Outcome 1 Death during treatment.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006086.pub4/references#CD006086-fig-0061">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006086.pub4/media/CDSR/CD006086/image_n/nCD006086-CMP-008-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006086-fig-0062"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006086.pub4/media/CDSR/CD006086/urn:x-wiley:14651858:media:CD006086:CD006086-CMP-008-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006086.pub4/media/CDSR/CD006086/image_t/tCD006086-CMP-008-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 8 Arginine versus placebo, Outcome 2 Cured at 6/8 months." data-id="CD006086-fig-0062" src="/cdsr/doi/10.1002/14651858.CD006086.pub4/media/CDSR/CD006086/image_n/nCD006086-CMP-008-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 8.2</div> <div class="figure-caption"> <p>Comparison 8 Arginine versus placebo, Outcome 2 Cured at 6/8 months.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006086.pub4/references#CD006086-fig-0062">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006086.pub4/media/CDSR/CD006086/image_n/nCD006086-CMP-008-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006086-fig-0063"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006086.pub4/media/CDSR/CD006086/urn:x-wiley:14651858:media:CD006086:CD006086-CMP-008-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006086.pub4/media/CDSR/CD006086/image_t/tCD006086-CMP-008-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 8 Arginine versus placebo, Outcome 3 Sputum‐smear or sputum‐culture positive." data-id="CD006086-fig-0063" src="/cdsr/doi/10.1002/14651858.CD006086.pub4/media/CDSR/CD006086/image_n/nCD006086-CMP-008-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 8.3</div> <div class="figure-caption"> <p>Comparison 8 Arginine versus placebo, Outcome 3 Sputum‐smear or sputum‐culture positive.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006086.pub4/references#CD006086-fig-0063">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006086.pub4/media/CDSR/CD006086/image_n/nCD006086-CMP-008-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006086-fig-0064"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006086.pub4/media/CDSR/CD006086/urn:x-wiley:14651858:media:CD006086:CD006086-CMP-008-04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006086.pub4/media/CDSR/CD006086/image_t/tCD006086-CMP-008-04.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 8 Arginine versus placebo, Outcome 4 Cough." data-id="CD006086-fig-0064" src="/cdsr/doi/10.1002/14651858.CD006086.pub4/media/CDSR/CD006086/image_n/nCD006086-CMP-008-04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 8.4</div> <div class="figure-caption"> <p>Comparison 8 Arginine versus placebo, Outcome 4 Cough.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006086.pub4/references#CD006086-fig-0064">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006086.pub4/media/CDSR/CD006086/image_n/nCD006086-CMP-008-04.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006086-fig-0065"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006086.pub4/media/CDSR/CD006086/urn:x-wiley:14651858:media:CD006086:CD006086-CMP-008-05" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006086.pub4/media/CDSR/CD006086/image_t/tCD006086-CMP-008-05.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 8 Arginine versus placebo, Outcome 5 Weight gain &gt; 10%." data-id="CD006086-fig-0065" src="/cdsr/doi/10.1002/14651858.CD006086.pub4/media/CDSR/CD006086/image_n/nCD006086-CMP-008-05.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 8.5</div> <div class="figure-caption"> <p>Comparison 8 Arginine versus placebo, Outcome 5 Weight gain &gt; 10%.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006086.pub4/references#CD006086-fig-0065">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006086.pub4/media/CDSR/CD006086/image_n/nCD006086-CMP-008-05.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006086-fig-0066"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006086.pub4/media/CDSR/CD006086/urn:x-wiley:14651858:media:CD006086:CD006086-CMP-009-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006086.pub4/media/CDSR/CD006086/image_t/tCD006086-CMP-009-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 9 Vitamin E plus selenium versus placebo, Outcome 1 Sputum‐smear positive at follow‐up." data-id="CD006086-fig-0066" src="/cdsr/doi/10.1002/14651858.CD006086.pub4/media/CDSR/CD006086/image_n/nCD006086-CMP-009-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 9.1</div> <div class="figure-caption"> <p>Comparison 9 Vitamin E plus selenium versus placebo, Outcome 1 Sputum‐smear positive at follow‐up. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006086.pub4/references#CD006086-fig-0066">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006086.pub4/media/CDSR/CD006086/image_n/nCD006086-CMP-009-01.png" target="_blank">Open in new tab</a></div> </div> </div> <div class="tables-list"> <div class="table"> <table class="summary-of-findings framed" data-id="CD006086-tbl-0001"> <div class="table-heading"><span class="table-label">Summary of findings for the main comparison.</span> <span class="table-title">'Summary of findings' table 1</span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Food provision compared with nutritional advice or no intervention for patients with active tuberculosis</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Patient or population:</b> adults and children with active tuberculosis </p> <p><b>Settings:</b> low‐ and middle‐income countries </p> <p><b>Intervention:</b> calorie supplementation as food or energy dense supplements </p> <p><b>Comparison:</b> nutritional advice, micronutrient supplement, or no intervention </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="center" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Illustrative comparative risks* (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Number of participants<br/> (trials)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Quality of the evidence<br/> (GRADE)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Comments</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Assumed risk</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Corresponding risk</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Standard care</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Increased calorie intake</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Death</b> </p> <p>(at 6 months)</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>3 per 100</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>1 per 100</b> <br/> (0 to 4) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>RR 0.34</b> <br/> (0.10 to 1.20) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>567<br/> (4 trials) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/> <b>very low</b><sup>1,2,3</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>We don't know if food supplementation reduces mortality from tuberculosis in food‐insecure settings </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Cured</b> </p> <p>(at 6 months)</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>48 per 100</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>44 per 100</b> <br/> (28 to 68) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>RR 0.91</b> <br/> (0.59 to 1.41) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>102<br/> (1 trial) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/> <b>very low</b><sup>2,3,4</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>We don't know if food supplementation increases cure in tuberculosis patients</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Treatment completion</b> <br/> (at 6 months) </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>79 per 100</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>85 per 100</b> <br/> (70 to 100) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not pooled</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>365<br/> (2 trials) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/> <b>very low</b><sup>3,5,6</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>We don't know if food supplementation increases treatment completion in tuberculosis patients </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Sputum negative</b> </p> <p>(at 8 weeks)</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>76 per 100</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>82 per 100</b> <br/> (65 to 100) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>RR 1.08</b> <br/> (0.86 to 1.37) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>222<br/> (3 trials) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/> <b>very low</b><sup>3,5,6</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>We don't know if food supplementation reduces the duration of sputum positivity in tuberculosis patients </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Mean weight gain</b> </p> <p>(At 8 weeks)</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not pooled</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>883<br/> (5 trials) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊝<br/> <b>moderate</b><sup>7,8</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Supplementation probably increases weight gain during treatment</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Quality of life</b> <br/> (At 8 weeks) </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not pooled</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>134<br/> (2 trials) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/> <b>low</b><sup>9,10</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Supplementation may increase quality of life scores during the first 2 months of treatment</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*The <b>assumed risk</b> is taken from the mean risk in the control groups in the included studies. The <b>corresponding risk</b> (and its 95% CI) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/> <b>Abbreviations:</b> CI = confidence interval; RR = risk ratio; GRADE = Grading of Recommendations Assessment, Development and Evaluation. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>GRADE Working Group grades of evidence<br/> <b>High quality:</b> further research is very unlikely to change our confidence in the estimate of effect.<br/> <b>Moderate quality:</b> further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.<br/> <b>Low quality:</b> further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.<br/> <b>Very low quality:</b> we are very uncertain about the estimate. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>1</sup>Three trials reported some deaths during the 6 months of treatment (<a href="./references#CD006086-bbs2-0006" title="JahnaviG , SudhaCH . Randomised controlled trial of food supplements in patients with newly diagnosed tuberculosis and wasting. Singapore Medical Journal2010;51(12):957‐62. ">Jahnavi 2010 IND</a>; <a href="./references#CD006086-bbs2-0007" title="JeremiahK , DentiP , ChigutsaE , Faurholt‐JepsenD , PrayGodG , RangeN , et al. Nutritional supplementation increases rifampin exposure among tuberculosis patients co‐infected with HIV. Antimicrobial Agents and Chemotherapy2014;58(6):3468‐74. ">Jeremiah 2014 TZA</a>; <a href="./references#CD006086-bbs2-0031" title="SudarsanamTD , JohnJ , KangG , MahendriV , GerriorJ , FranciosaM , et al. Pilot randomized trial of nutritional supplementation in patients with tuberculosis and HIV‐tuberculosis coinfection receiving directly observed short‐course chemotherapy for tuberculosis. Tropical Medicine and International Health2011;16(6):699‐706. ">Sudarsanam 2010 IND</a>), and 1 reported that no deaths occurred (<a href="./references#CD006086-bbs2-0013" title="MartinsN , MorrisP , KellyPM . Food incentives to improve completion of tuberculosis treatment: randomised controlled trial in Dili, Timor‐Leste. BMJ2009;229:b4248. ">Martins 2009 TLS</a>). The trials were conducted in Tanzania, Timor‐Leste, and India in participants with signs of undernutrition. <a href="./references#CD006086-bbs2-0013" title="MartinsN , MorrisP , KellyPM . Food incentives to improve completion of tuberculosis treatment: randomised controlled trial in Dili, Timor‐Leste. BMJ2009;229:b4248. ">Martins 2009 TLS</a> gave a daily hot meal, <a href="./references#CD006086-bbs2-0031" title="SudarsanamTD , JohnJ , KangG , MahendriV , GerriorJ , FranciosaM , et al. Pilot randomized trial of nutritional supplementation in patients with tuberculosis and HIV‐tuberculosis coinfection receiving directly observed short‐course chemotherapy for tuberculosis. Tropical Medicine and International Health2011;16(6):699‐706. ">Sudarsanam 2010 IND</a> gave monthly ration packs, <a href="./references#CD006086-bbs2-0006" title="JahnaviG , SudhaCH . Randomised controlled trial of food supplements in patients with newly diagnosed tuberculosis and wasting. Singapore Medical Journal2010;51(12):957‐62. ">Jahnavi 2010 IND</a> gave daily locally appropriate supplements, and <a href="./references#CD006086-bbs2-0007" title="JeremiahK , DentiP , ChigutsaE , Faurholt‐JepsenD , PrayGodG , RangeN , et al. Nutritional supplementation increases rifampin exposure among tuberculosis patients co‐infected with HIV. Antimicrobial Agents and Chemotherapy2014;58(6):3468‐74. ">Jeremiah 2014 TZA</a> gave high energy multivitamin enriched biscuits.<br/> <sup>2</sup>Downgraded by 1 for indirectness: trials are only available from limited settings. Food supplementation would plausibly have its biggest effect in highly food‐insecure or emergency settings which are not reflected in these trials.<br/> <sup>3</sup>Downgraded by 2 for imprecision: the trials and meta‐analysis are significantly underpowered to either detect or exclude an effect if it exists.<br/> <sup>4</sup>Data on successful cure at 6 months is only available from <a href="./references#CD006086-bbs2-0031" title="SudarsanamTD , JohnJ , KangG , MahendriV , GerriorJ , FranciosaM , et al. Pilot randomized trial of nutritional supplementation in patients with tuberculosis and HIV‐tuberculosis coinfection receiving directly observed short‐course chemotherapy for tuberculosis. Tropical Medicine and International Health2011;16(6):699‐706. ">Sudarsanam 2010 IND</a> which randomized tuberculosis patients in India to monthly ration packs or advice only.<br/> <sup>5</sup>Two trials report on tuberculosis treatment completion at 6 months (<a href="./references#CD006086-bbs2-0006" title="JahnaviG , SudhaCH . Randomised controlled trial of food supplements in patients with newly diagnosed tuberculosis and wasting. Singapore Medical Journal2010;51(12):957‐62. ">Jahnavi 2010 IND</a>; <a href="./references#CD006086-bbs2-0013" title="MartinsN , MorrisP , KellyPM . Food incentives to improve completion of tuberculosis treatment: randomised controlled trial in Dili, Timor‐Leste. BMJ2009;229:b4248. ">Martins 2009 TLS</a>). One trial was conducted in India and 1 in Timor‐Leste in participants with signs of undernutrition. Both trials gave daily locally appropriate supplements.<br/> <sup>6</sup>Downgraded by 1 for inconsistency. <a href="./references#CD006086-bbs2-0006" title="JahnaviG , SudhaCH . Randomised controlled trial of food supplements in patients with newly diagnosed tuberculosis and wasting. Singapore Medical Journal2010;51(12):957‐62. ">Jahnavi 2010 IND</a> found a statistically significant benefit while the larger trial, <a href="./references#CD006086-bbs2-0013" title="MartinsN , MorrisP , KellyPM . Food incentives to improve completion of tuberculosis treatment: randomised controlled trial in Dili, Timor‐Leste. BMJ2009;229:b4248. ">Martins 2009 TLS</a>, did not.<br/> <sup>7</sup>Five studies reported measures of weight gain but at different time‐points, which prevented meta‐analysis.<br/> <sup>8</sup>Downgraded by 1 for inconsistency. <a href="./references#CD006086-bbs2-0023" title="PraygodG , RangeN , Faurholt‐JepsenD , JeremiahK , Faurholt‐JepsenM , AabyeMG , et al. Daily multi‐micronutrient supplementation during tuberculosis treatment increases weight and grip strength among HIV‐uninfected but not HIV‐infected patients in Mwanza, Tanzania. The Journal of Nutrition2011;141:685‐91. PraygodG , RangeN , Faurholt‐JepsenD , JeremiahK , Faurholt‐JepsenM , AabyeMG , et al. The effect of energy‐protein supplementation on weight, body composition and handgrip strength among pulmonary tuberculosis HIV‐co‐infected patients: randomised controlled trial in Mwanza, Tanzania. The British Journal of Nutrition2012;107(2):263‐71. ">Praygod 2011b TZA</a> included only HIV‐positive patients and although the trend was towards a benefit this did not reach statistical significance. <a href="./references#CD006086-bbs2-0007" title="JeremiahK , DentiP , ChigutsaE , Faurholt‐JepsenD , PrayGodG , RangeN , et al. Nutritional supplementation increases rifampin exposure among tuberculosis patients co‐infected with HIV. Antimicrobial Agents and Chemotherapy2014;58(6):3468‐74. ">Jeremiah 2014 TZA</a> noted a greater increase in mean weight gain in the supplemented group compared to the non‐supplemented group after 8 weeks; however the difference was not appreciable (1.09 kg, P &lt; 0.6, authors' own figures). The 3 other trials all demonstrated clinically important benefits.<br/> <sup>9</sup>Downgraded by 1 for indirectness. Only 2 small trials, 1 from Singapore (<a href="./references#CD006086-bbs2-0020" title="PatonNI , ChuaYK , EarnestA , CheeCB . Randomized controlled trial of nutritional supplementation in patients with newly diagnosed tuberculosis and wasting. American Journal of Clinical Nutrition2004;80(2):460‐5. ">Paton 2004 SGP</a>) and 1 from India (<a href="./references#CD006086-bbs2-0006" title="JahnaviG , SudhaCH . Randomised controlled trial of food supplements in patients with newly diagnosed tuberculosis and wasting. Singapore Medical Journal2010;51(12):957‐62. ">Jahnavi 2010 IND</a>) report quality of life scores. The results can not be generalized to other populations or settings with any certainty.<br/> <sup>10</sup>Downgraded by 1 for imprecision. The presented data appear highly skewed and could not be pooled. </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Summary of findings for the main comparison.</span> <span class="table-title">'Summary of findings' table 1</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD006086.pub4/full#CD006086-tbl-0001">Navigate to table in review</a></div> </div> <div class="table"> <table class="summary-of-findings framed" data-id="CD006086-tbl-0002"> <div class="table-heading"><span class="table-label">Summary of findings 2.</span> <span class="table-title">'Summary of findings' table 2</span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Multi‐micronutrient supplementation compared with placebo for patients with active tuberculosis</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Patient or population:</b> adults and children with active tuberculosis </p> <p><b>Settings:</b> low‐ and middle‐income countries </p> <p><b>Intervention:</b> multi‐micronutrient supplements </p> <p><b>Comparison:</b> placebo or no intervention </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="center" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Illustrative comparative risks* (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Number of participants<br/> (studies)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Quality of the evidence<br/> (GRADE)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Comments</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Assumed risk</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Corresponding risk</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Placebo</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Multi‐micronutrients</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p><b>Death</b> </p> </td> <td align="center" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>HIV‐negative participants</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>RR 0.86</b> <br/> (0.46 to 1.6) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>1219<br/> (4 trials) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊝⊝<br/> <b>low</b><sup>1,2,3</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Multi‐micronutrient supplements may have little or no effect on mortality in HIV‐negative tuberculosis patients </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>40 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>34 per 1000</b> <br/> (18 to 64) </p> </td> </tr> <tr class="separated"> <td align="center" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>HIV‐positive participants</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>RR 0.92</b> <br/> (0.69 to 1.23) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>1429<br/> (3 trials) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊕⊝<br/> <b>moderate</b><sup>4,5</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Multi‐micronutrients probably have little or no effect on mortality in HIV‐positive tuberculosis patients not on ARV therapy </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>357 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>328 per 1000</b> <br/> (246 to 439) </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Cure rate</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>(0 trials)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>We don't know if multi‐micronutrients improve cure in tuberculosis patients</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Treatment completion</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>970 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>960 per 1000</b> </p> <p>(920 to 101)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>RR 0.99</b> (0.95 to 1.04) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>302</p> <p>(1 trial)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/> <b>very low</b><sup>6,7</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>We don't know if multi‐micronutrients improve treatment completion in tuberculosis patients </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Remaining sputum positive</b> <br/> (at 4 weeks) </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>309 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>312 per 1000</b> <br/> (263 to 371) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>RR 0.92</b> <br/> (0.63 to 1.35) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1020<br/> (2 studies) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/> <b>very low</b><sup>8,9,10</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>We don't know if multi‐micronutrients reduce the proportion of patients still sputum positive at 4 weeks </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Weight gain</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not pooled</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2940<br/> (5 trials) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/> <b>low</b><sup>11</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Multi‐micronutrient supplements may not improve weight gain in tuberculosis patients</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Quality of life</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>(0 trials)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>We don't know if multi‐micronutrients improve quality of life in tuberculosis patients</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*The <b>assumed risk</b> is taken from the risk in the control groups of the included studies. The <b>corresponding risk</b> (and its 95% CI) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/> <b>Abbreviations:</b> CI = confidence interval; RR = risk ratio; GRADE = Grading of Recommendations Assessment, Development and Evaluation. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>GRADE Working Group grades of evidence<br/> <b>High quality:</b> further research is very unlikely to change our confidence in the estimate of effect.<br/> <b>Moderate quality:</b> further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.<br/> <b>Low quality:</b> further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.<br/> <b>Very low quality:</b> we are very uncertain about the estimate. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>1</sup>Five RCTs comparing multi‐micronutrient supplementation with placebo in adults (<a href="./references#CD006086-bbs2-0025" title="RangeN , AndersenAB , MagnussenP , MugomelaA , FriisH . The effect of micronutrient supplementation on treatment outcome in patients with pulmonary tuberculosis: a randomised controlled trial in Mwanza, Tanzania. Tropical Medicine and International Health2005;10(9):826‐32. RangeN , ChangaluchaJ , KrarupH , MagnussenP , AndersenAB , FriisH . The effect of multi‐vitamin/mineral supplementation on mortality during treatment of pulmonary tuberculosis: a randomised two‐by‐two factorial trial in Mwanza, Tanzania. British Journal of Nutrition2006;95(4):762‐70. ">Range 2005 TZA</a>; <a href="./references#CD006086-bbs2-0028" title="SembaRD , KumwendaJ , ZijlstraE , RicksMO , vanLettowM , WhalenC , et al. Micronutrient supplements and mortality of HIV‐infected adults with pulmonary TB: a controlled clinical trial. International Journal of Tuberculosis and Lung Disease2007;11(8):854‐9. ">Semba 2007 MWI</a>; <a href="./references#CD006086-bbs2-0033" title="VillamorE , MugusiF , UrassaW , BoschR J , SaathoffE , MatsumotoK , et al. A trial of the effect of micronutrient supplementation on treatment outcome, T cell counts, morbidity, and mortality in adults with pulmonary tuberculosis. The Journal of Infectious Diseases2008;197(11):1499‐505. ">Villamor 2008 TZA</a>) and children (<a href="./references#CD006086-bbs2-0011" title="LodhaR , MukherjeeA , SinghV , SinghS , FriisH , Faurholt‐JepsenD , et al. Effect of micronutrient supplementation on treatment outcomes in children with intrathoracic tuberculosis: a randomized controlled trial. American Journal of Clinical Nutrition2014;100(5):1287‐97. ">Lodha 2014 IND</a>; <a href="./references#CD006086-bbs2-0014" title="MehtaS , MugusiFM , BoschRJ , AboudS , ChatterjeeA , FinkelsteinJL , et al. A randomized trial of multivitamin supplementation in children with tuberculosis in Tanzania. Nutrition Journal2011;10:120. NCT00145184 . Effect of Multivitamin Supplements on Clinical and Immunological Response in Childhood Tuberculosis. https://clinicaltrials.gov/ct2/show/NCT00145184 (accessed 4 February 2016). ">Mehta 2011 TZA</a>), reported deaths during treatment. The exact composition of nutrients varied from 1 to 10 times the DRI. Three studies are from Tanzania, 1 from Malawi, and 1 from India. There is evidence of participants being significantly undernourished at baseline.<br/> <sup>2</sup>No serious inconsistency: statistical heterogeneity was low. Although the estimate of effect is trending towards a benefit this is due to 1 trial (<a href="./references#CD006086-bbs2-0033" title="VillamorE , MugusiF , UrassaW , BoschR J , SaathoffE , MatsumotoK , et al. A trial of the effect of micronutrient supplementation on treatment outcome, T cell counts, morbidity, and mortality in adults with pulmonary tuberculosis. The Journal of Infectious Diseases2008;197(11):1499‐505. ">Villamor 2008 TZA</a>), the remaining trials found non significant trends in the opposite direction. Not downgraded.<br/> <sup>3</sup>Downgraded by 2 for imprecision: the 95% CI of the pooled effect crosses 1 and includes a 2% absolute reduction in death which might be considered beneficial given the low cost of the intervention. The optimal information size to reliably detect a clinically beneficial effect if there is 1 is greater than 2000.<br/> <sup>4</sup>Downgraded by 1 for indirectness: none of the participants in these trials were receiving antiretroviral therapy (<a href="./references#CD006086-bbs2-0025" title="RangeN , AndersenAB , MagnussenP , MugomelaA , FriisH . The effect of micronutrient supplementation on treatment outcome in patients with pulmonary tuberculosis: a randomised controlled trial in Mwanza, Tanzania. Tropical Medicine and International Health2005;10(9):826‐32. RangeN , ChangaluchaJ , KrarupH , MagnussenP , AndersenAB , FriisH . The effect of multi‐vitamin/mineral supplementation on mortality during treatment of pulmonary tuberculosis: a randomised two‐by‐two factorial trial in Mwanza, Tanzania. British Journal of Nutrition2006;95(4):762‐70. ">Range 2005 TZA</a>; <a href="./references#CD006086-bbs2-0028" title="SembaRD , KumwendaJ , ZijlstraE , RicksMO , vanLettowM , WhalenC , et al. Micronutrient supplements and mortality of HIV‐infected adults with pulmonary TB: a controlled clinical trial. International Journal of Tuberculosis and Lung Disease2007;11(8):854‐9. ">Semba 2007 MWI</a>; <a href="./references#CD006086-bbs2-0033" title="VillamorE , MugusiF , UrassaW , BoschR J , SaathoffE , MatsumotoK , et al. A trial of the effect of micronutrient supplementation on treatment outcome, T cell counts, morbidity, and mortality in adults with pulmonary tuberculosis. The Journal of Infectious Diseases2008;197(11):1499‐505. ">Villamor 2008 TZA</a>). The exact composition of nutrients varied from 1 to 10 times the DRI. Two studies are from Tanzania and 1 in Malawi. There is evidence of participants being significantly undernourished at baseline.<br/> <sup>5</sup>No serious imprecision: the 95% CI of the pooled effect crosses 1 and does includes a 5% absolute reduction in death which might be considered beneficial given the low cost of the intervention. However, the effect estimate is of no difference between the treatments and the optimal information size to reliably detect a clinically beneficial effect is met.<br/> <sup>6</sup>Downgraded by 2 for indirectness: current evidence is limited to 1 small trial (<a href="./references#CD006086-bbs2-0011" title="LodhaR , MukherjeeA , SinghV , SinghS , FriisH , Faurholt‐JepsenD , et al. Effect of micronutrient supplementation on treatment outcomes in children with intrathoracic tuberculosis: a randomized controlled trial. American Journal of Clinical Nutrition2014;100(5):1287‐97. ">Lodha 2014 IND</a>) conducted in moderately undernourished, HIV‐negative children in India, where treatment completion was very high in both groups. The result is not easily generalized to other settings.<br/> <sup>7</sup>Downgraded by 1 for imprecision: although this trial approaches adequate power to detect a result, the fact that treatment completion was so high in both arm renders the result irrelevant to settings where treatment completion is lower.<br/> <sup>8</sup>Downgraded by 1 for inconsistency. Statistical heterogeneity is high; 1 study found a non‐significant trend in favour of supplementation, and 1 study in favour of placebo.<br/> <sup>9</sup>Downgraded by 1 for indirectness. Both studies were conducted in Tanzania. Different populations may differ in their micronutrient deficiency or requirement.<br/> <sup>10</sup>Downgraded by 1 for imprecision. The 95% CI is wide and includes what may be clinically important effects.<br/> <sup>11</sup>Downgraded by 2 for inconsistency: Statistical heterogeneity is very high. Four studies from Tanzania and India found no evidence of improved weight gain with supplements, while 1 study from Tanzania found large increases in weight with micronutrients at 8 months. </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Summary of findings 2.</span> <span class="table-title">'Summary of findings' table 2</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD006086.pub4/full#CD006086-tbl-0002">Navigate to table in review</a></div> </div> <div class="table"> <table data-id="CD006086-tbl-0003"> <div class="table-heading"><span class="table-label">Table 1.</span> <span class="table-title">Effect of multi‐micronutrient supplementation on nutritional recovery</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Trial ID</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Population</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Weight measurement</b> </p> </td> <td align="center" bgcolor="#ffffff" colspan="2" rowspan="1" valign="top"> <p><b>Baseline nutritional status</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Duration of supplement and follow‐up</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Comment</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Supplement</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Placebo</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD006086-bbs2-0014" title="MehtaS , MugusiFM , BoschRJ , AboudS , ChatterjeeA , FinkelsteinJL , et al. A randomized trial of multivitamin supplementation in children with tuberculosis in Tanzania. Nutrition Journal2011;10:120. NCT00145184 . Effect of Multivitamin Supplements on Clinical and Immunological Response in Childhood Tuberculosis. https://clinicaltrials.gov/ct2/show/NCT00145184 (accessed 4 February 2016). ">Mehta 2011 TZA</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>HIV‐positive and HIV‐negative children</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Weight gain median (IQR)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>MUAC (cm)</p> <p>13.0 (11.9 to 14.25)</p> <p>Weight: 8.48kg (NR)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>MUAC (cm)</p> <p>13.0 (11.2 to 14.0)</p> <p>Weight kg: 7.95 kg (NR)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Supplement and follow‐up 2 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>The trial authors reported no effect of supplement on median weight, height, or mid‐upper arm circumference at 2 months </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD006086-bbs2-0011" title="LodhaR , MukherjeeA , SinghV , SinghS , FriisH , Faurholt‐JepsenD , et al. Effect of micronutrient supplementation on treatment outcomes in children with intrathoracic tuberculosis: a randomized controlled trial. American Journal of Clinical Nutrition2014;100(5):1287‐97. ">Lodha 2014 IND</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>HIV‐negative children</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Change in weight‐for‐age z score</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Weight‐for‐age z score (SD):</p> <p>−2.72 (1.85, MN+Z group);</p> <p>−2.8 (1.6, MN group)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Weight‐for‐age z score (SD): −2.8 (1.6)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Supplement and follow‐up 6 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>The trial authors reported no difference in weight (kg), weight‐for‐age z score, height‐for‐age z score, or BMI z score after 2 or 6 months supplementation with micronutrients with or without zinc (1 trial, 302 participants, <a href="./references#CD006086-fig-0017" title="">Analysis 3.7</a>) </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD006086-bbs2-0022" title="PraygodG , RangeN , Faurholt‐JepsenD , JeremiahK , Faurholt‐JepsenM , AabyeMG , et al. Daily multi‐micronutrient supplementation during tuberculosis treatment increases weight and grip strength among HIV‐uninfected but not HIV‐infected patients in Mwanza, Tanzania. The Journal of Nutrition2011;141(4):685‐91. ">Praygod 2011a TZA</a><sup>1</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>HIV‐positive and negative adults</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Mean weight gain (SD)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Mean BMI (SD): 18.9 kg/m² (2.8)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>mean BMI (SD): 18.9 kg/m² (3.1)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Supplement for 2 months</p> <p>Follow‐up at 2 and 5 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>There was no statistically significant difference in weight gain at 2 or 5 months. Subgroup analysis by HIV status found a statistically significant difference in weight gain in favour of supplements in HIV‐negative participants, and in favour of placebo in HIV‐positive participants (trial authors' own figures) </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD006086-bbs2-0033" title="VillamorE , MugusiF , UrassaW , BoschR J , SaathoffE , MatsumotoK , et al. A trial of the effect of micronutrient supplementation on treatment outcome, T cell counts, morbidity, and mortality in adults with pulmonary tuberculosis. The Journal of Infectious Diseases2008;197(11):1499‐505. ">Villamor 2008 TZA</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>HIV‐positive and negative adults</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Mean BMI (SD)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>HIV‐negative mean BMI (SD): 18.9 kg/m² (2.5)</p> <p>HIV‐positive mean BMI (SD): 19.3 kg/m² (2.8)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>HIV‐negative mean BMI (SD): 18.9 kg/m² (2.5)</p> <p>HIV‐positive mean BMI (SD): 19.6 kg/m² (2.9)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Supplement for 24 months and follow‐up at 8 and 24 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>The trial authors reported no statistically significant effect of supplement on BMI, mid‐upper arm circumference, fat mass, or fat free mass at 8 or 24 months, regardless of HIV status (no figures reported) </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD006086-bbs2-0025" title="RangeN , AndersenAB , MagnussenP , MugomelaA , FriisH . The effect of micronutrient supplementation on treatment outcome in patients with pulmonary tuberculosis: a randomised controlled trial in Mwanza, Tanzania. Tropical Medicine and International Health2005;10(9):826‐32. RangeN , ChangaluchaJ , KrarupH , MagnussenP , AndersenAB , FriisH . The effect of multi‐vitamin/mineral supplementation on mortality during treatment of pulmonary tuberculosis: a randomised two‐by‐two factorial trial in Mwanza, Tanzania. British Journal of Nutrition2006;95(4):762‐70. ">Range 2005 TZA</a><sup>2</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>HIV‐positive and negative adults</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Mean weight gain (SD)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Mean BMI (SD): 18.3 kg/m² (2.5) zinc + MMN group</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Mean BMI (SD): 18.7 kg/m² (2.7)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Supplement for 8 months and follow‐up 8 weeks and 7 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>There was a statistically significantly greater weight gain in supplemented group at 7 months. While the difference in weight was appreciable in both treatment (zinc + MMN and MMN groups) arms compared to placebo, the weight gain in the zinc + MMN arm appeared to be clinically important </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p>Abbreviations: SD = standard deviation; BMI = body mass index; MMN = multi‐micronutrient; HIV = human immunodeficiency virus; IQR = interquartile range; MUAC = mid‐upper arm circumference; NR = not reported;<br/> <sup>1</sup>The supplement administered by <a href="./references#CD006086-bbs2-0022" title="PraygodG , RangeN , Faurholt‐JepsenD , JeremiahK , Faurholt‐JepsenM , AabyeMG , et al. Daily multi‐micronutrient supplementation during tuberculosis treatment increases weight and grip strength among HIV‐uninfected but not HIV‐infected patients in Mwanza, Tanzania. The Journal of Nutrition2011;141(4):685‐91. ">Praygod 2011a TZA</a> included a similar dose of zinc to that used by <a href="./references#CD006086-bbs2-0025" title="RangeN , AndersenAB , MagnussenP , MugomelaA , FriisH . The effect of micronutrient supplementation on treatment outcome in patients with pulmonary tuberculosis: a randomised controlled trial in Mwanza, Tanzania. Tropical Medicine and International Health2005;10(9):826‐32. RangeN , ChangaluchaJ , KrarupH , MagnussenP , AndersenAB , FriisH . The effect of multi‐vitamin/mineral supplementation on mortality during treatment of pulmonary tuberculosis: a randomised two‐by‐two factorial trial in Mwanza, Tanzania. British Journal of Nutrition2006;95(4):762‐70. ">Range 2005 TZA</a>.<br/> <sup>2</sup>2 X 2 factorial design; Group 1: zinc plus placebo; Group 2: multivitamin and mineral tablet plus placebo; Group 3: zinc plus multivitamin and mineral tablet; Group 4: placebo plus placebo. </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Table 1.</span> <span class="table-title">Effect of multi‐micronutrient supplementation on nutritional recovery</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD006086.pub4/full#CD006086-tbl-0003">Navigate to table in review</a></div> </div> <div class="table"> <table data-id="CD006086-tbl-0004"> <div class="table-heading"><span class="table-label">Table 2.</span> <span class="table-title">Effects of vitamin A supplementation on serum vitamin A levels</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Trial ID</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Supplement dose</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Measure</b> </p> </td> <td align="center" bgcolor="#ffffff" colspan="2" rowspan="1" valign="top"> <p><b>Baseline</b> </p> </td> <td align="center" bgcolor="#ffffff" colspan="2" rowspan="1" valign="top"> <p><b>Follow‐up</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Follow‐up</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Comment</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Supplement</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Control</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Supplement</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Control</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD006086-bbs2-0005" title="HanekomWA , PotgeiterS , HughesEJ , MalanH , KessowG , HusseyGD . Vitamin A status and therapy in childhood pulmonary tuberculosis. Journal of Pediatrics1997;131(6):925‐7. ">Hanekom 1997 ZAF</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>200 000 IU vitamin A 2 doses at baseline</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Mean µg/L</p> <p>(SD)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>17.6</p> <p>(10.1)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>18.6</p> <p>(10.5)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>34.8</p> <p>(10.1)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>33.5</p> <p>(14.2)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>6 weeks</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No statistically significant difference in serum vitamin A levels at 6 weeks or 2 months </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD006086-bbs2-0004" title="GinawiIA , AhmedMQ , AhmadI , Al‐HazimiAM . Effect of zinc and vitamin a supplementation along with inter‐tubercular treatment in pulmonary tuberculosis in north Indian patients. International Journal of Pharmaceutical Sciences and Research2013;4(9):3426‐31. ">Ginawi 2013 IND</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>5000 IU vitamin A daily</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Mean µmol/L</p> <p>(SD)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.77</p> <p>(0.21)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.82</p> <p>(0.29)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1.2</p> <p>(0.27)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1.13</p> <p>(0.34)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No statistically significant difference in serum vitamin A levels at 2 or 6 months</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD006086-bbs2-0018" title="PakasiTA , KaryadiE , SuratihNMD , SaleanM , DarmawidjajaN , BorH , et al. Zinc and vitamin A supplementation fails to reduce sputum conversion time in severely malnourished pulmonary tuberculosis patients in Indonesia. Nutrition Journal2010;9:41. ">Pakasi 2010 IDN</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>5000 IU vitamin A daily for 6 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Median µmol/L</p> <p>(IQR)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.7</p> <p>(0.5 to 1.5)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.7</p> <p>(0.5 to 1.0)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1.5</p> <p>(1.0 to 2.0)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1.2</p> <p>(0.9 to 1.6)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No statistically significant difference at 2 or 6 months</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD006086-bbs2-0001" title="ArmijosRX , WeigelMM , ChaconR , FloresL , CamposA . Adjunctive micronutrient supplementation for pulmonary tuberculosis. Salud Pública de México2010;52(3):185‐9. ">Armijos 2010 MEX</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>5000 IU vitamin A plus</p> <p>50 mg zinc daily for 4 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Mean µmol/L</p> <p>(SD)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1.03</p> <p>(0.46)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1.04</p> <p>(0.48)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1.4</p> <p>(0.47)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1.29</p> <p>(0.35)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No statistically significant difference in serum vitamin A levels at 2 or 6 months</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD006086-bbs2-0008" title="KaryadiE , WestCE , SchultinkW , NelwanRH , GrossR , AminZ , et al. A double‐blind, placebo‐controlled study of vitamin A and zinc supplementation in persons with tuberculosis in Indonesia: effects on clinical response and nutritional status. American Journal of Clinical Nutrition2002;75(4):720‐7. ">Karyadi 2002 IDN</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>5000 IU vitamin A plus 15 mg zinc daily for 6 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Mean µmol/L</p> <p>(SD)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.82</p> <p>(0.25)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.9</p> <p>(0.25)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1.14</p> <p>(0.32)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1.08</p> <p>(0.25)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No statistically significant difference in serum vitamin A levels at 2 or 6 months</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD006086-bbs2-0004" title="GinawiIA , AhmedMQ , AhmadI , Al‐HazimiAM . Effect of zinc and vitamin a supplementation along with inter‐tubercular treatment in pulmonary tuberculosis in north Indian patients. International Journal of Pharmaceutical Sciences and Research2013;4(9):3426‐31. ">Ginawi 2013 IND</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>5000 IU vitamin A plus 15 mg zinc sulphate daily</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Mean µmol/L</p> <p>(SD)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.78</p> <p>(0.23)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.82</p> <p>(0.29)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1.14</p> <p>(0.25)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1.13</p> <p>(0.34)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No statistically significant difference in serum vitamin A levels at 2 or 6 months</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD006086-bbs2-0018" title="PakasiTA , KaryadiE , SuratihNMD , SaleanM , DarmawidjajaN , BorH , et al. Zinc and vitamin A supplementation fails to reduce sputum conversion time in severely malnourished pulmonary tuberculosis patients in Indonesia. Nutrition Journal2010;9:41. ">Pakasi 2010 IDN</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>5000 IU vitamin A plus 15 mg zinc sulphate daily for 6 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Median µmol/L</p> <p>(IQR)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.7</p> <p>(0.4 to 1.1)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.7</p> <p>(0.5 to 1.0)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1.3</p> <p>(1.0 to 1.9)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1.2</p> <p>(0.9 to 1.6)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No statistically significant difference in serum vitamin A levels at 2 or 6 months</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD006086-bbs2-0034" title="VisserME , GrewalHMS , SwartEC , DhansayMA , WalzlG , SwanevelderS , et al. The effect of vitamin A and zinc supplementation on treatment outcomes in pulmonary tuberculosis: a randomized controlled trial. American Journal of Clinical Nutrition2011;93(1):93‐100. ">Visser 2011 ZAF</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>200,000 IU vitamin A once plus 15 mg zinc sulphate 5 days per week for 8 weeks</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Median µd/dL</p> <p>(IQR)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>21.1 (15.1 to 27.8)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>21.2 (15.7 to 28.9)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>40.3 (28.7 to 48.5)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>35.8 (27.7 to 43.2)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No statistically significant difference in serum vitamin A levels at 2 or 8 weeks</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD006086-bbs2-0028" title="SembaRD , KumwendaJ , ZijlstraE , RicksMO , vanLettowM , WhalenC , et al. Micronutrient supplements and mortality of HIV‐infected adults with pulmonary TB: a controlled clinical trial. International Journal of Tuberculosis and Lung Disease2007;11(8):854‐9. ">Semba 2007 MWI</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>8000 IU vitamin A daily as part of a multi‐micronutrient supplement</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Geometric mean µmol/L (95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.60 (0.54 to 0.66)<sup>1</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.69 (0.63 to 0.75)<sup>1</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>NR</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>NR</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>8 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Presented graphically with an increase in serum vitamin A levels in both groups</p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="9"> <div class="table-footnote"> <p>Abbreviations: IU = international units; IQR = interquartile range; CI = confidence interval; SD = standard deviation.<br/> <sup>1</sup>Serum vitamin A levels for HIV‐negative participants. </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Table 2.</span> <span class="table-title">Effects of vitamin A supplementation on serum vitamin A levels</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD006086.pub4/full#CD006086-tbl-0004">Navigate to table in review</a></div> </div> <div class="table"> <table data-id="CD006086-tbl-0005"> <div class="table-heading"><span class="table-label">Table 3.</span> <span class="table-title">Effects of zinc supplementation on serum zinc levels</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Trial ID</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Supplement dose</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Measure</b> </p> </td> <td align="center" bgcolor="#ffffff" colspan="2" rowspan="1" valign="top"> <p><b>Baseline</b> </p> </td> <td align="center" bgcolor="#ffffff" colspan="2" rowspan="1" valign="top"> <p><b>Follow‐up</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Follow‐up</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Comment</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Supplement</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Control</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Supplement</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Control</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD006086-bbs2-0004" title="GinawiIA , AhmedMQ , AhmadI , Al‐HazimiAM . Effect of zinc and vitamin a supplementation along with inter‐tubercular treatment in pulmonary tuberculosis in north Indian patients. International Journal of Pharmaceutical Sciences and Research2013;4(9):3426‐31. ">Ginawi 2013 IND</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>15 mg zinc sulphate daily</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Mean µmol/L</p> <p>(SD)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>9.86</p> <p>(0.87)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>9.88</p> <p>(1.44)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>12.23</p> <p>(1.12)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>11.23</p> <p>(1.34)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Statistically significant increase in serum zinc levels in the zinc group at 2 and 6 months </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD006086-bbs2-0018" title="PakasiTA , KaryadiE , SuratihNMD , SaleanM , DarmawidjajaN , BorH , et al. Zinc and vitamin A supplementation fails to reduce sputum conversion time in severely malnourished pulmonary tuberculosis patients in Indonesia. Nutrition Journal2010;9:41. ">Pakasi 2010 IDN</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>15 mg zinc sulphate daily for 6 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Mean µmol/L</p> <p>(SD)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>11.6</p> <p>(2.2)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>11.8</p> <p>(2.4)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>11.7</p> <p>(2.43)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>11.7</p> <p>(2.33)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No statistically significant difference in serum zinc levels at 2 months</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD006086-bbs2-0001" title="ArmijosRX , WeigelMM , ChaconR , FloresL , CamposA . Adjunctive micronutrient supplementation for pulmonary tuberculosis. Salud Pública de México2010;52(3):185‐9. ">Armijos 2010 MEX</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>50 mg zinc plus 5000 IU vitamin A daily for 4 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Mean µmol/L</p> <p>(SD)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>11.29</p> <p>(2.57)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>11.69</p> <p>(2.1)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>12.85</p> <p>(3.4)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>10.13</p> <p>(1.61)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Statistically significant increase in serum zinc levels in zinc plus vitamin A group at 2 months. Increase not sustained post supplementation. </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD006086-bbs2-0008" title="KaryadiE , WestCE , SchultinkW , NelwanRH , GrossR , AminZ , et al. A double‐blind, placebo‐controlled study of vitamin A and zinc supplementation in persons with tuberculosis in Indonesia: effects on clinical response and nutritional status. American Journal of Clinical Nutrition2002;75(4):720‐7. ">Karyadi 2002 IDN</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>15 mg zinc plus 5000 IU vitamin A daily for 6 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Mean µmol/L</p> <p>(SD)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>11.52</p> <p>(1.64)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>11.15</p> <p>(1.77)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>11.22</p> <p>(2.4)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>10.22</p> <p>(2.28)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No statistically significant difference in serum zinc levels at 2 months</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD006086-bbs2-0004" title="GinawiIA , AhmedMQ , AhmadI , Al‐HazimiAM . Effect of zinc and vitamin a supplementation along with inter‐tubercular treatment in pulmonary tuberculosis in north Indian patients. International Journal of Pharmaceutical Sciences and Research2013;4(9):3426‐31. ">Ginawi 2013 IND</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>15 mg zinc sulphate plus 5000 IU vitamin A daily</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Mean µmol/L</p> <p>(SD)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>9.56</p> <p>(0.77)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>9.88</p> <p>(1.4)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>11.17</p> <p>(0.86)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>11.23</p> <p>(1.34)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No statistically significant difference in serum zinc levels at 2 months</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD006086-bbs2-0018" title="PakasiTA , KaryadiE , SuratihNMD , SaleanM , DarmawidjajaN , BorH , et al. Zinc and vitamin A supplementation fails to reduce sputum conversion time in severely malnourished pulmonary tuberculosis patients in Indonesia. Nutrition Journal2010;9:41. ">Pakasi 2010 IDN</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>15 mg zinc sulphate plus 5000 IU vitamin A daily for 6 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Mean µmol/L</p> <p>(SD)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>12.1</p> <p>(3.0)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>11.8</p> <p>(2.4)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>12.5</p> <p>(2.33)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>11.7</p> <p>(2.33)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No statistically significant difference in serum zinc levels at 2 months</p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="9"> <div class="table-footnote"> <p>Abbreviations: IU = international unit; SD = standard deviation.</p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Table 3.</span> <span class="table-title">Effects of zinc supplementation on serum zinc levels</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD006086.pub4/full#CD006086-tbl-0005">Navigate to table in review</a></div> </div> <div class="table"> <table data-id="CD006086-tbl-0006"> <div class="table-heading"><span class="table-label">Table 4.</span> <span class="table-title">Effect of vitamin A plus zinc supplementation on nutritional recovery</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Trial ID</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Population</b> </p> </td> <td align="center" bgcolor="#ffffff" colspan="2" rowspan="1" valign="top"> <p><b>Baseline nutritional status</b> </p> <p><b>Mean BMI (SD) kg/m²</b> </p> </td> <td align="center" bgcolor="#ffffff" colspan="2" rowspan="1" valign="top"> <p><b>Endpoint nutritional status</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Comments</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Vitamin A plus zinc</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Placebo</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Vitamin A plus zinc</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Placebo</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD006086-bbs2-0008" title="KaryadiE , WestCE , SchultinkW , NelwanRH , GrossR , AminZ , et al. A double‐blind, placebo‐controlled study of vitamin A and zinc supplementation in persons with tuberculosis in Indonesia: effects on clinical response and nutritional status. American Journal of Clinical Nutrition2002;75(4):720‐7. ">Karyadi 2002 IDN</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Adults HIV status unknown</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>17.6 (1.9)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>18.1 (3.2)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Mean BMI (SD) 6 months: 19.4 (2.5)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Mean BMI (SD) 6 months: 20.0 (3.2)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Statistically significantly greater body weight (kg) in supplemented group at 6 months (3.10 kg, 95% CI 0.74 to 5.46). No statistically significant differences in BMI, mid‐upper arm circumference, biceps skinfold thickness, triceps skinfold thickness, subscapular skinfold thickness, supra‐iliac skinfold thickness, body fat (%), or fat mass (kg) between groups at 2 or 6 months </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD006086-bbs2-0010" title="LawsonL , ThacherTD , YassinMA , OnuohaNA , UsmanA , EmenyonuNE , et al. Randomized controlled trial of zinc and vitamin A as co‐adjuvants for the treatment of pulmonary tuberculosis. Tropical Medicine and International Health2010;15(12):1481‐90. ">Lawson 2010 NGA</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Adults HIV‐positive and HIV‐negative</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>19.6 (3.5)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>19.8 (3.3)</p> </td> <td align="" bgcolor="#ffffff" colspan="2" rowspan="1" valign="top"> <p>BMI data reported graphically</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>BMI appears to increase along a similar trajectory for both supplemented and placebo groups at 2 and 6 months </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD006086-bbs2-0018" title="PakasiTA , KaryadiE , SuratihNMD , SaleanM , DarmawidjajaN , BorH , et al. Zinc and vitamin A supplementation fails to reduce sputum conversion time in severely malnourished pulmonary tuberculosis patients in Indonesia. Nutrition Journal2010;9:41. ">Pakasi 2010 IDN</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Adults HIV status unknown</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>16.6 (2.1)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>16.4 (2.5)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Mean BMI (SD) 6 months: 18.3 (2.0)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Mean BMI (SD) 6 months: 18.4 (2.6)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No statistically significant differences in BMI between the supplement and placebo group at 2 or 6 months </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD006086-bbs2-0034" title="VisserME , GrewalHMS , SwartEC , DhansayMA , WalzlG , SwanevelderS , et al. The effect of vitamin A and zinc supplementation on treatment outcomes in pulmonary tuberculosis: a randomized controlled trial. American Journal of Clinical Nutrition2011;93(1):93‐100. ">Visser 2011 ZAF</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Adults HIV‐positive and HIV‐negative</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Male: 18.9 (2.7)</p> <p>Female: 23.0 (4.3)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Male: 19.0 (2)</p> <p>Female: 21.6 (4.8)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Mean weight gain 2.3 kg</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Mean weight gain 2.2 kg</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No statistically significant difference in weight gain during the first 2 months of treatment (P = 0.68, trial authors' own figures) </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p>Abbreviations: HIV = human immunodeficiency virus; BMI = body mass index; SD = standard deviation. </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Table 4.</span> <span class="table-title">Effect of vitamin A plus zinc supplementation on nutritional recovery</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD006086.pub4/full#CD006086-tbl-0006">Navigate to table in review</a></div> </div> <div class="table"> <table data-id="CD006086-tbl-0007"> <div class="table-heading"><span class="table-label">Table 5.</span> <span class="table-title">Effects of vitamin D supplementation on serum vitamin D levels</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Trial ID</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Supplement dose</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Measure</b> </p> </td> <td align="center" bgcolor="#ffffff" colspan="2" rowspan="1" valign="top"> <p><b>Baseline</b> </p> </td> <td align="center" bgcolor="#ffffff" colspan="2" rowspan="1" valign="top"> <p><b>Follow‐up</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Follow‐up</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Comment</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Supplement</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Control</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Supplement</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Control</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD006086-bbs2-0015" title="MilyA , RekhaRS , KamalSM , ArifuzzamanAS , RahimZ , KhanL , et al. Significant effects of oral phenylbutyrate and vitamin D3 adjunctive therapy in pulmonary tuberculosis: a randomized controlled trial. PLoS One2015;10(9):e0138340. [DOI: 10.1371/journal.pone.0138340] ">Mily 2015 BGD</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>5000 IU daily for 8 weeks</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Mean nmol/L</p> <p>(SD)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>28.0</p> <p>(17.5)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>28.1</p> <p>(16.2)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>102</p> <p>(NR)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>30</p> <p>(NR)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>8 weeks</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>The follow‐up mean values inserted here have been approximated from a graph in the published paper. The trial authors reported that the group receiving vitamin D<sub>3</sub> supplementation exhibited significantly higher concentration of plasma 25‐hydroxyvitamin D<b>[</b>25(OH) D<sub>3</sub>] at week 8 compared to placebo after initiation of therapy (P &lt; 0.000) </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD006086-bbs2-0032" title="FredianiJ , TukvadzeN , SanikidzeE , KipianiM , HebbarG , TangprichaV , et al. Drug susceptibility influences macronutrient intake and body composition in tuberculosis patients. The FASEB Journal2014;28(Supplement 1):1014.4. TukvadzeN , SanikidzeE , KipianiM , HebbarG , EasleyKA , ShenviN , et al. High‐dose vitamin D3 in adults with pulmonary tuberculosis: a double‐blind randomised controlled trial. American Journal of Clinical Nutrition2015;102(5):1059‐69. ">Tukvadze 2015 GEO</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>50000 IU 3 times a week for 8 weeks, then every 2 weeks for 8 weeks</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Mean nmol/L</p> <p>(SD)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>30</p> <p>(NR)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>30</p> <p>(NR)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>250</p> <p>(NR)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>40</p> <p>(NR)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>8 weeks</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>The mean values inserted here have been approximated from a graph in the published paper. The trial authors reported that high‐dose vitamin D<sub>3</sub> resulted in a significant increase in plasma 25(OH)D concentrations to 250 nmol/L at study week 8 </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD006086-bbs2-0002" title="DaleyP , JagannathanV , JohnKR , SarojiniJ , LathaA , ViethR , et al. Adjunctive vitamin D for treatment of active tuberculosis in India: a randomised, double‐blind, placebo‐controlled trial. The Lancet. Infectious Diseases2015;15(5):528‐34. ">Daley 2015 IND</a><sup>1</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2.5 mg vitamin D<sub>3</sub> on days 0, 14, 28, and 42 </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Mean nmol/L</p> <p>(SD)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>63.1</p> <p>(46.6)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>62.2 (51.0)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>72.2</p> <p>(NR)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>60.4</p> <p>(NR)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>26 weeks</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Authors reported significant increase serum vitamin D levels in supplement group (P = 0.001) but not in the placebo group (P = 0.15). No difference in serum vitamin D levels between groups at week 26 (P = 0.24) </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD006086-bbs2-0009" title="KotaSK , JammulaS , KotaSK , TripathyPR , PandaS , ModiKD . Effect of vitamin D supplementation in type 2 diabetes patients with pulmonary tuberculosis. Diabetes and Metabolic Syndrome: Clinical Research &amp; Reviews2011;5(2):85‐9. ">Kota 2011 IND</a><sup>2</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>60,000 IU vitamin D<sub>3</sub> per week plus 1000 mg calcium carbonate per day </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Mean ng/ml</p> <p>(SD)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>12.8</p> <p>(4.5)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>11.1 (4.7)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>22.3</p> <p>(5.9)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>11.1</p> <p>(1.6)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>8 weeks</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Statistically significant increase in serum vitamin D level in the supplement group (P = 0.0001) at 4, 8, and 12 weeks </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD006086-bbs2-0012" title="MartineauAR , TimmsPM , BothamleyGH , HanifaY , IslamK , ClaxtonAP , et al. High‐dose vitamin D3 during intensive‐phase antimicrobial treatment for pulmonary tuberculosis: a double‐blind randomised controlled trial. Lancet2011;377(9761):242‐50. ">Martineau 2011 GBR</a><sup>3</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2.5 mg on days 0, 14, 28, and 42</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Mean nmol/L</p> <p>(SD)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>21.1</p> <p>(20.0)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>21.3 (19.0)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>101.4</p> <p>(NR)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>22.8</p> <p>(NR)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>8 weeks</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Statistically significant increase in serum vitamin D level in the supplement group (P &lt; 0.001) </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD006086-bbs2-0035" title="WejseC , GomesVF , RabnaP , GustafsonP , AabyP , LisseIM , et al. Vitamin D as supplementary treatment for tuberculosis ‐ a double‐blind randomised placebo‐controlled trial. American Journal of Respiratory and Critical Care Medicine2009;179(9):843‐50. ">Wejse 2008 GNB</a><sup>4</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>100,000 IU vitamin D<sub>3</sub> at 0, 5, and 8 months </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Mean nmol/L</p> <p>(SD)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>77.5</p> <p>(23.8)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>79.1 (21.8)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>105</p> <p>(95% CI 99 to 110)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>103</p> <p>(95% CI 96 to 110)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>8 weeks</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>There was no statistically significant difference in serum vitamin D levels at 8 weeks or 8 months between the groups </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD006086-bbs2-0016" title="MorcosMM , GabrAA , SamualS , KamelM , elBazM , elBeshryM , et al. Vitamin D administration to tuberculous children and its value. Bollettino Chimico Farmaceutico1998;137(5):157‐64. ">Morcos 1998 EGY</a><sup>5</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1000 IU daily for 8 weeks</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>NR</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>NR</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>NR</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>NR</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>NR</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>16 weeks</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>The trial authors reported that the serum vitamin D level rose in both groups and was not statistically different between groups (P &gt; 0.05). </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="9"> <div class="table-footnote"> <p>Abbreviations: NR = not reported; IU = international units; SD = standard deviation; 25(OH) D<sub>3</sub> = 25‐hydroxyvitamin D.<br/> <sup>1</sup><a href="./references#CD006086-bbs2-0002" title="DaleyP , JagannathanV , JohnKR , SarojiniJ , LathaA , ViethR , et al. Adjunctive vitamin D for treatment of active tuberculosis in India: a randomised, double‐blind, placebo‐controlled trial. The Lancet. Infectious Diseases2015;15(5):528‐34. ">Daley 2015 IND</a> only included HIV‐negative participants.<br/> <sup>2</sup><a href="./references#CD006086-bbs2-0009" title="KotaSK , JammulaS , KotaSK , TripathyPR , PandaS , ModiKD . Effect of vitamin D supplementation in type 2 diabetes patients with pulmonary tuberculosis. Diabetes and Metabolic Syndrome: Clinical Research &amp; Reviews2011;5(2):85‐9. ">Kota 2011 IND</a> only enrolled newly diagnosed tuberculosis cases with uncontrolled diabetes and serum vitamin D &lt; 20 ng/mL.<br/> <sup>3</sup><a href="./references#CD006086-bbs2-0012" title="MartineauAR , TimmsPM , BothamleyGH , HanifaY , IslamK , ClaxtonAP , et al. High‐dose vitamin D3 during intensive‐phase antimicrobial treatment for pulmonary tuberculosis: a double‐blind randomised controlled trial. Lancet2011;377(9761):242‐50. ">Martineau 2011 GBR</a> reported that at baseline almost all participants had serum vitamin D levels below the definition of insufficiency used by <a href="./references#CD006086-bbs2-0035" title="WejseC , GomesVF , RabnaP , GustafsonP , AabyP , LisseIM , et al. Vitamin D as supplementary treatment for tuberculosis ‐ a double‐blind randomised placebo‐controlled trial. American Journal of Respiratory and Critical Care Medicine2009;179(9):843‐50. ">Wejse 2008 GNB</a> (95% supplement group versus 98% control group).<br/> <sup>4</sup><a href="./references#CD006086-bbs2-0035" title="WejseC , GomesVF , RabnaP , GustafsonP , AabyP , LisseIM , et al. Vitamin D as supplementary treatment for tuberculosis ‐ a double‐blind randomised placebo‐controlled trial. American Journal of Respiratory and Critical Care Medicine2009;179(9):843‐50. ">Wejse 2008 GNB</a> reports that at baseline approximately 10% of participants were defined as being vitamin D deficient (serum 25 (OH)D<sub>3</sub>&lt; 50 nmol/L), and 45% as vitamin D insufficient (serum 25(OH)D<sub>3</sub> &lt; 75 nmol/L).<br/> <sup>5</sup><a href="./references#CD006086-bbs2-0016" title="MorcosMM , GabrAA , SamualS , KamelM , elBazM , elBeshryM , et al. Vitamin D administration to tuberculous children and its value. Bollettino Chimico Farmaceutico1998;137(5):157‐64. ">Morcos 1998 EGY</a> reported a mean vitamin D level of 17.91 pg/mL at baseline which is below the normal reference range (20 to 42 pg/mL). </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Table 5.</span> <span class="table-title">Effects of vitamin D supplementation on serum vitamin D levels</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD006086.pub4/full#CD006086-tbl-0007">Navigate to table in review</a></div> </div> <div class="table"> <table data-id="CD006086-tbl-0008"> <div class="table-heading"><span class="table-label">Table 6.</span> <span class="table-title">Adverse effects of vitamin D</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Trial ID</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Dose</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Severe adverse events</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Effects on calcium</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Other</b> </p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD006086-bbs2-0015" title="MilyA , RekhaRS , KamalSM , ArifuzzamanAS , RahimZ , KhanL , et al. Significant effects of oral phenylbutyrate and vitamin D3 adjunctive therapy in pulmonary tuberculosis: a randomized controlled trial. PLoS One2015;10(9):e0138340. [DOI: 10.1371/journal.pone.0138340] ">Mily 2015 BGD</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>5000 IU daily for 8 weeks</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>None in the vitamin D group</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Hypercalcemia: none</p> <p>Hypocalcemia: common but no differences between groups</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No differences between study arms</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD006086-bbs2-0032" title="FredianiJ , TukvadzeN , SanikidzeE , KipianiM , HebbarG , TangprichaV , et al. Drug susceptibility influences macronutrient intake and body composition in tuberculosis patients. The FASEB Journal2014;28(Supplement 1):1014.4. TukvadzeN , SanikidzeE , KipianiM , HebbarG , EasleyKA , ShenviN , et al. High‐dose vitamin D3 in adults with pulmonary tuberculosis: a double‐blind randomised controlled trial. American Journal of Clinical Nutrition2015;102(5):1059‐69. ">Tukvadze 2015 GEO</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>50,000 IU 3 times a week for 8 weeks, then every 2 weeks for 8 weeks</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>5/100 vitamin D versus 15/99 placebo</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Hypercalcemia: 3/100 vitamin D versus 7/99 placebo</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No differences between study arms</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD006086-bbs2-0002" title="DaleyP , JagannathanV , JohnKR , SarojiniJ , LathaA , ViethR , et al. Adjunctive vitamin D for treatment of active tuberculosis in India: a randomised, double‐blind, placebo‐controlled trial. The Lancet. Infectious Diseases2015;15(5):528‐34. ">Daley 2015 IND</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2.5 mg vitamin D<sub>3</sub> on days 0, 14, 28, and 42 </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>None in the vitamin D group</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Hypercalcaemia: none</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>4/121 vitamin D versus 3/126 placebo</p> <p>(none required a change in medical therapy)</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD006086-bbs2-0012" title="MartineauAR , TimmsPM , BothamleyGH , HanifaY , IslamK , ClaxtonAP , et al. High‐dose vitamin D3 during intensive‐phase antimicrobial treatment for pulmonary tuberculosis: a double‐blind randomised controlled trial. Lancet2011;377(9761):242‐50. ">Martineau 2011 GBR</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2.5 mg on days 0, 14, 28, and 42</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>7/71 vitamin D versus 2/70 placebo</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Hypercalcemia: 2/71 vitamin D versus 0/70 placebo</p> <p>Hypocalcaemia: 5/71 vitamin D versus 2/70 placebo</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No differences between study arms</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD006086-bbs2-0035" title="WejseC , GomesVF , RabnaP , GustafsonP , AabyP , LisseIM , et al. Vitamin D as supplementary treatment for tuberculosis ‐ a double‐blind randomised placebo‐controlled trial. American Journal of Respiratory and Critical Care Medicine2009;179(9):843‐50. ">Wejse 2008 GNB</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>100,000 IU vitamin D<sub>3</sub> at 0, 5, and 8 months </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No comment</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Hypercalcemia: at 2 months: 1/157 vitamin D versus 2/147 placebo</p> <p>At 8 months: none</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>At 2 months: only 24 reported any symptom, most commonly excessive thirst: 10/157 vitamin D versus 14/147 placebo (P = 0.31) </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="5"> <div class="table-footnote"> <p>Abbreviations: IU = international units.</p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Table 6.</span> <span class="table-title">Adverse effects of vitamin D</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD006086.pub4/full#CD006086-tbl-0008">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD006086-tbl-0009"> <div class="table-heading"><span class="table-label">Comparison 1.</span> <span class="table-title">Macronutrient supplementation</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Death (1 year of follow‐up) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>567</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.34 [0.10, 1.20]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.1 HIV‐positive</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>72</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.60 [0.12, 3.01]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.2 HIV‐negative</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>230</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.18 [0.02, 1.48]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.3 Unknown HIV status</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>265</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Cured (at 6 months) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>102</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.91 [0.59, 1.41]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.1 HIV‐positive</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>22</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.38 [0.46, 4.14]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.2 HIV‐negative</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>80</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.85 [0.53, 1.35]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 Treatment completion <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.1 HIV‐negative</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>100</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.20 [1.04, 1.37]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.2 Unknown HIV status</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>265</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.98 [0.86, 1.12]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4 Sputum negative at 8 weeks <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>222</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.08 [0.86, 1.37]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">5 Mean weight gain <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.1 After 6 weeks</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>34</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.73 [0.81, 2.65]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.2 After 8 weeks</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>689</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.78 [‐0.05, 1.60]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.3 After 12 weeks</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>100</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>2.6 [1.74, 3.46]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.4 After 20 weeks (12 weeks post supplementation)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>306</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.20 [‐1.34, 0.94]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.5 After 24 weeks</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>26</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.78 [‐0.25, 3.81]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.6 After 32 weeks</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>265</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>2.60 [0.52, 4.68]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">6 Change in maximum grip strength (kg) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>6.1 At 6 weeks</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>34</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>3.44 [0.78, 6.10]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>6.2 At 8 weeks</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>332</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.50 [‐0.63, 1.63]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>6.3 At 12 weeks</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>100</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.50 [1.08, 1.92]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>6.4 At 20 weeks</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>303</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.30 [‐0.11, 2.71]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>6.5 At 24 weeks</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>26</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.39 [‐3.05, 3.83]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">7 Change in quality of life score <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>7.1 At 6 weeks</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>7.2 At 24 weeks</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 1.</span> <span class="table-title">Macronutrient supplementation</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD006086.pub4/references#CD006086-tbl-0009">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD006086-tbl-0010"> <div class="table-heading"><span class="table-label">Comparison 2.</span> <span class="table-title">High cholesterol (850 mg/day) versus low cholesterol (250 mg/day) diet</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Sputum‐culture positive <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.1 At baseline</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.2 At 2 weeks</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.3 At 4 weeks</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.4 At 8 weeks</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 2.</span> <span class="table-title">High cholesterol (850 mg/day) versus low cholesterol (250 mg/day) diet</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD006086.pub4/references#CD006086-tbl-0010">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD006086-tbl-0011"> <div class="table-heading"><span class="table-label">Comparison 3.</span> <span class="table-title">Multivitamin and trace element tablets versus placebo</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Death during follow‐up in adults and children <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>2902</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.96 [0.79, 1.18]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.1 HIV‐negative individuals</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1218</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.86 [0.46, 1.60]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.2 HIV‐positive individuals</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1429</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.92 [0.69, 1.23]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.3 HIV‐positive and HIV‐negative individuals</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>255</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.59 [0.53, 4.72]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Tuberculosis treatment completion <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>302</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.99 [0.95, 1.04]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 Sputum‐smear or sputum‐culture positive at 1 month <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1020</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.92 [0.63, 1.35]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.1 Mixed HIV‐positive and HIV‐negative</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>392</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.20 [0.99, 1.45]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.2 HIV‐negative individuals only</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>306</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.73 [0.47, 1.13]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.3 HIV‐positive individuals only</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>322</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.77 [0.45, 1.31]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4 Sputum‐smear or sputum‐culture positive at 2 months <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>731</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.89 [0.59, 1.35]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">5 Clearance of chest X‐ray at 6 months <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>497</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.03 [0.90, 1.18]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">6 Weight <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>6.1 After 2 months of supplementation</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>6.2 After 5 months follow‐up (3 months post supplementation)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>6.3 After 6 months supplementation (children)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>6.4 After 7 months of supplementation</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">7 Anthropometrical changes at follow‐up <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>7.1 Weight‐for‐age z score at 2 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>7.2 Weight‐for‐age z score at 6 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>7.3 Weight (kg) at 2 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>7.4 Weight (kg) at 6 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>7.5 Height‐for‐age z score at 2 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>7.6 Height‐for‐age z score at 6 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>7.7 BMI z score at 2 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>7.8 BMI z score at 6 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">8 Mean change in handgrip strength (kg) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1480</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.16 [0.50, 1.81]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>8.1 At 2 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>771</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.22 [0.49, 1.95]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>8.2 At 5 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>709</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.90 [‐0.56, 2.36]</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 3.</span> <span class="table-title">Multivitamin and trace element tablets versus placebo</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD006086.pub4/references#CD006086-tbl-0011">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD006086-tbl-0012"> <div class="table-heading"><span class="table-label">Comparison 4.</span> <span class="table-title">Vitamin A versus placebo</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Children: mean serum retinol (normal range &gt; 20 µg/L) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.1 At baseline</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>85</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐1.0 [‐5.38, 3.38]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.2 At 6 weeks</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>85</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.30 [‐3.91, 6.51]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.3 At 3 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>85</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.70 [‐3.85, 5.25]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Adults: mean serum retinol (normal range &gt; 70 µmol/L) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.1 At baseline</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>242</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.06 [‐0.13, 0.01]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.2 At 2 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>242</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.05 [‐0.03, 0.14]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.3 At 6 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>242</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.07 [‐0.02, 0.16]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 Death <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>8</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>3308</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.97 [0.84, 1.12]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.1 Vitamin A alone</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>115</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.79 [0.19, 16.69]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.2 Vitamin A plus zinc</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>535</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>2.38 [0.87, 6.53]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.3 Vitamin A as part of a multi‐micronutrient supplement</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>2658</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.94 [0.81, 1.09]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4 Treatment completion <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>158</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.92 [0.80, 1.04]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">5 Symptomatic at 6 weeks <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">6 Sputum‐smear and sputum‐culture positive during follow‐up <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>6.1 Baseline</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>158</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.0 [0.98, 1.03]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>6.2 2 weeks</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>158</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.80 [0.50, 1.28]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>6.3 1 month</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>148</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.70 [0.33, 1.48]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>6.4 2 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>199</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.03 [0.23, 4.73]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">7 BMI (kg/m²) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>7.1 Baseline</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>158</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.10 [‐0.63, 0.83]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>7.2 2 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>148</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.30 [‐0.44, 1.04]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>7.3 6 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>136</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.30 [‐1.15, 0.55]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">8 Body fat (%) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>8.1 Baseline</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>158</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.90 [‐2.80, 1.00]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>8.2 2 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>148</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.90 [‐2.84, 1.04]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>8.3 6 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>136</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐1.80 [‐3.96, 0.36]</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 4.</span> <span class="table-title">Vitamin A versus placebo</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD006086.pub4/references#CD006086-tbl-0012">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD006086-tbl-0013"> <div class="table-heading"><span class="table-label">Comparison 5.</span> <span class="table-title">Zinc versus placebo</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Serum zinc level (normal range &gt; 10.7 µmol/L) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.1 At baseline</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>472</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.03 [‐0.36, 0.30]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.2 At 2 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>452</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.59 [0.24, 0.93]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.3 At 6 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>440</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.60 [0.31, 0.88]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Death by 6 to 8 months <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>7</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>2862</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.96 [0.82, 1.13]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.1 Zinc alone</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>714</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.25 [0.70, 2.22]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.2 Zinc plus vitamin A</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>477</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>2.08 [0.65, 6.64]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.3 Zinc as part of a multi‐micronutrient supplement</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1671</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.91 [0.77, 1.07]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 Death by 6 to 8 months (subgrouped by HIV status) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>815</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.25 [0.75, 2.09]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.1 HIV‐negative individuals</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>442</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.92 [0.53, 6.98]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.2 HIV‐positive individuals</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>211</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.06 [0.59, 1.91]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.3 HIV status unknown</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>162</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.70 [0.29, 9.89]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4 Treatment completion at 6 months <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>353</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.98 [0.92, 1.04]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">5 Sputum‐smear or sputum‐culture positive during follow‐up <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.1 At baseline</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>596</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.97 [0.92, 1.03]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.2 At 2 weeks</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>806</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.09 [1.02, 1.17]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.3 At 4 weeks</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>783</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.05 [0.93, 1.20]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.4 At 8 weeks</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1076</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.96 [0.72, 1.28]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">6 Clearance of chest X‐ray at 6 months <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">7 Weight at follow‐up <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>7.1 Baseline: weight (kg)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>7.2 2 months: weight (kg)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>7.3 6 months: weight (kg)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>7.4 7 months: weight (kg)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">8 BMI (kg/m²) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>8.1 Baseline</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>162</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.10 [‐0.62, 0.82]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>8.2 2 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>151</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.20 [‐0.55, 0.95]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>8.3 6 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>140</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.10 [‐0.70, 0.90]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">9 Body fat (%) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>9.1 Baseline</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>162</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.90 [‐2.51, 0.71]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>9.2 2 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>151</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐1.30 [‐3.07, 0.47]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>9.3 6 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>140</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐1.5 [‐3.51, 0.51]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">10 Weight‐for‐age z score <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>10.1 Baseline: weight‐for‐age z score</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>10.2 2 months: weight‐for‐age z score</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>10.3 6 months: weight‐for‐age z score</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">11 BMI‐for‐age z score <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>11.1 Baseline: BMI‐for‐age z score</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>11.2 2 months: BMI‐for‐age z score</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>11.3 6 months: BMI‐for‐age z score</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">12 Height‐for‐age z score at follow‐up <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>12.1 Baseline: height‐for‐age z score</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>12.2 2 months: height‐for‐age z score</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>12.3 6 months: height‐for‐age z score</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 5.</span> <span class="table-title">Zinc versus placebo</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD006086.pub4/references#CD006086-tbl-0013">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD006086-tbl-0014"> <div class="table-heading"><span class="table-label">Comparison 6.</span> <span class="table-title">Zinc plus vitamin A versus placebo</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Death by 6 months <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>578</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>2.33 [0.90, 6.07]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.1 HIV‐negative individuals</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>430</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.11 [0.31, 3.99]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.2 HIV‐positive individuals</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>136</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>5.94 [1.07, 32.96]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.3 Unknown HIV status</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>12</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Treatment completion at 6 months <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>152</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.95 [0.84, 1.07]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 Sputum‐smear and sputum‐culture positive during follow‐up <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>7</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.1 At baseline</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>652</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.0 [0.99, 1.01]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.2 1 month</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>485</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.01 [0.86, 1.17]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.3 2 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>7</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>726</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.90 [0.71, 1.15]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.4 3 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>266</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.95 [0.61, 1.49]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.5 4 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>266</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.51 [0.86, 2.65]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.6 5 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>33</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.7 6 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>113</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.2 [0.01, 4.04]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4 Body weight (kg) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.1 Baseline</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.2 2 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.3 6 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">5 BMI (kg/m²) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>664</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.09 [‐0.45, 0.28]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.1 Baseline</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>232</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.00 [‐0.62, 0.61]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.2 2 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>219</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.03 [‐0.65, 0.58]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.3 6 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>213</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.24 [‐0.91, 0.43]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">6 Mid upper arm circumference (cm) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>6.1 Baseline</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>6.2 2 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>6.3 6 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">7 Biceps skinfold thickness (mm) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>7.1 Baseline</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>7.2 2 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>7.3 6 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">8 Triceps skinfold thickness (mm) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>8.1 Baseline</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>8.2 2 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>8.3 6 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">9 Subscapular skinfold thickness (mm) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>9.1 Baseline</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>9.2 2 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>9.3 6 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">10 Suprailiac skinfold thickness (mm) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>10.1 Baseline</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>10.2 2 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>10.3 6 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">11 Body fat (%) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>11.1 Baseline</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>11.2 2 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>11.3 6 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">12 Fat mass (kg) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>12.1 Baseline</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>12.2 2 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>12.3 6 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">13 Karnofsky score <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>13.1 Baseline</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>13.2 2 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>13.3 6 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 6.</span> <span class="table-title">Zinc plus vitamin A versus placebo</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD006086.pub4/references#CD006086-tbl-0014">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD006086-tbl-0015"> <div class="table-heading"><span class="table-label">Comparison 7.</span> <span class="table-title">Vitamin D versus placebo or no supplement</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Serum vitamin D levels (nmol/L) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.1 At baseline</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>894</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.10 [‐3.01, 2.82]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.2 At 8 weeks</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>460</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>33.68 [3.99, 63.37]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.3 At 6 to 8 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>376</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>7.90 [0.52, 15.28]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Death during follow‐up (2 to 12 months) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>7</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>2649</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.96 [0.81, 1.12]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.1 Vitamin D alone</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>814</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.26 [0.79, 2.02]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.2 Vitamin D plus arginine</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>75</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.53 [0.06, 36.25]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.3 Vitamin D as part of a multi‐micronutrient supplement</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1760</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.91 [0.77, 1.08]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 Death during follow‐up (2 to 12 months) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>7</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>2649</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.97 [0.83, 1.13]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.1 HIV‐positive individuals</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1089</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.93 [0.80, 1.09]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.2 HIV‐negative individuals</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1403</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.26 [0.72, 2.21]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.3 HIV status mixed or unknown</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>157</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.5 [0.30, 7.38]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4 Cure at 6 months <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>151</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.99 [0.75, 1.31]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">5 Tuberculosis score <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1142</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.13 [‐0.32, 0.06]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.1 At baseline</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>348</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.10 [‐0.52, 0.31]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.2 2 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>297</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.02 [‐0.47, 0.42]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.3 5 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>271</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.16 [‐0.51, 0.19]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.4 8 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>226</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.19 [‐0.52, 0.14]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">6 Sputum‐smear or sputum‐culture positive <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>7</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>6.1 At baseline</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1022</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.97 [0.92, 1.03]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>6.2 4 weeks</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>929</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.87 [0.74, 1.03]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>6.3 6 weeks</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>656</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.76 [0.55, 1.03]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>6.4 8 weeks</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>856</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.81 [0.54, 1.20]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>6.5 5 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>148</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>3.0 [0.32, 28.18]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>6.6 6 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>247</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.74 [0.37, 1.47]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>6.7 8 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>147</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">7 Body mass index <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>7.1 At baseline</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>464</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.20 [‐0.71, 0.30]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>7.2 At 6 to 8 weeks</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>430</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.19 [‐0.70, 0.32]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">8 Body weight (kg) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>8.1 Before treatment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>150</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.20 [‐2.43, 2.83]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>8.2 At 8 weeks</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>150</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.08 [‐1.61, 3.77]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">9 Karnofsky score at 8 weeks <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>9.1 At baseline</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>247</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐1.47 [‐3.42, 0.48]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>9.2 At 8 weeks</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>212</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.85 [‐1.33, 3.03]</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 7.</span> <span class="table-title">Vitamin D versus placebo or no supplement</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD006086.pub4/references#CD006086-tbl-0015">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD006086-tbl-0016"> <div class="table-heading"><span class="table-label">Comparison 8.</span> <span class="table-title">Arginine versus placebo</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Death during treatment <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>394</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.67 [0.21, 2.09]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.1 HIV‐negative</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>56</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.2 HIV‐positive</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>59</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.58 [0.15, 16.44]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.3 HIV‐negative and positive</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>279</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.5 [0.13, 1.94]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Cured at 6/8 months <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>279</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.05 [0.90, 1.22]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 Sputum‐smear or sputum‐culture positive <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.1 At baseline</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>464</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.0 [0.98, 1.02]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.2 At 4 weeks</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>162</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.76 [0.51, 1.12]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.3 At 8 weeks</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>351</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.76 [0.41, 1.42]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.4 At 8 weeks (HIV‐negative only)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>56</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.12 [0.01, 2.07]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4 Cough <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>404</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.76 [0.62, 0.93]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.1 At 2 weeks</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>56</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.71 [0.53, 0.96]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.2 At 8 weeks</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>348</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.78 [0.61, 0.99]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">5 Weight gain &gt; 10% <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.1 HIV‐positive and HIV‐negative</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>170</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.17 [0.74, 1.84]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.2 HIV‐positive</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>65</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>2.15 [0.96, 4.78]</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 8.</span> <span class="table-title">Arginine versus placebo</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD006086.pub4/references#CD006086-tbl-0016">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD006086-tbl-0017"> <div class="table-heading"><span class="table-label">Comparison 9.</span> <span class="table-title">Vitamin E plus selenium versus placebo</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Sputum‐smear positive at follow‐up <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.1 15 days</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.2 30 days</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.3 45 days</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.4 60 days</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 9.</span> <span class="table-title">Vitamin E plus selenium versus placebo</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD006086.pub4/references#CD006086-tbl-0017">Navigate to table in review</a></div> </div> </div> <noscript> <img height="1" src="/scolaris-auth/report/nonjs/fulltexthtmlreg?doi=10.1002%2F14651858.CD006086.pub4&amp;rf=&amp;articleType=CDSR" style="display:none" width="1"> </img></noscript> <section class="translation-notes-modal" data-modal-class="translation-notes" data-modal-title="Translation notes" data-ok-btn-selector=".ok-btn" style="display: none"> <div class="translation-notes"> <div class="section-language-toggles"> <nav class="section-languages"> <ul> <li class="section-languages-legend">Available in</li> <li class="section-language"> <a class="" href="de#CD006086-note-0001">Deutsch</a> </li> <li class="section-language"> <a class="" href="es#CD006086-note-0010">Español</a> </li> <li class="section-language"> <a class="" href="fa#CD006086-note-0011">فارسی</a> </li> <li class="section-language"> <a class="" href="fr#CD006086-note-0007">Français</a> </li> <li class="section-language"> <a class="" href="hr#CD006086-note-0006">Hrvatski</a> </li> <li class="section-language"> <a class="" href="ja#CD006086-note-0005">日本語</a> </li> <li class="section-language"> <a class="" href="ko#CD006086-note-0003">한국어</a> </li> <li class="section-language"> <a class="" href="ms#CD006086-note-0004">Bahasa Malaysia</a> </li> <li class="section-language"> <a class="" href="pl#CD006086-note-0008">Polski</a> </li> <li class="section-language"> <a class="" href="pt#CD006086-note-0002">Português</a> </li> <li class="section-language"> <a class="" href="ta#CD006086-note-0009">தமிழ்</a> </li> <li class="section-language"> <a class="" href="zh_HANT#CD006086-note-0022">繁體中文</a> </li> </ul> </nav> </div> <section class="translation-notes-content"> </section> <button class="btn primary ok-btn pull-right" type="button">Close</button> </div> </section></article> </div> <div class="citation-modal" style="display: none"> <div class="export-citation-header"> <p class="inset-message" data-load-error="Unable to load citation data" id="citeProcText"></p> </div> <div class="export-citation-body row-fluid"> <div class="span12"> <div class="addthis_toolbox addthis_default_style addthis_16x16_style"> <nav class="inline-nav-list is-bordered"> <li> <h4 class="heading">Save citation to:</h4> </li> <li><a class="citation-btn-refworks at300b btn btn-link" href="#" id="refWorksCitationBtn"><span class="citation-icon refworks"></span>RefWorks</a></li> <li><a class="citation-btn-sciwheel at300b btn btn-link disabled" href="#" id="sciWheelCitationBtn" target="_blank"><span class="citation-icon sciwheel"></span>SciWheel</a></li> </nav> </div> </div> </div> <div class="row-fluid"> <div class="span12"> <div class="citation-format"> <h4>Copy or download citation</h4> <a href="/en/help/exporting-search-results" rel="noopener noreferrer" target="_blank">Export help</a> </div> <nav class="inline-nav-list has-dividers"> <li class="citation-option" data-option="plain"><button class="btn btn-link" type="button">Plain text</button></li> <li class="citation-option" data-option="endnote"><button class="btn btn-link" type="button">EndNote</button></li> <li class="citation-option" data-option="refmanager"><button class="btn btn-link" type="button">Reference Manager</button></li> <li class="citation-option" data-option="procite"><button class="btn btn-link" type="button">ProCite</button></li> <li class="citation-option" data-option="bibtex"><button class="btn btn-link" type="button">BibteX</button></li> <li class="citation-option" data-option="csv"><button class="btn btn-link" type="button">CSV (Excel)</button></li> </nav> <div class="citation-content"> <pre data-load-error="Unable to load citation data" id="citationContent" tabindex="0"></pre> </div> <div class="clearfix"> <form class="download-citation-form" data-citation-citeproc-url="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentdisplay_WAR_scolariscontentdisplay&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=citation-citeproc&amp;p_p_cacheability=cacheLevelPage&amp;p_p_col_id=column-1&amp;p_p_col_count=1" method="GET" target="citation-download-iframe"> <input id="siteId" name="siteId" type="hidden" value=""> <input id="downloadType" name="downloadType" type="hidden" value=""> <input id="style" name="style" type="hidden" value=""> <input id="articleId" name="articleId" type="hidden" value=""> <input name="p_p_id" type="hidden" value="scolariscontentdisplay_WAR_scolariscontentdisplay"><input name="p_p_lifecycle" type="hidden" value="2"><input name="p_p_state" type="hidden" value="normal"><input name="p_p_mode" type="hidden" value="view"/><input name="p_p_resource_id" type="hidden" value="citation-download"/><input name="p_p_cacheability" type="hidden" value="cacheLevelPage"/><input name="p_p_col_id" type="hidden" value="column-1"/><input name="p_p_col_count" type="hidden" value="1"/> <button class="btn primary wide pull-right" type="submit">Download</button> <div class="inline-checkbox pull-right"> <label title=" for=" withabstract"=""> <input checked="" class="checkbox" name="withAbstract" type="checkbox"/> <span class="checkbox-label">Include abstract</span> </label> </div> </input></input></input></input></input></input></input></form> <iframe aria-hidden="true" name="citation-download-iframe" src="" style="display: none; visibility: hidden" title="Citation download frame"></iframe> </div> </div> </div> </div> <div class="print-modal" data-modal-title="Print this review" style="display: none;"> <div class="print-options-wrapper"> <p><strong>All sections are selected by default</strong>, please select the sections you do not wish to print or use the select or deselect all button to add or remove sections.</p> <div class="print-options-controls"> <input checked="checked" class="print-options-select-all" title="Select/deselect all" type="checkbox"/> <span class="checkbox-label">Select/deselect all</span> </div> <ul class="print-options checkbox-list"> </ul> <button class="btn primary print-article pull-right"><i aria-hidden="true" class="fa fa-print"></i> Print</button> </div> </div> <div class="download-stats-data-modal" data-modal-title="Download data package" style="display: none;"> <div> <p> The data available are protected by copyright and may only be used in accordance with the <a class="external" href="/about/data-download" target="_blank">Terms and Conditions.</a> </p> <div class="hide-for-zip"> <p> <a class="external" href="https://revman.cochrane.org/#/rm5Converter" target="_blank">RevMan 5 files</a> can be converted to a <a class="external" href="https://links.cochrane.org/review-datapack-userguide" target="_blank">data package.</a> </p> </div> <p> Files in the data package can be imported to <a class="external" href="https://revman.cochrane.org/info" target="_blank">Review Manager software</a> or opened in other tools that support CSV and RIS. </p> <form class="download-stats-data-form" method="GET" target="_blank"> <input name="content-disposition" type="hidden" value="attachment"/> <input name="mime-type" type="hidden" value="application/octet-stream"/> <p class="print-options-controls"> <input aria-label="I agree to these terms and conditions" class="download-stats-data-toc-check-box" type="checkbox"/> <span aria-hidden="true" class="checkbox-label">I agree to these terms and conditions</span> <button class="btn primary download-stats-data pull-right" disabled=""><i aria-hidden="true" class="fa fa-download"></i> Download data</button> </p> </form> </div> </div> <div class="share-modal" data-modal-title="Share this review" style="display:none;"> </div> <div class="viewer-thumbnail-pane-html" style="display:none;"> <div class="figure-viewer-options"> <nav class="inline-nav-list"> <li class="figure-options-btn-container"><button class="btn btn-link" id="figureOptionBtn" type="button">Figures</button></li> <li class="table-options-btn-container"><button class="btn btn-link" id="tableOptionBtn" type="button">Tables</button></li> </nav> </div> <div class="figure-viewer-thumbnails"> <div class="figure-thumbnails is-visible" id="figureThumbnails"></div> <div class="table-thumbnails" id="tableThumbnails"></div> </div> </div> <div class="utilities-html" style="display:none;"> <div class="figure-viewer-utilities"> <a class="figure-viewer-menu-toggle" href="#"> <i class="fa fa-chevron-left"></i><span class="toggle-label" data-figure-hide-text="Hide thumbnails" data-figure-show-text="Show thumbnails" data-table-hide-text="Hide table list" data-table-show-text="Show table list">Hide thumbnails</span> </a> <a class="figure-viewer-navigateback" href="#"> <i class="fa fa-chevron-left"></i> </a> <a class="figure-viewer-rotate" href="#"> <i class="fa fa-undo"></i> </a> <a class="figure-viewer-download" href="#"> <i class="fa fa-download"></i> </a> <a class="figure-viewer-share" href="#"> <i class="fa fa-share-alt"></i> </a> <a class="figure-viewer-zoomin" href="#"> <i class="fa fa-plus"></i><span>zoom in</span> </a> <a class="figure-viewer-zoomout" href="#"> <i class="fa fa-minus"></i><span>zoom out</span> </a> </div> </div> <div class="controls-html" style="display:none;"> <div class="figure-viewer-navigation"> <a class="figure-viewer-nav previous" href="#"> <i class="fa fa-chevron-left"></i><span>left</span> </a> <a class="figure-viewer-nav next" href="#"> <i class="fa fa-chevron-right"></i><span>right</span> </a> </div> </div> <div class="mobile-thumbnail-selector-html" style="display:none;"> <div class="figure-viewer-mobile-thumbnails"> <select class="figure-selection"> <option>Figures</option> </select> <select class="table-selection"> <option>Tables</option> </select> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div>
</div>
<div class="portlet-boundary portlet-boundary_1_WAR_kaleodesignerportlet_ portlet-static portlet-static-end kaleo-designer-portlet" id="p_p_id_1_WAR_kaleodesignerportlet_">
<span id="p_1_WAR_kaleodesignerportlet"></span>
</div>
<form action="#" id="hrefFm" method="post" name="hrefFm">
<span></span>
</form>
</div>
<footer class="footer">
<div class="main-footer">
<div class="main-footer-wrapper container">
<div class="brand">
<p class="brand-name">Cochrane</p>
<a href="http://www.cochrane.org/" title="Cochrane logo">
<img alt="Cochrane logo" class="footer-logo logo-part-1" src="https://www.cochranelibrary.com/cochrane-theme/images/footer-logo-part-1.png"> <img alt="" class="footer-logo logo-part-2" src="https://www.cochranelibrary.com/cochrane-theme/images/footer-logo-part-2.png"> </img></img></a> </div> </div> </div> <div class="aux-footer"> <div class="aux-footer-nav-container container"> <nav class="aux-footer-nav"> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/">Browse Publications</a></li> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/">Browse by Subject</a></li> </ul> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/advertisers">Advertisers &amp; Agents</a></li> <li><a class="aux-footer-nav-link" href="https://hub.wiley.com/community/support/cochrane-library">Contact Us</a></li> </ul> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://hub.wiley.com/community/support/cochrane-library">Help &amp; Support</a></li> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/terms-and-conditions">Terms &amp; Conditions</a></li> </ul> </nav> </div> <div class="brand"> <div class="brand-container container"> <p class="copyright"> Copyright © 2000 - 2025 by <a class="" href="http://www.wiley.com">John Wiley &amp; Sons, Inc.</a> All Rights Reserved <br> Review our <a href="https://www.wiley.com/privacy"><strong>Privacy Policy</strong></a> <a href="https://www.wiley.com/cookies"><strong>Cookie Policy</strong></a> <a href="#" onclick="Osano.cm.showDrawer('osano-cm-dom-info-dialog-open')"><strong>Cookie Preferences</strong></a> </br></p> <a href="http://eu.wiley.com/"><img alt="Wiley logo" class="logo" src="https://www.cochranelibrary.com/cochrane-theme/images/en-US_wiley-footer-logo.png"/></a> </div> </div> <span class="wiley-semi-circle"></span> </div> <!--BEGIN QUALTRICS WEBSITE FEEDBACK SNIPPET--> <script type="text/javascript"> (function(){var g=function(e,h,f,g){ this.get=function(a){for(var a=a+"=",c=document.cookie.split(";"),b=0,e=c.length;b<e;b++){for(var d=c[b];" "==d.charAt(0);)d=d.substring(1,d.length);if(0==d.indexOf(a))return d.substring(a.length,d.length)}return null}; this.set=function(a,c){var b="",b=new Date;b.setTime(b.getTime()+6048E5);b="; expires="+b.toGMTString();document.cookie=a+"="+c+b+"; path=/; "}; this.check=function(){var a=this.get(f);if(a)a=a.split(":");else if(100!=e)"v"==h&&(e=Math.random()>=e/100?0:100),a=[h,e,0],this.set(f,a.join(":"));else return!0;var c=a[1];if(100==c)return!0;switch(a[0]){case "v":return!1;case "r":return c=a[2]%Math.floor(100/c),a[2]++,this.set(f,a.join(":")),!c}return!0}; this.go=function(){if(this.check()){var a=document.createElement("script");a.type="text/javascript";a.src=g;document.body&&document.body.appendChild(a)}}; this.start=function(){var t=this;"complete"!==document.readyState?window.addEventListener?window.addEventListener("load",function(){t.go()},!1):window.attachEvent&&window.attachEvent("onload",function(){t.go()}):t.go()};}; try{(new g(100,"r","QSI_S_ZN_cGCHHvWNpnJb1zf","https://zncgchhvwnpnjb1zf-wiley.siteintercept.qualtrics.com/SIE/?Q_ZID=ZN_cGCHHvWNpnJb1zf")).start()}catch(i){}})(); </script><div id="ZN_cGCHHvWNpnJb1zf"><!--DO NOT REMOVE-CONTENTS PLACED HERE--></div> <!--END WEBSITE FEEDBACK SNIPPET--> </footer> <div class="scolaris-modal-overlay"></div> <div class="scolaris-modal"> <div class="scolaris-modal-titlebar clearfix"> <p class="scolaris-modal-title"></p> <a class="scolaris-modal-close" href="#"><span>close</span><span class="icon fa fa-times"></span></a> <div class="scolaris-modal-ui"></div> </div> <!-- Static injection of addtoAny as dynamic injection not working properly--> <div class="scolaris-share-modal-content clearfix"> <div class="scolaris-modal-ui clearfix"> <div class="a2a_kit a2a_kit_size_32 a2a_default_style"> <a class="a2a_button_facebook share-button">  Facebook</a> <a class="a2a_button_x share-button">  X(Twitter)</a> <a class="a2a_button_whatsapp share-button">  WhatsApp</a> <a class="a2a_dd share-button">  View more</a> </div> </div> </div> <div class="scolaris-modal-content clearfix"> <div class="scolaris-modal-ui clearfix"></div> </div> <div class="scolaris-modal-ui clearfix"></div> </div> <div class="english-only-modal-wrapper" data-modal-class="english-only-modal" data-modal-title="Feature in English only" style="display: none"> <div class="english-only-modal"> <p class="message"></p> <button class="btn primary ok-btn pull-right" type="button">OK</button> <button class="btn primary border-only cancel-btn pull-right" type="button">Cancel</button> </div> </div> <!--[if gte IE 9]><!--> <script src="/cochrane-theme/vendor/ie9.js?t=1738734739000" type="text/javascript"></script> <!--<![endif]--> <script src="https://www.cochranelibrary.com/cochrane-theme/js/theme.js?t=1738734739000" type="text/javascript"></script> <script src="https://content.readcube.com/cochrane/checkout.js"></script> <script src="https://content.readcube.com/cochrane/epdf_linker.js" type="text/javascript"></script> <script src="https://crossmark-cdn.crossref.org/widget/v2.0/widget.js" type="text/javascript"></script> <script src="https://d1bxh8uas1mnw7.cloudfront.net/assets/embed.js" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/hit-highlighting.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/topics-lookup.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/institution.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/api-manager.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/pico.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/reference-linking.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/rightsLink.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.submit.failed.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.comment.form.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/safety-alerts.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.translation-notes-modal.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/notifications-portlet/notifications/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-search/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773542000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-topics/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-language-portlet/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773471000" type="text/javascript"></script> <script type="text/javascript">Liferay.Util.addInputFocus();</script> <script type="text/javascript">Liferay.Portlet.register("scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header_",portletId:"scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD006086\x2epub4\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD006086\x2epub4\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD006086\x2epub4\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD006086\x2epub4"});Liferay.Portlet.register("scolariscontentdisplay_WAR_scolariscontentdisplay");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_",portletId:"scolariscontentdisplay_WAR_scolariscontentdisplay",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolariscontentdisplay_WAR_scolariscontentdisplay\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dcolumn-1\x26p_p_col_pos\x3d0\x26p_p_col_count\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD006086\x2epub4\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD006086\x2epub4\x2526type\x253Dcdsr\x2526contentLanguage\x253D"});Liferay.provide(Liferay.Util,"openKaleoDesignerPortlet",function(c){var b=AUI();var e=Liferay.PortletURL.createURL("https://www.cochranelibrary.com/en/content?p_p_id=2_WAR_kaleodesignerportlet&p_p_lifecycle=0");e.setParameter("mvcPath","/designer/edit_kaleo_draft_definition.jsp");e.setParameter("availableFields",c.availableFields);e.setParameter("availablePropertyModels",c.availablePropertyModels);e.setParameter("ddmStructureId",c.ddmStructureId);e.setParameter("draftVersion",c.draftVersion);e.setParameter("kaleoProcessId",c.kaleoProcessId);e.setParameter("name",c.name);e.setParameter("openerWindowName",c.openerWindowName);e.setParameter("portletResourceNamespace",c.portletResourceNamespace);e.setParameter("propertiesSaveCallback",c.propertiesSaveCallback);e.setParameter("refreshOpenerOnClose",c.refreshOpenerOnClose);e.setParameter("saveCallback",c.saveCallback);e.setParameter("version",c.version);e.setWindowState("pop_up");c.uri=e.toString();var d=c.dialog;if(!d){var f=b.one(Liferay.Util.getOpener()).get("region");d={destroyOnHide:true};c.dialog=d}if(!("align" in d)){d.align=Liferay.Util.Window.ALIGN_CENTER}var a=c.dialogIframe;if(!a){a={closeOnEscape:false};c.dialogIframe=a}Liferay.Util.openWindow(c)},["liferay-portlet-url"]);Liferay.Portlet.register("1_WAR_kaleodesignerportlet");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_1_WAR_kaleodesignerportlet_",portletId:"1_WAR_kaleodesignerportlet",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3d1_WAR_kaleodesignerportlet\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD006086\x2epub4\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD006086\x2epub4\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD006086\x2epub4\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD006086\x2epub4"});Liferay.Portlet.register("scolarissearchportlet_WAR_scolarissearch");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolarissearchportlet_WAR_scolarissearch_",portletId:"scolarissearchportlet_WAR_scolarissearch",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolarissearchportlet_WAR_scolarissearch\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD006086\x2epub4\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD006086\x2epub4\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD006086\x2epub4\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD006086\x2epub4"});Liferay.Portlet.register("scolariscontentlanguagebanner_WAR_scolarislanguageportlet");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_",portletId:"scolariscontentlanguagebanner_WAR_scolarislanguageportlet",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolariscontentlanguagebanner_WAR_scolarislanguageportlet\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD006086\x2epub4\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD006086\x2epub4\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD006086\x2epub4\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD006086\x2epub4"});AUI().use("aui-base","liferay-menu","liferay-notice","liferay-poller","liferay-session",function(a){(function(){Liferay.Util.addInputType();Liferay.Portlet.ready(function(b,c){Liferay.Util.addInputType(c)});if(a.UA.mobile){Liferay.Util.addInputCancel()}})();(function(){new Liferay.Menu();var b=Liferay.Data.notices;for(var c=1;c<b.length;c++){new Liferay.Notice(b[c])}})();(function(){Liferay.Session=new Liferay.SessionBase({autoExtend:true,sessionLength:1800,redirectOnExpire:false,redirectUrl:"https\x3a\x2f\x2fwww\x2ecochranelibrary\x2ecom\x2fweb\x2fcochrane",warningLength:0})})()});</script> <script src="https://www.cochranelibrary.com/cochrane-theme/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1738734739000" type="text/javascript"></script> <script type="text/javascript"></script> <div class="mobile-righthand-nav"> <a class="rh-nav-close-btn" href="#"> <span>Close</span> <span class="fa fa-chevron-down"></span> </a> <div class="wrapper"> </div> <a class="rh-nav-open-btn" href="#"> <span>Review tools &amp; navigation</span> </a> </div> <iframe aria-hidden="true" id="printframe" name="printframe" style="position: absolute; left: -2000px; top: 0;" title="Print frame"></iframe> <iframe aria-hidden="true" id="citationExportFrame" name="citationExportFrame" style="position: absolute; left: -2000px; top: 0;" title="scolaris.citation.export.frame"></iframe> <nav> <div class="mobile-navigation"> <div class="close-container"> <a aria-label="Navigate back" class="main-nav-back-btn" href="#"><i class="fa fa-chevron-left"></i></a> <a class="main-nav-close-btn" href="#" title="Close menu">Close menu <i class="fa fa-times"></i></a> </div> <div class="mobile-search basic-search-container"> <div class="portlet-boundary portlet-boundary_scolarissearchportlet_WAR_scolarissearch_ portlet-static portlet-static-end" id="p_p_id_scolarissearchportlet_WAR_scolarissearch_"> <span id="p_scolarissearchportlet_WAR_scolarissearch"></span> <section class="portlet" id="portlet_scolarissearchportlet_WAR_scolarissearch"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Search\x20Portlet')"> <img alt="" id="ymag__null__null" src="/scolaris-search/icon.png"> <span class="taglib-text hide-accessible">Scolaris Search Portlet</span> </img></span> <span class="portlet-title-text">Scolaris Search Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarissearchportlet_WAR_scolarissearch" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="header-search"> <form action="https://www.cochranelibrary.com/en/content?p_auth=Nio3SV1W&amp;p_p_id=scolarissearchportlet_WAR_scolarissearch&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolarissearchportlet_WAR_scolarissearch_scolarisAction=redirectSearchResult" method="post"> <input name="searchType" type="hidden" value="basic"> <input name="facetDisplayName" type="hidden" value=""> <input name="facetQueryTerm" type="hidden" value=""/> <input name="facetQueryField" type="hidden" value=""/> <input name="facetCategory" type="hidden" value=""/> <fieldset class="fieldset"> <legend class="sr-only">Basic Search</legend> <div class="select search-by"> <select aria-label="Search by options" class="custom-select-enabled search-type" name="searchBy" title="Search by options"> <option value="1">Title Abstract Keyword</option> <option value="2">Record Title</option> <option value="3">Abstract</option> <option value="4">Author</option> <option value="5">Keyword</option> <option value="6">All Text</option> <option value="7">Publication Type</option> <option value="8">Source</option> <option value="9">DOI</option> <option value="14">Language</option> <option value="10">Accession Number</option> <option value="11">Trial Registry Number</option> <option value="12">Cochrane Group</option> <option value="13">Cochrane Topic</option> </select> </div> <div class="search-select-crg-container select" style="display: none;"> <select class="search-select-crg-list"></select> </div> <div class="search-select-topic-container select" data-topic-list-url="https://www.cochranelibrary.com/en/content?p_p_id=scolaristopics_WAR_scolaristopics&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=topics-list&amp;p_p_cacheability=cacheLevelPage" style="display: none;"> <select class="search-select-topic-list"></select> </div> <div class="search-select-cl-container select" style="display: none;"> <select class="search-select-cl-list"></select> </div> <div class="search-text-container"> <div class="control-group control-group-inline search-input-wrapper"> <input aria-label="Enter search term" class="field browser-search search-text ui-autocomplete-input" id="searchText" name="searchText" placeholder="Search" size="30" type="text" value=""/>
<div id="autocomplete-results"></div>
</div>
<div class="control-group control-group-inline search-button-wrapper">
<button aria-label="Search" class="searchByBtn" type="submit">
<i aria-hidden="true" class="fa fa-search"></i>
</button>
</div>
</div>
</fieldset>
</input></input></form>
</div>
<script>
    window.displayResultURL = 'https://www.cochranelibrary.com/en/content?p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=getSuggestions&p_p_cacheability=cacheLevelPage&_scolarissearchportlet_WAR_scolarissearch_templateType=full&_scolarissearchportlet_WAR_scolarissearch_urlTitle=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD006086.pub4&_scolarissearchportlet_WAR_scolarissearch_contentLanguage=&_scolarissearchportlet_WAR_scolarissearch_type=cdsr&_scolarissearchportlet_WAR_scolarissearch_doi=10.1002%2F14651858.CD006086.pub4';
    window.searchByOption = '';
</script>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<a class="btn secondary" href="/en/browse-by-topic">Browse </a>
<a class="btn secondary advanced-search-button" href="/en/advanced-search">Advanced search</a>
</div>
<div class="menu-items parent">
<div>
<div class="nav-root-item parent">
<a class="language-selection-title-link" href="#" title="Select language">
<span class="mobile-nav-language-title">Select your preferred language </span></a> <span class="icon fa fa-caret-down"></span>
<div class="mob-child">
<div class="portlet-boundary portlet-boundary_scolarislanguageselector_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav_">
<span id="p_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav"></span>
<section class="portlet" id="portlet_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Language\x20Selector')">
<img alt="" id="fdkn__null__null" src="/scolaris-language-portlet/icon.png"> <span class="taglib-text hide-accessible">Scolaris Language Selector</span> </img></span> <span class="portlet-title-text">Scolaris Language Selector</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="language-display" data-content-languages="[de, en, es, fa, fr, hi, hr, id, ja, ko, hu, ms, nl, pl, pt, ru, ro, ta, th, zh_HANT, zh_HANS]"> <a class="language-select-mobile" href="#" title="Select your preferred language"> <i class="fa fa-file-text"></i> English </a> <a class="language-select-mobile" href="#" title="Select your preferred language"> <i class="fa fa-globe"></i> English </a> </div> <div class="form-content language-selector-modal child"> <div class="row-fluid"> <h3><i class="fa fa-file-text"></i> Cochrane review language</h3> <p>Select your preferred language for Cochrane reviews and other content. Sections without translation will be in English.</p> <div class="dropdown-trigger" id="active-content-language"> <span>English</span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="language-selector-dropdown"> <a class="content-language-selector" data-languagecode="de" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=de">Deutsch</a> <a class="content-language-selector is-active" data-languagecode="en" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=en">English</a> <a class="content-language-selector" data-languagecode="es" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=es">Español</a> <a class="content-language-selector" data-languagecode="fa" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fa">فارسی</a> <a class="content-language-selector" data-languagecode="fr" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fr">Français</a> <a class="content-language-selector" data-languagecode="hi" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hi">हिन्दी</a> <a class="content-language-selector" data-languagecode="hr" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hr">Hrvatski</a> <a class="content-language-selector" data-languagecode="id" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=id">Bahasa Indonesia</a> <a class="content-language-selector" data-languagecode="ja" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ja">日本語</a> <a class="content-language-selector" data-languagecode="ko" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ko">한국어</a> <a class="content-language-selector" data-languagecode="hu" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hu">Magyar</a> <a class="content-language-selector" data-languagecode="ms" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ms">Bahasa Malaysia</a> <a class="content-language-selector" data-languagecode="nl" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=nl">Nederlands</a> <a class="content-language-selector" data-languagecode="pl" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pl">Polski</a> <a class="content-language-selector" data-languagecode="pt" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pt">Português</a> <a class="content-language-selector" data-languagecode="ru" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ru">Русский</a> <a class="content-language-selector" data-languagecode="ro" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ro">Română</a> <a class="content-language-selector" data-languagecode="ta" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ta">தமிழ்</a> <a class="content-language-selector" data-languagecode="th" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=th">ภาษาไทย</a> <a class="content-language-selector" data-languagecode="zh_HANT" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=zh_HANT">繁體中文</a> <a class="content-language-selector" data-languagecode="zh_HANS" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=zh_HANS">简体中文</a> </div> </div> <div class="row-fluid"> <h3 class="portal-language-header"><i class="fa fa-globe"></i> Website language</h3> <p>Select your preferred language for the Cochrane Library website.</p> <div class="dropdown-trigger" id="active-portal-language"> <span>English</span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="language-selector-dropdown"> <a class="portal-language-selector is-active" data-portallanguage="en" href="/en/cdsr/doi/10.1002/14651858.CD006086.pub4/full/en">English</a> <a class="portal-language-selector" data-portallanguage="es" href="/es/cdsr/doi/10.1002/14651858.CD006086.pub4/full/es">Español</a> </div> </div> <a class="btn secondary ok-btn pull-right" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage">Save</a> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
<div class="parent">
<a class="mobile-link signin" data-redirect="false" href="https://www.cochranelibrary.com/c/portal/login?p_l_id=20757&amp;redirect=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD006086.pub4%2Ffull" rel="nofollow">
                        Sign In
                    </a>
</div>
</div>
<div class="menu-items-footer">
<div class="utility-links">
<a class="cochrane-link" href="http://www.cochrane.org/" target="_blank">Visit Cochrane.org</a>
</div>
</div>
</div>
<div class="menu-items child"></div>
</div>
</nav><div class="basic-login-form-content" data-modal-title="Sign in" style="display: none;">
<div class="form-content">
<div class="row-fluid">
<div class="span12">
<div class="portlet-boundary portlet-boundary_58_ portlet-static portlet-static-end portlet-login" id="p_p_id_58_INSTANCE_MODAL_">
<span id="p_58_INSTANCE_MODAL"></span>
<section class="portlet" id="portlet_58_INSTANCE_MODAL">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Sign\x20In')">
<img alt="" id="dbam__null__null" src="https://www.cochranelibrary.com/cochrane-theme/images/spacer.png" style="background-image: url('https://www.cochranelibrary.com/sprite/html/icons/_sprite.png'); background-position: 50% -592px; background-repeat: no-repeat; height: 16px; width: 16px;"> <span class="taglib-text hide-accessible">Sign In</span> </img></span> <span class="portlet-title-text">Sign In</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_58_INSTANCE_MODAL" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <form action="https://www.cochranelibrary.com/en/content?p_p_id=58_INSTANCE_MODAL&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_58_INSTANCE_MODAL_struts_action=%2Flogin%2Flogin" autocomplete="on" class="form sign-in-form" id="_58_INSTANCE_MODAL_fm" method="post" name="_58_INSTANCE_MODAL_fm"> <fieldset class="input-container" disabled="disabled"> <legend class="sr-only">Cochrane Login</legend> <input name="_58_INSTANCE_MODAL_formDate" type="hidden" value="1740729179127"> <input class="field" id="_58_INSTANCE_MODAL_saveLastPath" name="_58_INSTANCE_MODAL_saveLastPath" type="hidden" value="false"> <input class="field" id="_58_INSTANCE_MODAL_redirect" name="_58_INSTANCE_MODAL_redirect" type="hidden" value="/cdsr/doi/10.1002/14651858.CD006086.pub4/full"> <input class="field" id="_58_INSTANCE_MODAL_doActionAfterLogin" name="_58_INSTANCE_MODAL_doActionAfterLogin" type="hidden" value="false"> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_MODAL_login"> Email Address </label> <input class="field clearable" id="_58_INSTANCE_MODAL_login" name="_58_INSTANCE_MODAL_login" type="text" value=""> </input></div> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_MODAL_password"> Password </label> <input class="field" id="_58_INSTANCE_MODAL_password" name="_58_INSTANCE_MODAL_password" type="password" value=""/> </div> <span id="_58_INSTANCE_MODAL_passwordCapsLockSpan" style="display: none;"> Caps Lock is on. </span> <div class="clearfix"> <div class="checkbox-list pull-left"> <div class="checkbox-list-item"> <div class="control-group form-inline input-checkbox-wrapper"> <label for="_58_INSTANCE_MODAL_rememberMeCheckbox"> <input id="_58_INSTANCE_MODAL_rememberMe" name="_58_INSTANCE_MODAL_rememberMe" type="hidden" value="true"/> <input checked="" class="field" id="_58_INSTANCE_MODAL_rememberMeCheckbox" name="_58_INSTANCE_MODAL_rememberMeCheckbox" onclick="Liferay.Util.updateCheckboxValue(this); " type="checkbox" value="true"/> Remember Me </label> </div> </div> </div> <div class="pull-right"> <a href="https://onlinelibrary.wiley.com/user/forgottenpassword" target="_blank">Forgotten password?</a> </div> </div> <div class="login-form-footer clearfix"> <div class="pull-left"> <button class="btn primary" type="submit">Sign in</button> <a class="btn secondary" href="https://onlinelibrary.wiley.com/user-registration" target="_blank">Register</a> </div> <div class="pull-right"> <a class="institutional-login-form-button" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentdisplay_WAR_scolariscontentdisplay&amp;p_p_lifecycle=0&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolariscontentdisplay_WAR_scolariscontentdisplay_action=institution-access">Institutional login</a> </div> </div> </input></input></input></input></fieldset> </form> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div></div>
<div class="institution-login-form-content" data-modal-title="Institutional login" style="display: none;">
<div class="form-content">
<div class="row-fluid access-content-wrapper">
<div class="span12">
<div class="section">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="obft__null__null" src="/scolaris-content-display/icon.png"> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </img></span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="access-content-section"> <div class="section-content"> <p>Search for your institution's name below to login via Shibboleth</p> <form action="/shibboleth" id="institutionLoginForm" method="post"> <div class="fieldset"> <div class="form-group access-input-wrapper"> <div class="ui-widget ui-front"> <label class="sr-only" for="institutionName">Institution name</label> <input class="field" id="institutionName" name="institutionName" type="text" value=""/>
</div>
<button class="btn primary" name="button" type="submit">Go</button>
</div>
<div class="message error" id="institutionLookupErrorDiv" style="display:none">
                        '<span id="enteredInstitionNameSpan"></span>' is not set up for this type of access on Wiley Online Library. Please contact your institution's administrator to ask about access.
                    </div>
</div>
<input id="entityId" name="entityId" type="hidden" value=""/>
</form>
<h4>Previously accessed institutions</h4>
<ul class="plain" id="previousInstitutions">
<li>(none)</li>
</ul>
</div>
<div class="section-content">
<div class="open-athens-login">
                Login using <a href="/openathens">OpenAthens</a>
</div>
</div>
</div>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<div class="portlet-boundary portlet-boundary_58_ portlet-static portlet-static-end portlet-login" id="p_p_id_58_INSTANCE_4_">
<span id="p_58_INSTANCE_4"></span>
<section class="portlet" id="portlet_58_INSTANCE_4">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Sign\x20In')">
<img alt="" id="joiu__null__null" src="https://www.cochranelibrary.com/cochrane-theme/images/spacer.png" style="background-image: url('https://www.cochranelibrary.com/sprite/html/icons/_sprite.png'); background-position: 50% -592px; background-repeat: no-repeat; height: 16px; width: 16px;"> <span class="taglib-text hide-accessible">Sign In</span> </img></span> <span class="portlet-title-text">Sign In</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_58_INSTANCE_4" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <p>If you have a <strong>Wiley Online Library</strong> institutional username and password, enter them here.</p> <form action="https://www.cochranelibrary.com/en/content?p_p_id=58_INSTANCE_4&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_58_INSTANCE_4_struts_action=%2Flogin%2Flogin" autocomplete="on" class="form sign-in-form" id="_58_INSTANCE_4_fm" method="post" name="_58_INSTANCE_4_fm"> <fieldset class="input-container" disabled="disabled"> <legend class="sr-only">Cochrane Login</legend> <input name="_58_INSTANCE_4_formDate" type="hidden" value="1740729179131"> <input class="field" id="_58_INSTANCE_4_saveLastPath" name="_58_INSTANCE_4_saveLastPath" type="hidden" value="false"> <input class="field" id="_58_INSTANCE_4_redirect" name="_58_INSTANCE_4_redirect" type="hidden" value="/cdsr/doi/10.1002/14651858.CD006086.pub4/full"> <input class="field" id="_58_INSTANCE_4_doActionAfterLogin" name="_58_INSTANCE_4_doActionAfterLogin" type="hidden" value="false"> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_4_login"> Username </label> <input class="field clearable" id="_58_INSTANCE_4_login" name="_58_INSTANCE_4_login" type="text" value=""> </input></div> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_4_password"> Password </label> <input class="field" id="_58_INSTANCE_4_password" name="_58_INSTANCE_4_password" type="password" value=""> </input></div> <input class="field" id="_58_INSTANCE_4_institutionalLogin" name="_58_INSTANCE_4_institutionalLogin" type="hidden" value="true"/> <span id="_58_INSTANCE_4_passwordCapsLockSpan" style="display: none;"> Caps Lock is on. </span> <div class="login-form-footer clearfix"> <div class="pull-left"> <button class="btn primary" type="submit">Sign in</button> </div> </div> </input></input></input></input></fieldset> </form> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div>
</div></div>
<div class="get-access-form-content" data-modal-title="Unlock gold-standard Cochrane evidence" style="display: none;">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="wpdq__null__null" src="/scolaris-content-display/icon.png"> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </img></span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="readcube-checkout-container-outer"> <div class="row-fluid access-content-wrapper"> <div class="span6 access-left-content"> <div class="section"> <div class="section-content"> <p>Improve your health decisions with access to trusted, independent evidence from the Cochrane Library. Unlock this review for uninterrupted access.</p> <p>Still deciding? <a href="https://m.info.wiley.com/webApp/cochranenewsletter"> Sign up to our newsletter to learn more </a> </p> </div> </div> <div class="section"> <div class="access-content-section"> <h3 class="title">Institutional users</h3> <div class="section-content"> <p>Search for your institution's name below to login via Shibboleth</p> <form action="/shibboleth" id="institutionLoginForm" method="post"> <div class="fieldset"> <div class="form-group access-input-wrapper"> <div class="ui-widget ui-front"> <label class="sr-only" for="institutionName">Institution name</label> <input class="field" id="institutionName" name="institutionName" type="text" value=""/> </div> <button class="btn primary" name="button" type="submit">Go</button> </div> <div class="message error" id="institutionLookupErrorDiv" style="display:none"> '<span id="enteredInstitionNameSpan"></span>' is not set up for this type of access on Wiley Online Library. Please contact your institution's administrator to ask about access. </div> </div> <input id="entityId" name="entityId" type="hidden" value=""/> </form> <h4>Previously accessed institutions</h4> <ul class="plain" id="previousInstitutions"> <li>(none)</li> </ul> </div> <div class="section-content"> <div class="open-athens-login"> Login using <a href="/openathens">OpenAthens</a> </div> </div> </div> </div> <div class="section"> <div class="access-content-section"> <h3 class="title"> Other access options </h3> <div class="section-content"> <ul class="plain"> <li> <a class="get-access-individual-login-button" href="/c/portal/login"> Individual access - via Wiley Online Library </a> </li> </ul> </div> </div> </div> </div> <div class="span6 access-right-content readcube-checkout-container"> <div class="section"> </div> </div> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/> <input id="openlabel" name="openlabel" type="hidden" value="Open access"/> </div> </section> </div> </div> <!-- Scolaris Version: --> <script type="text/javascript">if(window._satellite){_satellite.pageBottom()};</script> </div> <script>(function(){function c(){var b=a.contentDocument||a.contentWindow.document;if(b){var d=b.createElement('script');d.innerHTML="window.__CF$cv$params={r:'918ed68ecb65f55b',t:'MTc0MDcyOTE3OS4wMDAwMDA='};var a=document.createElement('script');a.nonce='';a.src='/cdn-cgi/challenge-platform/scripts/jsd/main.js';document.getElementsByTagName('head')[0].appendChild(a);";b.getElementsByTagName('head')[0].appendChild(d)}}if(document.body){var a=document.createElement('iframe');a.height=1;a.width=1;a.style.position='absolute';a.style.top=0;a.style.left=0;a.style.border='none';a.style.visibility='hidden';document.body.appendChild(a);if('loading'!==document.readyState)c();else if(window.addEventListener)document.addEventListener('DOMContentLoaded',c);else{var e=document.onreadystatechange||function(){};document.onreadystatechange=function(b){e(b);'loading'!==document.readyState&&(document.onreadystatechange=e,c())}}}})();</script></body> </html> 